
<html lang="en"     class="pb-page"  data-request-id="dcbeb1ae-f87b-4476-b07a-237400d23a70"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b01970;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-6"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer’s Disease Drug Discovery" /></meta><meta name="dc.Creator" content="Ellen Y.  Cotrina" /></meta><meta name="dc.Creator" content="Ana  Gimeno" /></meta><meta name="dc.Creator" content="Jordi  Llop" /></meta><meta name="dc.Creator" content="Jesús  Jiménez-Barbero" /></meta><meta name="dc.Creator" content="Jordi  Quintana" /></meta><meta name="dc.Creator" content="Gregorio  Valencia" /></meta><meta name="dc.Creator" content="Isabel  Cardoso" /></meta><meta name="dc.Creator" content="Rafel  Prohens" /></meta><meta name="dc.Creator" content="Gemma  Arsequell" /></meta><meta name="dc.Description" content="Transthyretin (TTR) modulates the deposition, processing, and toxicity of Abeta (Aβ) peptides. We have shown that this effect is enhanced in mice by treatment with small molecules such as iododiflu..." /></meta><meta name="Description" content="Transthyretin (TTR) modulates the deposition, processing, and toxicity of Abeta (Aβ) peptides. We have shown that this effect is enhanced in mice by treatment with small molecules such as iododiflu..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 3, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01970" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01970" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01970" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01970" /></link>
        
    
    

<title>Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer’s Disease Drug Discovery | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01970" /></meta><meta property="og:title" content="Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer’s Disease Drug Discovery" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0007.jpeg" /></meta><meta property="og:description" content="Transthyretin (TTR) modulates the deposition, processing, and toxicity of Abeta (Aβ) peptides. We have shown that this effect is enhanced in mice by treatment with small molecules such as iododiflunisal (IDIF, 4), a good TTR stabilizer. Here, we describe the thermodynamics of the formation of binary and ternary complexes among TTR, Aβ(1–42) peptide, and TTR stabilizers using isothermal titration calorimetry (ITC). A TTR/Aβ(1–42) (1:1) complex with a dissociation constant of Kd = 0.94 μM is formed; with IDIF (4), this constant improves up to Kd = 0.32 μM, indicating the presence of a ternary complex TTR/IDIF/Aβ(1–42). However, with the drugs diflunisal (1) or Tafamidis (2), an analogous chaperoning effect could not be observed. Similar phenomena could be recorded with the shorter peptide Aβ(12–28) (7). We propose the design of a simple assay system for the search of other chaperones that behave like IDIF and may become potential candidate drugs for Alzheimer’s disease (AD)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01970"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01970">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01970&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01970&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01970&amp;href=/doi/10.1021/acs.jmedchem.9b01970" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 3205-3214</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01967" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01979" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer’s Disease Drug Discovery</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ellen Y. Cotrina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ellen Y. Cotrina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut de Quı́mica Avançada de Catalunya (I.Q.A.C.-C.S.I.C.), 08034 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ellen+Y.++Cotrina">Ellen Y. Cotrina</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ana Gimeno</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana Gimeno</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 800, 48160 Derio, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana++Gimeno">Ana Gimeno</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9668-2605" title="Orcid link">http://orcid.org/0000-0001-9668-2605</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jordi Llop</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jordi Llop</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), 20014 San Sebastian, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jordi++Llop">Jordi Llop</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0821-9838" title="Orcid link">http://orcid.org/0000-0002-0821-9838</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jesús Jiménez-Barbero</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jesús Jiménez-Barbero</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 800, 48160 Derio, Spain</div><div class="loa-info-affiliations-info">Ikerbasque, Basque Foundation for Science, Maria Diaz de Haro 13, 48009 Bilbao, Spain</div><div class="loa-info-affiliations-info">Department of Organic Chemistry II, Faculty of Science & Technology, University of the Basque Country, 48940 Leioa, Bizkaia, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jes%C3%BAs++Jim%C3%A9nez-Barbero">Jesús Jiménez-Barbero</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5421-8513" title="Orcid link">http://orcid.org/0000-0001-5421-8513</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jordi Quintana</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jordi Quintana</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Programme on Biomedical Informatics, Universitat Pompeu Fabra (UPF-IMIM), 08003 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jordi++Quintana">Jordi Quintana</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7059-7418" title="Orcid link">http://orcid.org/0000-0002-7059-7418</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gregorio Valencia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregorio Valencia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut de Quı́mica Avançada de Catalunya (I.Q.A.C.-C.S.I.C.), 08034 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregorio++Valencia">Gregorio Valencia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Isabel Cardoso</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isabel Cardoso</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">IBMC—Instituto de Biologia Molecular e Celular, 4200-135 Porto, Portugal</div><div class="loa-info-affiliations-info">i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isabel++Cardoso">Isabel Cardoso</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rafel Prohens</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rafel Prohens</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Unitat de Polimorfisme i Calorimetria, Centres Cientı́fics i Tecnològics, Universitat de Barcelona, Baldiri Reixac 10, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rafel++Prohens">Rafel Prohens</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0294-1720" title="Orcid link">http://orcid.org/0000-0003-0294-1720</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Gemma Arsequell</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gemma Arsequell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut de Quı́mica Avançada de Catalunya (I.Q.A.C.-C.S.I.C.), 08034 Barcelona, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#4423212929256a253637213531212828042d3525276a27372d276a2137"><span class="__cf_email__" data-cfemail="1671737b7b7738776465736763737a7a567f6777753875657f75387365">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gemma++Arsequell">Gemma Arsequell</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7009-3738" title="Orcid link">http://orcid.org/0000-0002-7009-3738</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01970&amp;href=/doi/10.1021%2Facs.jmedchem.9b01970" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 3205–3214</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 3, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 November 2019</li><li><span class="item_label"><b>Published</b> online</span>3 March 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01970" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01970</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by-nc text">with CC-BY-NC-ND<a href="/page/policy/authorchoice_ccbyncnd_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01970"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">888</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01970" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer’s Disease Drug Discovery&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ellen&quot;,&quot;last_name&quot;:&quot;Y. Cotrina&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Gimeno&quot;},{&quot;first_name&quot;:&quot;Jordi&quot;,&quot;last_name&quot;:&quot;Llop&quot;},{&quot;first_name&quot;:&quot;Jesús&quot;,&quot;last_name&quot;:&quot;Jiménez-Barbero&quot;},{&quot;first_name&quot;:&quot;Jordi&quot;,&quot;last_name&quot;:&quot;Quintana&quot;},{&quot;first_name&quot;:&quot;Gregorio&quot;,&quot;last_name&quot;:&quot;Valencia&quot;},{&quot;first_name&quot;:&quot;Isabel&quot;,&quot;last_name&quot;:&quot;Cardoso&quot;},{&quot;first_name&quot;:&quot;Rafel&quot;,&quot;last_name&quot;:&quot;Prohens&quot;},{&quot;first_name&quot;:&quot;Gemma&quot;,&quot;last_name&quot;:&quot;Arsequell&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;3205-3214&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01970&quot;},&quot;abstract&quot;:&quot;Transthyretin (TTR) modulates the deposition, processing, and toxicity of Abeta (Aβ) peptides. We have shown that this effect is enhanced in mice by treatment with small molecules such as iododiflunisal (IDIF, 4), a good TTR stabilizer. Here, we describe the thermodynamics of the formation of binary and ternary complexes among TTR, Aβ(1–42) peptide, and TTR stabilizers using isothermal titration calorimetry (ITC). A TTR/Aβ(1–42) (1:1) complex with a dissociation constant of Kd = 0.94 μM is formed; with IDIF (4), this constant improves up to Kd = 0.32 μM, indicating the presence of a ternary complex TTR/IDIF/Aβ(1–42). However, with the drugs diflunisal (1) or Tafamidis (2), an analogous chaperoning effect could not be observed. Similar phenomena could be recorded with the shorter peptide Aβ(12–28) (7). We propose the design of a simple assay system for the search of other chaperones that behave like IDIF and may become potential candidate drugs for Alzheimer’s disease (AD).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01970&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01970" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01970&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01970" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01970&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01970" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01970&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01970&amp;href=/doi/10.1021/acs.jmedchem.9b01970" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01970" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01970" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01970%26sid%3Dliteratum%253Aachs%26pmid%3D32124607%26genre%3Darticle%26aulast%3DCotrina%26date%3D2020%26atitle%3DCalorimetric%2BStudies%2Bof%2BBinary%2Band%2BTernary%2BMolecular%2BInteractions%2Bbetween%2BTransthyretin%252C%2BA%25CE%25B2%2BPeptides%252C%2Band%2BSmall-Molecule%2BChaperones%2Btoward%2Ban%2BAlternative%2BStrategy%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%2BDrug%2BDiscovery%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D6%26spage%3D3205%26epage%3D3214%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291009" title="Nanofibers">Nanofibers</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290645" title="Aggregation">Aggregation</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291383" title="Thermodynamics">Thermodynamics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/jmcmar.2020.63.issue-6/20200326/jmcmar.2020.63.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Transthyretin (TTR) modulates the deposition, processing, and toxicity of Abeta (Aβ) peptides. We have shown that this effect is enhanced in mice by treatment with small molecules such as iododiflunisal (IDIF, <b>4</b>), a good TTR stabilizer. Here, we describe the thermodynamics of the formation of binary and ternary complexes among TTR, Aβ(1–42) peptide, and TTR stabilizers using isothermal titration calorimetry (ITC). A TTR/Aβ(1–42) (1:1) complex with a dissociation constant of <i>K</i><sub>d</sub> = 0.94 μM is formed; with IDIF (<b>4</b>), this constant improves up to <i>K</i><sub>d</sub> = 0.32 μM, indicating the presence of a ternary complex TTR/IDIF/Aβ(1–42). However, with the drugs diflunisal (<b>1</b>) or Tafamidis (<b>2</b>), an analogous chaperoning effect could not be observed. Similar phenomena could be recorded with the shorter peptide Aβ(12–28) (<b>7</b>). We propose the design of a simple assay system for the search of other chaperones that behave like IDIF and may become potential candidate drugs for Alzheimer’s disease (AD).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a complex neurodegenerative brain disease characterized by extracellular amyloid plaques, intracellular neurofibrillary tangles, and neuronal death.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The amyloid hypothesis of AD has guided a huge effort in drug discovery and development, leading to many small-molecule and biological drug candidates.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Regrettably, only five treatment options are currently approved to treat this disease,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> but none is a truly disease-modifying intervention. In spite of this sad situation, a number of novel therapeutic approaches are currently being investigated. One of them is targeting protein–protein interactions (PPi) between Aβ and other amyloid-binding proteins such as gelsolin,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> ApoJ (clusterin),<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> ApoE,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> human serum albumin (HSA),<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> humanin,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> the neuronal Tau protein,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and transthyretin (TTR).<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14−16)</a></div><div class="NLM_p">The present investigation relates to TTR, which is a 55 kDa homotetramer multifaceted protein responsible for the transport of thyroid hormones (thyroxine, T4) and retinol in plasma and cerebrospinal fluid (CSF).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Several physiological and epidemiological clues point to a possible direct involvement of TTR in AD. One of the most significant observations is the decreased TTR levels in CSF in AD patients that parallels similar variations in CSF-Aβ levels<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> and suggests that TTR is a biomarker of AD.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> TTR is the main Aβ-binding protein in the CSF.<a onclick="showRef(event, 'ref14 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref14 ref22 ref23">(14,22,23)</a> This binding is believed to naturally prevent Aβ aggregation and toxicity in this media. This putative neuroprotective effect of TTR is also supported by a number of biochemical and animal studies, some of them, conducted in one of our consortiated laboratories.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a></div><div class="NLM_p">TTR tetrameric stability appears as a relevant factor in its interaction with the Aβ peptide. Supporting this hypothesis, in vitro studies showed that amyloidogenic TTR variants bind with lower affinity to Aβ peptide than does the wild-type (wt) or nonamyloidogenic TTR,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> also affecting the ability to avoid Aβ aggregation and toxicity.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Recently, some researchers have suggested that TTR interferes with Aβ amyloid formation by redirecting oligomeric nuclei into nonamyloid aggregates.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">Since TTR binds T4 in its central hydrophobic channel, we have suggested that, in AD, TTR is destabilized and its clearance accelerated, thus explaining its lower levels.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> TTR is also an amyloidogenic protein. Thus, TTR stability is also a key factor in familial amyloid polyneuropathy (FAP),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> a TTR-related hereditary amyloidosis. TTR tetrameric stabilization has been defined as the basis for one of the possible therapeutic strategies in FAP.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35">(32−35)</a> Some of the TTR tetramer stabilizers are drugs, such as the NSAID diflunisal (<b>1</b>),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> the orphan drug Tafamidis (<b>2</b>),<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37−40)</a> and Tolcapone (<b>3</b>),<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> a drug for the treatment of Parkinson’s disease recently repositioned for FAP (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Chemical Structures of TTR Tetramer Kinetic Stabilizers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Diflunisal (<b>1</b>), Tafamidis (<b>2</b>), and Tolcapone (<b>3</b>) are registered drugs.</p></p></figure><div class="NLM_p">By using in vitro studies, we have earlier demonstrated that TTR/Aβ interactions can be enhanced by a small set of tetramer-stabilizing compounds,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> one of them being iododiflunisal (IDIF, <b>4</b>), a small-molecule iodinated derivative of the NSAID diflunisal (<b>1</b>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43−45)</a> Remarkably, in vivo administration of IDIF (<b>4</b>) to a mice model of AD resulted in the binding and stabilization of the TTR tetramer, decrease in brain Aβ levels and deposition, and improvement in the cognitive functions that are impaired in this AD-like neuropathology.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Isothermal titration calorimetry (ITC) studies. The binary complex [TTR + Aβ(1–42)] at pH 7.4 in 25 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-(2-ethanesulfonic acid) (HEPES) buffer, 10 mM glycine, and 5% dimethyl sulfoxide (DMSO) (final concentration) at 25 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this study, we have used isothermal titration calorimetry (ITC),<a onclick="showRef(event, 'ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49">(47−49)</a> a powerful biophysical technique for the quantitative analysis of PPi.<a onclick="showRef(event, 'ref50 ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52 ref53">(50−53)</a> ITC provides the complete thermodynamic profile in terms of free energy (Δ<i>G</i>), enthalpy (Δ<i>H</i>), entropy (Δ<i>S</i>), binding constant (<i>K</i><sub>d</sub>), and stoichiometry (<i>n</i>) of the interaction from a single experiment. Since ITC is extremely sensitive to the energetics of conformational changes and intermolecular interactions, this technique is one of the gold standard biophysical methods that can be used to interrogate ternary molecular systems,<a onclick="showRef(event, 'ref54 ref55 ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56 ref57 ref58">(54−58)</a> such as the one formed by TTR, Aβ peptides, and IDIF (<b>4</b>). Thus, the goal of the present study was to determine the thermodynamic parameters of the intermolecular interaction in solution between TTR and Aβ(1–42). We also wanted to elucidate the structural bases for the enhancement of the TTR/Aβ interaction driven by our chaperone compound IDIF (<b>4</b>). With these aims and for comparative reasons, we have also assayed if other known TTR tetramer stabilizer drugs, such as the drugs diflunisal (<b>1</b>) and Tafamidis (<b>2</b>), behave as chaperones of the TTR/Aβ interaction. In addition and following the clues revealed by previous structural information gathered by STD-NMR experiments, we have also investigated if shorter Aβ peptide sequences perform similarly in stabilizing these systems.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(59)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11057" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11057" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> ITC Analysis of Binary and Ternary Complex Formation between TTR, Aβ(1–42), and TTR Tetramer Stabilizers</h3><div class="NLM_p">To characterize the binding process of the full-length Aβ(1–42) to TTR, we have used a depsipeptide precursor of Aβ(1–42). This depsipeptide precursor is converted into the corresponding native Aβ(1–42) peptide, in situ, by a change in pH.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(60,61)</a> This is a guarantee that Aβ(1–42) is in a monomeric state, free of aggregates, at the beginning of each experiment. Thus, the binary complex TTR/Aβ(1–42) was prepared by the titration of a solution of TTR (20 μM) by a solution of Aβ(1–42) (200 μM) yielding the diagrams and calorimetric constants reported in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.</div><div class="NLM_p">The calculated binding constant for the formation for this (1:1) TTR/Aβ(1–42) complex is <i>K</i><sub>d</sub> = 0.94 μM. A comparison of this figure with other literature data of <i>K</i><sub>d</sub> constants of TTR binding with other Aβ peptides can only be done with a TTR/Aβ(1–40) complex, which stands at <i>K</i><sub>d</sub> = 24 μM.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(62)</a> Although both Aβ sequences are very closely related, their amyloid properties are rather different, Aβ(1–42) being more amyloidogenic.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(63)</a> This property may likely be the cause of this difference. In any event, we have also repeated this experiment with Aβ(1–40), which in our conditions yields <i>K</i><sub>d</sub> = 7.1 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_001.pdf" class="ext-link">Figure S19</a>).</div><div class="NLM_p">Furthermore, to study the effect of the TTR tetramer stabilizers on the TTR/Aβ(1–42) complex, binary complexes of TTR/stabilizers were first prepared and analyzed (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_001.pdf" class="ext-link">Figure S17</a>). In a second set of experiments, the binary complexes were subsequently titrated with Aβ(1–42) solutions. In <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, this procedure is expressed by the equation: (TTR + stabilizer) + Aβ(1–42). IDIF (<b>4</b>) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) and Tafamidis (<b>2</b>) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) were used as stabilizers.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. ITC studies. (A) Titration of [TTR + IDIF (<b>4</b>)] complex with Aβ(1–42). (B) Titration of [TTR + Tafamidis (<b>2</b>)] complex with Aβ(1–42). All of them at pH 7.4 in 25 mM HEPES buffer, 10 mM glycine, and 5% DMSO (final concentration) at 25 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The calorimetric constants for the stabilizers’ interactions are reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The thermodynamic profile showed that IDIF (<b>4</b>) has a cooperative effect, the binding of Aβ(1–42) + [IDIF (<b>4</b>) + TTR] with <i>K</i><sub>d</sub> = 0.32 μM is approximately threefold stronger than that of [Aβ(1–42) + TTR] with <i>K</i><sub>d</sub> = 0.94 μM, and again a strong enthalpy/entropy compensation is observed in this system when IDIF (<b>4</b>) is the ligand. These results confirm the chaperoning effect exerted by IDIF (<b>4</b>) at enhancing the TTR/Aβ interaction. Interestingly, an analogous stabilizing effect of IDIF (<b>4</b>) is observed when tested on TTR/Aβ(1–40) complexes (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_001.pdf" class="ext-link">Figure S20 and Table S2</a>). On the other hand, Tafamidis (<b>2</b>) falls rather behind IDIF (<b>4</b>), with a binding constant of <i>K</i><sub>d</sub> = 1.05 μM that is very close to the original TTR/Aβ(1–42) complex (0.94 μM) indicating that Tafamidis (<b>2</b>) has a negligible effect.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Thermodynamic Parameters for the Titration of (A) Aβ(1–42) and (TTR), (B) Ternary Complex of Aβ(1–42) and [TTR + IDIF (<b>4</b>)], and (C) Ternary Complex of Aβ(1–42) and [TTR + Tafamidis (<b>2</b>)] at 25 °C</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0010.gif" alt="" id="fx1" /></img><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Thioflavin T (ThT) Analysis of the Aggregation Properties of the Binary and Ternary Complexes of TTR, Aβ(1–42) and TTR Tetramer Stabilizers</h3><div class="NLM_p">The possible chaperoning effect of the TTR stabilizers in preventing TTR/Aβ(1–42) complex aggregation has been studied by ThT fluorescence assays, which monitor the increase of fluorescence during the aggregation process.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(64)</a> The ThT assays were performed to study the aggregation of Aβ(1–42) alone or in the presence of TTR or when TTR had been preincubated with the TTR tetramer stabilizer drugs IDIF (<b>4</b>) or Tafamidis (<b>2</b>). The results from ThT assays (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) corroborated our ITC results. The aggregation of Aβ(1–42) was reduced in the presence of TTR, and even more when TTR was complexed with IDIF (<b>4</b>), but not when TTR was complexed with Tafamidis (<b>2</b>). An almost negligible ThT signal was detected when analyzing the [TTR + IDIF (<b>4</b>)] complex, indicating that only the small-molecule IDIF (<b>4</b>) has a chaperone effect further enhancing the TTR/Aβ interaction. These results obtained by ThT fluorescence assays have also been corroborated by turbidity assays (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_001.pdf" class="ext-link">Figure S6</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ThT assays of the aggregation of Aβ(1–42) alone (50 μM), in complex with TTR (25 μM), or in complex with TTR stabilized with different small compounds (50 μM), [TTR/IDIF (<b>4</b>), TTR/DIF (<b>1</b>), and TTR/Tafamidis (<b>2</b>)]. ThT fluorescence was measured at 37 °C each 10 min for 3 h, then each 20 min from 3 to 6 h, and then at 8 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Percentage of Fibril Formation Obtained from ThT Assays<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">ThT (au)</th><th class="colsep0 rowsep0" align="center" char="±">% fibril formation</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aβ(1–42)</td><td class="colsep0 rowsep0" align="char" char="±">60 810 ± 566</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aβ(1–42) + TTR</td><td class="colsep0 rowsep0" align="char" char="±">19 836 ± 913</td><td class="colsep0 rowsep0" align="char" char="±">25 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aβ(1–42) + [TTR + IDIF (<b>4</b>)]</td><td class="colsep0 rowsep0" align="char" char="±">2224 ± 439</td><td class="colsep0 rowsep0" align="char" char="±">6 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aβ(1–42) + [TTR + DIF (<b>1</b>)]</td><td class="colsep0 rowsep0" align="char" char="±">21 852 ± 946</td><td class="colsep0 rowsep0" align="char" char="±">26 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aβ(1–42) + [TTR + Tafamidis (<b>2</b>)]</td><td class="colsep0 rowsep0" align="char" char="±">19 188 ± 923</td><td class="colsep0 rowsep0" align="char" char="±">24 ± 2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The concentrations used: Aβ(1–42) (50 μM) and TTR (25 μM) for the different small compounds (50 μM).</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> ITC Studies of the Interaction between TTR and Short Aβ Sequences</h3><div class="NLM_p">In our previous STD-NMR spectroscopy studies in solution,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(59)</a> we have identified structural elements implicated in the TTR/Aβ interaction that indicate the close proximity of the V18, F19, and F20 fragment of the Aβ(12–28) sequence to V94, F95, and T96 of TTR, highlighting V18 to F20 as the main structural motif for the recognition process. This Aβ(12–28) peptide is reported in the literature to essentially exhibit the same neurotoxic behavior and fibril formation properties as the full-length Aβ(1–42) peptide.<a onclick="showRef(event, 'ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref65 ref66 ref67">(65−67)</a> To confirm that these are the key structural elements involved in the TTR/Aβ(1–42) complex, we have prepared the following short sequences of Aβ(1–42), namely, Aβ(1–11) (<b>5</b>), Aβ(10–20) (<b>6</b>), Aβ(12–28) (<b>7</b>), and Aβ(25–35) (<b>8</b>) and subsequently characterized their interaction with TTR (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) by ITC.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Sequences of Amyloid Peptides Used in This Study: Aβ(1–42) and Other Short Amyloid β Sequences, Including Three Aβ(12–28) Ala Mutants (<b>9</b>, <b>10</b>, and <b>11</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0009.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">ITC studies for the binary complexes between different short sequences of Aβ and TTR are summarized in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. Only the binding isotherm of the binary complex between Aβ(12–28) (<b>7</b>) and TTR showed a typical thermodynamic profile (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). Accordingly, a full thermodynamic characterization was performed (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The thermograms for the binary complexes between TTR and Aβ(1–11) (<b>5</b>) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) and TTR and Aβ(25–35) (<b>8</b>) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C) show negligible enthalpy changes, confirming that there was no significant interaction between each of these sequences and TTR. In the case of the binding of TTR to Aβ(10–20) (<b>6</b>) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), a very low enthalpy change was observed. Thus, these results are in agreement with those from our previous STD-NMR spectroscopy studies.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(59)</a></div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. ITC analysis of different short sequences of amyloid β Aβ(1–42) binding to TTR at pH 7.4 in 25 mM HEPES buffer, 10 mM glycine, and 5% DMSO at 25 °C. The binary systems are: (A) TTR + Aβ(1–11) (<b>5</b>), (B) TTR + Aβ(10–20) (<b>6</b>), (C) TTR + Aβ(25–35) (<b>8</b>), (D) TTR + Aβ(12,28) (<b>7</b>), (E) TTR + V18A Aβ(12–28) (<b>9</b>), (F) TTR + F19A Aβ(12–28) (<b>10</b>), and (G) TTR + F20A Aβ(12–28) (<b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Thermodynamic Parameters for the Complex Formation between Different Short Sequences of Aβ and TTR at 25 °C</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0011.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">To provide further insights into the interaction between the specific sequence Aβ(12–28) and TTR, three Ala mutants in the residues V18 to F20 of the Aβ(12–28) were prepared (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) and ITC experiments were performed. The binding isotherms obtained between Ala mutants of Aβ(12–28) (<b>9</b>, <b>10</b>, and <b>11</b>) and TTR are also shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>.</div><div class="NLM_p last">As it can be deduced from these ITC results, replacement of any residue from V18 to F20 for Ala has a detrimental effect in the binding of Aβ(12–28) to TTR, indicating that these residues are essential for the interaction with TTR.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(59)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> ITC Studies of the Binary and Ternary Complexes between TTR, Aβ(12–28) and IDIF (<b>4</b>), Diflunisal (<b>1</b>), and Tafamidis (<b>2</b>)</h3><div class="NLM_p">To investigate if IDIF shows the same chaperoning character as in the previous TTR/Aβ(1–42) complexes against this shorter, Aβ(12–28) model peptide, we have performed ITC studies and compared the interaction between Aβ(12–28) with TTR alone or with TTR preincubated with the TTR tetramer stabilizers IDIF, diflunisal, and Tafamidis. Results are shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and the full thermodynamic characterizations are displayed in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. ITC analysis of (A) binary complex TTR + Aβ(12–28), (B) ternary complex [TTR + IDIF (<b>4</b>)] and Aβ(12–28), (C) ternary complex [TTR + Diflunisal (<b>1</b>)] and Aβ(12–28), and (D) ternary complex [TTR + Tafamidis (<b>4</b>)] and Aβ(12–28). All of these ITC studies were performed at pH 7.4 in 25 mM HEPES buffer, 10 mM glycine, and 5% DMSO (final concentration) at 25 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Thermodynamic Parameters for the Titration of (A) Binary Complex Aβ(12–28) and TTR, Ternary Complexes (B) Aβ(12–28) and [TTR + IDIF (<b>4</b>)] and (C) Aβ(12–28) and [TTR + Diflunisal (<b>1</b>)], and (D) Ternary Complex of Aβ(12–28) and [TTR + Tafamidis (<b>2</b>)] at 25 °C</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0012.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">The interactions with Aβ(12–28), both the one with TTR and the one with TTR complexed with IDIF, are enthalpy-driven with a favorable entropic contribution. The titration of the binary complex (TTR + IDIF) with Aβ(12–28) has a notable improvement of binding (<i>K</i><sub>d</sub> = 0,81 μM) compared to the [TTR + Aβ(12–28)] binary complex (<i>K</i><sub>d</sub> = 3,00 μM) (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). When TTR is stabilized with IDIF (<b>4</b>), the complex with Aβ(12–28) is almost three times stronger than with TTR alone.</div><div class="NLM_p last">These results highlight that although diflunisal (<b>1</b>) and Tafamidis (<b>2</b>) are good TTR tetrameric stabilizers, these compounds do not enhance the TTR/Aβ interaction, and therefore not all TTR tetramer stabilizers are chaperones of the TTR/Aβ interaction, and they need to be assayed for this specific purpose.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Transmission Electron Microscopy (TEM) Study of the Aggregation of Complexes Formed by TTR, Aβ(12–28) and Either IDIF (<b>4</b>) or Tafamidis (<b>2</b>)</h3><div class="NLM_p">To further confirm the chaperone effect of IDIF on the TTR/Aβ(12–28) interaction, as suggested by the ITC experiments, we studied the morphology of the species of Aβ(12–28) by transmission electron microscopy (TEM). After 48 h of incubation at 37 °C, the Aβ(12–28) peptide alone (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A–C) formed abundant, long and complex fibrils, higher-ordered structured fibrils, constituted by several protofilaments, which presented as more rigid (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B) and with twisting of the fibrils (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B, arrows) or as more relaxed fibrils with the protofilaments laterally assembled (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Morphologic assessment by TEM of the influence of TTR on Aβ(12–28) aggregation after 48 h of incubation at 37 °C. (A–C) Aβ(12–28) peptide alone, (D) Aβ(12–28) in the presence of TTR, (E) Aβ(12–28) in the presence of TTR preincubated with IDIF, and (F) Aβ(12–28) in the presence of TTR preincubated with Tafamidis. Scale bar (A, B, D, E, and F) = 200 nm; C = 100 nm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This ultrastructural analysis showed that the presence of TTR clearly prevented Aβ(12–28) fibrillization, resulting in the presence of fewer, less complex fibrils and small aggregates (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D), compared to the control, the Aβ(12–28) alone (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A–C), which presented long and complex fibrils.</div><div class="NLM_p last">Importantly, here we showed that preincubation of TTR with IDIF completely abolished the presence of Aβ(12–28) fibrils and only round particles and prefibrillar species were visualized (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E). However, when TTR was preincubated with Tafamidis (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>F), there was no significant effect beyond the effect of TTR itself, since small fibers were detected.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">These calorimetric studies demonstrate that TTR forms (1:1) complexes with Aβ(1–42) with <i>K</i><sub>d</sub> = 0.93 μM. In the presence of the TTR tetramer stabilizer IDIF, these complexes are chaperoned showing <i>K</i><sub>d</sub> = 0.31 μM. This effect was not detected when using the drug Tafamidis (<b>2</b>) instead of IDIF (<b>4</b>). In addition, it was observed that the shorter Aβ sequence, Aβ(12–28) in complex with TTR imitates almost exactly the calorimetric behavior of the full Aβ(1–42) in complex with TTR. The effect of the TTR tetramer stabilizers IDIF, diflunisal, and Tafamidis upon these later complexes is analogous to the ones formed by full Aβ(1–42). The magnitude of this effect is stabilizing for IDIF but negligible for diflunisal (<b>1</b>) and Tafamidis (<b>2</b>). We hope that using this simpler and easy-handling Aβ(12–28) peptide, screening strategies for the identification of compounds chaperoning the TTR–Aβ peptides complexes could be realized. In turn, these strategies could aid in the search for potential drug candidates in AD drug discovery.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemical Compounds</h3><div class="NLM_p last">Amyloid β peptides Aβ(1–11) (<b>5</b>), Aβ(10–20) (<b>6</b>), Aβ(12–28) (<b>7</b>), and Aβ(25–35) (<b>8</b>) as trifluoroacetate salts were purchased from Bachem AG (Switzerland) (ref.: H-2956, H-1388, H-7910, and H-1192, respectively). Depsi-Aβ(1–42) peptide, a chemically modified β-amyloid (1–42) precursor containing an isoacyl dipeptide at residues Gly-Ser, was available from GenScript (ref.: RP10017-1, purity by HPLC > 96%). Aβ(1–40) peptide was available from rPeptide (β-amyloid (1–40), Ultra Pure, HFIP, ref: A-1153-2, purity > 97%, Lot#05271640H, <a href="http://www.rpeptide.com" class="extLink">www.rpeptide.com</a>). <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-2-ethanesulfonic acid) (HEPES), glycine, <i>Tris</i>(hydroxymethyl)-aminomethane (Tris), dimethyl sulfoxide (DMSO), and the NSAID drug diflunisal (DIF, <b>1</b>) were purchased from Sigma-Aldrich (D3281, purity > 98%) and used without further purification. The small-molecule compound iododiflunisal (IDIF, <b>4</b>) was synthesized in our lab IQAC-CSIC by iodination of the NSAID diflunisal (<b>1</b>) following our procedures.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The drug Tafamidis (<b>2</b>) was prepared in our lab following the procedures described in the literature.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Purity of all final compounds was proved to be ≥95% by means of HPLC, HR-MS, and NMR techniques.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Solid-Phase Peptide Synthesis of Aβ(12–28) Peptide and Mutants of Aβ(12–28) Peptide</h3><div class="NLM_p last">Amyloid peptide sequences Aβ(1–11) (<b>5</b>) and Aβ(12–28) (<b>7</b>) were purchased from Bachem AG (Switzerland) as trifluoroacetate salts (H-2956 and H-7910, respectively). H-2956 showed purity by HPLC > 96%, and H-7910 showed purity by HPLC > 96%. The Aβ(12–28) peptide and its corresponding mutants [V18A Aβ(12–28) (<b>9</b>); F19A Aβ(12–28) (<b>10</b>); and F20A Aβ(12–28) (<b>11</b>)] were synthesized by manual Solid-Phase Peptide Synthesis (SPPS) using Fmoc chemistry with the corresponding Fmoc-protected amino acids. Cleavage from resin was performed using TFA/H<sub>2</sub>O/TIS (95:2.5:2.5) (v/v/v), and the peptides were precipitated with <i>tert</i>-butyl methyl ether. The peptides were purified by reversed-phase–high-performance liquid chromatography (RP–HPLC) using a VersaFlash system and characterized by analytical RP–HPLC and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-ToF-MS) (purity by HPLC > 96%). The characterization of the Aβ(12–28) peptide prepared in our lab was compared to a commercial sample acquired from Bachem (H-7910).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Preparation of Aβ(1–42)</h3><div class="NLM_p last">The native Aβ(1–42) peptide was obtained from depsi-Aβ(1–42) peptide (Genscript, RP10017-1, purity by HPLC > 96%), a chemically modified β-amyloid (1–42) precursor, by a switching procedure involving a change in pH and immediate use.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Recombinant Wild-Type Human TTR (wt rhTTR) Production and Purification</h3><div class="NLM_p last">Human wild-type rhTTR gene was cloned into a pET expression system and transformed into <i>Escherichia coli</i> BL21(DE3) Star. The phTTRwt-I/pET-38b(+) plasmid was provided by Prof. Antoni Planas (IQS, URL). The production of recombinant protein was performed at the Erlenmeyer scale, and the production and purification of protein were done as described previously following an optimized version of our protocol.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Recombinant wild-type hTTR was produced using a pET expression system. The expressed protein only contains an additional methionine on the <i>N</i>-terminus compared to the mature natural human protein sequence. wt rhTTR protein was expressed in <i>E. coli</i> BL21–(DE3) cells harboring the corresponding plasmid. Expression cultures in 2xYT-rich medium containing 100 μg/mL kanamycin were grown at 37 °C to an optical density (at 600 nm) of 4 (OD600 ≈4); then induced by addition of IPTG (1 mM final concentration); grown at 37 °C for 20 h; harvested by centrifugation at 4 °C, 10,000 rpm for 10 min; and resuspended in a cell lysis buffer (0.5 M Tris–HCl, pH 7.6). Cell disruption and lysis were performed by French press followed by a sonication step at 4 °C. Cell debris was discarded after centrifugation at 4 °C, 11,000 rpm for 30 min. Intracellular proteins were fractionated by ammonium sulfate precipitation in three steps. Each precipitation was followed by centrifugation at 12 °C, 12,500 rpm for 30 min. The pellets were analyzed by SDS-PAGE (14% acrylamide). The TTR-containing fractions were resuspended in 20 mM Tris–HCl, 0.1 M NaCl, pH 7.6 (buffer A) and dialyzed against the same buffer. It was purified by ion-exchange chromatography using a Q-Sepharose High-Performance (Amersham Biosciences) anion-exchange column and eluting with a NaCl linear gradient using 0.1 M NaCl in 20 mM Tris–HCl pH 7.6 (buffer A) to 0.5 M NaCl 20 mM Tris–HCl pH 7.6 (buffer B). All TTR-enriched fractions were dialyzed against deionized water in three steps and were lyophilized. The protein was further purified by gel filtration chromatography using a Superdex 75 prep grade resin (GE Healthcare Bio-Sciences AB) and eluting with 20 mM Tris pH 7.6 and 0.1 M NaCl. Purest fractions were combined and dialyzed against deionized water and lyophilized. The purity of the protein preparations was > 95% as judged by SDS-PAGE. Average production yields were 150–200 mg of purified protein per liter of culture. Protein concentration was determined spectrophotometrically at 280 nm using a calculated extinction coefficient value of 17 780 M<sup>–1</sup> cm<sup>–1</sup> for wtTTR. The protein was stored at −20 °C.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Isothermal Titration Calorimetry (ITC) Assay</h3><div class="NLM_p last">Experiments were carried out in a VP-ITC (MicroCal, LLC, Northampton, MA). In a titration experiment, the ligand in the syringe is added in small aliquots to the macromolecule, in our case the TTR protein in the calorimeter cell, which is filled with an effective volume that is sensed calorimetrically. The TTR solution of 20 μM and Aβ or ligand solutions of 200 μM were prepared in the same buffer. The titrant was injected over 20 or 30 times at a constant interval of 300 s with a 450 rpm rotating stirrer syringe into the sample cell containing its binding partner. All of the solutions were prepared with a 25 mM HEPES buffer, 10 mM glycine, pH 7.4, and 5% DMSO (final concentration), and it was corroborated that in these conditions, TTR and Aβ(1–42) are stable. The Aβ(1–42) working solution was prepared at 200 μM and used immediately to avoid premature aggregate formation. The TTR stock solution was prepared at 40 μM. Ligand stock solution was prepared at 10 mM in DMSO. All solutions were prepared in the same buffer and filtered prior to use. In the control experiments, the titrant (ligand or Aβ) was injected into the buffer in the sample cell to measure the heat of dilution. This value of the heat of dilution was subtracted from the titration data. The experiments were performed at 25 °C. Titration data were analyzed by evaluation software MicroCal Origin, Version 7.0. The binding curves were fitted by the nonlinear regression method to one set of sites binding model. This leads to the calculation of <i>K</i>, <i>n</i>, Δ<i>H</i>, Δ<i>S</i>, and Δ<i>G</i>. Each experiment was conducted three times, and the mean value with standard deviations is provided.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Transmission Electron Microscopy (TEM)</h3><div class="NLM_p last">Aβ(12–28) peptide (100 μM), alone or with TTR (20 μM) (alone or preincubated with a stabilizer for 1 h at 37 °C), was incubated at 37 °C for 48 h. For visualization by TEM, 5 μL sample aliquots were absorbed to a carbon-coated collodion film supported on 200-mesh copper grids, for 5 min, and negatively stained with 1% uranyl acetate. Grids were exhaustively examined with a JEOL JEM-1400 transmission electron microscope equipped with an Orious Sc1000 digital camera.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> ThT Fluorescence Assay</h3><div class="NLM_p last">Samples were prepared in 25 mM HEPES buffer, 10 mM glycine, pH 7.4, and 5% DMSO (final concentration) containing 20 μM ThT. The Aβ(1–42) peptide was adjusted to 50 μM, TTR to 25 μM, and the small-molecule compound to 50 μM as final concentrations. Briefly, samples of Aβ(1–42) alone or with TTR or with TTR preincubated with a small molecule were mixed with ThT. Fluorescence spectra were acquired in cells thermostated at 37 °C, with 15 s of shaking at 500 rpm every 30 min. ThT fluorescence assays were acquired in each cell of a 96-well plate containing 200 μL of sample. Excitation was at 430 nm, and emission spectra were recorded at 485 nm using a Beckman Coulter DTX 880 Multimode Detector plate reader. The results are the mean values of four replicates.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01970" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01970?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01970</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Recombinant wild-type human (wt rhTTR) production and purification and MALDI-TOF MS; turbidity assays of the binary and ternary assay complex formation using Aβ(1–42); synthesis of Aβ(12–28) (<b>7</b>) and three Ala mutants (<b>8</b>, <b>9</b>, and <b>10</b>); additional isothermal titration calorimetry (ITC) studies (binary and ternary interactions and control experiments) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of key compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_001.pdf">jm9b01970_si_001.pdf (2.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_002.csv">jm9b01970_si_002.csv (5.59 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01970" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gemma Arsequell</span> - <span class="hlFld-Affiliation affiliation">Institut
de Quı́mica Avançada de Catalunya (I.Q.A.C.-C.S.I.C.), 08034 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7009-3738" title="Orcid link">http://orcid.org/0000-0002-7009-3738</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b5d2d0d8d8d49bd4c7c6d0c4c0d0d9d9f5dcc4d4d69bd6c6dcd69bd0c6"><span class="__cf_email__" data-cfemail="80e7e5edede1aee1f2f3e5f1f5e5ececc0e9f1e1e3aee3f3e9e3aee5f3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ellen Y. Cotrina</span> - <span class="hlFld-Affiliation affiliation">Institut
de Quı́mica Avançada de Catalunya (I.Q.A.C.-C.S.I.C.), 08034 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Gimeno</span> - <span class="hlFld-Affiliation affiliation">CIC
bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building
800, 48160 Derio, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9668-2605" title="Orcid link">http://orcid.org/0000-0001-9668-2605</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jordi Llop</span> - <span class="hlFld-Affiliation affiliation">CIC
biomaGUNE, Basque Research and Technology Alliance (BRTA), 20014 San Sebastian, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0821-9838" title="Orcid link">http://orcid.org/0000-0002-0821-9838</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jesús Jiménez-Barbero</span> - <span class="hlFld-Affiliation affiliation">CIC
bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building
800, 48160 Derio, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Ikerbasque,
Basque Foundation for Science, Maria Diaz de Haro 13, 48009 Bilbao, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Organic Chemistry II, Faculty of Science & Technology, University of the Basque Country, 48940 Leioa, Bizkaia, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5421-8513" title="Orcid link">http://orcid.org/0000-0001-5421-8513</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jordi Quintana</span> - <span class="hlFld-Affiliation affiliation">Research
Programme on Biomedical Informatics, Universitat
Pompeu Fabra (UPF-IMIM), 08003 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7059-7418" title="Orcid link">http://orcid.org/0000-0002-7059-7418</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregorio Valencia</span> - <span class="hlFld-Affiliation affiliation">Institut
de Quı́mica Avançada de Catalunya (I.Q.A.C.-C.S.I.C.), 08034 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabel Cardoso</span> - <span class="hlFld-Affiliation affiliation">IBMC—Instituto
de Biologia Molecular e Celular, 4200-135 Porto, Portugal</span>; 
    <span class="hlFld-Affiliation affiliation">i3S—Instituto
de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rafel Prohens</span> - <span class="hlFld-Affiliation affiliation">Unitat
de Polimorfisme i Calorimetria, Centres Cientı́fics i
Tecnològics, Universitat de Barcelona, Baldiri Reixac 10, 08028 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0294-1720" title="Orcid link">http://orcid.org/0000-0003-0294-1720</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported by a grant from the Fundació Marató de TV3 (Neurodegenerative Diseases Call, project reference: 20140330-31-32-33-34, http://www.ccma.cat/tv3/marato/en/projectes-financats/2013/212/).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e1427-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">I.C. worked under the Investigator FCT Program, which is financed by national funds through FCT and cofinanced by ESF through HPOP, type 4.2—Promotion of Scientific Employment. G.A. from IQAC-CSIC acknowledges a grant from Fundació Marató de TV3, Spain (Project ref 20140330-31-32-33-34) and also acknowledges financial support from the Spanish Ministry of Economy (CTQ2016-76840-R). E.Y.C. acknowledges a contract from Fundació Marató de TV3, Spain (Project ref 20140330-31-32-33-34) and a 1-year contract from Ford-Fundación Apadrina la Ciencia. The group at CIC bioGUNE acknowledges the European Research Council for financial support (ERC-2017-AdG, project number 788143-RECGLYC-ANMR), Instituto de Salud Carlos III of Spain, ISCIII (grant PRB3 IPT17/0019 to A.G.), Agencia Estatal Investigación of Spain, AEI (grants CTQ2015-64597-C2-1-P and RTI2018-094751-B-C21), and the Severo Ochoa Excellence Accreditation (SEV-2016-0644). J.L. from CIC biomaGUNE acknowledges the Spanish Ministry of Economy and Competitiveness for financial support through grant CTQ2017-87637-R. G.A. from IQAC-CSIC acknowledges Prof. Antoni Planas (IQS-URL) for full technical support and supervision on the TTR production.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">TEM</td><td class="NLM_def"><p class="first last">transmission electron microscopy</p></td></tr><tr><td class="NLM_term">ThT</td><td class="NLM_def"><p class="first last">thioflavin T</p></td></tr><tr><td class="NLM_term">TTR</td><td class="NLM_def"><p class="first last">transthyretin</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">IDIF</td><td class="NLM_def"><p class="first last">iododiflunisal</p></td></tr><tr><td class="NLM_term">on</td><td class="NLM_def"><p class="first last">overnight</p></td></tr><tr><td class="NLM_term">PPi</td><td class="NLM_def"><p class="first last">protein–protein interactions</p></td></tr><tr><td class="NLM_term">SPPS</td><td class="NLM_def"><p class="first last">solid-phase peptide synthesis</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52103" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52103" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 69 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Alzheimer’s
Association Report</span> <span> </span><span class="NLM_article-title">2019 Alzheimer’s
Disease Facts and Figures</span>. <i>Alzheimer's
Dementia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2019.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.jalz.2019.01.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=321-387&author=Alzheimer%E2%80%99s%0AAssociation+Report&title=2019+Alzheimer%E2%80%99s%0ADisease+Facts+and+Figures&doi=10.1016%2Fj.jalz.2019.01.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2019.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2019.01.010%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D2019%2520Alzheimer%25E2%2580%2599s%250ADisease%2520Facts%2520and%2520Figures%26jtitle%3DAlzheimer%2527s%250ADementia%26date%3D2019%26volume%3D15%26spage%3D321%26epage%3D387%26doi%3D10.1016%2Fj.jalz.2019.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease at 25 years</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.15252/emmm.201606210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.15252%2Femmm.201606210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=27025652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=595-608&author=D.+J.+Selkoeauthor=J.+Hardy&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease+at+25+years&doi=10.15252%2Femmm.201606210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease at 25 years</span></div><div class="casAuthors">Selkoe, Dennis J.; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">595-608</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Despite continuing debate about the amyloid β-protein or Aβ hypothesis, new lines of evidence from labs. and clinics worldwide support the concept that an imbalance between prodn. and clearance of Aβ42 and related Aβ peptides is a very early, often initiating factor in Alzheimer's disease AD.  Confirmation that presenilin is the catalytic site of γ-secretase has provided a linchpin: all dominant mutations causing early-onset AD occur either in the substrate amyloid precursor protein, APP or the protease presenilin of the reaction that generates Aβ.  Duplication of the wild-type APP gene in Down's syndrome leads to Aβ deposits in the teens, followed by microgliosis, astrocytosis, and neurofibrillary tangles typical of AD.  Apolipoprotein E4, which predisposes to AD in > 40% of cases, has been found to impair Aβ clearance from the brain.  Sol. oligomers of Aβ42 isolated from AD patients' brains can decrease synapse no., inhibit long-term potentiation, and enhance long-term synaptic depression in rodent hippocampus, and injecting them into healthy rats impairs memory.  The human oligomers also induce hyperphosphorylation of tau at AD-relevant epitopes and cause neuritic dystrophy in cultured neurons.  Crossing human APP with human tau transgenic mice enhances tau-pos. neurotoxicity.  In humans, new studies show that low cerebrospinal fluid CSF Aβ42 and amyloid-PET positivity precede other AD manifestations by many years.  Most importantly, recent trials of three different Aβ antibodies solanezumab, crenezumab, and aducanumab have suggested a slowing of cognitive decline in post hoc analyses of mild AD subjects.  Although many factors contribute to AD pathogenesis, Aβ dyshomeostasis has emerged as the most extensively validated and compelling therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGo1qmyvVtbVg90H21EOLACvtfcHk0lidLwWDRYp2NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D&md5=b7a2003ba5d341f5eef5c7e9454235ce</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.15252%2Femmm.201606210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201606210%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520at%252025%2520years%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D595%26epage%3D608%26doi%3D10.15252%2Femmm.201606210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doig, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Castillo-Frias, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthoumieu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasica-Labouze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterpone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derreumaux, P.</span></span> <span> </span><span class="NLM_article-title">Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer’s Disease?</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1437</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00188</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1CmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1435-1437&author=A.+J.+Doigauthor=M.+P.+Del+Castillo-Friasauthor=O.+Berthoumieuauthor=B.+Tarusauthor=J.+Nasica-Labouzeauthor=F.+Sterponeauthor=P.+H.+Nguyenauthor=N.+M.+Hooperauthor=P.+Fallerauthor=P.+Derreumaux&title=Why+Is+Research+on+Amyloid-%CE%B2+Failing+to+Give+New+Drugs+for+Alzheimer%E2%80%99s+Disease%3F&doi=10.1021%2Facschemneuro.7b00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?</span></div><div class="casAuthors">Doig, Andrew J.; del Castillo-Frias, Maria P.; Berthoumieu, Olivia; Tarus, Bogdan; Nasica-Labouze, Jessica; Sterpone, Fabio; Nguyen, Phuong H.; Hooper, Nigel M.; Faller, Peter; Derreumaux, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1435-1437</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two hallmarks of Alzheimer's disease (AD) are the presence of neurofibrillary tangles (NFT) made of aggregates of the hyperphosphorylated tau protein and of amyloid plaques composed of amyloid-β (Aβ) peptides, primarily Aβ1-40 and Aβ1-42.  Targeting the prodn., aggregation, and toxicity of Aβ with small mol. drugs or antibodies is an active area of AD research due to the general acceptance of the amyloid cascade hypothesis, but thus far all drugs targeting Aβ have failed.  From a review of the recent literature and our own experience based on in vitro, in silico, and in vivo studies, we present some reasons to explain this repetitive failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrimFSfyVV9VrVg90H21EOLACvtfcHk0lidLwWDRYp2NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1CmsLo%253D&md5=26bc5126993b4d8df4eaf9ddf81e981a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00188%26sid%3Dliteratum%253Aachs%26aulast%3DDoig%26aufirst%3DA.%2BJ.%26aulast%3DDel%2BCastillo-Frias%26aufirst%3DM.%2BP.%26aulast%3DBerthoumieu%26aufirst%3DO.%26aulast%3DTarus%26aufirst%3DB.%26aulast%3DNasica-Labouze%26aufirst%3DJ.%26aulast%3DSterpone%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DP.%2BH.%26aulast%3DHooper%26aufirst%3DN.%2BM.%26aulast%3DFaller%26aufirst%3DP.%26aulast%3DDerreumaux%26aufirst%3DP.%26atitle%3DWhy%2520Is%2520Research%2520on%2520Amyloid-%25CE%25B2%2520Failing%2520to%2520Give%2520New%2520Drugs%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1435%26epage%3D1437%26doi%3D10.1021%2Facschemneuro.7b00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, K.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease drug development pipeline: 2019</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2019.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.trci.2019.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BB3Mvgt1Sjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=272-293&author=J.+Cummingsauthor=G.+Leeauthor=A.+Ritterauthor=M.+Sabbaghauthor=K.+Zhong&title=Alzheimer%E2%80%99s+disease+drug+development+pipeline%3A+2019&doi=10.1016%2Fj.trci.2019.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug development pipeline: 2019</span></div><div class="casAuthors">Cummings Jeffrey; Cummings Jeffrey; Lee Garam; Ritter Aaron; Sabbagh Marwan; Zhong Kate</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">272-293</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction:  Alzheimer's disease (AD) has few available treatments, and there is a high rate of failure in AD drug development programs.  Study of the AD drug development pipeline can provide insight into the evolution of drug development and how best to optimize development practices.  Methods:  We reviewed clinicaltrials.gov and identified all pharmacologic AD trials of all agents currently being developed for treatment of AD.  Results:  There are 132 agents in clinical trials for the treatment of AD.  Twenty-eight agents are in 42 phase 3 trials; 74 agents are in 83 phase 2 trials; and 30 agents are in 31 phase 1 trials.  There is an increase in the number of agents in each phase compared with that in the 2018 pipeline.  Nineteen agents in trials target cognitive enhancement, and 14 are intended to treat neuropsychiatric and behavioral symptoms.  There are 96 agents in disease modification trials; of these, 38 (40%) have amyloid as the primary target or as one of several effects.  Eighteen of the antiamyloid agents are small molecules, and 20 are monoclonal antibodies or biological therapies.  Seven small molecules and ten biologics have tau as a primary or combination target (18%).  Amyloid is the most common specific target in phase 3 and phase 2 disease modification trials.  Novel biomarkers (e.g., neurofilament light), new outcomes (e.g., AD Composite Score [ADCOMS]), enrollment of earlier populations, and innovative trial designs (e.g., Bayesian adaptive designs) are new features in recent clinical trials.  Discussion:  Drug development continues robustly at all phases despite setbacks in several programs in the recent past.  Continuing unmet needs require a commitment to growing and accelerating the pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrOd1ZrATvKxFwe7cAcrfPfW6udTcc2eahpGJcrWjnzbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mvgt1Sjtw%253D%253D&md5=be9948127a7c81739f234d356396fbf4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2019.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2019.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DRitter%26aufirst%3DA.%26aulast%3DSabbagh%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug%2520development%2520pipeline%253A%25202019%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2019%26volume%3D5%26spage%3D272%26epage%3D293%26doi%3D10.1016%2Fj.trci.2019.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Z.</span></span> <span> </span><span class="NLM_article-title">Potential therapeutic implications of gelsolin in Alzheimer’s disease</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.3233/JAD-141548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3233%2FJAD-141548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=25208622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1GksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=13-25&author=L.+Jiauthor=X.+Zhaoauthor=Z.+Hua&title=Potential+therapeutic+implications+of+gelsolin+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-141548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Potential Therapeutic Implications of Gelsolin in Alzheimer's Disease</span></div><div class="casAuthors">Ji, Lina; Zhao, Xi; Hua, Zichun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-25</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The presence of amyloid plaques and vascular amyloid deposits is one of the pathol. features of Alzheimer's disease (AD).  Amyloid plaques and vascular deposits mainly consist of amyloid-β (Aβ), which is a metabolic product of amyloid-β protein precursor cleaved by β- and γ-secretase.  Sol. Aβ monomers readily aggregate into oligomers preceding the formation of insol. fibrils, and Aβ oligomers are more toxic than fibrils.  Intensive therapeutic efforts have been attempted in the treatment of AD targeting Aβ, including preventing Aβ generation, inhibiting Aβ aggregation, and promoting Aβ clearance.  The results show that amyloid plaque burden is reduced together with improved cognition performance in AD.  Gelsolin, a multifunctional actin-binding protein, exists intracellularly as a cytoplasmic form and extracellularly as a secreted form in blood/cerebrospinal fluid.  Gelsolin is suggested to be implicated in AD, based on the findings that some changes of gelsolin are correlated with disease progression rate in AD patients.  Gelsolin binds Aβ, inhibits its aggregation into fibrils, and protects cells from apoptosis induced by Aβ.  More importantly, administration or overexpression of gelsolin results in significant redn. of amyloid load and decrease of Aβ level in AD transgenic mice.  In this article, we review the most recent progress of gelsolin as a potential therapeutic strategy for treatment of AD, and discuss the possible mechanism involved in the clearance of amyloid plaques in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhoVmvIcBY0rVg90H21EOLACvtfcHk0ljlAVS-IYX4JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1GksQ%253D%253D&md5=30fa81c8004f05d3db262dfb4c631b19</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3233%2FJAD-141548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-141548%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DZ.%26atitle%3DPotential%2520therapeutic%2520implications%2520of%2520gelsolin%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2015%26volume%3D44%26spage%3D13%26epage%3D25%26doi%3D10.3233%2FJAD-141548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagare, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">Role of clusterin in the brain vascular clearance of amyloid-β</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">8681</span>– <span class="NLM_lpage">8682</span>, <span class="refDoi"> DOI: 10.1073/pnas.1711357114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1073%2Fpnas.1711357114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28765369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlelsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=8681-8682&author=A.+R.+Nelsonauthor=A.+P.+Sagareauthor=B.+V.+Zlokovic&title=Role+of+clusterin+in+the+brain+vascular+clearance+of+amyloid-%CE%B2&doi=10.1073%2Fpnas.1711357114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Role of clusterin in the brain vascular clearance of amyloid-β</span></div><div class="casAuthors">Nelson, Amy R.; Sagare, Abhay P.; Zlokovic, Berislav V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">8681-8682</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A polemic in response to A. M. Wojtas et al. (ibid., E6962-71) is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroVVXFgm8wvbVg90H21EOLACvtfcHk0ljlAVS-IYX4JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlelsrnO&md5=01ace9869d9b7682aae06849586427e1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1711357114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1711357114%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DA.%2BR.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DRole%2520of%2520clusterin%2520in%2520the%2520brain%2520vascular%2520clearance%2520of%2520amyloid-%25CE%25B2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D8681%26epage%3D8682%26doi%3D10.1073%2Fpnas.1711357114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beeg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stravalaci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrá, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diomede, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span> <span> </span><span class="NLM_article-title">Clusterin binds to Aβ1-42 oligomers with high affinity and interferes with peptide aggregation by inhibiting primary and secondary nucleation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">6958</span>– <span class="NLM_lpage">6966</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.689539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1074%2Fjbc.M115.689539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=26884339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVynsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=6958-6966&author=M.+Beegauthor=M.+Stravalaciauthor=M.+Romeoauthor=A.+D.+Carr%C3%A1author=A.+Cagnottoauthor=A.+Rossiauthor=L.+Diomedeauthor=M.+Salmonaauthor=M.+Gobbi&title=Clusterin+binds+to+A%CE%B21-42+oligomers+with+high+affinity+and+interferes+with+peptide+aggregation+by+inhibiting+primary+and+secondary+nucleation&doi=10.1074%2Fjbc.M115.689539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Clusterin Binds to Aβ1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation</span></div><div class="casAuthors">Beeg, Marten; Stravalaci, Matteo; Romeo, Margherita; Carra, Arianna Dorotea; Cagnotto, Alfredo; Rossi, Alessandro; Diomede, Luisa; Salmona, Mario; Gobbi, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6958-6966</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The aggregation of amyloid β protein (Aβ) is a fundamental pathogenic mechanism leading to the neuronal damage present in Alzheimer disease, and sol. Aβ oligomers are thought to be a major toxic culprit.  Thus, better knowledge and specific targeting of the pathways that lead to these noxious species may result in valuable therapeutic strategies.  We characterized some effects of the mol. chaperone clusterin, providing new and more detailed evidence of its potential neuroprotective effects.  Using a classical thioflavin T assay, we obsd. a dose-dependent inhibition of the aggregation process.  The global anal. of time courses under different conditions demonstrated that clusterin has no effect on the elongation rate but mainly interferes with the nucleation processes (both primary and secondary), reducing the no. of nuclei available for further fibril growth.  Then, using a recently developed immunoassay based on surface plasmon resonance, we obtained direct evidence of a high-affinity (KD = 1 nm) interaction of clusterin with biol. relevant Aβ1-42 oligomers, selectively captured on the sensor chip.  Moreover, with the same technol., we obsd. that substoichiometric concns. of clusterin prevent oligomer interaction with the antibody 4G8, suggesting that the chaperone shields hydrophobic residues exposed on the oligomeric assemblies.  Finally, we found that preincubation with clusterin antagonizes the toxic effects of Aβ1-42 oligomers, as evaluated in a recently developed in vivo model in Caenorhabditis elegans.  These data substantiate the interaction of clusterin with biol. active regions exposed on nuclei/oligomers of Aβ1-42, providing a mol. basis for the neuroprotective effects of the chaperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX7V8aBxdCj7Vg90H21EOLACvtfcHk0ljvoBkxAOWSpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVynsLs%253D&md5=6235942d9ef2008aaf73efa5d22106f1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.689539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.689539%26sid%3Dliteratum%253Aachs%26aulast%3DBeeg%26aufirst%3DM.%26aulast%3DStravalaci%26aufirst%3DM.%26aulast%3DRomeo%26aufirst%3DM.%26aulast%3DCarr%25C3%25A1%26aufirst%3DA.%2BD.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DDiomede%26aufirst%3DL.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DM.%26atitle%3DClusterin%2520binds%2520to%2520A%25CE%25B21-42%2520oligomers%2520with%2520high%2520affinity%2520and%2520interferes%2520with%2520peptide%2520aggregation%2520by%2520inhibiting%2520primary%2520and%2520secondary%2520nucleation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D6958%26epage%3D6966%26doi%3D10.1074%2Fjbc.M115.689539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allington, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martá-Ariza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholtzova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verghese, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, T.</span></span> <span> </span><span class="NLM_article-title">Targeting Apolipoprotein E/amyloid β binding by peptoid CPO_Aβ17-21 P ameliorates Alzheimer’s disease related pathology and cognitive decline</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">8009</span> <span class="refDoi"> DOI: 10.1038/s41598-017-08604-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1038%2Fs41598-017-08604-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28808293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BC1cfnsF2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=S.+Liuauthor=S.+Parkauthor=G.+Allingtonauthor=F.+Prelliauthor=Y.+Sunauthor=M.+Mart%C3%A1-Arizaauthor=H.+Scholtzovaauthor=G.+Biswasauthor=B.+Brownauthor=P.+B.+Vergheseauthor=P.+D.+Mehtaauthor=Y.+U.+Kwonauthor=T.+Wisniewski&title=Targeting+Apolipoprotein+E%2Famyloid+%CE%B2+binding+by+peptoid+CPO_A%CE%B217-21+P+ameliorates+Alzheimer%E2%80%99s+disease+related+pathology+and+cognitive+decline&doi=10.1038%2Fs41598-017-08604-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer's Disease Related Pathology and Cognitive Decline</span></div><div class="casAuthors">Liu Shan; Prelli Frances; Sun Yanjie; Marta-Ariza Mitchell; Scholtzova Henrieta; Brown Bernard; Park Shinae; Biswas Goutam; Kwon Yong-Uk; Allington Grant; Verghese Philip B; Mehta Pankaj D; Wisniewski Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8009</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inheritance of the apolipoprotein E4 (apoE4) genotype has been identified as the major genetic risk factor for late onset Alzheimer's disease (AD).  Studies have shown that apoE, apoE4 in particular, binds to amyloid-β (Aβ) peptides at residues 12-28 of Aβ and this binding modulates Aβ accumulation and disease progression.  We have previously shown in several AD transgenic mice lines that blocking the apoE/Aβ interaction with Aβ12-28 P reduced Aβ and tau-related pathology, leading to cognitive improvements in treated AD mice.  Recently, we have designed a small peptoid library derived from the Aβ12-28 P sequence to screen for new apoE/Aβ binding inhibitors with higher efficacy and safety.  Peptoids are better drug candidates than peptides due to their inherently more favorable pharmacokinetic properties.  One of the lead peptoid compounds, CPO_Aβ17-21 P, diminished the apoE/Aβ interaction and attenuated the apoE4 pro-fibrillogenic effects on Aβ aggregation in vitro as well as apoE4 potentiation of Aβ cytotoxicity.  CPO_Aβ17-21 P reduced Aβ-related pathology coupled with cognitive improvements in an AD APP/PS1 transgenic mouse model.  Our study suggests the non-toxic, non-fibrillogenic peptoid CPO_Aβ17-21 P has significant promise as a new AD therapeutic agent which targets the Aβ related apoE pathway, with improved efficacy and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjd31aDSCp-g5nADWVYHg1fW6udTcc2ebwvgKc-Bbik7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfnsF2gtw%253D%253D&md5=e304422373adcdc18b5cffdf49da9e74</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-08604-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-08604-8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DAllington%26aufirst%3DG.%26aulast%3DPrelli%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMart%25C3%25A1-Ariza%26aufirst%3DM.%26aulast%3DScholtzova%26aufirst%3DH.%26aulast%3DBiswas%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DVerghese%26aufirst%3DP.%2BB.%26aulast%3DMehta%26aufirst%3DP.%2BD.%26aulast%3DKwon%26aufirst%3DY.%2BU.%26aulast%3DWisniewski%26aufirst%3DT.%26atitle%3DTargeting%2520Apolipoprotein%2520E%252Famyloid%2520%25CE%25B2%2520binding%2520by%2520peptoid%2520CPO_A%25CE%25B217-21%2520P%2520ameliorates%2520Alzheimer%25E2%2580%2599s%2520disease%2520related%2520pathology%2520and%2520cognitive%2520decline%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26doi%3D10.1038%2Fs41598-017-08604-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nasica-Labouze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterpone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthoumieu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchete, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coté, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doig, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchionna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mousseau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paravastu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strodel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viles, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derreumaux, P.</span></span> <span> </span><span class="NLM_article-title">Amyloid β Protein and Alzheimer’s Disease: When Computer Simulations Complement Experimental Studies</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">3518</span>– <span class="NLM_lpage">3563</span>, <span class="refDoi"> DOI: 10.1021/cr500638n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500638n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksl2hurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=3518-3563&author=J.+Nasica-Labouzeauthor=P.+H.+Nguyenauthor=F.+Sterponeauthor=O.+Berthoumieuauthor=N.+V.+Bucheteauthor=S.+Cot%C3%A9author=A.+De+Simoneauthor=A.+J.+Doigauthor=P.+Fallerauthor=A.+Garciaauthor=A.+Laioauthor=M.+S.+Liauthor=S.+Melchionnaauthor=N.+Mousseauauthor=Y.+Muauthor=A.+Paravastuauthor=S.+Pasqualiauthor=D.+J.+Rosenmanauthor=B.+Strodelauthor=B.+Tarusauthor=J.+H.+Vilesauthor=T.+Zhangauthor=C.+Wangauthor=P.+Derreumaux&title=Amyloid+%CE%B2+Protein+and+Alzheimer%E2%80%99s+Disease%3A+When+Computer+Simulations+Complement+Experimental+Studies&doi=10.1021%2Fcr500638n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies</span></div><div class="casAuthors">Nasica-Labouze, Jessica; Nguyen, Phuong H.; Sterpone, Fabio; Berthoumieu, Olivia; Buchete, Nicolae-Viorel; Cote, Sebastien; De Simone, Alfonso; Doig, Andrew J.; Faller, Peter; Garcia, Angel; Laio, Alessandro; Mai, Suan Li; Melchionna, Simone; Mousseau, Normand; Mu, Yuguang; Paravastu, Anant; Pasquali, Samuela; Rosenman, David J.; Strodel, Birgit; Tarus, Bogdan; Viles, John H.; Zhang, Tong; Wang, Chunyu; Derreumaux, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3518-3563</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, discussing the contribution of biophys. and biochem. studies and computer simulations to characterize the mol. structures of Aβ1-40/1-42 monomers, oligomers, protofibrils, and amyloid fibrils in aq. soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5CTJQj138t7Vg90H21EOLACvtfcHk0liaxG47JhDWFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksl2hurs%253D&md5=fdd061847c9171aec5d4a4b9d871768d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcr500638n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500638n%26sid%3Dliteratum%253Aachs%26aulast%3DNasica-Labouze%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DP.%2BH.%26aulast%3DSterpone%26aufirst%3DF.%26aulast%3DBerthoumieu%26aufirst%3DO.%26aulast%3DBuchete%26aufirst%3DN.%2BV.%26aulast%3DCot%25C3%25A9%26aufirst%3DS.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DDoig%26aufirst%3DA.%2BJ.%26aulast%3DFaller%26aufirst%3DP.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DLaio%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DM.%2BS.%26aulast%3DMelchionna%26aufirst%3DS.%26aulast%3DMousseau%26aufirst%3DN.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DParavastu%26aufirst%3DA.%26aulast%3DPasquali%26aufirst%3DS.%26aulast%3DRosenman%26aufirst%3DD.%2BJ.%26aulast%3DStrodel%26aufirst%3DB.%26aulast%3DTarus%26aufirst%3DB.%26aulast%3DViles%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DDerreumaux%26aufirst%3DP.%26atitle%3DAmyloid%2520%25CE%25B2%2520Protein%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520When%2520Computer%2520Simulations%2520Complement%2520Experimental%2520Studies%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D3518%26epage%3D3563%26doi%3D10.1021%2Fcr500638n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Algamal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahsan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melacini, G.</span></span> <span> </span><span class="NLM_article-title">Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid β (Aβ) peptides in the monomer and protofibril states</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">17158</span>– <span class="NLM_lpage">17168</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.792853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1074%2Fjbc.M117.792853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28798235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs12lsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=17158-17168&author=M.+Algamalauthor=R.+Ahmedauthor=N.+Jafariauthor=B.+Ahsanauthor=J.+Ortegaauthor=G.+Melacini&title=Atomic-resolution+map+of+the+interactions+between+an+amyloid+inhibitor+protein+and+amyloid+%CE%B2+%28A%CE%B2%29+peptides+in+the+monomer+and+protofibril+states&doi=10.1074%2Fjbc.M117.792853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid β (Aβ) peptides in the monomer and protofibril states</span></div><div class="casAuthors">Algamal, Moustafa; Ahmed, Rashik; Jafari, Naeimeh; Ahsan, Bilal; Ortega, Joaquin; Melacini, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">17158-17168</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Self-assocn. of amyloid β (Aβ) peptides is a hallmark of Alzheimer's disease and serves as a general prototype for amyloid formation.  A key endogenous inhibitor of Aβ self-assocn. is human serum albumin (HSA), which binds ∼90% of plasma Aβ.  However, the exact mol. mechanism by which HSA binds Aβ monomers and protofibrils is not fully understood.  Here, using dark-state exchange satn. transfer NMR and relaxation expts. complemented by morphol. characterization, we mapped the HSA-Aβ interactions at at. resoln. by examg. the effects of HSA on Aβ monomers and sol. high-mol. wt. oligomeric protofibrils.  We found that HSA binds both monomeric and protofibrillar Aβ, but the affinity of HSA for Aβ monomers is lower than for Aβ protofibrils (Kd values are submillimolar rather than micromolar) yet physiol. relevant because of the ∼0.6-0.7 mm plasma HSA concn.  In both Aβ protofibrils and monomers, HSA targets key Aβ self-recognition sites spanning the β strands found in cross-β protofibril structures, leading to a net switch from direct to tethered contacts between the monomeric Aβ and the protofibril surface.  These HSA-Aβ interactions are isoform-specific, because the HSA affinity of Aβ monomers is lower for Aβ(1-42) than for Aβ(1-40).  In addn., the HSA-induced perturbations of the monomer/protofibrils pseudo-equil. extend to the C-terminal residues in the Aβ(1-42) isoform but not in Aβ(1-40).  These results provide an unprecedented view of how albumin interacts with Aβ and illustrate the potential of dark-state exchange satn. transfer NMR in mapping the interactions between amyloid-inhibitory proteins and amyloidogenic peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7KTuRtShbhbVg90H21EOLACvtfcHk0liaxG47JhDWFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs12lsrrL&md5=a3a292d4cb8875a3fd6d1e937e7aa5a2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.792853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.792853%26sid%3Dliteratum%253Aachs%26aulast%3DAlgamal%26aufirst%3DM.%26aulast%3DAhmed%26aufirst%3DR.%26aulast%3DJafari%26aufirst%3DN.%26aulast%3DAhsan%26aufirst%3DB.%26aulast%3DOrtega%26aufirst%3DJ.%26aulast%3DMelacini%26aufirst%3DG.%26atitle%3DAtomic-resolution%2520map%2520of%2520the%2520interactions%2520between%2520an%2520amyloid%2520inhibitor%2520protein%2520and%2520amyloid%2520%25CE%25B2%2520%2528A%25CE%25B2%2529%2520peptides%2520in%2520the%2520monomer%2520and%2520protofibril%2520states%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D17158%26epage%3D17168%26doi%3D10.1074%2Fjbc.M117.792853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczepiorkowski, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grifols, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Páez, A.</span></span> <span> </span><span class="NLM_article-title">Plasma exchange for Alzheimer’s disease Management by Albumin Replacement (AMBAR) trial: study design and progress</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2019.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.trci.2019.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BB3cbivFWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=61-69&author=M.+Boadaauthor=O.+L%C3%B3pezauthor=L.+N%C3%BA%C3%B1ezauthor=Z.+M.+Szczepiorkowskiauthor=M.+Torresauthor=C.+Grifolsauthor=A.+P%C3%A1ez&title=Plasma+exchange+for+Alzheimer%E2%80%99s+disease+Management+by+Albumin+Replacement+%28AMBAR%29+trial%3A+study+design+and+progress&doi=10.1016%2Fj.trci.2019.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress</span></div><div class="casAuthors">Boada Merce; Boada Merce; Lopez Oscar; Nunez Laura; Torres Mireia; Grifols Carlota; Paez Antonio; Szczepiorkowski Zbigniew M</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61-69</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction:  Preliminary studies have shown that treatment with plasma exchange (PE) plus therapeutic albumin replacement in patients with Alzheimer's disease (AD) induced mobilization of plasma and cerebrospinal fluid amyloid β protein, associated with an improvement in memory and language functions, as well as the stabilization of brain perfusion, which persisted after treatment discontinuation.  Methods:  Alzheimer's Management By Albumin Replacement (AMBAR) is a multicenter, randomized, blinded and placebo-controlled, parallel-group, phase IIb/III trial enrolling patients with mild to moderate AD.  The study evaluates PE with different replacement volumes of therapeutic albumin (5% and 20% Albutein(®), Grifols), with or without intravenous immunoglobulin (Flebogamma(®) 5% DIF, Grifols).  Patients are randomized to one of three active treatment groups or one control (sham PE) group (1:1:1:1).  The intervention regime includes a first 6-week stage of intensive treatment, followed by a second 12-month stage of maintenance treatment.  The change from the baseline to the end of treatment periods in the ADAS-Cog and ADCS-ADL scores are the coprimary efficacy variables.  Secondary efficacy variables include change from the baseline in scores on cognitive, functional, behavioral, and overall progression tests; changes in plasma and cerebrospinal fluid levels of amyloid β and tau protein; and assessment of structural and functional changes in brain areas of interest.  Safety and tolerability are assessed.  Results:  The study has enrolled 496 patients from 41 centers (19 in Spain and 22 in the USA); 347 of these patients were randomized and underwent close to 5000 PEs, of which approximately 25% were sham PEs.  Discussion:  We present an innovative approach for treating AD.  The study has been designed to demonstrate clinical efficacy, defined as slow decline of the patient's cognition and brain function.  The sample size has adequate power to detect differences between any of the active treatment groups and the control group, as well as between the three active treatment groups combined and the control group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCXP-Ku5LR4CCEBeYuoi7AfW6udTcc2eabiiqrQE-thrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbivFWqtQ%253D%253D&md5=bae6d62543f0f3a49014694ba49a5cc3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2019.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2019.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DBoada%26aufirst%3DM.%26aulast%3DL%25C3%25B3pez%26aufirst%3DO.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DL.%26aulast%3DSzczepiorkowski%26aufirst%3DZ.%2BM.%26aulast%3DTorres%26aufirst%3DM.%26aulast%3DGrifols%26aufirst%3DC.%26aulast%3DP%25C3%25A1ez%26aufirst%3DA.%26atitle%3DPlasma%2520exchange%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520Management%2520by%2520Albumin%2520Replacement%2520%2528AMBAR%2529%2520trial%253A%2520study%2520design%2520and%2520progress%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2019%26volume%3D5%26spage%3D61%26epage%3D69%26doi%3D10.1016%2Fj.trci.2019.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stravalaci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiordaliso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diomede, L.</span></span> <span> </span><span class="NLM_article-title">Humanin specifically interacts with amyloid-β oligomers and counteracts their in vivo toxicity</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.3233/JAD-160951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3233%2FJAD-160951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28282805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvFyjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=857-871&author=M.+Romeoauthor=M.+Stravalaciauthor=M.+Beegauthor=A.+Rossiauthor=F.+Fiordalisoauthor=A.+Corbelliauthor=M.+Salmonaauthor=M.+Gobbiauthor=A.+Cagnottoauthor=L.+Diomede&title=Humanin+specifically+interacts+with+amyloid-%CE%B2+oligomers+and+counteracts+their+in+vivo+toxicity&doi=10.3233%2FJAD-160951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity</span></div><div class="casAuthors">Romeo, Margherita; Stravalaci, Matteo; Beeg, Marten; Rossi, Alessandro; Fiordaliso, Fabio; Corbelli, Alessandro; Salmona, Mario; Gobbi, Marco; Cagnotto, Alfredo; Diomede, Luisa; Galzitskaya, Oxana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">857-871</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The 24-residue peptide humanin (HN) has been proposed as a peptide-based inhibitor able to interact directly with amyloid-β (Aβ) oligomers and interfere with the formation and/or biol. properties of toxic Aβ species.  When administered exogenously, HN, or its synthetic S14G-deriv. (HNG), exerted multiple cytoprotective effects, counteracting the Aβ-induced toxicity.  Whether these peptides interact directly with Aβ, particularly with the sol. oligomeric assemblies, remains largely unknown.  We here investigated the ability of HN and HNG to interact directly with highly aggregating Aβ42, and interfere with the formation and toxicity of its oligomers.  Expts. were run in cell-free conditions and in vivo in a transgenic C. elegans strain in which the Aβ toxicity was specifically due to oligomeric species.  Thioflavin-T assay indicated that both HN and HNG delay the formation and reduce the final amt. of Aβ42 fibrils.  In vitro surface plasmon resonance studies indicated that they interact with Aβ42 oligomers favoring the formation of amorphous larger assemblies, obsd. with turbidity and electron microscopy.  In vivo studies indicated that both HN and HNG decrease the relative abundance of A11-pos. prefibrillar oligomers as well as OC-pos. fibrillar oligomers and had similar protective effects.  However, while HN possibly decreased the oligomers by promoting their assembly into larger aggregates, the redn. of oligomers caused by HNG can be ascribed to a marked decrease of the total Aβ levels, likely the consequence of the HNG-induced overexpression of the Aβ-degrading enzyme neprilysin.  These findings provide information on the mechanisms underlying the anti-oligomeric effects of HN and HNG and illustrate the role of S14G substitution in regulating the in vivo mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDuGmS6GKK17Vg90H21EOLACvtfcHk0lj41khLfnm6Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvFyjs78%253D&md5=a70ec1027f04b1f429bde2552254eca8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3233%2FJAD-160951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-160951%26sid%3Dliteratum%253Aachs%26aulast%3DRomeo%26aufirst%3DM.%26aulast%3DStravalaci%26aufirst%3DM.%26aulast%3DBeeg%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DFiordaliso%26aufirst%3DF.%26aulast%3DCorbelli%26aufirst%3DA.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DDiomede%26aufirst%3DL.%26atitle%3DHumanin%2520specifically%2520interacts%2520with%2520amyloid-%25CE%25B2%2520oligomers%2520and%2520counteracts%2520their%2520in%2520vivo%2520toxicity%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2017%26volume%3D57%26spage%3D857%26epage%3D871%26doi%3D10.3233%2FJAD-160951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wallin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiruma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wärmländer, S. K. T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huvent, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahams, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gräslund, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippens, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span> <span> </span><span class="NLM_article-title">The neuronal Tau protein blocks in vitro fibrillation of the amyloid-β (Aβ) peptide at the oligomeric stage</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">8138</span>– <span class="NLM_lpage">8146</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b13623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b13623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Gmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=8138-8146&author=C.+Wallinauthor=Y.+Hirumaauthor=S.+K.+T.+S.+W%C3%A4rml%C3%A4nderauthor=I.+Huventauthor=J.+Jarvetauthor=J.+P.+Abrahamsauthor=A.+Gr%C3%A4slundauthor=G.+Lippensauthor=J.+Luo&title=The+neuronal+Tau+protein+blocks+in+vitro+fibrillation+of+the+amyloid-%CE%B2+%28A%CE%B2%29+peptide+at+the+oligomeric+stage&doi=10.1021%2Fjacs.7b13623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Neuronal Tau Protein Blocks in Vitro Fibrillation of the Amyloid-β (Aβ) Peptide at the Oligomeric Stage</span></div><div class="casAuthors">Wallin, Cecilia; Hiruma, Yoshitaka; Waermlaender, Sebastian K. T. S.; Huvent, Isabelle; Jarvet, Juri; Abrahams, Jan Pieter; Graeslund, Astrid; Lippens, Guy; Luo, Jinghui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">8138-8146</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In Alzheimer's disease, amyloid-β (Aβ) plaques and tau neurofibrillary tangles are the 2 pathol. hallmarks.  The co-occurrence and combined reciprocal pathol. effects of Aβ and tau protein aggregation have been obsd. in animal models of the disease.  However, the mol. mechanism of their interaction remain unknown.  Here, using a variety of biophys. measurements, we show that the native full-length tau protein solubilizes the Aβ40 peptide and prevents its fibrillation.  The tau protein delayed the amyloid fibrillation of the Aβ40 peptide at substoichiometric ratios, showing different binding affinities toward the different stages of the aggregated Aβ40 peptides.  The Aβ monomer structure remained random coil in the presence of tau, as obsd. by NMR and CD spectroscopy and photoinduced crosslinking methods.  We propose a potential interaction mechanism for the influence of tau on Aβ fibrillation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDMOOQ1oInOLVg90H21EOLACvtfcHk0li5_6TygiZgQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Gmtb4%253D&md5=76c3262edb560cc457d2414be674308e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b13623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b13623%26sid%3Dliteratum%253Aachs%26aulast%3DWallin%26aufirst%3DC.%26aulast%3DHiruma%26aufirst%3DY.%26aulast%3DW%25C3%25A4rml%25C3%25A4nder%26aufirst%3DS.%2BK.%2BT.%2BS.%26aulast%3DHuvent%26aufirst%3DI.%26aulast%3DJarvet%26aufirst%3DJ.%26aulast%3DAbrahams%26aufirst%3DJ.%2BP.%26aulast%3DGr%25C3%25A4slund%26aufirst%3DA.%26aulast%3DLippens%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DJ.%26atitle%3DThe%2520neuronal%2520Tau%2520protein%2520blocks%2520in%2520vitro%2520fibrillation%2520of%2520the%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520peptide%2520at%2520the%2520oligomeric%2520stage%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D8138%26epage%3D8146%26doi%3D10.1021%2Fjacs.7b13623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwarzman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitek, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyubski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strittmatter, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enghilde, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhasin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisgraber, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagorki, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talafous, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roses, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldgaber, D.</span></span> <span> </span><span class="NLM_article-title">Transthyretin sequesters amyloid beta protein and prevents amyloid formation</span>. <i>Proc. Nat. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">8368</span>– <span class="NLM_lpage">8372</span>, <span class="refDoi"> DOI: 10.1073/pnas.91.18.8368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1073%2Fpnas.91.18.8368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=8078889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8368-8372&author=A.+L.+Schwarzmanauthor=L.+Gregoriauthor=M.+P.+Vitekauthor=S.+Lyubskiauthor=W.+J.+Strittmatterauthor=J.+J.+Enghildeauthor=R.+Bhasinauthor=J.+Silvermanauthor=K.+H.+Weisgraberauthor=P.+K.+Coyleauthor=M.+G.+Zagorkiauthor=J.+Talafousauthor=M.+Eisenbergauthor=A.+M.+Saundersauthor=A.+D.+Rosesauthor=D.+Goldgaber&title=Transthyretin+sequesters+amyloid+beta+protein+and+prevents+amyloid+formation&doi=10.1073%2Fpnas.91.18.8368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin sequesters amyloid β protein and prevents amyloid formation</span></div><div class="casAuthors">Schwarzman, Alexander L.; Gregori, Luisa; Vitek, Michael P.; Lyubski, Sergey; Strittmatter, Warren J.; Enghilde, Jan J.; Bhasin, Ramaninder; Silverman, Josh; Weisgraber, Karl H.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8368-72</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The cardinal pathol. features of Alzheimer disease are depositions of aggregated amyloid β protein (Aβ) in the brain and cerebrovasculature.  However, the Aβ is found in a sol. form in cerebrospinal fluid in healthy individuals and patients with Alzheimer disease.  The authors postulate that sequestration of Aβ precludes amyloid formation.  Failure to sequester Aβ in Alzheimer disease may result in amyloidosis.  When the authors added Aβ to cerebrospinal fluid of patients and controls it was rapidly sequestered into stable complexes with transthyretin.  Complexes with apolipoprotein E, which has been shown to bind Aβ in vitro, were not obsd. in cerebrospinal fluid.  Addnl. in vitro studies showed that both purified transthyretin and apolipoprotein E prevent amyloid formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9A7K_dww2NLVg90H21EOLACvtfcHk0li5_6TygiZgQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKktLk%253D&md5=bf6aeaf5679794ea29c69933064a9b6c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8368%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarzman%26aufirst%3DA.%2BL.%26aulast%3DGregori%26aufirst%3DL.%26aulast%3DVitek%26aufirst%3DM.%2BP.%26aulast%3DLyubski%26aufirst%3DS.%26aulast%3DStrittmatter%26aufirst%3DW.%2BJ.%26aulast%3DEnghilde%26aufirst%3DJ.%2BJ.%26aulast%3DBhasin%26aufirst%3DR.%26aulast%3DSilverman%26aufirst%3DJ.%26aulast%3DWeisgraber%26aufirst%3DK.%2BH.%26aulast%3DCoyle%26aufirst%3DP.%2BK.%26aulast%3DZagorki%26aufirst%3DM.%2BG.%26aulast%3DTalafous%26aufirst%3DJ.%26aulast%3DEisenberg%26aufirst%3DM.%26aulast%3DSaunders%26aufirst%3DA.%2BM.%26aulast%3DRoses%26aufirst%3DA.%2BD.%26aulast%3DGoldgaber%26aufirst%3DD.%26atitle%3DTransthyretin%2520sequesters%2520amyloid%2520beta%2520protein%2520and%2520prevents%2520amyloid%2520formation%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D8368%26epage%3D8372%26doi%3D10.1073%2Fpnas.91.18.8368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pate, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shusta, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. M.</span></span> <span> </span><span class="NLM_article-title">Transthyretin mimetics as anti-β-amyloid agents: a comparison of peptide and protein approaches</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">968</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fcmdc.201800031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=29512286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVKksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=968-979&author=K.+M.+Pateauthor=B.+J.+Kimauthor=E.+V.+Shustaauthor=R.+M.+Murphy&title=Transthyretin+mimetics+as+anti-%CE%B2-amyloid+agents%3A+a+comparison+of+peptide+and+protein+approaches&doi=10.1002%2Fcmdc.201800031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin mimetics as anti-β-amyloid agents: A comparison of peptide and protein approaches</span></div><div class="casAuthors">Pate, Kayla M.; Kim, Brandon J.; Shusta, Eric V.; Murphy, Regina M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">968-979</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">β-Amyloid (Aβ) aggregation is causally linked to neuronal pathol. in Alzheimer's disease; therefore, several small mols., antibodies, and peptides have been tested as anti-Aβ agents.  We developed 2 compds. based on the Aβ-binding domain of transthyretin (TTR): cyclic peptide cG8 and engineered protein mTTR (F87M/L110M mutant), and compared them for therapeutically relevant properties.  Both mTTR and cG8 inhibited fibrillogenesis of Aβ, with mTTR inhibiting at a lower concn. than cG8.  Both inhibited the aggregation of amylin but not of α-synuclein.  They both bound more Aβ aggregates than monomers, and neither disaggregates preformed fibrils; cG8 retained more of its activity in the presence of biol. materials and was more resistant to proteolysis than mTTR.  We examd. the effect of mTTR or cG8 on Aβ binding to human neurons.  When mTTR was co-incubated with Aβ under oligomer-forming conditions, Aβ morphol. was drastically changed and Aβ-cell deposition significantly decreased.  In contrast, cG8 did not affect the morphol. but decreased the amt. of Aβ deposited.  These results provide guidance for further evolution of TTR-mimetic anti-amyloid agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEdFGuWGkpU7Vg90H21EOLACvtfcHk0lhHe4QoL21cEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVKksbw%253D&md5=72b028ec9c92fa9007652131f9a74d94</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800031%26sid%3Dliteratum%253Aachs%26aulast%3DPate%26aufirst%3DK.%2BM.%26aulast%3DKim%26aufirst%3DB.%2BJ.%26aulast%3DShusta%26aufirst%3DE.%2BV.%26aulast%3DMurphy%26aufirst%3DR.%2BM.%26atitle%3DTransthyretin%2520mimetics%2520as%2520anti-%25CE%25B2-amyloid%2520agents%253A%2520a%2520comparison%2520of%2520peptide%2520and%2520protein%2520approaches%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D968%26epage%3D979%26doi%3D10.1002%2Fcmdc.201800031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posey, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buxbaum, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappu, R. V.</span></span> <span> </span><span class="NLM_article-title">Inhibition of amyloid beta fibril formation by monomeric human transthyretin</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1252</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1002/pro.3396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fpro.3396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=29498118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlyksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=1252-1261&author=K.+Garaiauthor=A.+E.+Poseyauthor=X.+Liauthor=J.+N.+Buxbaumauthor=R.+V.+Pappu&title=Inhibition+of+amyloid+beta+fibril+formation+by+monomeric+human+transthyretin&doi=10.1002%2Fpro.3396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of amyloid beta fibril formation by monomeric human transthyretin</span></div><div class="casAuthors">Garai, Kanchan; Posey, Ammon E.; Li, Xinyi; Buxbaum, Joel N.; Pappu, Rohit V.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1252-1261</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Transthyretin (TTR) is a homotetrameric protein that is found in the plasma and cerebrospinal fluid.  Dissocn. of TTR tetramers sets off a downhill cascade of amyloid formation through polymn. of monomeric TTR.  Interestingly, TTR has an addnl., biol. relevant activity, which pertains to its ability to slow the progression of amyloid beta (Aβ) assocd. pathol. in transgenic mice.  In vitro, both TTR and a kinetically stable variant of monomeric TTR (M-TTR) inhibit the fibril formation of Aβ1-40/42 mols.  Published evidence suggests that tetrameric TTR binds preferentially to Aβ monomers, thus destabilizing fibril formation by depleting the pool of Aβ monomers from aggregating mixts.  Here, we investigate the effects of M-TTR on the in vitro aggregation of Aβ1-42.  Our data confirm previous observations that fibril formation of Aβ is suppressed in the presence of sub-stoichiometric amts. of M-TTR.  Despite this, we find that sub-stoichiometric levels of M-TTR are not bona fide inhibitors of aggregation.  Instead, they co-aggregate with Aβ to promote the formation of large, micron-scale insol., non-fibrillar amorphous deposits.  Based on fluorescence correlation spectroscopy measurements, we find that M-TTR does not interact with monomeric Aβ.  Two-color coincidence anal. of the fluorescence bursts of Aβ and M-TTR labeled with different fluorophores shows that M-TTR co-assembles with sol. Aβ aggregates and this appears to drive the co-aggregation into amorphous ppts.  Our results suggest that mimicking the co-aggregation activity with protein-based therapeutics might be a worthwhile strategy for rerouting amyloid beta peptides into inert, insol., and amorphous deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMdzV8KWyTGbVg90H21EOLACvtfcHk0lhHe4QoL21cEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlyksbY%253D&md5=4b02a5bb17d2912438782d65f1629b58</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fpro.3396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3396%26sid%3Dliteratum%253Aachs%26aulast%3DGarai%26aufirst%3DK.%26aulast%3DPosey%26aufirst%3DA.%2BE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BN.%26aulast%3DPappu%26aufirst%3DR.%2BV.%26atitle%3DInhibition%2520of%2520amyloid%2520beta%2520fibril%2520formation%2520by%2520monomeric%2520human%2520transthyretin%26jtitle%3DProtein%2520Sci.%26date%3D2018%26volume%3D27%26spage%3D1252%26epage%3D1261%26doi%3D10.1002%2Fpro.3396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span> <span> </span><span class="NLM_article-title">Transthyretin: a multifaceted protein</span>. <i>Biomol. Concepts</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1515/bmc-2013-0038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1515%2Fbmc-2013-0038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=25372741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKmurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=45-54&author=M.+Vieiraauthor=M.+J.+Saraiva&title=Transthyretin%3A+a+multifaceted+protein&doi=10.1515%2Fbmc-2013-0038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin: a multifaceted protein</span></div><div class="casAuthors">Vieira, Marta; Saraiva, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular Concepts</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">BCIOB8</span>;
        ISSN:<span class="NLM_cas:issn">1868-5021</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Transthyretin is a highly conserved homotetrameric protein, mainly synthesized by the liver and the choroid plexus of brain.  The carrier role of TTR is well-known; however, many other functions have emerged, namely in the nervous system.  Behavior, cognition, neuropeptide amidation, neurogenesis, nerve regeneration, axonal growth and 14-3-3ζ metab. are some of the processes where TTR has an important role.  TTR aggregates are responsible for many amyloidosis such as familial amyloidotic polyneuropathy and cardiomyopathy.  Normal TTR can also aggregate and deposit in the heart of old people and in preeclampsia placental tissue.  Differences in TTR levels have been found in several neuropathologies, but its neuroprotective role, until now, was described in ischemia and Alzheimer's disease.  The aim of this review is to stress the relevance of TTR, besides its well-known role on transport of thyroxine and retinol-binding protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyXcOGE6oRy7Vg90H21EOLACvtfcHk0lhHe4QoL21cEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKmurbE&md5=5dfaf06a6cb8a0394d17d1586aa6a1e8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1515%2Fbmc-2013-0038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbmc-2013-0038%26sid%3Dliteratum%253Aachs%26aulast%3DVieira%26aufirst%3DM.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26atitle%3DTransthyretin%253A%2520a%2520multifaceted%2520protein%26jtitle%3DBiomol.%2520Concepts%26date%3D2014%26volume%3D5%26spage%3D45%26epage%3D54%26doi%3D10.1515%2Fbmc-2013-0038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serot, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couturier, M.</span></span> <span> </span><span class="NLM_article-title">Cerebrospinal fluid transthyretin: aging and late onset Alzheimer’s disease</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1136/jnnp.63.4.506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1136%2Fjnnp.63.4.506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=9343132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADyaK1c%252FgtFaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1997&pages=506-550&author=J.+M.+Serotauthor=D.+Christmannauthor=T.+Dubostauthor=M.+Couturier&title=Cerebrospinal+fluid+transthyretin%3A+aging+and+late+onset+Alzheimer%E2%80%99s+disease&doi=10.1136%2Fjnnp.63.4.506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease</span></div><div class="casAuthors">Serot J M; Christmann D; Dubost T; Couturier M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">506-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">The deposition of insoluble beta-amyloid protein fibrils is probably the central event in the pathogenesis of Alzheimer's disease.  Cerebrospinal fluid inhibits this fibril formation, likely by the intervention of one or several proteins binding to soluble beta-amyloid protein.  In vitro, transthyretin (TTR), a CSF protein, impedes amyloid fibrillogenesis.  Lowered concentrations of CSFTTR could therefore be associated with Alzheimer's disease.  Concentrations of TTR in CSF samples from 149 consecutive patients were assayed, using a kinetic nephelemetric method.  These concentrations were correlated positively with age, but were significantly lower in patients with Alzheimer's disease.  These data raise the possibility that amyloid fibril formation could be promoted in patients with late onset Alzheimer's disease by the lack of sufficient concentrations of TTR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOYErehQplYwMthz5_Rx5rfW6udTcc2eae4zPyhJ-4Wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c%252FgtFaqtQ%253D%253D&md5=7760afe63a5908e9bbbf5e85c6c840dd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.63.4.506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.63.4.506%26sid%3Dliteratum%253Aachs%26aulast%3DSerot%26aufirst%3DJ.%2BM.%26aulast%3DChristmann%26aufirst%3DD.%26aulast%3DDubost%26aufirst%3DT.%26aulast%3DCouturier%26aufirst%3DM.%26atitle%3DCerebrospinal%2520fluid%2520transthyretin%253A%2520aging%2520and%2520late%2520onset%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D1997%26volume%3D63%26spage%3D506%26epage%3D550%26doi%3D10.1136%2Fjnnp.63.4.506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldeiras, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span> <span> </span><span class="NLM_article-title">Transthyretin decrease in plasma of MCI and AD patients: investigation of mechanisms for disease modulation</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">889</span>, <span class="refDoi"> DOI: 10.2174/156720512803251057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.2174%2F156720512803251057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=22698061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1yhurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=881-889&author=C.+A.+Ribeiroauthor=I.+Santanaauthor=C.+Oliveiraauthor=I.+Baldeirasauthor=J.+Moreiraauthor=M.+J.+Saraivaauthor=I.+Cardoso&title=Transthyretin+decrease+in+plasma+of+MCI+and+AD+patients%3A+investigation+of+mechanisms+for+disease+modulation&doi=10.2174%2F156720512803251057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin decrease in plasma of MCI and AD patients: investigation of mechanisms for disease modulation</span></div><div class="casAuthors">Ribeiro, Carlos A.; Santana, Isabel; Oliveira, Catarina; Baldeiras, Ines; Moreira, Jorge; Saraiva, Maria Joao; Cardoso, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">881-889</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Different authors described that transthyretin (TTR) is decreased in the cerebrospinal fluid (CSF) of Alzheimer's disease (AD) patients and thus TTR is a potential CSF biomarker in AD.  However, descriptions of what happens to TTR in plasma of these patients are lacking in the literature.  The authors investigated TTR levels in plasma samples from 55 patients with mild-cognitive impairment (MCI), 56 patients with AD and 41 non-demented controls, and found that TTR is decreased in both MCI and AD groups, suggesting that TTR might be used for staging early AD.  In MCI and AD groups, women showed significantly lower plasma TTR levels when compared to MCI and AD men, resp., and to women control group.  In the AD women group, TTR levels correlated with disease stage, reflecting disease severity.  Although MCI and AD men groups presented TTR levels lower than men in the control group, the difference was not statistically significant.  Genetic anal. for ApoE revealed no relationship between TTR levels and the presence of the ε4 allele, for both men and women, in both patient groups.  Importantly, the authors assessed thyroxine binding to TTR in plasma and found, in both MCI and AD groups, that TTR had reduced capacity to carry the hormone.  Finally, the authors measured plasma estradiol levels in women and showed a redn. in both groups.  Thus, this study prompts TTR as an early plasma biomarker in AD indicating that disease modulation by TTR is gender dependent; this study provides hypotheses into the mechanisms involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTvYA3nXqQDLVg90H21EOLACvtfcHk0liuSiaEJpsOBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1yhurzL&md5=3bab515c300be0fab1a31ef6b59eae0b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F156720512803251057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720512803251057%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DC.%2BA.%26aulast%3DSantana%26aufirst%3DI.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DBaldeiras%26aufirst%3DI.%26aulast%3DMoreira%26aufirst%3DJ.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DCardoso%26aufirst%3DI.%26atitle%3DTransthyretin%2520decrease%2520in%2520plasma%2520of%2520MCI%2520and%2520AD%2520patients%253A%2520investigation%2520of%2520mechanisms%2520for%2520disease%2520modulation%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2012%26volume%3D9%26spage%3D881%26epage%3D889%26doi%3D10.2174%2F156720512803251057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span> <span> </span><span class="NLM_article-title">Human serum transthyretin levels correlate inversely with Alzheimer’s disease</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.3233/JAD-2011-102145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3233%2FJAD-2011-102145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=21335655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=77-84&author=S.+H.+Hanauthor=E.+S.+Jungauthor=J.+H.+Sohnauthor=H.+J.+Hongauthor=H.+S.+Hongauthor=J.+W.+Kimauthor=D.+L.+Naauthor=M.+Kimauthor=H.+Kimauthor=H.+J.+Haauthor=Y.+H.+Kimauthor=N.+Huhauthor=M.+W.+Jungauthor=I.+Mook-Jung&title=Human+serum+transthyretin+levels+correlate+inversely+with+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2011-102145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Human Serum Transthyretin Levels Correlate Inversely with Alzheimer's Disease</span></div><div class="casAuthors">Han, Sun-Ho; Jung, Eun Sun; Sohn, Ji-Hoon; Hong, Hyun Joo; Hong, Hyun Seok; Kim, Jong Won; Na, Duk Lyul; Kim, Manho; Kim, Hee; Ha, Hee Jin; Kim, Young Ho; Huh, Namjung; Jung, Min Whan; Mook-Jung, Inhee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the fastest growing neurodegenerative disease in the elderly population, and the search for therapeutic targets and diagnostic AD biomarkers is an exigent issue.  Because amyloid-β (Aβ) aggregation constitutes the epicenter of AD pathol., Aβ-binding proteins that regulate Aβ aggregation, such as transthyretin (TTR), have attracted much attention.  TTR binds to Aβ, prevents its aggregation, and consequently inhibits Aβ-induced cellular toxicity.  Decreased TTR levels in cerebrospinal fluid (CSF) from AD patients suggest that TTR is a biomarker of AD.  But, studies on TTR as a biomarker have focused on CSF; no study has evaluated peripheral levels of TTR in AD.  Here, we examd. the relationship between serum TTR levels and AD.  We measured TTR levels in serum samples from 90 nondemented controls and 111 AD patients and obsd. significantly lower serum TTR levels in AD (p < 0.001).  Notably, females in the control group had lower serum TTR levels compared with male in the control (p = 0.006), while no difference in gender was noted in the AD group.  There were no age-related changes in serum TTR levels.  Thus, this study demonstrates a clear neg. correlation between serum TTR levels and AD, suggesting that TTR is not only involved in AD pathol. process but also suggested as possible peripheral biomarker for AD diagnosis in serum level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2bGIIN2VFbVg90H21EOLACvtfcHk0lhUp-n76W3QBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSit74%253D&md5=8aa840966876bcc39fc97424f3343c47</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-102145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-102145%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DJung%26aufirst%3DE.%2BS.%26aulast%3DSohn%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DH.%2BJ.%26aulast%3DHong%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DNa%26aufirst%3DD.%2BL.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DHuh%26aufirst%3DN.%26aulast%3DJung%26aufirst%3DM.%2BW.%26aulast%3DMook-Jung%26aufirst%3DI.%26atitle%3DHuman%2520serum%2520transthyretin%2520levels%2520correlate%2520inversely%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D25%26spage%3D77%26epage%3D84%26doi%3D10.3233%2FJAD-2011-102145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velayudhan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Güntert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lourdusamy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovestone, S.</span></span> <span> </span><span class="NLM_article-title">Plasma transthyretin as a candidate marker for Alzheimer’s disease</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.3233/JAD-2011-110611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3233%2FJAD-2011-110611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=22002789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVertLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=369-375&author=L.+Velayudhanauthor=R.+Killickauthor=A.+Hyeauthor=A.+Kinseyauthor=A.+G%C3%BCntertauthor=S.+Lynhamauthor=M.+Wardauthor=R.+Leungauthor=A.+Lourdusamyauthor=A.+W.+Toauthor=J.+Powellauthor=S.+Lovestone&title=Plasma+transthyretin+as+a+candidate+marker+for+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2011-110611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma Transthyretin as a Candidate Marker for Alzheimer's Disease</span></div><div class="casAuthors">Velayudhan, Latha; Killick, Richard; Hye, Abdul; Kinsey, Anna; Guntert, Andreas; Lynham, Steven; Ward, Malcolm; Leung, Rufina; Lourdusamy, Anbarasu; To, Alvina W. M.; Powell, John; Lovestone, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">369-375</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Diagnosis of the progressive neurodegenerative disorder Alzheimer's disease (AD) can only definitively be made postmortem.  The most promising AD biomarkers identified to date are found in cerebrospinal fluid (CSF).  Among these, one of the most interesting candidates is transthyretin (TTR), the carrier of thyroxine and retinol, which also binds with amyloid-β (Aβ), and it has been suggested that it protects against Aβ deposition.  A biomarker detectable in plasma would have great diagnostic value and could be of use for detg. disease progression and the monitoring of therapeutic efficacy due to its greater accessibility over CSF-based markers.  We aimed to validate TTR as a prognostic marker in AD and to det. its relation with cognitive measures.  We examd. the plasma protein levels of TTR in 90 people with late-onset AD and 50 age-matched non-demented controls (NDC) by immunoblotting and found lower plasma TTR levels in AD compared to NDC (p = 0.004).  We then quantified plasma TTR by enzyme-linked immunosorbent assays in a larger independent cohort (n = 270) including subjects with mild to severe AD.  Plasma TTR levels were significantly lower in AD cases with rapid cognitive decline and with severe cognitive impairment.  Regression analyses showed plasma TTR levels also predicted cognitive decline over the ensuing 6 mo.  These data indicate that plasma TTR is a strong candidate AD biomarker that should be included in the development of blood based biomarker panels for disease diagnosis and also suggests that plasma TTR is a marker of disease severity and progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyk4X7q1SOk7Vg90H21EOLACvtfcHk0lhUp-n76W3QBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVertLc%253D&md5=c649917f74adaf8c0cc4c376be62e4b1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-110611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-110611%26sid%3Dliteratum%253Aachs%26aulast%3DVelayudhan%26aufirst%3DL.%26aulast%3DKillick%26aufirst%3DR.%26aulast%3DHye%26aufirst%3DA.%26aulast%3DKinsey%26aufirst%3DA.%26aulast%3DG%25C3%25BCntert%26aufirst%3DA.%26aulast%3DLynham%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DR.%26aulast%3DLourdusamy%26aufirst%3DA.%26aulast%3DTo%26aufirst%3DA.%2BW.%26aulast%3DPowell%26aufirst%3DJ.%26aulast%3DLovestone%26aufirst%3DS.%26atitle%3DPlasma%2520transthyretin%2520as%2520a%2520candidate%2520marker%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D28%26spage%3D369%26epage%3D375%26doi%3D10.3233%2FJAD-2011-110611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pate, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. M.</span></span> <span> </span><span class="NLM_article-title">Cerebrospinal fluid proteins as regulators of beta-amyloid aggregation and toxicity</span>. <i>Isr. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1002/ijch.201600078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fijch.201600078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=29129937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ohs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=602-612&author=K.+M.+Pateauthor=R.+M.+Murphy&title=Cerebrospinal+fluid+proteins+as+regulators+of+beta-amyloid+aggregation+and+toxicity&doi=10.1002%2Fijch.201600078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity</span></div><div class="casAuthors">Pate, Kayla M.; Murphy, Regina M.</div><div class="citationInfo"><span class="NLM_cas:title">Israel Journal of Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">602-612</span>CODEN:
                <span class="NLM_cas:coden">ISJCAT</span>;
        ISSN:<span class="NLM_cas:issn">0021-2148</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Amyloid disorders, such as Alzheimer's, are almost invariably late-onset diseases.  One defining diagnostic feature of Alzheimer's disease is the deposition of beta-amyloid as extracellular plaques, primarily in the hippocampus.  This raises the question: are there natural protective agents that prevent beta-amyloid from depositing, and is it loss of this protection that leads to onset of disease.  Proteins in cerebrospinal fluid (CSF) have been suggested to act as just such natural protective agents.  Here, we describe some of the early evidence that led to this suggestion, and we discuss, in greater detail, two CSF proteins that have garnered the bulk of the attention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRUaVQOrwMrbVg90H21EOLACvtfcHk0ljtiEdCr0AqmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ohs7c%253D&md5=1dac62ca9864485de6291117454dba4a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fijch.201600078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijch.201600078%26sid%3Dliteratum%253Aachs%26aulast%3DPate%26aufirst%3DK.%2BM.%26aulast%3DMurphy%26aufirst%3DR.%2BM.%26atitle%3DCerebrospinal%2520fluid%2520proteins%2520as%2520regulators%2520of%2520beta-amyloid%2520aggregation%2520and%2520toxicity%26jtitle%3DIsr.%2520J.%2520Chem.%26date%3D2017%26volume%3D57%26spage%3D602%26epage%3D612%26doi%3D10.1002%2Fijch.201600078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davidsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westman-Brinkmalm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindbjer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreasen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjögren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span> <span> </span><span class="NLM_article-title">Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients</span>. <i>Neuroreport</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">615</span>, <span class="refDoi"> DOI: 10.1097/00001756-200204160-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1097%2F00001756-200204160-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=11973456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFKktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=611-615&author=P.+Davidssonauthor=A.+Westman-Brinkmalmauthor=C.+L.+Nilssonauthor=M.+Lindbjerauthor=L.+Paulsonauthor=N.+Andreasenauthor=M.+Sj%C3%B6grenauthor=K.+Blennow&title=Proteome+analysis+of+cerebrospinal+fluid+proteins+in+Alzheimer+patients&doi=10.1097%2F00001756-200204160-00015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients</span></div><div class="casAuthors">Davidsson, Pia; Westman-Brinkmalm, Ann; Nilsson, Carol L.; Lindbjer, Maria; Paulson, Linda; Andreasen, Niels; Sjoegren, Magnus; Blennow, Kaj</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">611-615</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">By comparing the CSF proteome between Alzheimer disease (AD) patients and controls it may be possible to identify proteins that play a role in the disease process and thus to study the pathogenesis of AD.  We used mini-gel technol. in a two-dimensional electrophoresis procedure, sensitive SYPRO Ruby staining and mass spectrometry for clin. screening of disease-influenced CSF proteins in 15 AD patients and 12 controls.  The levels of six proteins and their isoforms, including proapolipoprotein, apolipoprotein E, β-2 microglobulin, retinol-binding protein, transthyretin, and ubiquitin, were significantly altered in CSF of AD patients.  The most prominently altered proteins were the apolipoproteins, esp. proapolipoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbJ1YZVvyqZrVg90H21EOLACvtfcHk0ljtiEdCr0AqmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFKktLs%253D&md5=54c1cd338404291f20628e092a82be7d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1097%2F00001756-200204160-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200204160-00015%26sid%3Dliteratum%253Aachs%26aulast%3DDavidsson%26aufirst%3DP.%26aulast%3DWestman-Brinkmalm%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DC.%2BL.%26aulast%3DLindbjer%26aufirst%3DM.%26aulast%3DPaulson%26aufirst%3DL.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DSj%25C3%25B6gren%26aufirst%3DM.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DProteome%2520analysis%2520of%2520cerebrospinal%2520fluid%2520proteins%2520in%2520Alzheimer%2520patients%26jtitle%3DNeuroreport%26date%3D2002%26volume%3D13%26spage%3D611%26epage%3D615%26doi%3D10.1097%2F00001756-200204160-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span> <span> </span><span class="NLM_article-title">Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">7380</span>– <span class="NLM_lpage">7388</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.22-17-07380.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1523%2FJNEUROSCI.22-17-07380.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=12196559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFCmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=7380-7388&author=T.+D.+Steinauthor=J.+A.+Johnson&title=Lack+of+neurodegeneration+in+transgenic+mice+overexpressing+mutant+amyloid+precursor+protein+is+associated+with+increased+levels+of+transthyretin+and+the+activation+of+cell+survival+pathways&doi=10.1523%2FJNEUROSCI.22-17-07380.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways</span></div><div class="casAuthors">Stein, Thor D.; Johnson, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7380-7388</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Tg2576 mice overexpress a mutant form of human amyloid precursor protein with the Swedish mutation (APPSw), resulting in high β-amyloid (Aβ) levels in the brain.  Despite this, amyloid plaques do not develop until 12 mo of age, and there is no neuronal loss in mice as old as 16 mo.  Gene expression profiles in the hippocampus and cerebellum of 6-mo-old APPSw mice were compared with age-matched controls.  The expression of transthyretin, a protein shown to sequester Aβ and prevent amyloid fibril formation in vitro, and several genes in the insulin-signaling pathway, e.g., insulin-like growth factor-2, were increased selectively in the hippocampus of APPSw mice.  Concomitant activation of the insulin-like growth factor-1 receptor, Akt, and extracellular signal-regulated protein kinase 1 and 2 as well as increased phosphorylation of Bad also were unique to the hippocampus of APPSw mice.  In addn., the increased expression of transthyretin and insulin-like growth factor-2 and the increased phosphorylation of Bad in hippocampal neurons were maintained in 12-mo-old APPSw mice when compared with age-matched controls.  These results suggest that the slow progression and lack of full-fledged Alzheimer's disease pathol. in the hippocampal neurons of APPSw mice result from the genetic reprogramming of neural cells to cope with increased levels of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf0bjlyYSWG7Vg90H21EOLACvtfcHk0liJbhyGlTiFZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFCmsLs%253D&md5=6b294e87ff29438db1364f3b99a44079</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-17-07380.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-17-07380.2002%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DT.%2BD.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26atitle%3DLack%2520of%2520neurodegeneration%2520in%2520transgenic%2520mice%2520overexpressing%2520mutant%2520amyloid%2520precursor%2520protein%2520is%2520associated%2520with%2520increased%2520levels%2520of%2520transthyretin%2520and%2520the%2520activation%2520of%2520cell%2520survival%2520pathways%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D7380%26epage%3D7388%26doi%3D10.1523%2FJNEUROSCI.22-17-07380.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buxbaum, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reixach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friske, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masliah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartfai, T.</span></span> <span> </span><span class="NLM_article-title">Transthyretin protects Alzheimer’s mice from the behavioral and biochemical effects of Aβ toxicity</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">2681</span>– <span class="NLM_lpage">2686</span>, <span class="refDoi"> DOI: 10.1073/pnas.0712197105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1073%2Fpnas.0712197105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=18272491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1yjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2681-2686&author=J.+N.+Buxbaumauthor=Z.+Yeauthor=N.+Reixachauthor=L.+Friskeauthor=C.+Levyauthor=P.+Dasauthor=T.+Goldeauthor=E.+Masliahauthor=A.+R.+Robertsauthor=T.+Bartfai&title=Transthyretin+protects+Alzheimer%E2%80%99s+mice+from+the+behavioral+and+biochemical+effects+of+A%CE%B2+toxicity&doi=10.1073%2Fpnas.0712197105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity</span></div><div class="casAuthors">Buxbaum, Joel N.; Ye, Zhengyi; Reixach, Natalia; Friske, Linsey; Levy, Coree; Das, Pritam; Golde, Todd; Masliah, Eliezer; Roberts, Amanda R.; Bartfai, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2681-2686</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cells that have evolved to produce large quantities of secreted proteins to serve the integrated functions of complex multicellular organisms are equipped to compensate for protein misfolding.  Hepatocytes and plasma cells have well developed chaperone and proteasome systems to ensure that secreted proteins transit the cell efficiently.  The no. of neurodegenerative disorders assocd. with protein misfolding suggests that neurons are particularly sensitive to the pathogenic effects of aggregates of misfolded mols. because those systems are less well developed in this lineage.  Aggregates of the amyloidogenic (Aβ1-42) peptide play a major role in the pathogenesis of Alzheimer's disease (AD), although the precise mechanism is unclear.  In genetic studies examg. protein-protein interactions that could constitute native mechanisms of neuroprotection in vivo, overexpression of a WT human transthyretin (TTR) transgene was ameliorative in the APP23 transgenic murine model of human AD.  Targeted silencing of the endogenous TTR gene accelerated the development of the neuropathol. phenotype.  Intraneuronal TTR was seen in the brains of normal humans and mice and in AD patients and APP23 mice.  The APP23 brains showed colocalization of extracellular TTR with AP in plaques.  Using surface plasmon resonance we obtained in vitro evidence of direct protein-protein interaction between TTR and Aβ aggregates.  These findings suggest that TTR is protective because of its capacity to bind toxic or pretoxic Aβ aggregates in both the intracellular and extracellular environment in a chaper-one-like manner.  The interaction may represent a unique normal host defense mechanism, enhancement of which could be therapeutically useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZznQdfQDwg7Vg90H21EOLACvtfcHk0liJbhyGlTiFZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1yjur8%253D&md5=07b152af53f06d57d8855a538d970e2f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0712197105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0712197105%26sid%3Dliteratum%253Aachs%26aulast%3DBuxbaum%26aufirst%3DJ.%2BN.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DReixach%26aufirst%3DN.%26aulast%3DFriske%26aufirst%3DL.%26aulast%3DLevy%26aufirst%3DC.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DGolde%26aufirst%3DT.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DA.%2BR.%26aulast%3DBartfai%26aufirst%3DT.%26atitle%3DTransthyretin%2520protects%2520Alzheimer%25E2%2580%2599s%2520mice%2520from%2520the%2520behavioral%2520and%2520biochemical%2520effects%2520of%2520A%25CE%25B2%2520toxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2681%26epage%3D2686%26doi%3D10.1073%2Fpnas.0712197105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anders, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Carli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span> <span> </span><span class="NLM_article-title">Neutralization of transthyretin reverses the neuroprotective effects of secreted Amyloid Precursor Protein (APP) in APPSw mice resulting in Tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">7707</span>– <span class="NLM_lpage">7717</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2211-04.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1523%2FJNEUROSCI.2211-04.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=15342738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1Oqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=7707-7717&author=T.+D.+Steinauthor=N.+J.+Andersauthor=C.+De+Carliauthor=S.+L.+Chanauthor=M.+P.+Mattsonauthor=J.+A.+Johnson&title=Neutralization+of+transthyretin+reverses+the+neuroprotective+effects+of+secreted+Amyloid+Precursor+Protein+%28APP%29+in+APPSw+mice+resulting+in+Tau+phosphorylation+and+loss+of+hippocampal+neurons%3A+support+for+the+amyloid+hypothesis&doi=10.1523%2FJNEUROSCI.2211-04.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons: Support for the amyloid hypothesis</span></div><div class="casAuthors">Stein, Thor D.; Anders, Nicholas J.; DeCarli, Charles; Chan, Sic L.; Mattson, Mark P.; Johnson, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">7707-7717</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) may be caused by the abnormal processing of the amyloid precursor protein (APP) and the accumulation of β-amyloid (Aβ).  The amyloid precursor protein can be proteolytically cleaved into multiple fragments, many of which have distinct biol. actions.  Although a high level of Aβ can be toxic, the α-secretase cleaved APP (sAPPα) is neuroprotective.  However, the mechanism of sAPPα protection is unknown.  The sAPPα increases the expression levels of several neuroprotective genes and protects organotypic hippocampal cultures from Aβ-induced tau phosphorylation and neuronal death.  Antibody interference and small interfering RNA knock-down demonstrate that the sAPPα-driven expression of transthyretin and insulin-like growth factor 2 is necessary for protection against Aβ-induced neuronal death.  Mice overexpressing mutant APP possess high levels of sAPPα and transthyretin and do not develop the tau phosphorylation or neuronal loss characteristic of human AD.  Chronic infusion of an antibody against transthyretin into the hippocampus of mice overexpressing APP with the Swedish mutation (APPSw) leads to increased Aβ, tau phosphorylation, and neuronal loss and apoptosis within the CA1 neuronal field.  Therefore, the elevated expression of transthyretin is mediated by sAPPα and protects APPSw mice from developing many of the neuropathologies obsd. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_CIiDkIw1CbVg90H21EOLACvtfcHk0lgS9_k5wnt_Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1Oqtr4%253D&md5=6e08733e5461c9becedb355f6880c3fa</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2211-04.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2211-04.2004%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DT.%2BD.%26aulast%3DAnders%26aufirst%3DN.%2BJ.%26aulast%3DDe%2BCarli%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DS.%2BL.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26atitle%3DNeutralization%2520of%2520transthyretin%2520reverses%2520the%2520neuroprotective%2520effects%2520of%2520secreted%2520Amyloid%2520Precursor%2520Protein%2520%2528APP%2529%2520in%2520APPSw%2520mice%2520resulting%2520in%2520Tau%2520phosphorylation%2520and%2520loss%2520of%2520hippocampal%2520neurons%253A%2520support%2520for%2520the%2520amyloid%2520hypothesis%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D7707%26epage%3D7717%26doi%3D10.1523%2FJNEUROSCI.2211-04.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span> <span> </span><span class="NLM_article-title">Transthyretin binding to A-beta peptide--impact on A-beta fibrillogenesis and toxicity</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>582</i></span>,  <span class="NLM_fpage">936</span>– <span class="NLM_lpage">942</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2008.02.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.febslet.2008.02.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=18295603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFyitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2008&pages=936-942&author=R.+Costaauthor=A.+Gon%C3%A7alvesauthor=M.+J.+Saraivaauthor=I.+Cardoso&title=Transthyretin+binding+to+A-beta+peptide%2D%2Dimpact+on+A-beta+fibrillogenesis+and+toxicity&doi=10.1016%2Fj.febslet.2008.02.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin binding to A-Beta peptide -Impact on A-Beta fibrillogenesis and toxicity</span></div><div class="casAuthors">Costa, R.; Goncalves, A.; Saraiva, M. J.; Cardoso, I.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">582</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">936-942</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">It has been suggested that transthyretin (TTR) is involved in preventing A-Beta fibrillization in Alzheimer's disease (AD).  Here, we characterized the TTR/A-Beta interaction by competition binding assays.  TTR binds to different A-Beta peptide species: sol. (Kd, 28 nM), oligomers and fibrils; diverse TTR variants bind differentially to A-Beta.  TEM anal. demonstrated that TTR is capable of interfering with A-Beta fibrillization by both inhibiting and disrupting fibril formation.  Co-incubation of the two mols. resulted in the abolishment of A-Beta toxicity.  Our results confirmed TTR as an A-Beta ligand and indicated the inhibition/disruption of A-Beta fibrils as a possible mechanism underlying the protective role of TTR in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFLjMqE4Vzj7Vg90H21EOLACvtfcHk0lgS9_k5wnt_Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFyitLw%253D&md5=6f61a15215bc5fea32e14f8cf68b696d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2008.02.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2008.02.034%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DR.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DA.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DCardoso%26aufirst%3DI.%26atitle%3DTransthyretin%2520binding%2520to%2520A-beta%2520peptide--impact%2520on%2520A-beta%2520fibrillogenesis%2520and%2520toxicity%26jtitle%3DFEBS%2520Lett.%26date%3D2008%26volume%3D582%26spage%3D936%26epage%3D942%26doi%3D10.1016%2Fj.febslet.2008.02.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span> <span> </span><span class="NLM_article-title">stability of the transthyretin molecule as a key factor in the interaction with A-beta peptide - relevance in Alzheimer’s disease</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e45368</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0045368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1371%2Fjournal.pone.0045368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=23028965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWjsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=C.+A.+Ribeiroauthor=M.+J.+Saraivaauthor=I.+Cardoso&title=stability+of+the+transthyretin+molecule+as+a+key+factor+in+the+interaction+with+A-beta+peptide+-+relevance+in+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0045368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Stability of the transthyretin molecule as a key factor in the interaction with A-Beta peptide - relevance in Alzheimer's disease</span></div><div class="casAuthors">Ribeiro, Carlos A.; Saraiva, Maria Joao; Cardoso, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e45368</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Transthyretin (TTR) protects against A-Beta toxicity by binding the peptide thus inhibiting its aggregation.  Previous work showed different TTR mutations interact differently with A-Beta, with increasing affinities correlating with decreasing amyloidogenicity of the TTR mutant; this did not impact on the levels of inhibition of A-Beta aggregation, as assessed by transmission electron microscopy.  Our work aimed at probing differences in binding to A-Beta by WT, T119M and L55P TTR using quant. assays, and at identifying factors affecting this interaction.  We addressed the impact of such factors in TTR ability to degrade A-Beta.  Using a dot blot approach with the anti-oligomeric antibody A11, we showed that A-Beta formed oligomers transiently, indicating aggregation and fibril formation, whereas in the presence of WT and T119M TTR the oligomers persisted longer, indicative that these variants avoided further aggregation into fibrils.  In contrast, L55PTTR was not able to inhibit oligomerization or to prevent evolution to aggregates and fibrils.  Furthermore, apoptosis assessment showed WT and T119M TTR were able to protect against A-Beta toxicity.  Because the amyloidogenic potential of TTR is inversely correlated with its stability, the use of drugs able to stabilize TTR tetrameric fold could result in increased TTR/A-Beta binding.  Here we showed that iododiflunisal, 3-dinitrophenol, resveratrol, [2-(3,5-dichlorophenyl)amino] (DCPA) and [4-(3,5-difluorophenyl)] (DFPB) were able to increase TTR binding to A-Beta; however only DCPA and DFPB improved TTR proteolytic activity.  Thyroxine, a TTR ligand, did not influence TTR/A-Beta interaction and A-Beta degrdn. by TTR, whereas RBP, another TTR ligand, not only obstructed the interaction but also inhibited TTR proteolytic activity.  Our results showed differences between WT and T119M TTR, and L55PTTR mutant regarding their interaction with A-Beta and prompt the stability of TTR as a key factor in this interaction, which may be relevant in AD pathogenesis and for the design of therapeutic TTR-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz7GYGzRGrDLVg90H21EOLACvtfcHk0lirbyvLIa1rCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWjsLzI&md5=2d431c7778452e72163669dabce3ac44</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0045368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0045368%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DC.%2BA.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DCardoso%26aufirst%3DI.%26atitle%3Dstability%2520of%2520the%2520transthyretin%2520molecule%2520as%2520a%2520key%2520factor%2520in%2520the%2520interaction%2520with%2520A-beta%2520peptide%2520-%2520relevance%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0045368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pamrén, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brännström, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golchin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iakovleva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandblad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharibyan, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, A.</span></span> <span> </span><span class="NLM_article-title">Transthyretin Interferes with Aβ Amyloid Formation by Redirecting Oligomeric Nuclei into Non-Amyloid Aggregates</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">2722</span>– <span class="NLM_lpage">2733</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2018.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.jmb.2018.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=29890120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCmsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2018&pages=2722-2733&author=L.+Nilssonauthor=A.+Pamr%C3%A9nauthor=T.+Islamauthor=K.+Br%C3%A4nnstr%C3%B6mauthor=S.+A.+Golchinauthor=N.+Petterssonauthor=I.+Iakovlevaauthor=L.+Sandbladauthor=A.+L.+Gharibyanauthor=A.+Olofsson&title=Transthyretin+Interferes+with+A%CE%B2+Amyloid+Formation+by+Redirecting+Oligomeric+Nuclei+into+Non-Amyloid+Aggregates&doi=10.1016%2Fj.jmb.2018.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin Interferes with Aβ Amyloid Formation by Redirecting Oligomeric Nuclei into Non-Amyloid Aggregates</span></div><div class="casAuthors">Nilsson, Lina; Pamren, Annelie; Islam, Tohidul; Braennstroem, Kristoffer; Golchin, Solmaz A.; Pettersson, Nina; Iakovleva, Irina; Sandblad, Linda; Gharibyan, Anna L.; Olofsson, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2722-2733</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The pathol. Aβ aggregates assocd. with Alzheimer's disease follow a nucleation-dependent path of formation.  A nucleus represents an oligomeric assembly of Aβ peptides that acts as a template for subsequent incorporation of monomers to form a fibrillar structure.  Nuclei can form de novo or via surface-catalyzed secondary nucleation, and the combined rates of elongation and nucleation control the overall rate of fibril formation.  Transthyretin (TTR) obstructs Aβ fibril formation in favor of alternative non-fibrillar assemblies, but the mechanism behind this activity is not fully understood.  This study shows that TTR does not significantly disturb fibril elongation; rather, it effectively interferes with the formation of oligomeric nuclei.  We demonstrate that this interference can be modulated by altering the relative contribution of elongation and nucleation, and we show how TTR's effects can range from being essentially ineffective to almost complete inhibition of fibril formation without changing the concn. of TTR or monomeric Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzrSVXFPuNvbVg90H21EOLACvtfcHk0lirbyvLIa1rCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCmsbbJ&md5=85815a1f5a2aa5b78283b048d25523c5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2018.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2018.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DL.%26aulast%3DPamr%25C3%25A9n%26aufirst%3DA.%26aulast%3DIslam%26aufirst%3DT.%26aulast%3DBr%25C3%25A4nnstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DGolchin%26aufirst%3DS.%2BA.%26aulast%3DPettersson%26aufirst%3DN.%26aulast%3DIakovleva%26aufirst%3DI.%26aulast%3DSandblad%26aufirst%3DL.%26aulast%3DGharibyan%26aufirst%3DA.%2BL.%26aulast%3DOlofsson%26aufirst%3DA.%26atitle%3DTransthyretin%2520Interferes%2520with%2520A%25CE%25B2%2520Amyloid%2520Formation%2520by%2520Redirecting%2520Oligomeric%2520Nuclei%2520into%2520Non-Amyloid%2520Aggregates%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D430%26spage%3D2722%26epage%3D2733%26doi%3D10.1016%2Fj.jmb.2018.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span> <span> </span><span class="NLM_article-title">Transthyretin stability is critical in assisting beta amyloid clearance-Relevance of transthyretin stabilization in Alzheimer’s disease</span>. <i>CNS Neurosci. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1111/cns.12707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1111%2Fcns.12707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28570028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKitrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=605-619&author=M.+Alemiauthor=S.+C.+Silvaauthor=I.+Santanaauthor=I.+Cardoso&title=Transthyretin+stability+is+critical+in+assisting+beta+amyloid+clearance-Relevance+of+transthyretin+stabilization+in+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fcns.12707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease</span></div><div class="casAuthors">Alemi, Mobina; Silva, Sara C.; Santana, Isabel; Cardoso, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : The absence of transthyretin (TTR) in AD mice decreases brain Aβ clearance and reduces the low-d. lipoprotein receptor-related protein 1 (LRP1).  It is possible that neuroprotection by TTR is dependent on its tetramer structural stability, as studies using TTR mutants showed that unstable L55P TTR has low affinity for Aβ, and TTR tetrameric stabilizers such as iododiflunisal ameliorate AD features in vivo.  Methods : We firstly investigated TTR folding status in human plasma measuring the resistance to urea denaturation.  The importance of TTR stability on Aβ internalization was studied in human cerebral microvascular endothelial (hCMEC/D3) and hepatoma cells (HepG2), by flow cytometry.  To investigate the fate of Aβ at the blood-brain barrier, Aβ efflux from hCMEC/D3 cells seeded on transwells was measured using ELISA.  Further, to assess Aβ colocalization with lysosomes, Lysotracker was used.  Moreover, levels of LRP1 were assessed in the liver and plasma of mice with different TTR backgrounds or treated with iododiflunisal.  Results : We showed that TTR stability is decreased in AD and that WT TTR and drug-stabilized L55P TTR are able to increase uptake of Aβ.  Furthermore, measurement of Aβ efflux showed that stable or stabilized TTR increased Aβ efflux from the basolateral to the apical side.  Moreover, HepG2 cells incubated with Aβ in the presence of WT TTR, but not L55P TTR, showed an increased no. of lysosomes.  Further, in the presence of WT TTR, Aβ peptide colocalized with lysosomes, indicating that only stable TTR assists Aβ internalization, leading to its degrdn.  Finally, we demonstrated that only stable TTR can increase LRP1 levels.  Conclusion : TTR stabilization exerts a pos. effect on Aβ clearance and LRP1 levels, suggesting that TTR protective role in AD is dependent on its stability.  These results provide relevant information for the design of TTR-based therapeutic strategies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrKmDdsa4lU7Vg90H21EOLACvtfcHk0lgcbslSCbpdUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKitrvE&md5=df944637335b6c7e67728794b4bbbdb9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fcns.12707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcns.12707%26sid%3Dliteratum%253Aachs%26aulast%3DAlemi%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DS.%2BC.%26aulast%3DSantana%26aufirst%3DI.%26aulast%3DCardoso%26aufirst%3DI.%26atitle%3DTransthyretin%2520stability%2520is%2520critical%2520in%2520assisting%2520beta%2520amyloid%2520clearance-Relevance%2520of%2520transthyretin%2520stabilization%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2017%26volume%3D23%26spage%3D605%26epage%3D619%26doi%3D10.1111%2Fcns.12707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerschen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planté-Bordeneuve, V.</span></span> <span> </span><span class="NLM_article-title">Current and future treatment approaches in transthyretin Familial Amyloid Polyneuropathy</span>. <i>Curr. Treat. Options Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">53</span>, <span class="refDoi"> DOI: 10.1007/s11940-016-0436-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1007%2Fs11940-016-0436-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=27873215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BC2snptVSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=53&author=P.+Kerschenauthor=V.+Plant%C3%A9-Bordeneuve&title=Current+and+future+treatment+approaches+in+transthyretin+Familial+Amyloid+Polyneuropathy&doi=10.1007%2Fs11940-016-0436-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy</span></div><div class="casAuthors">Kerschen Philippe; Plante-Bordeneuve Violaine; Plante-Bordeneuve Violaine</div><div class="citationInfo"><span class="NLM_cas:title">Current treatment options in neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">53</span>
        ISSN:<span class="NLM_cas:issn">1092-8480</span>.
    </div><div class="casAbstract">OPINION STATEMENT:  Treatment of transthyretin familial amyloid polyneuropathy (TTR FAP) must be tailored to disease stage.  Patients with early stage disease (i.e., without major impairment in walking ability), especially younger patients, should be referred as soon as possible for liver transplantation (LT) in the absence of major comorbid conditions.  LT remains the most effective treatment option to date and should be offered to these patients as early as possible.  Bridging therapy with an oral TTR stabilizer (tafamidis or diflunisal, according to local access to these treatments) should be started as soon as the diagnosis of TTR FAP is established.  Early stage patients who do not wish to or have contraindications to LT should be treated with an oral TTR stabilizer or get access to the newly developed therapeutic options (IONIS TTR-Rx, patisiran, doxycycline/TUDCA).  Late stage patients (presenting with significant walking impairment) are usually older and notoriously difficult to treat.  They should be offered an oral TTR stabilizer but are not candidates for LT due to a significant rate of perioperative complications and increased risk of progressive neurological and especially cardiac disease despite LT.  Access to the different therapies in development should also be considered depending on respective inclusion and exclusion criteria.  The abovementioned treatment options were mostly validated in Val30Met mutation patients, but should also be offered to non-Val30Met patients, although mortality rates after LT are higher in these patients.  Treatment decisions should be made on an individual basis.  Screening for heart, eye, and renal involvement is mandatory for every patient at disease diagnosis and regularly thereafter, even in transplanted patients.  Symptomatic treatment should be offered as needed, as well as genetic counseling to at-risk family members.  Asymptomatic mutation carriers should benefit from regular screening for early symptoms of disease.  Current therapeutic management of TTR FAP will hopefully be changed in the near future with data from the ongoing phase 2/3 studies testing the TTR gene silencing agents.  In the longer term, it is likely that combined therapeutic approaches will be necessary to reverse the disease process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJfr6oNEsYE5ggzHGM8X5CfW6udTcc2eaNx1y0a_FxX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snptVSqtg%253D%253D&md5=1b59079c6a8ab55941bb2aaf7c252d47</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs11940-016-0436-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11940-016-0436-z%26sid%3Dliteratum%253Aachs%26aulast%3DKerschen%26aufirst%3DP.%26aulast%3DPlant%25C3%25A9-Bordeneuve%26aufirst%3DV.%26atitle%3DCurrent%2520and%2520future%2520treatment%2520approaches%2520in%2520transthyretin%2520Familial%2520Amyloid%2520Polyneuropathy%26jtitle%3DCurr.%2520Treat.%2520Options%2520Neurol.%26date%3D2016%26volume%3D18%26spage%3D53%26doi%3D10.1007%2Fs11940-016-0436-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gales, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damas, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span> <span> </span><span class="NLM_article-title">Small Transthyretin (TTR) Ligands as Possible Therapeutic Agents in TTR Amyloidoses</span>. <i>Curr. Drug Targets CNS Neurol. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.2174/156800705774322076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.2174%2F156800705774322076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=16266291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2gsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=587-596&author=M.+R.+Almeidaauthor=L.+Galesauthor=A.+M.+Damasauthor=I.+Cardosoauthor=M.+J.+Saraiva&title=Small+Transthyretin+%28TTR%29+Ligands+as+Possible+Therapeutic+Agents+in+TTR+Amyloidoses&doi=10.2174%2F156800705774322076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidosis</span></div><div class="casAuthors">Almeida, M. R.; Gales, L.; Damas, A. M.; Cardoso, I.; Saraiva, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">587-596</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  In transthyretin (TTR) amyloidosis TTR variants deposit as amyloid fibrils giving origin, in most cases, to peripheral polyneuropathy, cardiomyopathy, carpal tunnel syndrome and/or amyloid deposition in the eye.  More than eighty TTR variants are known, most of them being pathogenic.  The mechanism of TTR fibril formation is still not completely elucidated.  However it is widely accepted that the amino acid substitutions in the TTR variants contribute to a destabilizing effect on the TTR tetramer mol., which in particular conditions dissoc. into non native monomeric intermediates that aggregate and polymerize in amyloid fibrils that further elongate.  Since this is a multi-step process there is the possibility to impair TTR amyloid fibril formation at different stages of the process namely by tetramer stabilization, inhibition of fibril formation or fibril disruption.  Till now the only efficient therapy available is liver transplant when performed in an early phase of the onset of the disease symptoms.  Since this is a very invasive therapy alternatives are desirable.  In that sense, several compds. have been proposed to impair amyloid formation or disruption.  Based on the proposed mechanism for TTR amyloid fibril formation we discuss the action of some of the proposed TTR stabilizers such as derivs. of some NSAIDs (diflunisal, diclofenac, flufenamic acid, and derivs.) and the action of amyloid disrupters such as 4'-iodo-4'-deoxydoxorubicin (I-DOX) and tetracyclines.  Among all these compds., TTR stabilizers seems to be the most interesting since they would impair very early the process of amyloid formation and could also have a prophylactic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdNXW22cs8UbVg90H21EOLACvtfcHk0lgTnUfOgPN-Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2gsLrL&md5=5587e7a5c156e29c1772f5b7bb4f4107</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F156800705774322076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800705774322076%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DM.%2BR.%26aulast%3DGales%26aufirst%3DL.%26aulast%3DDamas%26aufirst%3DA.%2BM.%26aulast%3DCardoso%26aufirst%3DI.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26atitle%3DSmall%2520Transthyretin%2520%2528TTR%2529%2520Ligands%2520as%2520Possible%2520Therapeutic%2520Agents%2520in%2520TTR%2520Amyloidoses%26jtitle%3DCurr.%2520Drug%2520Targets%2520CNS%2520Neurol.%2520Disord.%26date%3D2005%26volume%3D4%26spage%3D587%26epage%3D596%26doi%3D10.2174%2F156800705774322076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span> <span> </span><span class="NLM_article-title">Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1042/BJ20040011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1042%2FBJ20040011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=15080795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslGntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2004&pages=351-356&author=M.+R.+Almeidaauthor=B.+Macedoauthor=I.+Cardosoauthor=I.+Alvesauthor=G.+Valenciaauthor=G.+Arsequellauthor=A.+Planasauthor=M.+J.+Saraiva&title=Selective+binding+to+transthyretin+and+tetramer+stabilization+in+serum+from+patients+with+familial+amyloidotic+polyneuropathy+by+an+iodinated+diflunisal+derivative&doi=10.1042%2FBJ20040011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative</span></div><div class="casAuthors">Almeida, Maria Rosario; Macedo, Barbara; Cardoso, Isabel; Alves, Isabel; Valencia, Gregorio; Arsequell, Gemma; Planas, Antoni; Saraiva, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-356</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">In familial amyloidotic polyneuropathy, TTR (transthyretin) variants are deposited as amyloid fibrils.  It is thought that this process involves TTR tetramer dissocn., which leads to partially unfolded monomers that aggregate and polymerize into amyloid fibrils.  This process can be counteracted by stabilization of the tetramer.  Several small compds., such as diclofenac, diflunisal and flufenamic acid, have been reported to bind to TTR in vitro, in the T4 (thyroxine) binding channel that runs through the TTR tetramer, and consequently are considered to stabilize TTR.  However, if these agents bind plasma proteins other than TTR, decreased drug availability will occur, compromising their use as therapeutic agents for TTR amyloidosis.  In the present work, the authors compared the action of these compds. and of new derivs. designed to increase both selectivity of binding to TTR and inhibitory potency in relation to TTR amyloid fibril formation.  The authors found two diflunisal derivs. that, in contrast with diclofenac, flufenamic acid and diflunisal, displaced T4 from TTR in plasma preferentially over binding to albumin and thyroxine binding globulin.  The same diflunisal derivs. also had a stabilizing effect on TTR tetramers in plasma, as studied by isoelec. focusing of whole plasma under semi-denaturing conditions.  In addn., by TEM, the authors demonstrated that, in contrast with other proposed TTR stabilizers (namely diclofenac, flufenamic acid and diflunisal), one of the diflunisal derivs. tested efficiently inhibited TTR aggregation.  Taken together, our ex vivo and in vitro studies present evidence for the selectivity and efficiency of novel diflunisal derivs. as TTR stabilizers and as inhibitors of fibril formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7yUhh-llFj7Vg90H21EOLACvtfcHk0lhWYchJmZs4MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslGntr8%253D&md5=02ccfa2b447c263613ea8b7bf95eb49a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1042%2FBJ20040011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20040011%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DM.%2BR.%26aulast%3DMacedo%26aufirst%3DB.%26aulast%3DCardoso%26aufirst%3DI.%26aulast%3DAlves%26aufirst%3DI.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DPlanas%26aufirst%3DA.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26atitle%3DSelective%2520binding%2520to%2520transthyretin%2520and%2520tetramer%2520stabilization%2520in%2520serum%2520from%2520patients%2520with%2520familial%2520amyloidotic%2520polyneuropathy%2520by%2520an%2520iodinated%2520diflunisal%2520derivative%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D381%26spage%3D351%26epage%3D356%26doi%3D10.1042%2FBJ20040011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekijima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamski-Werner, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span> <span> </span><span class="NLM_article-title">Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidosis</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">911</span>– <span class="NLM_lpage">921</span>, <span class="refDoi"> DOI: 10.1021/ar020073i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar020073i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWnurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2005&pages=911-921&author=S.+M.+Johnsonauthor=R.+L.+Wisemanauthor=Y.+Sekijimaauthor=N.+S.+Greenauthor=S.+L.+Adamski-Wernerauthor=J.+W.+Kelly&title=Native+state+kinetic+stabilization+as+a+strategy+to+ameliorate+protein+misfolding+diseases%3A+a+focus+on+the+transthyretin+amyloidosis&doi=10.1021%2Far020073i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Native State Kinetic Stabilization as a Strategy To Ameliorate Protein Misfolding Diseases: A Focus on the Transthyretin Amyloidoses</span></div><div class="casAuthors">Johnson, Steven M.; Wiseman, R. Luke; Sekijima, Yoshiki; Green, Nora S.; Adamski-Werner, Sara L.; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">911-921</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Small mol.-mediated protein stabilization inside or outside of the cell is a promising strategy to treat protein misfolding/misassembly diseases.  Herein we focus on the transthyretin (TTR) amyloidoses and demonstrate that preferential ligand binding to and stabilization of the native state over the dissociative transition state raises the kinetic barrier of dissocn. (rate-limiting for amyloidogenesis), slowing and in many cases preventing TTR amyloid fibril formation.  Since T119M-TTR subunit incorporation into tetramers otherwise composed of disease-assocd. subunits also imparts kinetic stability on the tetramer and ameliorates amyloidosis in humans, it is likely that small mol.-mediated native state kinetic stabilization will also alleviate TTR amyloidoses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO_-e1jnwgLbVg90H21EOLACvtfcHk0lhWYchJmZs4MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWnurvO&md5=864588505ec798d1fd87ce3423320af4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Far020073i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far020073i%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DWiseman%26aufirst%3DR.%2BL.%26aulast%3DSekijima%26aufirst%3DY.%26aulast%3DGreen%26aufirst%3DN.%2BS.%26aulast%3DAdamski-Werner%26aufirst%3DS.%2BL.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DNative%2520state%2520kinetic%2520stabilization%2520as%2520a%2520strategy%2520to%2520ameliorate%2520protein%2520misfolding%2520diseases%253A%2520a%2520focus%2520on%2520the%2520transthyretin%2520amyloidosis%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2005%26volume%3D38%26spage%3D911%26epage%3D921%26doi%3D10.1021%2Far020073i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nencetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span> <span> </span><span class="NLM_article-title">TTR fibril formation inhibitors: is there a SAR?</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2356</span>– <span class="NLM_lpage">2379</span>, <span class="refDoi"> DOI: 10.2174/092986712800269326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.2174%2F092986712800269326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=22471984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1egsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=2356-2379&author=S.+Nencettiauthor=E.+Orlandini&title=TTR+fibril+formation+inhibitors%3A+is+there+a+SAR%3F&doi=10.2174%2F092986712800269326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">TTR fibril formation inhibitors: is there a SAR?</span></div><div class="casAuthors">Nencetti, S.; Orlandini, E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2356-2379</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Transthyretin is a homotetrameric protein that carries thyroxine and retinol binding protein in plasma and is assocd. with a variety of amyloid diseases.  One approach to the potential treatment of TTR amyloidosis is the stabilization of the native tetramer, over the dissociative transition state, through the binding of small mols.; this increases the kinetic barrier for tetramer dissocn. and prevents protein misfolding.  Several mols. discovered through focused screening, or created utilizing the structure-based design, were studied to identify the structural features that could make up for a good candidate drug.  In this review, we examine several different chem. classes of TTR fibril formation inhibitors, highlighting the structural modifications that have led to an improvement or to a decrease of their potency and/or selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFCEaKYu7bnbVg90H21EOLACvtfcHk0liUqDexJuXUmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1egsro%253D&md5=1cdf556f5cedc4f1c83168d018ce1e07</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F092986712800269326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712800269326%26sid%3Dliteratum%253Aachs%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DOrlandini%26aufirst%3DE.%26atitle%3DTTR%2520fibril%2520formation%2520inhibitors%253A%2520is%2520there%2520a%2520SAR%253F%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D2356%26epage%3D2379%26doi%3D10.2174%2F092986712800269326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berk, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhr, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekijima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heneghan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldenrust, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorevic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisbee, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyck, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obici, L.</span></span> <span> </span><span class="NLM_article-title">Familial amyloidosis consortium. the diflunisal trial: study accrual and drug tolerance</span>. <i>Amyloid</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.3109/13506129.2012.678509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3109%2F13506129.2012.678509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=22551208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsF2rsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=37-38&author=J.+L.+Berkauthor=O.+B.+Suhrauthor=Y.+Sekijimaauthor=T.+Yamashitaauthor=M.+Heneghanauthor=S.+R.+Zeldenrustauthor=Y.+Andoauthor=S.+Ikedaauthor=P.+Gorevicauthor=G.+Merliniauthor=J.+W.+Kellyauthor=M.+Skinnerauthor=A.+B.+Bisbeeauthor=P.+J.+Dyckauthor=L.+Obici&title=Familial+amyloidosis+consortium.+the+diflunisal+trial%3A+study+accrual+and+drug+tolerance&doi=10.3109%2F13506129.2012.678509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The Diflunisal Trial: Study accrual and drug tolerance</span></div><div class="casAuthors">Berk, John L.; Suhr, Ole B.; Sekijima, Yoshiki; Yamashita, Taro; Heneghan, Michael; Zeldenrust, Steven R.; Ando, Yukio; Ikeda, Shu-ichi; Gorevic, Peter; Merlini, Giampaolo; Kelly, Jeffrey W.; Skinner, Martha; Bisbee, Alice B.; Dyck, Peter J.; Obici, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Amyloid</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">37-38</span>CODEN:
                <span class="NLM_cas:coden">AIJIET</span>;
        ISSN:<span class="NLM_cas:issn">1350-6129</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Familial amyloidotic polyneuropathy (FAP) is a protein folding disorder that induces neuropathy and cardiomyopathy, leading to death within 7-15 years after onset of clin. disease.  In vitro, small ligands binding the thyroid hormone docking site stabilize tetrameric transthyretin, inhibiting amyloid fibril formation.  We undertook a randomized, placebo-controlled clin. trial to det. whether diflunisal, a well-known non-steroidal anti-inflammatory drug (NSAID) alters neurol. disease progression in FAP.  We enrolled 130 subjects with wide age and FAP mutation representation.  To date, few recognized complications of NSAIDs have occurred in the study cohort.  Data collection will be completed by Nov. 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAhVf5wQzYqrVg90H21EOLACvtfcHk0liUqDexJuXUmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsF2rsbk%253D&md5=b0cef903001d53bbc743b99ffc575a1d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3109%2F13506129.2012.678509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F13506129.2012.678509%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DJ.%2BL.%26aulast%3DSuhr%26aufirst%3DO.%2BB.%26aulast%3DSekijima%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DHeneghan%26aufirst%3DM.%26aulast%3DZeldenrust%26aufirst%3DS.%2BR.%26aulast%3DAndo%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DGorevic%26aufirst%3DP.%26aulast%3DMerlini%26aufirst%3DG.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DSkinner%26aufirst%3DM.%26aulast%3DBisbee%26aufirst%3DA.%2BB.%26aulast%3DDyck%26aufirst%3DP.%2BJ.%26aulast%3DObici%26aufirst%3DL.%26atitle%3DFamilial%2520amyloidosis%2520consortium.%2520the%2520diflunisal%2520trial%253A%2520study%2520accrual%2520and%2520drug%2520tolerance%26jtitle%3DAmyloid%26date%3D2012%26volume%3D19%26spage%3D37%26epage%3D38%26doi%3D10.3109%2F13506129.2012.678509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulawa, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planté-Bordeneuve, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaudinière, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mundayat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huertas, P.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action and clinical application of Tafamidis in hereditary transthyretin amyloidosis</span>. <i>Neurol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1007/s40120-016-0040-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1007%2Fs40120-016-0040-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=26894299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BC28jit12rtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=1-25&author=T.+Coelhoauthor=G.+Merliniauthor=C.+E.+Bulawaauthor=J.+A.+Flemingauthor=D.+P.+Judgeauthor=J.+W.+Kellyauthor=M.+S.+Maurerauthor=V.+Plant%C3%A9-Bordeneuveauthor=R.+Labaudini%C3%A8reauthor=R.+Mundayatauthor=S.+Rileyauthor=I.+Lombardoauthor=P.+Huertas&title=Mechanism+of+action+and+clinical+application+of+Tafamidis+in+hereditary+transthyretin+amyloidosis&doi=10.1007%2Fs40120-016-0040-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis</span></div><div class="casAuthors">Coelho Teresa; Merlini Giampaolo; Bulawa Christine E; Fleming James A; Judge Daniel P; Kelly Jeffery W; Maurer Mathew S; Plante-Bordeneuve Violaine; Labaudiniere Richard; Mundayat Rajiv; Riley Steve; Lombardo Ilise; Huertas Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Neurology and therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-25</span>
        ISSN:<span class="NLM_cas:issn">2193-8253</span>.
    </div><div class="casAbstract">Transthyretin (TTR) transports the retinol-binding protein-vitamin A complex and is a minor transporter of thyroxine in blood.  Its tetrameric structure undergoes rate-limiting dissociation and monomer misfolding, enabling TTR to aggregate or to become amyloidogenic.  Mutations in the TTR gene generally destabilize the tetramer and/or accelerate tetramer dissociation, promoting amyloidogenesis.  TTR-related amyloidoses are rare, fatal, protein-misfolding disorders, characterized by formation of soluble aggregates of variable structure and tissue deposition of amyloid.  The TTR amyloidoses present with a spectrum of manifestations, encompassing progressive neuropathy and/or cardiomyopathy.  Until recently, the only accepted treatment to halt progression of hereditary TTR amyloidosis was liver transplantation, which replaces the hepatic source of mutant TTR with the less amyloidogenic wild-type TTR.  Tafamidis meglumine is a rationally designed, non-NSAID benzoxazole derivative that binds with high affinity and selectivity to TTR and kinetically stabilizes the tetramer, slowing monomer formation, misfolding, and amyloidogenesis.  Tafamidis is the first pharmacotherapy approved to slow the progression of peripheral neurologic impairment in TTR familial amyloid polyneuropathy.  Here we describe the mechanism of action of tafamidis and review the clinical data, demonstrating that tafamidis treatment slows neurologic deterioration and preserves nutritional status, as well as quality of life in patients with early-stage Val30Met amyloidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcjwtDHHoc2pQHPYJuLg8TfW6udTcc2eZinzo_aISL27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jit12rtA%253D%253D&md5=cbf6666ed975691337c8b2f351036d7f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs40120-016-0040-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40120-016-0040-x%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DT.%26aulast%3DMerlini%26aufirst%3DG.%26aulast%3DBulawa%26aufirst%3DC.%2BE.%26aulast%3DFleming%26aufirst%3DJ.%2BA.%26aulast%3DJudge%26aufirst%3DD.%2BP.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DMaurer%26aufirst%3DM.%2BS.%26aulast%3DPlant%25C3%25A9-Bordeneuve%26aufirst%3DV.%26aulast%3DLabaudini%25C3%25A8re%26aufirst%3DR.%26aulast%3DMundayat%26aufirst%3DR.%26aulast%3DRiley%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DI.%26aulast%3DHuertas%26aufirst%3DP.%26atitle%3DMechanism%2520of%2520action%2520and%2520clinical%2520application%2520of%2520Tafamidis%2520in%2520hereditary%2520transthyretin%2520amyloidosis%26jtitle%3DNeurol.%2520Ther.%26date%3D2016%26volume%3D5%26spage%3D1%26epage%3D25%26doi%3D10.1007%2Fs40120-016-0040-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nencetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span> <span> </span><span class="NLM_article-title">Tafamidis (Vyndaqel): A light for FAP patients</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1617</span>– <span class="NLM_lpage">1619</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fcmdc.201300245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=24000164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGlur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1617-1619&author=S.+Nencettiauthor=A.+Rosselloauthor=E.+Orlandini&title=Tafamidis+%28Vyndaqel%29%3A+A+light+for+FAP+patients&doi=10.1002%2Fcmdc.201300245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tafamidis (Vyndaqel): A Light for FAP Patients</span></div><div class="casAuthors">Nencetti, Susanna; Rossello, Armando; Orlandini, Elisabetta</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1617-1619</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Transthyretin familial amyloid polyneuropathies (TTR- FAP) are a rare form of autosomal-dominant amyloidosis characterized by extracellular deposition of TTRamyloid fibrils resulting from TTR misfolding.  This pathol. induces nerve lesions and polyneuropathy, particularly in the peripheral nervous system.  Native-state kinetic stabilization of the TTR tetramer by small mols. acting in a similar manner to the natural hormone T4 is recognized as a potential therapeutic strategy in preventνing TTR amyloid fibril formation, offering a potential alternative to liver transplantation for the treatment of patients with FAP.  In Dec. 2012, a well- known USFDA-approved nonsteroidal anti-inflammatory drug, diflunisal, completed clin. trials in FAP patients.  However, its primary activity eventually becomes a side effect in the theraνpy of FAP patients.  In conjunction with Pfizer, Kelly's group recently received approval by the European Medicines Agency for tafamidis meglumine (Fx-1006A, trade name Vyndaqel) in the treatment of FAP.  This compd. lacks the anti-inflammatory activity (present in NSAIDs) contraindicated for patients with cardiomyopathy.  This important advance originated from the observation that the benzoxazole scaffold, appropriately substituted with a carboxylic acid at C4-C7, and with a halogenated Ph ring at C2, is a good fit for the TTR binding site.  On the basis of promising results obtained from preclin. studies, tafamidis was selected for clin. development, on the hypothesis that it could halt or slow the progression of neurodegeneration in FAP patients.  A randomized placebo-controlled double-blind trial in patients with TTR-FAP was carried out to evaluate the ability of tafamidis to stabilize the TTR tetramer and the clin. progression of the disease over 18 mo.  Tafamidis was administered orally at 20 mg per day as a single dose to patients.  The results indicated that relative to placebo control, tafamidis can delay peripheral neurol. deterioration, preserve nerve fiber function, and maintain nutritional status over the clin. trial period, supporting the hypothesis that preventing TTR tetramer dissocn. with tafamidis can slow the neurodegenerative process.  The limited duraνtion of the clin. trial did not afford ests. of long-term effects, such as side effects that result from stabilization of the TTR tetramer, survival of TTR-FAP patients, and non-neurol. manifestation of disease such as cardiomyopathy.  In concluνsion, further studies will evaluate whether tafamidis could become a viable therapeutic treatment that slows disease progression, providing a light for FAP patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWVq_IkPtnx7Vg90H21EOLACvtfcHk0lhVl6tdWXSoYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGlur7I&md5=9185e02f28100272d3f30508d7883e98</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300245%26sid%3Dliteratum%253Aachs%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DRossello%26aufirst%3DA.%26aulast%3DOrlandini%26aufirst%3DE.%26atitle%3DTafamidis%2520%2528Vyndaqel%2529%253A%2520A%2520light%2520for%2520FAP%2520patients%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1617%26epage%3D1619%26doi%3D10.1002%2Fcmdc.201300245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, E. D.</span></span> <span> </span><span class="NLM_article-title">Tafamidis: A review in transthyretin amyloidosis with polyneuropathy</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1007/s40265-019-01129-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1007%2Fs40265-019-01129-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=31098895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWmtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=863-874&author=Y.+N.+Lambauthor=E.+D.+Deeks&title=Tafamidis%3A+A+review+in+transthyretin+amyloidosis+with+polyneuropathy&doi=10.1007%2Fs40265-019-01129-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy</span></div><div class="casAuthors">Lamb, Yvette N.; Deeks, Emma D.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">863-874</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Transthyretin amyloidosis with polyneuropathy (ATTR-PN), a rare and progressive hereditary disorder, results from mutations in the gene coding for the transthyretin (TTR) protein that destabilize the protein's tetrameric structure.  In over 40 countries worldwide, tafamidis (Vyndaqel) is approved for the treatment of TTR amyloidosis in adults with stage 1 symptomatic polyneuropathy, to delay peripheral neurol. impairment.  Tafamidis is administered orally once daily, as a soft capsule.  Evidence from clin. studies, including an 18-mo placebo-controlled trial and subsequent long-term, open-label extension studies (providing data from ≤ 6 years of treatment), indicate that tafamidis slowed deterioration of neurol. function and maintained health-related quality of life in patients with early-stage ATTR-PN and the Val30Met mutation.  TTR tetramers were stabilized in nearly all patients, and nutritional status was generally maintained or improved.  Similar benefit was seen with tafamidis over 12 mo in a noncomparative trial in patients with non-Val30Met ATTR-PN, although disease progression in this population (which was older and had had ATTR-PN for longer than Val30Met patients) became more notable with continued therapy in an extension study.  Data for up to 10 years from large registry and referral center studies support the long-term effectiveness and safety of tafamidis in delaying disease progression and conferring survival benefits in patients with stage 1 ATTR-PN.  Tafamidis was generally well tolerated, with no new safety signals detected during the long-term trial or real-world experience.  Thus, based on up to 10 years' experience, tafamidis continues to be a valuable option in the treatment of early-stage ATTR-PN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMa9d1adtjwLVg90H21EOLACvtfcHk0lhVl6tdWXSoYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWmtL3F&md5=4b24681e65dfc76805b1afe0257a58ae</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs40265-019-01129-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-019-01129-6%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DY.%2BN.%26aulast%3DDeeks%26aufirst%3DE.%2BD.%26atitle%3DTafamidis%253A%2520A%2520review%2520in%2520transthyretin%2520amyloidosis%2520with%2520polyneuropathy%26jtitle%3DDrugs%26date%3D2019%26volume%3D79%26spage%3D863%26epage%3D874%26doi%3D10.1007%2Fs40265-019-01129-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulawa, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foss, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaudinière, R.</span></span> <span> </span><span class="NLM_article-title">Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">9629</span>– <span class="NLM_lpage">9634</span>, <span class="refDoi"> DOI: 10.1073/pnas.1121005109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1073%2Fpnas.1121005109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=22645360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=9629-9634&author=C.+E.+Bulawaauthor=S.+Connellyauthor=M.+Devitauthor=L.+Wangauthor=C.+Weigelauthor=J.+A.+Flemingauthor=J.+Packmanauthor=E.+T.+Powersauthor=R.+L.+Wisemanauthor=T.+R.+Fossauthor=I.+A.+Wilsonauthor=J.+W.+Kellyauthor=R.+Labaudini%C3%A8re&title=Tafamidis%2C+a+potent+and+selective+transthyretin+kinetic+stabilizer+that+inhibits+the+amyloid+cascade&doi=10.1073%2Fpnas.1121005109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade</span></div><div class="casAuthors">Bulawa, Christine E.; Connelly, Stephen; DeVit, Michael; Wang, Lan; Weigel, Charlotte; Fleming, James A.; Packman, Jeff; Powers, Evan T.; Wiseman, R. Luke; Foss, Theodore R.; Wilson, Ian A.; Kelly, Jeffery W.; Labaudiniere, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9629-9634, S9629/1-S9629/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The transthyretin amyloidoses (ATTR) are invariably fatal diseases characterized by progressive neuropathy and/or cardiomyopathy.  ATTR are caused by aggregation of transthyretin (TTR), a natively tetrameric protein involved in the transport of thyroxine and the vitamin A-retinol-binding protein complex.  Mutations within TTR that cause autosomal dominant forms of disease facilitate tetramer dissocn., monomer misfolding, and aggregation, although wild-type TTR can also form amyloid fibrils in elderly patients.  Because tetramer dissocn. is the rate-limiting step in TTR amyloidogenesis, targeted therapies have focused on small mols. that kinetically stabilize the tetramer, inhibiting TTR amyloid fibril formation.  One such compd., tafamidis meglumine (Fx-1006A), has recently completed Phase II/111 trials for the treatment of Transthyretin type familial amyloid polyneuropathy (TTR-FAP) and demonstrated a slowing of disease progression in patients heterozygous for the V30M TTR mutation.  Herein we describe the mol. and structural basis of TTR tetramer stabilization by tafamidis.  Tafamidis binds selectively and with neg. cooperativity (KdS ∼2 nM and ∼200 nM) to the two normally unoccupied thyroxine-binding sites of the tetramer, and kinetically stabilizes TTR.  Patient-derived amyloidogenic variants of TTR, including kinetically and thermodynamically less stable mutants, are also stabilized by tafamidis binding.  The crystal structure of tafamidis-bound TTR suggests that binding stabilizes the weaker dimer-dimer interface against dissocn., the rate-limiting step of amyloidogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfzfMIrqJGHLVg90H21EOLACvtfcHk0lhRGHlhHDZyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWjtb4%253D&md5=05bf9cd644ab6a3dda78bb1620986910</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1121005109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1121005109%26sid%3Dliteratum%253Aachs%26aulast%3DBulawa%26aufirst%3DC.%2BE.%26aulast%3DConnelly%26aufirst%3DS.%26aulast%3DDevit%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWeigel%26aufirst%3DC.%26aulast%3DFleming%26aufirst%3DJ.%2BA.%26aulast%3DPackman%26aufirst%3DJ.%26aulast%3DPowers%26aufirst%3DE.%2BT.%26aulast%3DWiseman%26aufirst%3DR.%2BL.%26aulast%3DFoss%26aufirst%3DT.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DLabaudini%25C3%25A8re%26aufirst%3DR.%26atitle%3DTafamidis%252C%2520a%2520potent%2520and%2520selective%2520transthyretin%2520kinetic%2520stabilizer%2520that%2520inhibits%2520the%2520amyloid%2520cascade%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D9629%26epage%3D9634%26doi%3D10.1073%2Fpnas.1121005109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sant’Anna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallego, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira-Henriques, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esperante, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huertas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reixach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez-Campoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reverter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reig, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventura, S.</span></span> <span> </span><span class="NLM_article-title">Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">10787</span> <span class="refDoi"> DOI: 10.1038/ncomms10787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1038%2Fncomms10787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=26902880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1ehtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=R.+Sant%E2%80%99Annaauthor=P.+Gallegoauthor=L.+Z.+Robinsonauthor=A.+Pereira-Henriquesauthor=N.+Ferreiraauthor=F.+Pinheiroauthor=S.+Esperanteauthor=I.+Pallaresauthor=O.+Huertasauthor=M.+R.+Almeidaauthor=N.+Reixachauthor=R.+Insaauthor=A.+Velazquez-Campoyauthor=D.+Reverterauthor=N.+Reigauthor=S.+Ventura&title=Repositioning+tolcapone+as+a+potent+inhibitor+of+transthyretin+amyloidogenesis+and+associated+cellular+toxicity&doi=10.1038%2Fncomms10787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity</span></div><div class="casAuthors">Sant'Anna, Ricardo; Gallego, Pablo; Robinson, Lei Z.; Pereira-Henriques, Alda; Ferreira, Nelson; Pinheiro, Francisca; Esperante, Sebastian; Pallares, Irantzu; Huertas, Oscar; Rosario Almeida, Maria; Reixach, Natalia; Insa, Raul; Velazquez-Campoy, Adrian; Reverter, David; Reig, Nuria; Ventura, Salvador</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10787</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Transthyretin (TTR) is a plasma homotetrameric protein implicated in fatal systemic amyloidoses.  TTR tetramer dissocn. precedes pathol. TTR aggregation.  Native state stabilizers are promising drugs to treat TTR amyloidoses.  Here we repurpose tolcapone, an FDA-approved mol. for Parkinson's disease, as a potent TTR aggregation inhibitor.  Tolcapone binds specifically to TTR in human plasma, stabilizes the native tetramer in vivo in mice and humans and inhibits TTR cytotoxicity.  Crystal structures of tolcapone bound to wild-type TTR and to the V122I cardiomyopathy-assocd. variant show that it docks better into the TTR T4 pocket than tafamidis, so far the only drug on the market to treat TTR amyloidoses.  These data indicate that tolcapone, already in clin. trials for familial amyloid polyneuropathy, is a strong candidate for therapeutic intervention in these diseases, including those affecting the central nervous system, for which no small-mol. therapy exists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptjm7CULfu47Vg90H21EOLACvtfcHk0lhRGHlhHDZyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1ehtr0%253D&md5=a0a29250b2f01100f5226f092ee8b562</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fncomms10787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10787%26sid%3Dliteratum%253Aachs%26aulast%3DSant%25E2%2580%2599Anna%26aufirst%3DR.%26aulast%3DGallego%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DL.%2BZ.%26aulast%3DPereira-Henriques%26aufirst%3DA.%26aulast%3DFerreira%26aufirst%3DN.%26aulast%3DPinheiro%26aufirst%3DF.%26aulast%3DEsperante%26aufirst%3DS.%26aulast%3DPallares%26aufirst%3DI.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DAlmeida%26aufirst%3DM.%2BR.%26aulast%3DReixach%26aufirst%3DN.%26aulast%3DInsa%26aufirst%3DR.%26aulast%3DVelazquez-Campoy%26aufirst%3DA.%26aulast%3DReverter%26aufirst%3DD.%26aulast%3DReig%26aufirst%3DN.%26aulast%3DVentura%26aufirst%3DS.%26atitle%3DRepositioning%2520tolcapone%2520as%2520a%2520potent%2520inhibitor%2520of%2520transthyretin%2520amyloidogenesis%2520and%2520associated%2520cellular%2520toxicity%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26doi%3D10.1038%2Fncomms10787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gamez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadó, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reig, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suñé, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casasnovas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas-Garcia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insa, R.</span></span> <span> </span><span class="NLM_article-title">Transthyretin stabilization activity of the catechol-<i>O</i>-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study</span>. <i>Amyloid</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1080/13506129.2019.1597702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1080%2F13506129.2019.1597702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=31119947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVajtr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=74-84&author=J.+Gamezauthor=M.+Salvad%C3%B3author=N.+Reigauthor=P.+Su%C3%B1%C3%A9author=C.+Casasnovasauthor=R.+Rojas-Garciaauthor=R.+Insa&title=Transthyretin+stabilization+activity+of+the+catechol-O-methyltransferase+inhibitor+tolcapone+%28SOM0226%29+in+hereditary+ATTR+amyloidosis+patients+and+asymptomatic+carriers%3A+proof-of-concept+study&doi=10.1080%2F13506129.2019.1597702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study#</span></div><div class="casAuthors">Gamez, Josep; Salvado, Maria; Reig, Nuria; Sune, Pilar; Casasnovas, Carles; Rojas-Garcia, Ricard; Insa, Raul</div><div class="citationInfo"><span class="NLM_cas:title">Amyloid</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">74-84</span>CODEN:
                <span class="NLM_cas:coden">AIJIET</span>;
        ISSN:<span class="NLM_cas:issn">1350-6129</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">To assess the transthyretin (TTR) stabilization activity of tolcapone (SOM0226) in patients with hereditary ATTR amyloidosis, asymptomatic carriers and healthy volunteers.  A phase IIa proof-of-concept trial included two phases sepd. by a 6-wk washout period.  Phase A: single 200 mg dose of tolcapone; phase B: three 100 mg doses taken at 4 h intervals.  The primary efficacy variable was TTR stabilization.  Seventeen subjects were included (wild type, n = 6; mutation TTR Val30Met, n = 11).  TTR stabilization was obsd. in all participants.  Two hours after dosing, 82% of participants in phase A and 93% of those in phase B reached a TTR stabilization value of at least 20%.  In phase A, there was an increase of 52% in TTR stabilization vs baseline values 2 h after dosing, which decreased to 22.9% at 8 h.  In phase B, there was a significant increase of 38.8% in TTR stabilization 2 h after the first 100 mg dose.  This difference was maintained after 10 h and decreased after 24 h.  No serious adverse events were obsd.  The ability of tolcapone for stabilizing TTR supports further development and repositioning of the drug for the treatment of ATTR amyloidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3MIzn1HTglrVg90H21EOLACvtfcHk0lhRGHlhHDZyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVajtr7O&md5=663e7e6944fdf8335c57983a6539a735</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1080%2F13506129.2019.1597702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13506129.2019.1597702%26sid%3Dliteratum%253Aachs%26aulast%3DGamez%26aufirst%3DJ.%26aulast%3DSalvad%25C3%25B3%26aufirst%3DM.%26aulast%3DReig%26aufirst%3DN.%26aulast%3DSu%25C3%25B1%25C3%25A9%26aufirst%3DP.%26aulast%3DCasasnovas%26aufirst%3DC.%26aulast%3DRojas-Garcia%26aufirst%3DR.%26aulast%3DInsa%26aufirst%3DR.%26atitle%3DTransthyretin%2520stabilization%2520activity%2520of%2520the%2520catechol-O-methyltransferase%2520inhibitor%2520tolcapone%2520%2528SOM0226%2529%2520in%2520hereditary%2520ATTR%2520amyloidosis%2520patients%2520and%2520asymptomatic%2520carriers%253A%2520proof-of-concept%2520study%26jtitle%3DAmyloid%26date%3D2019%26volume%3D26%26spage%3D74%26epage%3D84%26doi%3D10.1080%2F13506129.2019.1597702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span> <span> </span><span class="NLM_article-title">Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1042/BJ20040011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1042%2FBJ20040011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=15080795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslGntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2004&pages=351-356&author=M.+R.+Almeidaauthor=B.+Macedoauthor=I.+Cardosoauthor=I.+Alvesauthor=G.+Valenciaauthor=G.+Arsequellauthor=A.+Planasauthor=M.+J.+Saraiva&title=Selective+binding+to+transthyretin+and+tetramer+stabilization+in+serum+from+patients+with+familial+amyloidotic+polyneuropathy+by+an+iodinated+diflunisal+derivative&doi=10.1042%2FBJ20040011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative</span></div><div class="casAuthors">Almeida, Maria Rosario; Macedo, Barbara; Cardoso, Isabel; Alves, Isabel; Valencia, Gregorio; Arsequell, Gemma; Planas, Antoni; Saraiva, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-356</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">In familial amyloidotic polyneuropathy, TTR (transthyretin) variants are deposited as amyloid fibrils.  It is thought that this process involves TTR tetramer dissocn., which leads to partially unfolded monomers that aggregate and polymerize into amyloid fibrils.  This process can be counteracted by stabilization of the tetramer.  Several small compds., such as diclofenac, diflunisal and flufenamic acid, have been reported to bind to TTR in vitro, in the T4 (thyroxine) binding channel that runs through the TTR tetramer, and consequently are considered to stabilize TTR.  However, if these agents bind plasma proteins other than TTR, decreased drug availability will occur, compromising their use as therapeutic agents for TTR amyloidosis.  In the present work, the authors compared the action of these compds. and of new derivs. designed to increase both selectivity of binding to TTR and inhibitory potency in relation to TTR amyloid fibril formation.  The authors found two diflunisal derivs. that, in contrast with diclofenac, flufenamic acid and diflunisal, displaced T4 from TTR in plasma preferentially over binding to albumin and thyroxine binding globulin.  The same diflunisal derivs. also had a stabilizing effect on TTR tetramers in plasma, as studied by isoelec. focusing of whole plasma under semi-denaturing conditions.  In addn., by TEM, the authors demonstrated that, in contrast with other proposed TTR stabilizers (namely diclofenac, flufenamic acid and diflunisal), one of the diflunisal derivs. tested efficiently inhibited TTR aggregation.  Taken together, our ex vivo and in vitro studies present evidence for the selectivity and efficiency of novel diflunisal derivs. as TTR stabilizers and as inhibitors of fibril formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7yUhh-llFj7Vg90H21EOLACvtfcHk0lg1JYpw2wxabw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslGntr8%253D&md5=02ccfa2b447c263613ea8b7bf95eb49a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1042%2FBJ20040011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20040011%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DM.%2BR.%26aulast%3DMacedo%26aufirst%3DB.%26aulast%3DCardoso%26aufirst%3DI.%26aulast%3DAlves%26aufirst%3DI.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DPlanas%26aufirst%3DA.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26atitle%3DSelective%2520binding%2520to%2520transthyretin%2520and%2520tetramer%2520stabilization%2520in%2520serum%2520from%2520patients%2520with%2520familial%2520amyloidotic%2520polyneuropathy%2520by%2520an%2520iodinated%2520diflunisal%2520derivative%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D381%26spage%3D351%26epage%3D356%26doi%3D10.1042%2FBJ20040011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mairal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gales, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballesteros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barluenga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centeno, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damas, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span> <span> </span><span class="NLM_article-title">Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e4124</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0004124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1371%2Fjournal.pone.0004124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=19125186" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=T.+Mairalauthor=J.+Nietoauthor=M.+Pintoauthor=M.+R.+Almeidaauthor=L.+Galesauthor=A.+Ballesterosauthor=J.+Barluengaauthor=J.+J.+P%C3%A9rezauthor=J.+T.+V%C3%A1zquezauthor=N.+B.+Centenoauthor=M.+J.+Saraivaauthor=A.+M.+Damasauthor=A.+Planasauthor=G.+Arsequellauthor=G.+Valencia&title=Iodine+atoms%3A+a+new+molecular+feature+for+the+design+of+potent+transthyretin+fibrillogenesis+inhibitors&doi=10.1371%2Fjournal.pone.0004124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004124%26sid%3Dliteratum%253Aachs%26aulast%3DMairal%26aufirst%3DT.%26aulast%3DNieto%26aufirst%3DJ.%26aulast%3DPinto%26aufirst%3DM.%26aulast%3DAlmeida%26aufirst%3DM.%2BR.%26aulast%3DGales%26aufirst%3DL.%26aulast%3DBallesteros%26aufirst%3DA.%26aulast%3DBarluenga%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez%26aufirst%3DJ.%2BJ.%26aulast%3DV%25C3%25A1zquez%26aufirst%3DJ.%2BT.%26aulast%3DCenteno%26aufirst%3DN.%2BB.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DDamas%26aufirst%3DA.%2BM.%26aulast%3DPlanas%26aufirst%3DA.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DValencia%26aufirst%3DG.%26atitle%3DIodine%2520atoms%253A%2520a%2520new%2520molecular%2520feature%2520for%2520the%2520design%2520of%2520potent%2520transthyretin%2520fibrillogenesis%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0004124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gales, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo-Ribeiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damas, A. M.</span></span> <span> </span><span class="NLM_article-title">Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1042/BJ20042035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1042%2FBJ20042035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=15689188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Glt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2005&pages=615-662&author=L.+Galesauthor=S.+Macedo-Ribeiroauthor=G.+Arsequellauthor=G.+Valenciaauthor=M.+J.+Saraivaauthor=A.+M.+Damas&title=Human+transthyretin+in+complex+with+iododiflunisal%3A+structural+features+associated+with+a+potent+amyloid+inhibitor&doi=10.1042%2FBJ20042035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor</span></div><div class="casAuthors">Gales, Luis; Macedo-Ribeiro, Sandra; Arsequell, Gemma; Valencia, Gregorio; Saraiva, Maria Joao; Damas, Ana Margarida</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">615-621</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Ex vivo and in vitro studies have revealed the remarkable amyloid inhibitory potency and specificity of iododiflunisal in relation to transthyretin, a protein implicated in familial amyloidotic polyneuropathy.  In the present paper, the crystal structure of transthyretin complexed with this diflunisal deriv. is reported, which enables a detailed anal. of the protein-ligand interactions.  Iododiflunisal binds very deep in the hormone-binding channel.  The iodine substituent is tightly anchored into a pocket of the binding site and the fluorine atoms provide extra hydrophobic contacts with the protein.  The carboxylate substituent is involved in an electrostatic interaction with the Nζ of a lysine residue.  Moreover, ligand-induced conformational alterations in the side chain of some residues result in the formation of new intersubunit hydrogen bonds.  All these new interactions, induced by iododiflunisal, increase the stability of the tetramer impairing the formation of amyloid fibrils.  The crystal structure of this complex opens perspectives for the design of more specific and effective drugs for familial amyloidotic polyneuropathy patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkgoLC5Fn1AbVg90H21EOLACvtfcHk0lg1JYpw2wxabw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Glt78%253D&md5=9b1f6421c1c11ec1cc80dbc0498a4438</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1042%2FBJ20042035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20042035%26sid%3Dliteratum%253Aachs%26aulast%3DGales%26aufirst%3DL.%26aulast%3DMacedo-Ribeiro%26aufirst%3DS.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DDamas%26aufirst%3DA.%2BM.%26atitle%3DHuman%2520transthyretin%2520in%2520complex%2520with%2520iododiflunisal%253A%2520structural%2520features%2520associated%2520with%2520a%2520potent%2520amyloid%2520inhibitor%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D388%26spage%3D615%26epage%3D662%26doi%3D10.1042%2FBJ20042035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guido, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span> <span> </span><span class="NLM_article-title">Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer’s disease mouse model</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.3233/JAD-131355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3233%2FJAD-131355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=24169237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=357-370&author=C.+A.+Ribeiroauthor=S.+M.+Oliveiraauthor=L.+F.+Guidoauthor=A.+Magalhaesauthor=G.+Valenciaauthor=G.+Arsequellauthor=M.+J.+Saraivaauthor=I.+Cardoso&title=Transthyretin+stabilization+by+iododiflunisal+promotes+amyloid-%CE%B2+peptide+clearance%2C+decreases+its+deposition%2C+and+ameliorates+cognitive+deficits+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.3233%2FJAD-131355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin Stabilization by Iododiflunisal Promotes Amyloid-β Peptide Clearance, Decreases its Deposition, and Ameliorates Cognitive Deficits in an Alzheimer's Disease Mouse Model</span></div><div class="casAuthors">Ribeiro, Carlos A.; Oliveira, Sandra Marisa; Guido, Luis F.; Magalhaes, Ana; Valencia, Gregorio; Arsequell, Gemma; Saraiva, Maria Joao; Cardoso, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-370</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common form of dementia and now represents 50-70% of total dementia cases.  Over the last two decades, transthyretin (TTR) has been assocd. with AD and, very recently, a novel concept of TTR stability has been established in vitro as a key factor in TTR/amyloid-β (Aβ) interaction.  Small compds., TTR stabilizers (usually non-steroid anti-inflammatory drugs), bind to the thyroxine (T4) central binding channel, increasing TTR tetrameric stability and TTR/Aβ interaction.  In this work, we evaluated in vivo the effects of one of the TTR stabilizers identified as improving TTR/Aβ interaction, iododiflunisal (IDIF), in Aβ deposition and other AD features, using AβPPswe/PS1A246E transgenic mice, either carrying two or just one copy of the TTR gene (AD/TTR+/+ or AD/TTR+/-, resp.), available and characterized in our lab.  The results showed that IDIF administered orally bound TTR in plasma and stabilized the protein, as assessed by T4 displacement assays, and was able to enter the brain as revealed by mass spectrometry anal. of cerebrospinal fluid.  TTR levels, both in plasma and cerebrospinal fluid, were not altered.  In AD/TTR+/- mice, IDIF administration resulted not only in decreased brain Aβ levels and deposition but also in improved cognitive function assocd. with the AD-like neuropathol. in this mouse model, although no improvements were detectable in the AD/TTR+/+ animals.  Further, in AD/TTR+/- mice, Aβ levels were reduced in plasma suggesting TTR promoted Aβ clearance from the brain and from the periphery.  Taken together, these results strengthen the importance of TTR stability in the design of therapeutic drugs, highlighting the capacity of IDIF to be used in AD treatment to prevent and to slow the progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj-Xs6bazqTbVg90H21EOLACvtfcHk0ljFGRFxRmDbDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKls70%253D&md5=d5874bd24bbc016cf2836e7e1060d95e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3233%2FJAD-131355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-131355%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DC.%2BA.%26aulast%3DOliveira%26aufirst%3DS.%2BM.%26aulast%3DGuido%26aufirst%3DL.%2BF.%26aulast%3DMagalhaes%26aufirst%3DA.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DCardoso%26aufirst%3DI.%26atitle%3DTransthyretin%2520stabilization%2520by%2520iododiflunisal%2520promotes%2520amyloid-%25CE%25B2%2520peptide%2520clearance%252C%2520decreases%2520its%2520deposition%252C%2520and%2520ameliorates%2520cognitive%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D39%26spage%3D357%26epage%3D370%26doi%3D10.3233%2FJAD-131355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, M. L.</span></span> <span> </span><span class="NLM_article-title">Characterization of binding interactions by isothermal titration calorimetry</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/S0958-1669(97)80154-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2FS0958-1669%2897%2980154-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=9013658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFCnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=31-35&author=M.+L.+Doyle&title=Characterization+of+binding+interactions+by+isothermal+titration+calorimetry&doi=10.1016%2FS0958-1669%2897%2980154-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of binding interactions by isothermal titration calorimetry</span></div><div class="casAuthors">Doyle, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-35</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">Isothermal titrn. calorimetry is a high-accuracy method for measuring binding affinities.  Titrn. calorimetry is a universal method that has broad impact throughout biotechnol.  In recent years, microcalorimeters that are capable of characterizing binding interactions of biol. macromols. have become com. available.  Results from these studies are providing new insight into the mol. nature of macromol. interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk3s4qStjFsbVg90H21EOLACvtfcHk0ljFGRFxRmDbDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFCnurk%253D&md5=7276363da1012547157036cd25ab75ed</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0958-1669%2897%2980154-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0958-1669%252897%252980154-1%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DM.%2BL.%26atitle%3DCharacterization%2520of%2520binding%2520interactions%2520by%2520isothermal%2520titration%2520calorimetry%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D1997%26volume%3D8%26spage%3D31%26epage%3D35%26doi%3D10.1016%2FS0958-1669%2897%2980154-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raman, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nall, B. T.</span></span> <span> </span><span class="NLM_article-title">Isothermal titration calorimetry of protein-protein interactions</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1006/meth.1999.0852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1006%2Fmeth.1999.0852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10527727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK1MXms1ynsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=213-221&author=M.+M.+Pierceauthor=C.+S.+Ramanauthor=B.+T.+Nall&title=Isothermal+titration+calorimetry+of+protein-protein+interactions&doi=10.1006%2Fmeth.1999.0852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Isothermal Titration Calorimetry of Protein-Protein Interactions</span></div><div class="casAuthors">Pierce, Michael M.; Raman, C. S.; Nall, Barry T.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Orlando, Florida)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The interaction of biological macromols., whether protein-DNA, antibody-antigen, hormone-receptor, etc., illustrates the complexity and diversity of mol. recognition.  The importance of such interactions in the immune response, signal transduction cascades, and gene expression cannot be overstated.  It is of great interest to det. the nature of the forces that stabilize the interaction.  The thermodn. of assocn. are characterized by the stoichiometry of the interaction (n), the assocn. const. (Ka), the free energy (ΔGb), enthalpy (ΔHb), entropy (ΔSb), and heat capacity of binding (ΔCp).  In combination with structural information, the energetics of binding can provide a complete dissection of the interaction and aid in identifying the most important regions of the interface and the energetic contributions.  Various indirect methods (ELISA, RIA, surface plasmon resonance, etc.) are routinely used to characterize biol. important interactions.  Here we describe the use of isothermal titrn. calorimetry (ITC) in the study of protein-protein interactions.  ITC is the most quant. means available for measuring the thermodn. properties of a protein-protein interaction.  ITC measures the binding equil. directly by detg. the heat evolved on assocn. of a ligand with its binding partner.  In a single expt., the values of the binding const. (Ka), the stoichiometry (n), and the enthalpy of binding (ΔHb) are detd.  The free energy and entropy of binding are detd. from the assocn. const.  The temp. dependence of the ΔHb parameter, measured by performing the titrn. at varying temps., describes the ΔCp term.  As a practical application of the method, we describe the use of ITC to study the interaction between cytochrome c and two monoclonal antibodies.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwZfOrMhYWUbVg90H21EOLACvtfcHk0ljFGRFxRmDbDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXms1ynsrs%253D&md5=fe8d90e5475a5a4d95464c3889697b79</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1006%2Fmeth.1999.0852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmeth.1999.0852%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DM.%2BM.%26aulast%3DRaman%26aufirst%3DC.%2BS.%26aulast%3DNall%26aufirst%3DB.%2BT.%26atitle%3DIsothermal%2520titration%2520calorimetry%2520of%2520protein-protein%2520interactions%26jtitle%3DMethods%26date%3D1999%26volume%3D19%26spage%3D213%26epage%3D221%26doi%3D10.1006%2Fmeth.1999.0852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jelesarov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosshard, H. R.</span></span> <span> </span><span class="NLM_article-title">Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition</span>. <i>J. Mol. Recognit.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2F%28SICI%291099-1352%28199901%2F02%2912%3A1%3C3%3A%3AAID-JMR441%3E3.0.CO%3B2-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10398392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK1MXit1CjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1999&pages=3-10&author=I.+Jelesarovauthor=H.+R.+Bosshard&title=Isothermal+titration+calorimetry+and+differential+scanning+calorimetry+as+complementary+tools+to+investigate+the+energetics+of+biomolecular+recognition&doi=10.1002%2F%28SICI%291099-1352%28199901%2F02%2912%3A1%3C3%3A%3AAID-JMR441%3E3.0.CO%3B2-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition</span></div><div class="casAuthors">Jelesarov, Ilian; Bosshard, Hans Rudolf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-18</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  The principles of isothermal titrn. calorimetry (ITC) and differential scanning calorimetry (DSC) are reviewed together with the basic thermodn. formalism on which the two techniques are based.  Although ITC is particularly suitable to follow the energetics of an assocn. reaction between biomols., the combination of ITC and DSC provides a more comprehensive description of the thermodn. of an assocg. system.  The reason is that the parameters ΔG, ΔH, ΔS, and ΔCp obtained from ITC are global properties of the system under study.  They may be composed to varying degrees of contributions from the binding reaction proper, from conformational changes of the component mols. during assocn., and from changes in mol./solvent interactions and in the state of protonation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQTbTlhTQlwLVg90H21EOLACvtfcHk0ljFGRFxRmDbDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1CjsrY%253D&md5=eb36c32891890f3289a9356f56e47327</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1352%28199901%2F02%2912%3A1%3C3%3A%3AAID-JMR441%3E3.0.CO%3B2-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1352%2528199901%252F02%252912%253A1%253C3%253A%253AAID-JMR441%253E3.0.CO%253B2-6%26sid%3Dliteratum%253Aachs%26aulast%3DJelesarov%26aufirst%3DI.%26aulast%3DBosshard%26aufirst%3DH.%2BR.%26atitle%3DIsothermal%2520titration%2520calorimetry%2520and%2520differential%2520scanning%2520calorimetry%2520as%2520complementary%2520tools%2520to%2520investigate%2520the%2520energetics%2520of%2520biomolecular%2520recognition%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D1999%26volume%3D12%26spage%3D3%26epage%3D10%26doi%3D10.1002%2F%28SICI%291099-1352%28199901%2F02%2912%3A1%3C3%3A%3AAID-JMR441%3E3.0.CO%3B2-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brautigam, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuck, P.</span></span> <span> </span><span class="NLM_article-title">Integration and global analysis of isothermal titration calorimetry data for studying macromolecular interactions</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">882</span>– <span class="NLM_lpage">894</span>, <span class="refDoi"> DOI: 10.1038/nprot.2016.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1038%2Fnprot.2016.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=27055097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlWjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=882-894&author=C.+A.+Brautigamauthor=H.+Zhaoauthor=C.+Vargasauthor=S.+Kellerauthor=P.+Schuck&title=Integration+and+global+analysis+of+isothermal+titration+calorimetry+data+for+studying+macromolecular+interactions&doi=10.1038%2Fnprot.2016.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Integration and global analysis of isothermal titration calorimetry data for studying macromolecular interactions</span></div><div class="casAuthors">Brautigam, Chad A.; Zhao, Huaying; Vargas, Carolyn; Keller, Sandro; Schuck, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">882-894</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Isothermal titrn. calorimetry (ITC) is a powerful and widely used method to measure the energetics of macromol. interactions by recording a thermogram of differential heating power during a titrn.  However, traditional ITC anal. is limited by stochastic thermogram noise and by the limited information content of a single titrn. expt.  Here we present a protocol for bias-free thermogram integration based on automated shape anal. of the injection peaks, followed by combination of isotherms from different calorimetric titrn. expts. into a global anal., statistical anal. of binding parameters and graphical presentation of the results.  This is performed using the integrated public-domain software packages NITPIC, SEDPHAT and GUSSI.  The recently developed low-noise thermogram integration approach and global anal. allow for more precise parameter ests. and more reliable quantification of multisite and multicomponent cooperative and competitive interactions.  Titrn. expts. typically take 1-2.5 h each, and global anal. usually takes 10-20 min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2Yx-XI9KHMrVg90H21EOLACvtfcHk0lgLNVKq3_E38Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlWjt70%253D&md5=3684775a4b363c89378d291ec7e538b1</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2016.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2016.044%26sid%3Dliteratum%253Aachs%26aulast%3DBrautigam%26aufirst%3DC.%2BA.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DVargas%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DS.%26aulast%3DSchuck%26aufirst%3DP.%26atitle%3DIntegration%2520and%2520global%2520analysis%2520of%2520isothermal%2520titration%2520calorimetry%2520data%2520for%2520studying%2520macromolecular%2520interactions%26jtitle%3DNat.%2520Protoc.%26date%3D2016%26volume%3D11%26spage%3D882%26epage%3D894%26doi%3D10.1038%2Fnprot.2016.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez-Campoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leavitt, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">Characterization of protein-protein interactions by isothermal titration calorimetry</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>261</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=15064448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslyjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=2004&pages=35-54&author=A.+Velazquez-Campoyauthor=S.+A.+Leavittauthor=E.+Freire&title=Characterization+of+protein-protein+interactions+by+isothermal+titration+calorimetry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of protein-protein interactions by isothermal titration calorimetry</span></div><div class="casAuthors">Velazquez-Campoy, Adrian; Leavitt, Stephanie A.; Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">Protein-Protein Interactions</span>),
    <span class="NLM_cas:pages">35-54</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Isothermal titrn. calorimetry (ITC) is a powerful technique to study both protein-ligand and protein-protein interactions.  This methods chapter is devoted to describing protein-protein interactions, in particular, the assocn. between two different proteins and the self-assocn. of a protein into homodimers.  ITC is the only technique that dets. directly the thermodn. parameters of a given reaction: ΔG, ΔH, ΔS, and ΔCP.  Isothermal titrn. calorimeters have evolved over the years and one of the latest models is the VP-ITC produced by Microcal, Inc.  In this chapter we will be describing the general procedure for performing an ITC expt. as well as for the specific cases of porcine pancreatic trypsin binding to soybean trypsin inhibitor and the dissocn. of bovine pancreatic α-chymotrypsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1uW12dYTq8LVg90H21EOLACvtfcHk0lgLNVKq3_E38Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslyjtL8%253D&md5=dd7530e6677a825692de77ff7b5dc914</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelazquez-Campoy%26aufirst%3DA.%26aulast%3DLeavitt%26aufirst%3DS.%2BA.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DCharacterization%2520of%2520protein-protein%2520interactions%2520by%2520isothermal%2520titration%2520calorimetry%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2004%26volume%3D261%26spage%3D35%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clavería-Gimeno, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vega, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abian, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez-Campoy, A.</span></span> <span> </span><span class="NLM_article-title">A look at ligand binding thermodynamics in drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1080/17460441.2017.1297418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1080%2F17460441.2017.1297418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28276703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1WmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=363-377&author=R.+Claver%C3%ADa-Gimenoauthor=S.+Vegaauthor=O.+Abianauthor=A.+Velazquez-Campoy&title=A+look+at+ligand+binding+thermodynamics+in+drug+discovery&doi=10.1080%2F17460441.2017.1297418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A look at ligand binding thermodynamics in drug discovery</span></div><div class="casAuthors">Claveria-Gimeno, Rafael; Vega, Sonia; Abian, Olga; Velazquez-Campoy, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">363-377</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug discovery is a challenging endeavor requiring the interplay of many different research areas.  Gathering information on ligand binding thermodn. may help considerably in reducing the risk within a high uncertainty scenario, allowing early rejection of flawed compds. and pushing forward optimal candidates.  In particular, the free energy, the enthalpy, and the entropy of binding provide fundamental information on the intermol. forces driving such interaction.  The authors review the current status and recent developments in the application of ligand binding thermodn. in drug discovery.  The thermodn. binding profile (Gibbs energy, enthalpy, and entropy of binding) can be used for lead selection and optimization (binding enthalpy, selectivity, and adaptability).  Binding thermodn. provides fundamental information on the forces driving the formation of the drug-target complex.  It has been widely accepted that binding thermodn. may be used as a decision criterion along the ligand optimization process in drug discovery and development.  In particular, the binding enthalpy may be used as a guide when selecting and optimizing compds. over a set of potential candidates.  However, this has been recently called into question by arguing certain difficulties and in the light of certain exptl. examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooaiRxAajaz7Vg90H21EOLACvtfcHk0lgLNVKq3_E38Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1WmsLY%253D&md5=db8bc2ee1e5da6b60ea95c83fb8d3d06</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1080%2F17460441.2017.1297418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2017.1297418%26sid%3Dliteratum%253Aachs%26aulast%3DClaver%25C3%25ADa-Gimeno%26aufirst%3DR.%26aulast%3DVega%26aufirst%3DS.%26aulast%3DAbian%26aufirst%3DO.%26aulast%3DVelazquez-Campoy%26aufirst%3DA.%26atitle%3DA%2520look%2520at%2520ligand%2520binding%2520thermodynamics%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26spage%3D363%26epage%3D377%26doi%3D10.1080%2F17460441.2017.1297418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez-Campoy, A.</span>; <span class="NLM_string-name">Leavitt, S. A.</span>; <span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">Characterization of Protein-Protein Interactions by Isothermal Titration Calorimetry in Protein–Protein Interactions: Methods and Applications</span>. In  <i>Methods in Molecular Biology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerkord, C.L.</span>; <span class="NLM_string-name">Fu, H.</span></span>, Eds.; <span class="NLM_publisher-name">Springer Science + Business Media</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">1278</span>, pp  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">204</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=183-204&author=A.+Velazquez-Campoy&author=S.+A.+Leavitt&author=E.+Freireauthor=C.L.+Meyerkord&author=H.+Fu&title=Methods+in+Molecular+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVelazquez-Campoy%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520Protein-Protein%2520Interactions%2520by%2520Isothermal%2520Titration%2520Calorimetry%2520in%2520Protein%25E2%2580%2593Protein%2520Interactions%253A%2520Methods%2520and%2520Applications%26btitle%3DMethods%2520in%2520Molecular%2520Biology%26aulast%3DMeyerkord%26aufirst%3DC.L.%26pub%3DSpringer%2520Science%2520%252B%2520Business%2520Media%26date%3D2015%26volume%3D1278%26spage%3D183%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradrick, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beechem, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howell, E. E.</span></span> <span> </span><span class="NLM_article-title">Unusual binding stoichiometries and cooperativity are observed during binary and ternary complex formation in the single active pore of R67 dihydrofolate reductase, a D2 symmetric protein</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">11414</span>– <span class="NLM_lpage">11424</span>, <span class="refDoi"> DOI: 10.1021/bi960205d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi960205d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK28XkvVGqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=11414-11424&author=T.+D.+Bradrickauthor=J.+M.+Beechemauthor=E.+E.+Howell&title=Unusual+binding+stoichiometries+and+cooperativity+are+observed+during+binary+and+ternary+complex+formation+in+the+single+active+pore+of+R67+dihydrofolate+reductase%2C+a+D2+symmetric+protein&doi=10.1021%2Fbi960205d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Unusual Binding Stoichiometries and Cooperativity Are Observed during Binary and Ternary Complex Formation in the Single Active Pore of R67 Dihydrofolate Reductase, a D2 Symmetric Protein</span></div><div class="casAuthors">Bradrick, Thomas D.; Beechem, Joseph M.; Howell, Elizabeth E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">11414-11424</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">R67 dihydrofolate reductase (DHFR) is an R-plasmid-encoded enzyme that confers resistance to the antibacterial drug, trimethoprim.  This DHFR variant is not homologous in either sequence or structure to chromosomal DHFRs.  A recent crystal structure of the active tetrameric species describes a single active site pore that traverses the length of the protein (Narayana et al., 1995).  Related sites (due to a 222 symmetry element at the center of the active site pore) are used for binding of ligands, i.e., each half-pore can accommodate either the substrate, dihydrofolate, or the cofactor, NADPH, although dihydrofolate and NADPH are bound differently.  Ligand binding in R67 DHFR was evaluated using time-resolved fluorescence anisotropy and isothermal titrn. calorimetry techniques.  Under binary complex conditions, two mols. of either NADPH, folate, dihydrofolate, or N10 propargyl-5,8-dideazafolate (CB3717) can be bound.  Binding of NADPH displays neg. cooperativity, binding of either folate or dihydrofolate shows pos. cooperativity, and binding of CB3717 shows two identical sites.  Any asymmetry introduced by binding of one ligand is proposed to induce the cooperativity assocd. with binding of the second ligand.  Evaluation of ternary complex formation demonstrates that one mol. of folate binds to a 1:1 mixt. of R67 DHFR + NADPH.  These binding results indicate a max. of two ligands bind in the pore.  A mechanism describing catalysis is proposed that is consistent with the binding results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPTl2c8AvGKLVg90H21EOLACvtfcHk0lhXQBmFPpy5Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvVGqsbc%253D&md5=f85af8ec7de91eb41c60c55aae8604a9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fbi960205d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi960205d%26sid%3Dliteratum%253Aachs%26aulast%3DBradrick%26aufirst%3DT.%2BD.%26aulast%3DBeechem%26aufirst%3DJ.%2BM.%26aulast%3DHowell%26aufirst%3DE.%2BE.%26atitle%3DUnusual%2520binding%2520stoichiometries%2520and%2520cooperativity%2520are%2520observed%2520during%2520binary%2520and%2520ternary%2520complex%2520formation%2520in%2520the%2520single%2520active%2520pore%2520of%2520R67%2520dihydrofolate%2520reductase%252C%2520a%2520D2%2520symmetric%2520protein%26jtitle%3DBiochemistry%26date%3D1996%26volume%3D35%26spage%3D11414%26epage%3D11424%26doi%3D10.1021%2Fbi960205d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez-Campoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goñi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peregrina, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, M.</span></span> <span> </span><span class="NLM_article-title">Exact analysis of heterotropic interactions in proteins: Characterization of cooperative ligand binding by isothermal titration calorimetry</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1887</span>– <span class="NLM_lpage">1904</span>, <span class="refDoi"> DOI: 10.1529/biophysj.106.086561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1529%2Fbiophysj.106.086561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=16766617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD28XovFynsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2006&pages=1887-1904&author=A.+Velazquez-Campoyauthor=G.+Go%C3%B1iauthor=J.+R.+Peregrinaauthor=M.+Medina&title=Exact+analysis+of+heterotropic+interactions+in+proteins%3A+Characterization+of+cooperative+ligand+binding+by+isothermal+titration+calorimetry&doi=10.1529%2Fbiophysj.106.086561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Exact analysis of heterotropic interactions in proteins: Characterization of cooperative ligand binding by isothermal titration calorimetry</span></div><div class="casAuthors">Velazquez-Campoy, Adrian; Goni, Guillermina; Peregrina, Jose Ramon; Medina, Milagros</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1887-1904</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">Intramol. interaction networks in proteins are responsible for heterotropic ligand binding cooperativity, a biol. important, widespread phenomenon in nature (e.g., signaling transduction cascades, enzymic cofactors, enzymic allosteric activators or inhibitors, gene transcription, or repression).  The cooperative binding of two (or more) different ligands to a macromol. is the underlying principle.  To date, heterotropic effects have been studied mainly kinetically in enzymic systems.  Until now, approx. approaches have been employed for studying equil. heterotropic ligand binding effects, except in two special cases in which an exact anal. was developed: independent binding (no cooperativity) and competitive binding (maximal neg. cooperativity).  The exact anal. and methodol. for characterizing ligand binding cooperativity interactions in the general case (any degree of cooperativity) using isothermal titrn. calorimetry are presented in this work.  Intramol. interaction pathways within the allosteric macromol. can be identified and characterized using this methodol.  As an example, the thermodn. characterization of the binding interaction between ferredoxin-NADP+ reductase and its three substrates, NADP+, ferredoxin, and flavodoxin, as well as the characterization of their binding cooperativity interaction, is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7klTmXU5cD7Vg90H21EOLACvtfcHk0lhXQBmFPpy5Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovFynsr8%253D&md5=820520c40a1f7f0cc5b00cbba380c3fe</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1529%2Fbiophysj.106.086561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1529%252Fbiophysj.106.086561%26sid%3Dliteratum%253Aachs%26aulast%3DVelazquez-Campoy%26aufirst%3DA.%26aulast%3DGo%25C3%25B1i%26aufirst%3DG.%26aulast%3DPeregrina%26aufirst%3DJ.%2BR.%26aulast%3DMedina%26aufirst%3DM.%26atitle%3DExact%2520analysis%2520of%2520heterotropic%2520interactions%2520in%2520proteins%253A%2520Characterization%2520of%2520cooperative%2520ligand%2520binding%2520by%2520isothermal%2520titration%2520calorimetry%26jtitle%3DBiophys.%2520J.%26date%3D2006%26volume%3D91%26spage%3D1887%26epage%3D1904%26doi%3D10.1529%2Fbiophysj.106.086561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verstraete, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Schie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyncke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavernier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauwels, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peelman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, S. N.</span></span> <span> </span><span class="NLM_article-title">Structural basis of the proinflammatory signaling complex mediated by TSLP</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1038/nsmb.2794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1038%2Fnsmb.2794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=24632570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlCrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=375-382&author=K.+Verstraeteauthor=L.+van+Schieauthor=L.+Vynckeauthor=Y.+Blochauthor=J.+Tavernierauthor=E.+Pauwelsauthor=F.+Peelmanauthor=S.+N.+Savvides&title=Structural+basis+of+the+proinflammatory+signaling+complex+mediated+by+TSLP&doi=10.1038%2Fnsmb.2794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of the proinflammatory signaling complex mediated by TSLP</span></div><div class="casAuthors">Verstraete, Kenneth; van Schie, Loes; Vyncke, Laurens; Bloch, Yehudi; Tavernier, Jan; Pauwels, Ewald; Peelman, Frank; Savvides, Savvas N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-382</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thymic stromal lymphopoietin (TSLP), a cytokine produced by epithelial cells at barrier surfaces, is pivotal for the development of widespread chronic inflammatory disorders such as asthma and atopic dermatitis.  The structure of the mouse TSLP-mediated signaling complex reveals how TSLP establishes extensive interfaces with its cognate receptor (TSLPR) and the shared interleukin 7 receptor α-chain (IL-7Rα) to evoke membrane-proximal receptor-receptor contacts poised for intracellular signaling.  Binding of TSLP to TSLPR is a mechanistic prerequisite for recruitment of IL-7Rα to the high-affinity ternary complex, which we propose is coupled to a structural switch in TSLP at the crossroads of the cytokine-receptor interfaces.  Functional interrogation of TSLP-receptor interfaces points to putative interaction hotspots that could be exploited for antagonist design.  Finally, we derive the structural rationale for the functional duality of IL-7Rα and establish a consensus for the geometry of ternary complexes mediated by interleukin 2 (IL-2)-family cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn5mK6rmKOlLVg90H21EOLACvtfcHk0lhXQBmFPpy5Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlCrsb0%253D&md5=e0a570c26ca4ddef14199500872b1563</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2794%26sid%3Dliteratum%253Aachs%26aulast%3DVerstraete%26aufirst%3DK.%26aulast%3Dvan%2BSchie%26aufirst%3DL.%26aulast%3DVyncke%26aufirst%3DL.%26aulast%3DBloch%26aufirst%3DY.%26aulast%3DTavernier%26aufirst%3DJ.%26aulast%3DPauwels%26aufirst%3DE.%26aulast%3DPeelman%26aufirst%3DF.%26aulast%3DSavvides%26aufirst%3DS.%2BN.%26atitle%3DStructural%2520basis%2520of%2520the%2520proinflammatory%2520signaling%2520complex%2520mediated%2520by%2520TSLP%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D375%26epage%3D382%26doi%3D10.1038%2Fnsmb.2794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders</span>. <i>Essays Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1042/EBC20170041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1042%2FEBC20170041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=29118097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BC1M7pt1Gmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=505-516&author=S.+J.+Hughesauthor=A.+Ciulli&title=Molecular+recognition+of+ternary+complexes%3A+a+new+dimension+in+the+structure-guided+design+of+chemical+degraders&doi=10.1042%2FEBC20170041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders</span></div><div class="casAuthors">Hughes Scott J; Ciulli Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Essays in biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">505-516</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Molecular glues and bivalent inducers of protein degradation (also known as PROTACs) represent a fascinating new modality in pharmacotherapeutics: the potential to knockdown previously thought 'undruggable' targets at sub-stoichiometric concentrations in ways not possible using conventional inhibitors.  Mounting evidence suggests these chemical agents, in concert with their target proteins, can be modelled as three-body binding equilibria that can exhibit significant cooperativity as a result of specific ligand-induced molecular recognition.  Despite this, many existing drug design and optimization regimens still fixate on binary target engagement, in part due to limited structural data on ternary complexes.  Recent crystal structures of protein complexes mediated by degrader molecules, including the first PROTAC ternary complex, underscore the importance of protein-protein interactions and intramolecular contacts to the mode of action of this class of compounds.  These discoveries have opened the door to a new paradigm for structure-guided drug design: borrowing surface area and molecular recognition from nature to elicit cellular signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqZGQ3bfUY0b5XHngOXiV_fW6udTcc2ebMqflrXe2iyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7pt1Gmuw%253D%253D&md5=7470e559372f05d34c5924524a6d04bc</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1042%2FEBC20170041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FEBC20170041%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DS.%2BJ.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DMolecular%2520recognition%2520of%2520ternary%2520complexes%253A%2520a%2520new%2520dimension%2520in%2520the%2520structure-guided%2520design%2520of%2520chemical%2520degraders%26jtitle%3DEssays%2520Biochem.%26date%3D2017%26volume%3D61%26spage%3D505%26epage%3D516%26doi%3D10.1042%2FEBC20170041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houtman, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samelson, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuck, P.</span></span> <span> </span><span class="NLM_article-title">Studying multisite binary and ternary protein interactions by global analysis of isothermal titration calorimetry data in SEDPHAT: application to adaptor protein complexes in cell signaling</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1110/ps.062558507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1110%2Fps.062558507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=17192587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsF2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=30-42&author=J.+C.+Houtmanauthor=P.+H.+Brownauthor=B.+Bowdenauthor=H.+Yamaguchiauthor=E.+Appellaauthor=L.+E.+Samelsonauthor=P.+Schuck&title=Studying+multisite+binary+and+ternary+protein+interactions+by+global+analysis+of+isothermal+titration+calorimetry+data+in+SEDPHAT%3A+application+to+adaptor+protein+complexes+in+cell+signaling&doi=10.1110%2Fps.062558507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Studying multisite binary and ternary protein interactions by global analysis of isothermal titration calorimetry data in SEDPHAT: application to adaptor protein complexes in cell signaling</span></div><div class="casAuthors">Houtman, Jon C. D.; Brown, Patrick H.; Bowden, Brent; Yamaguchi, Hiroshi; Appella, Ettore; Samelson, Lawrence E.; Schuck, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-42</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Multisite interactions and the formation of ternary or higher-order protein complexes are ubiquitous features of protein interactions.  Cooperativity between different ligands is a hallmark for information transfer, and is frequently crit. for the biol. function.  We describe a new computational platform for the global anal. of isothermal titrn. calorimetry (ITC) data for the study of binary and ternary multisite interactions, implemented as part of the public domain multimethod anal. software SEDPHAT.  The global anal. of titrns. performed in different orientations was explored, and the potential for unraveling cooperativity parameters in multisite interactions was assessed in theory and expt.  To demonstrate the practical potential and limitations of global analyses of ITC titrns. for the study of cooperative multiprotein interactions, we have examd. the interactions of three proteins that are crit. for signal transduction after T-cell activation, LAT, Grb2, and Sos1.  We have shown previously that multivalent interactions between these three mols. promote the assembly of large multiprotein complexes important for T-cell receptor activation.  By global anal. of the heats of binding obsd. in sets of ITC injections in different orientations, which allowed us to follow the formation of binary and ternary complexes, we obsd. neg. and pos. cooperativity that may be important to control the pathway of assembly and disassembly of adaptor protein particles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZxOktxBGCHbVg90H21EOLACvtfcHk0lgE2XZvHQ8HnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsF2huw%253D%253D&md5=ee98cdbbdaf5249b60c6d31f689b4402</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1110%2Fps.062558507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.062558507%26sid%3Dliteratum%253Aachs%26aulast%3DHoutman%26aufirst%3DJ.%2BC.%26aulast%3DBrown%26aufirst%3DP.%2BH.%26aulast%3DBowden%26aufirst%3DB.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DAppella%26aufirst%3DE.%26aulast%3DSamelson%26aufirst%3DL.%2BE.%26aulast%3DSchuck%26aufirst%3DP.%26atitle%3DStudying%2520multisite%2520binary%2520and%2520ternary%2520protein%2520interactions%2520by%2520global%2520analysis%2520of%2520isothermal%2520titration%2520calorimetry%2520data%2520in%2520SEDPHAT%253A%2520application%2520to%2520adaptor%2520protein%2520complexes%2520in%2520cell%2520signaling%26jtitle%3DProtein%2520Sci.%26date%3D2007%26volume%3D16%26spage%3D30%26epage%3D42%26doi%3D10.1110%2Fps.062558507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gimeno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotrina, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Barbero, J.</span></span> <span> </span><span class="NLM_article-title">Insights on the interaction between transthyretin and Aβ in solution. A Saturation Transfer Difference (STD) NMR analysis of the role of iododiflunisal</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5749</span>– <span class="NLM_lpage">5758</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00428</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00428" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1Kntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5749-5758&author=A.+Gimenoauthor=L.+M.+Santosauthor=M.+Alemiauthor=J.+Rivasauthor=D.+Blasiauthor=Y.+Cotrinaauthor=J.+Llopauthor=G.+Valenciaauthor=I.+Cardosoauthor=J.+Quintanaauthor=G.+Arsequellauthor=J.+Jim%C3%A9nez-Barbero&title=Insights+on+the+interaction+between+transthyretin+and+A%CE%B2+in+solution.+A+Saturation+Transfer+Difference+%28STD%29+NMR+analysis+of+the+role+of+iododiflunisal&doi=10.1021%2Facs.jmedchem.7b00428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Insights on the Interaction between Transthyretin and Aβ in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of Iododiflunisal</span></div><div class="casAuthors">Gimeno, Ana; Santos, Luis M.; Alemi, Mobina; Rivas, Josep; Blasi, Daniel; Cotrina, Ellen Y.; Llop, Jordi; Valencia, Gregorio; Cardoso, Isabel; Quintana, Jordi; Arsequell, Gemma; Jimenez-Barbero, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5749-5758</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several strategies against Alzheimer disease (AD) are directed toward targeting Aβ-peptides.  The ability of transthyretin (TTR) to bind Aβ-peptides and the pos. effect exerted by some TTR stabilizers for modulating the TTR-Aβ interaction have been previously studied.  Here, key structural features of the interaction between TTR and Aβ(12-28) peptide, the essential recognition element of Aβ, have been unraveled by STD-NMR spectroscopy methods in soln.  Mol. aspects related with the role of the TTR stabilizer, iododiflunisal (IDIF), on the TTR-Aβ complex were also examd.  The NMR results, assisted by mol. modeling protocols, provided a structural model for the TTR-Aβ interaction, as well as for the ternary complex formed in the presence of IDIF.  This basic structural information could be relevant for providing light on the mechanisms involved in the ameliorating effects of AD symptoms obsd. in AD/TTR± animal models after IDIF treatment and eventually for designing new mols. toward AD therapeutic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYFHzRMCro1rVg90H21EOLACvtfcHk0lhnZYQE4x0ZkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1Kntrw%253D&md5=8e4c5275309c8d1129655c6d30a9c82d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00428%26sid%3Dliteratum%253Aachs%26aulast%3DGimeno%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DL.%2BM.%26aulast%3DAlemi%26aufirst%3DM.%26aulast%3DRivas%26aufirst%3DJ.%26aulast%3DBlasi%26aufirst%3DD.%26aulast%3DCotrina%26aufirst%3DY.%26aulast%3DLlop%26aufirst%3DJ.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DCardoso%26aufirst%3DI.%26aulast%3DQuintana%26aufirst%3DJ.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DJim%25C3%25A9nez-Barbero%26aufirst%3DJ.%26atitle%3DInsights%2520on%2520the%2520interaction%2520between%2520transthyretin%2520and%2520A%25CE%25B2%2520in%2520solution.%2520A%2520Saturation%2520Transfer%2520Difference%2520%2528STD%2529%2520NMR%2520analysis%2520of%2520the%2520role%2520of%2520iododiflunisal%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5749%26epage%3D5758%26doi%3D10.1021%2Facs.jmedchem.7b00428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sohma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span> <span> </span><span class="NLM_article-title">Design synthesis of a novel water-soluble Aβ1-42 isopeptide: an efficient strategy for the preparation of Alzheimer’s disease-related peptide Aβ1–42 via O–N intramolecular acyl migration reaction</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5965</span>– <span class="NLM_lpage">5968</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2004.06.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.tetlet.2004.06.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Wnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=5965-5968&author=Y.+Sohmaauthor=M.+Sasakiauthor=Y.+Hayashiauthor=T.+Kimuraauthor=Y.+Kiso&title=Design+synthesis+of+a+novel+water-soluble+A%CE%B21-42+isopeptide%3A+an+efficient+strategy+for+the+preparation+of+Alzheimer%E2%80%99s+disease-related+peptide+A%CE%B21%E2%80%9342+via+O%E2%80%93N+intramolecular+acyl+migration+reaction&doi=10.1016%2Fj.tetlet.2004.06.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of a novel water-soluble Aβ1-42 isopeptide: an efficient strategy for the preparation of Alzheimer's disease-related peptide, Aβ1-42, via O-N intramolecular acyl migration reaction</span></div><div class="casAuthors">Sohma, Youhei; Sasaki, Masato; Hayashi, Yoshio; Kimura, Tooru; Kiso, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">5965-5968</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A novel water-sol. isopeptide of Alzheimer's disease-related peptide Aβ1-42, 26-O-acyl isoAβ1-42, which could efficiently convert to intact Aβ1-42 under physiol. conditions via O-N intramol. acyl migration, was synthesized providing a new system useful for investigation of biol. function of Aβ1-42.  26-O-acyl isoAβ1-42 was prepd. by std. solid phase synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHckVStHmzK7Vg90H21EOLACvtfcHk0lhnZYQE4x0ZkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Wnu7Y%253D&md5=7f919ee073cfce215f0e83ca5ca9d6ab</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2004.06.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2004.06.059%26sid%3Dliteratum%253Aachs%26aulast%3DSohma%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DKiso%26aufirst%3DY.%26atitle%3DDesign%2520synthesis%2520of%2520a%2520novel%2520water-soluble%2520A%25CE%25B21-42%2520isopeptide%253A%2520an%2520efficient%2520strategy%2520for%2520the%2520preparation%2520of%2520Alzheimer%25E2%2580%2599s%2520disease-related%2520peptide%2520A%25CE%25B21%25E2%2580%259342%2520via%2520O%25E2%2580%2593N%2520intramolecular%2520acyl%2520migration%2520reaction%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D5965%26epage%3D5968%26doi%3D10.1016%2Fj.tetlet.2004.06.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beeg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stravalaci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span> <span> </span><span class="NLM_article-title">A modified protocol to prepare seed-free starting solutions of amyloid-β (Aβ) 1-40 and Aβ 1-42 from the corresponding depsipeptides</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>411</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2010.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.ab.2010.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=21185802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFOrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2011&pages=297-299&author=M.+Beegauthor=M.+Stravalaciauthor=A.+Bastoneauthor=M.+Salmonaauthor=M.+Gobbi&title=A+modified+protocol+to+prepare+seed-free+starting+solutions+of+amyloid-%CE%B2+%28A%CE%B2%29+1-40+and+A%CE%B2+1-42+from+the+corresponding+depsipeptides&doi=10.1016%2Fj.ab.2010.12.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Modified protocol to prepare seed-free starting solutions of amyloid-β (Aβ)1-40 and Aβ1-42 from corresponding depsipeptides</span></div><div class="casAuthors">Beeg, Marten; Stravalaci, Matteo; Bastone, Antonio; Salmona, Mario; Gobbi, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">297-299</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prepg. reliable, seed-free stock solns. of the highly amyloidogenic peptides amyloid-β (Aβ) is difficult.  Besides the formation of aggregates during synthesis and storage, dissoln. of the peptide is a crit. step because vortexing can induce aggregation.  To overcome this, synthesis of the more water-sol. depsi-Aβ1-42 peptide, from which the native sequence is easily obtained, has been suggested.  We further refined this technique, including a cutoff filtration step and switching the depsipeptide in basic conditions, to stabilize the formed native peptide.  The obtained solns. of native Aβ1-40 and Aβ1-42 peptides were homogeneous and aggregate free, as indicated by thioflavin T and CD anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq737R6Q-u0S7Vg90H21EOLACvtfcHk0liHCJsUAs-mUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFOrur8%253D&md5=1085960627ab139a374d424a4e519471</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2010.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2010.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DBeeg%26aufirst%3DM.%26aulast%3DStravalaci%26aufirst%3DM.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DM.%26atitle%3DA%2520modified%2520protocol%2520to%2520prepare%2520seed-free%2520starting%2520solutions%2520of%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%25201-40%2520and%2520A%25CE%25B2%25201-42%2520from%2520the%2520corresponding%2520depsipeptides%26jtitle%3DAnal.%2520Biochem.%26date%3D2011%26volume%3D411%26spage%3D297%26epage%3D299%26doi%3D10.1016%2Fj.ab.2010.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladiwala, A. R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tessier, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buxbaum, J. N.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">19423</span>– <span class="NLM_lpage">19433</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2561-13.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1523%2FJNEUROSCI.2561-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=24336709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOrtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=19423-19433&author=X.+Liauthor=X.+Zhangauthor=A.+R.+A.+Ladiwalaauthor=D.+Duauthor=J.+K.+Yadavauthor=P.+M.+Tessierauthor=P.+E.+Wrightauthor=J.+W.+Kellyauthor=J.+N.+Buxbaum&title=Mechanisms+of+transthyretin+inhibition+of+%CE%B2-amyloid+aggregation+in+vitro&doi=10.1523%2FJNEUROSCI.2561-13.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro</span></div><div class="casAuthors">Li, Xinyi; Zhang, Xin; Ladiwala, Ali Reza A.; Du, Deguo; Yadav, Jay K.; Tessier, Peter M.; Wright, Peter E.; Kelly, Jeffery W.; Buxbaum, Joel N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">19423-19433</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Tissue-specific overexpression of the human systemic amyloid precursor transthyretin (TTR) ameliorates Alzheimer's disease (AD) phenotypes in APP23 mice.  TTR-β-amyloid (Aβ) complexes have been isolated from APP23 and some human AD brains.  We now show that substoichiometric concns. of TTR tetramers suppress Aβ aggregation in vitro via an interaction between the thyroxine binding pocket of the TTR tetramer and Aβ residues 18-21 (NMR and epitope mapping).  The KD is micromolar, and the stoichiometry is <1 for the interaction (isothermal titrn. calorimetry).  Similar expts. show that engineered monomeric TTR, the best inhibitor of Aβ fibril formation in vitro, did not bind Aβ monomers in liq. phase, suggesting that inhibition of fibrillogenesis is mediated by TTR tetramer binding to Aβ monomer and both tetramer and monomer binding of Aβ oligomers.  The thousand-fold greater concn. of tetramer relative to monomer in vivo makes it the likely suppressor of Aβ aggregation and disease in the APP23 mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq52OKtnJ05hbVg90H21EOLACvtfcHk0liHCJsUAs-mUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOrtLzK&md5=48fabf89f9aed01aa8226a0569f6706e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2561-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2561-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLadiwala%26aufirst%3DA.%2BR.%2BA.%26aulast%3DDu%26aufirst%3DD.%26aulast%3DYadav%26aufirst%3DJ.%2BK.%26aulast%3DTessier%26aufirst%3DP.%2BM.%26aulast%3DWright%26aufirst%3DP.%2BE.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BN.%26atitle%3DMechanisms%2520of%2520transthyretin%2520inhibition%2520of%2520%25CE%25B2-amyloid%2520aggregation%2520in%2520vitro%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D19423%26epage%3D19433%26doi%3D10.1523%2FJNEUROSCI.2561-13.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meisl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellstrand, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frohm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkegaard, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowles, T. P.</span></span> <span> </span><span class="NLM_article-title">Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">9384</span>– <span class="NLM_lpage">9389</span>, <span class="refDoi"> DOI: 10.1073/pnas.1401564111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1073%2Fpnas.1401564111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=24938782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVSltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=9384-9389&author=G.+Meislauthor=X.+Yangauthor=E.+Hellstrandauthor=B.+Frohmauthor=J.+B.+Kirkegaardauthor=S.+I.+Cohenauthor=C.+M.+Dobsonauthor=S.+Linseauthor=T.+P.+Knowles&title=Differences+in+nucleation+behavior+underlie+the+contrasting+aggregation+kinetics+of+the+A%CE%B240+and+A%CE%B242+peptides&doi=10.1073%2Fpnas.1401564111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides</span></div><div class="casAuthors">Meisl, Georg; Yang, Xiaoting; Hellstrand, Erik; Frohm, Birgitta; Kirkegaard, Julius B.; Cohen, Samuel I. A.; Dobson, Christopher M.; Linse, Sara; Knowles, Tuomas P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9384-9389</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The two major forms of the amyloid-beta (Aβ) peptide found in plaques in patients suffering from Alzheimer's disease, Aβ40 and Aβ42, only differ by two amino acids in the C-terminal region, yet they display markedly different aggregation behavior.  The origins of these differences have remained challenging to connect to specific mol.-level processes underlying the aggregation reaction.  In this paper we use a general strategy to apply the conventional workflow of chem. kinetics to the aggregation of the Aβ40 peptide to identify the differences between Aβ40 and Aβ42 in terms of the microscopic determinants of the aggregation reaction.  Our results reveal that the major source of aggregates in the case of Aβ40 is a fibril-catalyzed nucleation process, the multistep nature of which is evident through its satn. behavior.  Moreover, our results show that the significant differences in the obsd. behavior of the two proteins originate not simply from a uniform increase in all microscopic rates for Aβ42 compared with Aβ40, but rather are due to a shift of more than one order of magnitude in the relative importance of primary nucleation vs. fibril-catalyzed secondary nucleation processes.  This anal. sheds light on the microscopic determinants of the aggregation behavior of the principal forms of Aβ and outlines a general approach toward achieving an understanding at the mol. level of the aberrant deposition of insol. peptides in neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVUCSJmBA-wbVg90H21EOLACvtfcHk0libVUqZo1a2Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVSltrg%253D&md5=227d47c161dae92810a90e94c4467c4c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1401564111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1401564111%26sid%3Dliteratum%253Aachs%26aulast%3DMeisl%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DHellstrand%26aufirst%3DE.%26aulast%3DFrohm%26aufirst%3DB.%26aulast%3DKirkegaard%26aufirst%3DJ.%2BB.%26aulast%3DCohen%26aufirst%3DS.%2BI.%26aulast%3DDobson%26aufirst%3DC.%2BM.%26aulast%3DLinse%26aufirst%3DS.%26aulast%3DKnowles%26aufirst%3DT.%2BP.%26atitle%3DDifferences%2520in%2520nucleation%2520behavior%2520underlie%2520the%2520contrasting%2520aggregation%2520kinetics%2520of%2520the%2520A%25CE%25B240%2520and%2520A%25CE%25B242%2520peptides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2014%26volume%3D111%26spage%3D9384%26epage%3D9389%26doi%3D10.1073%2Fpnas.1401564111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LeVine, H.,  3rd</span></span> <span> </span><span class="NLM_article-title">Thioflavine T interaction with synthetic Alzheimer’s disease beta-amyloid peptides: detection of amyloid aggregation in solution</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1002/pro.5560020312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fpro.5560020312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=8453378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK3sXksVCntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1993&pages=404-410&author=H.+LeVine&title=Thioflavine+T+interaction+with+synthetic+Alzheimer%E2%80%99s+disease+beta-amyloid+peptides%3A+detection+of+amyloid+aggregation+in+solution&doi=10.1002%2Fpro.5560020312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Thioflavin T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution</span></div><div class="casAuthors">LeVine, Harry, III</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">404-10</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    </div><div class="casAbstract">Thioflavine T (ThT) assocs. rapidly with aggregated fibrils of the synthetic β/A4-derived peptides β(1-28) and β(1-40), giving rise to a new excitation (ex) (absorption) max. at 450 nm and enhanced emission (em) at 482 nm, as opposed to the 385 nm (ex) and 445 nm (em) of the free dye.  This change is dependent on the aggregated state as monomeric or dimeric peptides do not react, and guanidine dissocn. of aggregates destroys the signal.  There was no effect of high salt concns.  Binding to the β(1-40) is of lower affinity, Kd 2 μM, while it sats. with a Kd of 0.54 μM for β(1-28).  Insulin fibrils converted to a β-sheet conformation fluoresce intensely with ThT.  A variety of polyhydroxy, polyanionic, or polycationic materials fail to interact or impede interaction with the amyloid peptides.  This fluorometric technique should allow the kinetic elucidation of the amyloid fibril assembly process as well as the testing of agents that might modulate their assembly or disassembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGqSauseHbKrVg90H21EOLACvtfcHk0libVUqZo1a2Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVCntLo%253D&md5=d4bfff1cedf68a3c9379a87d88c3f97a</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560020312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560020312%26sid%3Dliteratum%253Aachs%26aulast%3DLeVine%26aufirst%3DH.%26atitle%3DThioflavine%2520T%2520interaction%2520with%2520synthetic%2520Alzheimer%25E2%2580%2599s%2520disease%2520beta-amyloid%2520peptides%253A%2520detection%2520of%2520amyloid%2520aggregation%2520in%2520solution%26jtitle%3DProtein%2520Sci.%26date%3D1993%26volume%3D2%26spage%3D404%26epage%3D410%26doi%3D10.1002%2Fpro.5560020312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLachlan, D. R.</span></span> <span> </span><span class="NLM_article-title">Alzheimer Aβ amyloid forms an inhibitory neuronal substrate</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1227</span>– <span class="NLM_lpage">1230</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1994.62031227.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1046%2Fj.1471-4159.1994.62031227.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=8113806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK2cXitFCgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1994&pages=1227-1230&author=P.+E.+Fraserauthor=L.+Levesqueauthor=D.+R.+McLachlan&title=Alzheimer+A%CE%B2+amyloid+forms+an+inhibitory+neuronal+substrate&doi=10.1046%2Fj.1471-4159.1994.62031227.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer Aβ amyloid forms an inhibitory neuronal substrate</span></div><div class="casAuthors">Fraser, P. E.; Levesque, L.; McLachlan, D. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1227-30</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is identified by the accumulation of amyloid plaques, neurofibrillary degeneration, and the accompanying neuronal loss.  AD amyloid assembles into compact fibrous deposits from the amyloid (A) protein, which is a proteolytic fragment of the membrane-assocd. amyloid precursor protein.  To examine the effects of amyloid on neuron growth, a hybrid mouse motoneuron cell line (NSC34) exhibiting spontaneous process formation was exposed to artificial "plaques" created from aggregated synthetic Aβ peptides.  These correspond to full-length Aβ- residues 1-40 (Aβ1-40), an internal β-sheet region comprising residues 11-28 (Aβ-11-28), and a proposed toxic fragment comprising residues 25-35 (Aβ-25-35).  Fibers were immobilized onto culture dishes, and addn. of cells to these in vitro plaques revealed that Aβ was not a permissive substrate for cell adhesion.  Neurites in close contact with these deposits displayed abnormal swelling and a tendency to avoid contact with the Aβ fibers.  In contrast, Aβ did not affect the adhesion or growth of rat astrocytes, implicating a specific Aβ-neuron relationship.  The inhibitory effects were also unique to Aβ-neuron relationship.  The inhibitory effects were also unique to Aβ as no response was obsd. to deposits of pancreatic islet amyloid polypeptide fibers.  Considering the importance of cell adhesion in neurite elongation and axonal guidance, the antiadhesive properties of Aβ amyloid plaques found in vivo may contribute to the neuronal loss responsible for the clin. manifestations of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXSzQBAZskJ7Vg90H21EOLACvtfcHk0lijNWnA3v5sVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitFCgur4%253D&md5=8dbe9629dc5329bb9ba871515dd113a1</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1994.62031227.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1994.62031227.x%26sid%3Dliteratum%253Aachs%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DLevesque%26aufirst%3DL.%26aulast%3DMcLachlan%26aufirst%3DD.%2BR.%26atitle%3DAlzheimer%2520A%25CE%25B2%2520amyloid%2520forms%2520an%2520inhibitory%2520neuronal%2520substrate%26jtitle%3DJ.%2520Neurochem.%26date%3D1994%26volume%3D62%26spage%3D1227%26epage%3D1230%26doi%3D10.1046%2Fj.1471-4159.1994.62031227.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flood, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span> <span> </span><span class="NLM_article-title">An amyloid β protein fragment, Aβ (12-28), equipotently impairs post-training memory processing when injected into different limbic system structures</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>663</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(94)91273-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2F0006-8993%2894%2991273-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=7874511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFygtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=663&publication_year=1994&pages=271-276&author=J.+F.+Floodauthor=J.+E.+Morleyauthor=E.+Roberts&title=An+amyloid+%CE%B2+protein+fragment%2C+A%CE%B2+%2812-28%29%2C+equipotently+impairs+post-training+memory+processing+when+injected+into+different+limbic+system+structures&doi=10.1016%2F0006-8993%2894%2991273-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">An amyloid β-protein fragment, Aβ[12-28], equipotently impairs post-training memory processing when injected into different limbic system structures</span></div><div class="casAuthors">Flood, James F.; Morley, John E.; Roberts, Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">663</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-6</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Previously, amyloid β-protein (Aβ) fragments 1-28, 12-28 and 12-20 were found to impair retention in mice when injected intracerebroventricularly after footshock active avoidance training.  The authors now have measured the dose-dependence of amnestic effects of peptide 12-28 stereotactically injected into amygdala, caudate, hippocampus, mammillary bodies and septum, which limbic structures are known to be involved in memory processing and into the medial thalamus, which largely is involved in sensory processing during training.  Peptide 12-28 impaired retention with remarkably similar efficacy when injected into limbic structures but was not at all amnestic upon thalamic injection.  Present results together with those in the literature lead the authors to suggest that Aβ may exert dysregulatory cognitive effects by incoordination of K+-channel function in neurons, glia and endothelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruiVip1QctKrVg90H21EOLACvtfcHk0lijNWnA3v5sVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFygtbo%253D&md5=6d4b0ea361d04efd2d701220719f0c61</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2894%2991273-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252894%252991273-4%26sid%3Dliteratum%253Aachs%26aulast%3DFlood%26aufirst%3DJ.%2BF.%26aulast%3DMorley%26aufirst%3DJ.%2BE.%26aulast%3DRoberts%26aufirst%3DE.%26atitle%3DAn%2520amyloid%2520%25CE%25B2%2520protein%2520fragment%252C%2520A%25CE%25B2%2520%252812-28%2529%252C%2520equipotently%2520impairs%2520post-training%2520memory%2520processing%2520when%2520injected%2520into%2520different%2520limbic%2520system%2520structures%26jtitle%3DBrain%2520Res.%26date%3D1994%26volume%3D663%26spage%3D271%26epage%3D276%26doi%3D10.1016%2F0006-8993%2894%2991273-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarvet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, L. E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graslund, A.</span></span> <span> </span><span class="NLM_article-title">Reversible random coil to β-sheet transition and the early stage of aggregation of the Aβ(12–28) fragment from the Alzheimer peptide</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">4261</span>– <span class="NLM_lpage">4268</span>, <span class="refDoi"> DOI: 10.1021/ja991167z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja991167z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFChu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=4261-4268&author=J.+Jarvetauthor=P.+Dambergauthor=K.+Bodellauthor=L.+E.+G.+Erikssonauthor=A.+Graslund&title=Reversible+random+coil+to+%CE%B2-sheet+transition+and+the+early+stage+of+aggregation+of+the+A%CE%B2%2812%E2%80%9328%29+fragment+from+the+Alzheimer+peptide&doi=10.1021%2Fja991167z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible Random Coil to β-Sheet Transition and the Early Stage of Aggregation of the Aβ(12-28) Fragment from the Alzheimer Peptide</span></div><div class="casAuthors">Jarvet, Jueri; Damberg, Peter; Bodell, Karl; Eriksson, L. E. Goeran; Graeslund, Astrid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4261-4268</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Alzheimer peptide fragment Aβ(12-28) was studied at millimolar concn. by parallel expts. with high-resoln. NMR and CD in soln. at a pH close to the isoelec. point of the peptide.  A prepn. procedure using low temp. and low ionic strength buffer gave a sample with stable and reproducible properties.  Reversible changes in secondary structure and state of aggregation were studied by variation of temp.  High-temp. promotes aggregation and β-sheet induction, whereas low-temp. shifts the equil. toward low mol. wt. fractions and less β-sheet like structure.  NMR diffusion expts. show that the dominating, most low mol. wt. fraction is monomeric.  With increasing temp., residues F20A21E22, overlapping with the so-called central hydrophobic segment of the Aβ peptide, exhibit the most pronounced α-proton NMR secondary chem. shift changes from random coil toward more β-sheet like structure.  High ionic strength also promotes aggregation and β-sheet induction.  The combined spectroscopic results, including also mol. wt. estns. by cutoff filters, are summarized in a scheme in which monomeric mostly random coil and heterogeneous aggregated partly β-sheet forms of the peptide are in a temp.-dependent equil., a situation which corresponds to an early stage of the fibrillogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmx4BiYmoYXrVg90H21EOLACvtfcHk0lijNWnA3v5sVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFChu7g%253D&md5=3f411cd6e20865be3bdf32bb41a5d26d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fja991167z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja991167z%26sid%3Dliteratum%253Aachs%26aulast%3DJarvet%26aufirst%3DJ.%26aulast%3DDamberg%26aufirst%3DP.%26aulast%3DBodell%26aufirst%3DK.%26aulast%3DEriksson%26aufirst%3DL.%2BE.%2BG.%26aulast%3DGraslund%26aufirst%3DA.%26atitle%3DReversible%2520random%2520coil%2520to%2520%25CE%25B2-sheet%2520transition%2520and%2520the%2520early%2520stage%2520of%2520aggregation%2520of%2520the%2520A%25CE%25B2%252812%25E2%2580%259328%2529%2520fragment%2520from%2520the%2520Alzheimer%2520peptide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D4261%26epage%3D4268%26doi%3D10.1021%2Fja991167z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Razavi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palaninathan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamedmohaideen, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deechongkit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dendle, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span> <span> </span><span class="NLM_article-title">Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">2758</span>– <span class="NLM_lpage">2761</span>, <span class="refDoi"> DOI: 10.1002/anie.200351179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fanie.200351179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlCjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2758-2761&author=H.+Razaviauthor=S.+K.+Palaninathanauthor=E.+T.+Powersauthor=R.+L.+Wisemanauthor=H.+E.+Purkeyauthor=N.+N.+Mohamedmohaideenauthor=S.+Deechongkitauthor=K.+P.+Chiangauthor=M.+T.+Dendleauthor=J.+C.+Sacchettiniauthor=J.+W.+Kelly&title=Benzoxazoles+as+transthyretin+amyloid+fibril+inhibitors%3A+synthesis%2C+evaluation%2C+and+mechanism+of+action&doi=10.1002%2Fanie.200351179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazoles as transthyretin amyloid fibril inhibitors: Synthesis, evaluation, and mechanism of action</span></div><div class="casAuthors">Razavi, Hossein; Palaninathan, Satheesh K.; Powers, Evan T.; Wiseman, R. Luke; Purkey, Hans E.; Mohamedmohaideen, Nilofar N.; Deechongkit, Songpon; Chiang, Kyle P.; Dendle, Maria T. A.; Sacchettini, James C.; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2758-2761</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Benzoxazoles prevent misfolding: Benzoxazole-based inhibitors of transthyretin (TTR) amyloid fibril formation are among the most effective found to date.  They stabilize TTR against both acid-mediated misfolding and urea denaturation by raising the activation barrier to tetramer dissocn., the rate-limiting step for amyloid formation.  The figure depicts the co-crystal structure of one of the better benzoxazole inhibitors bound to TTR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN6V6zDEc-irVg90H21EOLACvtfcHk0liiUf9KH7XQgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlCjtb0%253D&md5=0d83f0e2ee80978801d7f51c250ee88a</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351179%26sid%3Dliteratum%253Aachs%26aulast%3DRazavi%26aufirst%3DH.%26aulast%3DPalaninathan%26aufirst%3DS.%2BK.%26aulast%3DPowers%26aufirst%3DE.%2BT.%26aulast%3DWiseman%26aufirst%3DR.%2BL.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DMohamedmohaideen%26aufirst%3DN.%2BN.%26aulast%3DDeechongkit%26aufirst%3DS.%26aulast%3DChiang%26aufirst%3DK.%2BP.%26aulast%3DDendle%26aufirst%3DM.%2BT.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DBenzoxazoles%2520as%2520transthyretin%2520amyloid%2520fibril%2520inhibitors%253A%2520synthesis%252C%2520evaluation%252C%2520and%2520mechanism%2520of%2520action%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D2758%26epage%3D2761%26doi%3D10.1002%2Fanie.200351179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolado, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A.</span></span> <span> </span><span class="NLM_article-title">Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1021/cc049849s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc049849s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Olsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=246-252&author=I.+Doladoauthor=J.+Nietoauthor=M.+J.+M.+Saraivaauthor=G.+Arsequellauthor=G.+Valenciaauthor=A.+Planas&title=Kinetic+assay+for+high-throughput+screening+of+in+vitro+transthyretin+amyloid+fibrillogenesis+inhibitors&doi=10.1021%2Fcc049849s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic Assay for High-Throughput Screening of In Vitro Transthyretin Amyloid Fibrillogenesis Inhibitors</span></div><div class="casAuthors">Dolado, Ignacio; Nieto, Joan; Saraiva, Maria Joao M.; Arsequell, Gemma; Valencia, Gregori; Planas, Antoni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-252</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stabilization of tetrameric transthyretin (TTR) by binding of small ligands is a current strategy aimed at inhibiting amyloid fibrillogenesis in transthyretin-assocd. pathologies, such as senile systemic amyloidosis (SSA) and familial amyloidotic polyneuropathy (FAP).  A kinetic assay is developed for rapid evaluation of compds. as potential in vitro inhibitors in a high-throughput screening format.  It is based on monitoring the time-dependent increase of absorbance due to turbidity occurring by acid-induced protein aggregation.  The method uses the highly amyloidogenic Y78F mutant of human transthyretin (heterologously expressed in Escherichia coli cells).  Initial rates of protein aggregation at different inhibitor concns. follow a monoexponential dose-response curve from which inhibition parameters are calcd.  For the assay development, thyroid hormones and nonsteroidal anti-inflammatory drugs were chosen among other ref. compds.  Some of them are already known to be in vitro inhibitors of TTR amyloidogenesis.  Anal. time is optimized to last 1.5 h, and the method is implemented in microtiter plates for screening of libraries of potential fibrillogenesis inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplJThxssB3ErVg90H21EOLACvtfcHk0liiUf9KH7XQgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Olsrs%253D&md5=dbb3a5b90bb9e98548354cf82b9f89e9</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fcc049849s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc049849s%26sid%3Dliteratum%253Aachs%26aulast%3DDolado%26aufirst%3DI.%26aulast%3DNieto%26aufirst%3DJ.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%2BM.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DPlanas%26aufirst%3DA.%26atitle%3DKinetic%2520assay%2520for%2520high-throughput%2520screening%2520of%2520in%2520vitro%2520transthyretin%2520amyloid%2520fibrillogenesis%2520inhibitors%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2005%26volume%3D7%26spage%3D246%26epage%3D252%26doi%3D10.1021%2Fcc049849s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref64':['cit64'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Mahalakshmi  Harish</span>, <span class="hlFld-ContribAuthor ">Prasanna  Venkatraman</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of biophysical tools for quantitative protein interactions and drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Emerging Topics in Life Sciences</span><span> <strong>2021,</strong> <em>5 </em>
                                    (1)
                                     , 1-12. <a href="https://doi.org/10.1042/ETLS20200258" title="DOI URL">https://doi.org/10.1042/ETLS20200258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/ETLS20200258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FETLS20200258%26sid%3Dliteratum%253Aachs%26jtitle%3DEmerging%2520Topics%2520in%2520Life%2520Sciences%26atitle%3DEvolution%252Bof%252Bbiophysical%252Btools%252Bfor%252Bquantitative%252Bprotein%252Binteractions%252Band%252Bdrug%252Bdiscovery%26aulast%3DBose%26aufirst%3DKakoli%26date%3D2021%26date%3D2021%26volume%3D5%26issue%3D1%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ellen Y.  Cotrina</span>, <span class="hlFld-ContribAuthor ">Ana  Gimeno</span>, <span class="hlFld-ContribAuthor ">Jordi  Llop</span>, <span class="hlFld-ContribAuthor ">Jesús  Jiménez‐Barbero</span>, <span class="hlFld-ContribAuthor ">Jordi  Quintana</span>, <span class="hlFld-ContribAuthor ">Rafel  Prohens</span>, <span class="hlFld-ContribAuthor ">Isabel  Cardoso</span>, <span class="hlFld-ContribAuthor ">Gemma  Arsequell</span>. </span><span class="cited-content_cbyCitation_article-title">An Assay for Screening Potential Drug Candidates for Alzheimer's Disease That Act as Chaperones of the Transthyretin and Amyloid‐β Peptides Interaction. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (72)
                                     , 17462-17469. <a href="https://doi.org/10.1002/chem.202002933" title="DOI URL">https://doi.org/10.1002/chem.202002933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202002933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202002933%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DAn%252BAssay%252Bfor%252BScreening%252BPotential%252BDrug%252BCandidates%252Bfor%252BAlzheimer%252527s%252BDisease%252BThat%252BAct%252Bas%252BChaperones%252Bof%252Bthe%252BTransthyretin%252Band%252BAmyloid%2525E2%252580%252590%2525CE%2525B2%252BPeptides%252BInteraction%26aulast%3DCotrina%26aufirst%3DEllen%2BY.%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D72%26spage%3D17462%26epage%3D17469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ellen Y.  Cotrina</span>, <span class="hlFld-ContribAuthor ">Daniel  Blasi</span>, <span class="hlFld-ContribAuthor ">Marta  Vilà</span>, <span class="hlFld-ContribAuthor ">Antoni  Planas</span>, <span class="hlFld-ContribAuthor ">Cele  Abad-Zapatero</span>, <span class="hlFld-ContribAuthor ">Nuria B.  Centeno</span>, <span class="hlFld-ContribAuthor ">Jordi  Quintana</span>, <span class="hlFld-ContribAuthor ">Gemma  Arsequell</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of kinetic stabilizers of tetrameric transthyretin: A prospective ligand efficiency-guided approach. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (23)
                                     , 115794. <a href="https://doi.org/10.1016/j.bmc.2020.115794" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115794</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115794%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Bkinetic%252Bstabilizers%252Bof%252Btetrameric%252Btransthyretin%25253A%252BA%252Bprospective%252Bligand%252Befficiency-guided%252Bapproach%26aulast%3DCotrina%26aufirst%3DEllen%2BY.%26date%3D2020%26volume%3D28%26issue%3D23%26spage%3D115794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luka  Rejc</span>, <span class="hlFld-ContribAuthor ">Vanessa  Gómez-Vallejo</span>, <span class="hlFld-ContribAuthor ">Xabier  Rios</span>, <span class="hlFld-ContribAuthor ">Unai  Cossío</span>, <span class="hlFld-ContribAuthor ">Zuriñe  Baz</span>, <span class="hlFld-ContribAuthor ">Edurne  Mujica</span>, <span class="hlFld-ContribAuthor ">Tiago  Gião</span>, <span class="hlFld-ContribAuthor ">Ellen Y.  Cotrina</span>, <span class="hlFld-ContribAuthor ">Jesús  Jiménez-Barbero</span>, <span class="hlFld-ContribAuthor ">Jordi  Quintana</span>, <span class="hlFld-ContribAuthor ">Gemma  Arsequell</span>, <span class="hlFld-ContribAuthor ">Isabel  Cardoso</span>, <span class="hlFld-ContribAuthor ">Jordi  Llop</span>. </span><span class="cited-content_cbyCitation_article-title">Oral Treatment with Iododiflunisal Delays Hippocampal Amyloid-β Formation in a Transgenic Mouse Model of Alzheimer’s Disease: A Longitudinal in vivo Molecular Imaging Study1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2020,</strong> <em>77 </em>
                                    (1)
                                     , 99-112. <a href="https://doi.org/10.3233/JAD-200570" title="DOI URL">https://doi.org/10.3233/JAD-200570</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-200570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-200570%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DOral%252BTreatment%252Bwith%252BIododiflunisal%252BDelays%252BHippocampal%252BAmyloid-%2525CE%2525B2%252BFormation%252Bin%252Ba%252BTransgenic%252BMouse%252BModel%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BA%252BLongitudinal%252Bin%252Bvivo%252BMolecular%252BImaging%252BStudy1%26aulast%3DRejc%26aufirst%3DLuka%26date%3D2020%26volume%3D77%26issue%3D1%26spage%3D99%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lidia  Ciccone</span>, <span class="hlFld-ContribAuthor ">Chenghui  Shi</span>, <span class="hlFld-ContribAuthor ">Davide  di Lorenzo</span>, <span class="hlFld-ContribAuthor ">Anne-Cécile  Van Baelen</span>, <span class="hlFld-ContribAuthor ">Nicolo  Tonali</span>. </span><span class="cited-content_cbyCitation_article-title">The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (10)
                                     , 2439. <a href="https://doi.org/10.3390/molecules25102439" title="DOI URL">https://doi.org/10.3390/molecules25102439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25102439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25102439%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BPositive%252BSide%252Bof%252Bthe%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BAmyloid%252BCross-Interactions%25253A%252BThe%252BCase%252Bof%252Bthe%252BA%2525CE%2525B2%252B1-42%252BPeptide%252Bwith%252BTau%25252C%252BTTR%25252C%252BCysC%25252C%252Band%252BApoA1%26aulast%3DCiccone%26aufirst%3DLidia%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D10%26spage%3D2439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiago  Gião</span>, <span class="hlFld-ContribAuthor ">Joana  Saavedra</span>, <span class="hlFld-ContribAuthor ">Ellen  Cotrina</span>, <span class="hlFld-ContribAuthor ">Jordi  Quintana</span>, <span class="hlFld-ContribAuthor ">Jordi  Llop</span>, <span class="hlFld-ContribAuthor ">Gemma  Arsequell</span>, <span class="hlFld-ContribAuthor ">Isabel  Cardoso</span>. </span><span class="cited-content_cbyCitation_article-title">Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (6)
                                     , 2075. <a href="https://doi.org/10.3390/ijms21062075" title="DOI URL">https://doi.org/10.3390/ijms21062075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21062075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21062075%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DUndiscovered%252BRoles%252Bfor%252BTransthyretin%25253A%252BFrom%252Ba%252BTransporter%252BProtein%252Bto%252Ba%252BNew%252BTherapeutic%252BTarget%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGi%25C3%25A3o%26aufirst%3DTiago%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D6%26spage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lidia  Ciccone</span>, <span class="hlFld-ContribAuthor ">Nicoló  Tonali</span>, <span class="hlFld-ContribAuthor ">Susanna  Nencetti</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Orlandini</span>. </span><span class="cited-content_cbyCitation_article-title">Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1145-1162. <a href="https://doi.org/10.1080/14756366.2020.1760262" title="DOI URL">https://doi.org/10.1080/14756366.2020.1760262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1760262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1760262%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DNatural%252Bcompounds%252Bas%252Binhibitors%252Bof%252Btransthyretin%252Bamyloidosis%252Band%252Bneuroprotective%252Bagents%25253A%252Banalysis%252Bof%252Bstructural%252Bdata%252Bfor%252Bfuture%252Bdrug%252Bdesign%26aulast%3DCiccone%26aufirst%3DLidia%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1145%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Chemical Structures of TTR Tetramer Kinetic Stabilizers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Diflunisal (<b>1</b>), Tafamidis (<b>2</b>), and Tolcapone (<b>3</b>) are registered drugs.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Isothermal titration calorimetry (ITC) studies. The binary complex [TTR + Aβ(1–42)] at pH 7.4 in 25 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-(2-ethanesulfonic acid) (HEPES) buffer, 10 mM glycine, and 5% dimethyl sulfoxide (DMSO) (final concentration) at 25 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. ITC studies. (A) Titration of [TTR + IDIF (<b>4</b>)] complex with Aβ(1–42). (B) Titration of [TTR + Tafamidis (<b>2</b>)] complex with Aβ(1–42). All of them at pH 7.4 in 25 mM HEPES buffer, 10 mM glycine, and 5% DMSO (final concentration) at 25 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ThT assays of the aggregation of Aβ(1–42) alone (50 μM), in complex with TTR (25 μM), or in complex with TTR stabilized with different small compounds (50 μM), [TTR/IDIF (<b>4</b>), TTR/DIF (<b>1</b>), and TTR/Tafamidis (<b>2</b>)]. ThT fluorescence was measured at 37 °C each 10 min for 3 h, then each 20 min from 3 to 6 h, and then at 8 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. ITC analysis of different short sequences of amyloid β Aβ(1–42) binding to TTR at pH 7.4 in 25 mM HEPES buffer, 10 mM glycine, and 5% DMSO at 25 °C. The binary systems are: (A) TTR + Aβ(1–11) (<b>5</b>), (B) TTR + Aβ(10–20) (<b>6</b>), (C) TTR + Aβ(25–35) (<b>8</b>), (D) TTR + Aβ(12,28) (<b>7</b>), (E) TTR + V18A Aβ(12–28) (<b>9</b>), (F) TTR + F19A Aβ(12–28) (<b>10</b>), and (G) TTR + F20A Aβ(12–28) (<b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. ITC analysis of (A) binary complex TTR + Aβ(12–28), (B) ternary complex [TTR + IDIF (<b>4</b>)] and Aβ(12–28), (C) ternary complex [TTR + Diflunisal (<b>1</b>)] and Aβ(12–28), and (D) ternary complex [TTR + Tafamidis (<b>4</b>)] and Aβ(12–28). All of these ITC studies were performed at pH 7.4 in 25 mM HEPES buffer, 10 mM glycine, and 5% DMSO (final concentration) at 25 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/medium/jm9b01970_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Morphologic assessment by TEM of the influence of TTR on Aβ(12–28) aggregation after 48 h of incubation at 37 °C. (A–C) Aβ(12–28) peptide alone, (D) Aβ(12–28) in the presence of TTR, (E) Aβ(12–28) in the presence of TTR preincubated with IDIF, and (F) Aβ(12–28) in the presence of TTR preincubated with Tafamidis. Scale bar (A, B, D, E, and F) = 200 nm; C = 100 nm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01970/20210312/images/large/jm9b01970_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01970&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58356" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58356" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 69 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Alzheimer’s
Association Report</span> <span> </span><span class="NLM_article-title">2019 Alzheimer’s
Disease Facts and Figures</span>. <i>Alzheimer's
Dementia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2019.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.jalz.2019.01.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=321-387&author=Alzheimer%E2%80%99s%0AAssociation+Report&title=2019+Alzheimer%E2%80%99s%0ADisease+Facts+and+Figures&doi=10.1016%2Fj.jalz.2019.01.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2019.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2019.01.010%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D2019%2520Alzheimer%25E2%2580%2599s%250ADisease%2520Facts%2520and%2520Figures%26jtitle%3DAlzheimer%2527s%250ADementia%26date%3D2019%26volume%3D15%26spage%3D321%26epage%3D387%26doi%3D10.1016%2Fj.jalz.2019.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease at 25 years</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.15252/emmm.201606210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.15252%2Femmm.201606210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=27025652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=595-608&author=D.+J.+Selkoeauthor=J.+Hardy&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease+at+25+years&doi=10.15252%2Femmm.201606210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease at 25 years</span></div><div class="casAuthors">Selkoe, Dennis J.; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">595-608</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Despite continuing debate about the amyloid β-protein or Aβ hypothesis, new lines of evidence from labs. and clinics worldwide support the concept that an imbalance between prodn. and clearance of Aβ42 and related Aβ peptides is a very early, often initiating factor in Alzheimer's disease AD.  Confirmation that presenilin is the catalytic site of γ-secretase has provided a linchpin: all dominant mutations causing early-onset AD occur either in the substrate amyloid precursor protein, APP or the protease presenilin of the reaction that generates Aβ.  Duplication of the wild-type APP gene in Down's syndrome leads to Aβ deposits in the teens, followed by microgliosis, astrocytosis, and neurofibrillary tangles typical of AD.  Apolipoprotein E4, which predisposes to AD in > 40% of cases, has been found to impair Aβ clearance from the brain.  Sol. oligomers of Aβ42 isolated from AD patients' brains can decrease synapse no., inhibit long-term potentiation, and enhance long-term synaptic depression in rodent hippocampus, and injecting them into healthy rats impairs memory.  The human oligomers also induce hyperphosphorylation of tau at AD-relevant epitopes and cause neuritic dystrophy in cultured neurons.  Crossing human APP with human tau transgenic mice enhances tau-pos. neurotoxicity.  In humans, new studies show that low cerebrospinal fluid CSF Aβ42 and amyloid-PET positivity precede other AD manifestations by many years.  Most importantly, recent trials of three different Aβ antibodies solanezumab, crenezumab, and aducanumab have suggested a slowing of cognitive decline in post hoc analyses of mild AD subjects.  Although many factors contribute to AD pathogenesis, Aβ dyshomeostasis has emerged as the most extensively validated and compelling therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGo1qmyvVtbVg90H21EOLACvtfcHk0li_Q70AUnrBdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D&md5=b7a2003ba5d341f5eef5c7e9454235ce</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.15252%2Femmm.201606210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201606210%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520at%252025%2520years%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D595%26epage%3D608%26doi%3D10.15252%2Femmm.201606210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doig, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Castillo-Frias, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthoumieu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasica-Labouze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterpone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derreumaux, P.</span></span> <span> </span><span class="NLM_article-title">Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer’s Disease?</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1437</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00188</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1CmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1435-1437&author=A.+J.+Doigauthor=M.+P.+Del+Castillo-Friasauthor=O.+Berthoumieuauthor=B.+Tarusauthor=J.+Nasica-Labouzeauthor=F.+Sterponeauthor=P.+H.+Nguyenauthor=N.+M.+Hooperauthor=P.+Fallerauthor=P.+Derreumaux&title=Why+Is+Research+on+Amyloid-%CE%B2+Failing+to+Give+New+Drugs+for+Alzheimer%E2%80%99s+Disease%3F&doi=10.1021%2Facschemneuro.7b00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?</span></div><div class="casAuthors">Doig, Andrew J.; del Castillo-Frias, Maria P.; Berthoumieu, Olivia; Tarus, Bogdan; Nasica-Labouze, Jessica; Sterpone, Fabio; Nguyen, Phuong H.; Hooper, Nigel M.; Faller, Peter; Derreumaux, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1435-1437</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two hallmarks of Alzheimer's disease (AD) are the presence of neurofibrillary tangles (NFT) made of aggregates of the hyperphosphorylated tau protein and of amyloid plaques composed of amyloid-β (Aβ) peptides, primarily Aβ1-40 and Aβ1-42.  Targeting the prodn., aggregation, and toxicity of Aβ with small mol. drugs or antibodies is an active area of AD research due to the general acceptance of the amyloid cascade hypothesis, but thus far all drugs targeting Aβ have failed.  From a review of the recent literature and our own experience based on in vitro, in silico, and in vivo studies, we present some reasons to explain this repetitive failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrimFSfyVV9VrVg90H21EOLACvtfcHk0ljFTCIXGEBHuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1CmsLo%253D&md5=26bc5126993b4d8df4eaf9ddf81e981a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00188%26sid%3Dliteratum%253Aachs%26aulast%3DDoig%26aufirst%3DA.%2BJ.%26aulast%3DDel%2BCastillo-Frias%26aufirst%3DM.%2BP.%26aulast%3DBerthoumieu%26aufirst%3DO.%26aulast%3DTarus%26aufirst%3DB.%26aulast%3DNasica-Labouze%26aufirst%3DJ.%26aulast%3DSterpone%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DP.%2BH.%26aulast%3DHooper%26aufirst%3DN.%2BM.%26aulast%3DFaller%26aufirst%3DP.%26aulast%3DDerreumaux%26aufirst%3DP.%26atitle%3DWhy%2520Is%2520Research%2520on%2520Amyloid-%25CE%25B2%2520Failing%2520to%2520Give%2520New%2520Drugs%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1435%26epage%3D1437%26doi%3D10.1021%2Facschemneuro.7b00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, K.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease drug development pipeline: 2019</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2019.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.trci.2019.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BB3Mvgt1Sjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=272-293&author=J.+Cummingsauthor=G.+Leeauthor=A.+Ritterauthor=M.+Sabbaghauthor=K.+Zhong&title=Alzheimer%E2%80%99s+disease+drug+development+pipeline%3A+2019&doi=10.1016%2Fj.trci.2019.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug development pipeline: 2019</span></div><div class="casAuthors">Cummings Jeffrey; Cummings Jeffrey; Lee Garam; Ritter Aaron; Sabbagh Marwan; Zhong Kate</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">272-293</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction:  Alzheimer's disease (AD) has few available treatments, and there is a high rate of failure in AD drug development programs.  Study of the AD drug development pipeline can provide insight into the evolution of drug development and how best to optimize development practices.  Methods:  We reviewed clinicaltrials.gov and identified all pharmacologic AD trials of all agents currently being developed for treatment of AD.  Results:  There are 132 agents in clinical trials for the treatment of AD.  Twenty-eight agents are in 42 phase 3 trials; 74 agents are in 83 phase 2 trials; and 30 agents are in 31 phase 1 trials.  There is an increase in the number of agents in each phase compared with that in the 2018 pipeline.  Nineteen agents in trials target cognitive enhancement, and 14 are intended to treat neuropsychiatric and behavioral symptoms.  There are 96 agents in disease modification trials; of these, 38 (40%) have amyloid as the primary target or as one of several effects.  Eighteen of the antiamyloid agents are small molecules, and 20 are monoclonal antibodies or biological therapies.  Seven small molecules and ten biologics have tau as a primary or combination target (18%).  Amyloid is the most common specific target in phase 3 and phase 2 disease modification trials.  Novel biomarkers (e.g., neurofilament light), new outcomes (e.g., AD Composite Score [ADCOMS]), enrollment of earlier populations, and innovative trial designs (e.g., Bayesian adaptive designs) are new features in recent clinical trials.  Discussion:  Drug development continues robustly at all phases despite setbacks in several programs in the recent past.  Continuing unmet needs require a commitment to growing and accelerating the pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrOd1ZrATvKxFwe7cAcrfPfW6udTcc2eaja-ng_qnZFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mvgt1Sjtw%253D%253D&md5=be9948127a7c81739f234d356396fbf4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2019.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2019.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DRitter%26aufirst%3DA.%26aulast%3DSabbagh%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug%2520development%2520pipeline%253A%25202019%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2019%26volume%3D5%26spage%3D272%26epage%3D293%26doi%3D10.1016%2Fj.trci.2019.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Z.</span></span> <span> </span><span class="NLM_article-title">Potential therapeutic implications of gelsolin in Alzheimer’s disease</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.3233/JAD-141548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3233%2FJAD-141548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=25208622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1GksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=13-25&author=L.+Jiauthor=X.+Zhaoauthor=Z.+Hua&title=Potential+therapeutic+implications+of+gelsolin+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-141548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Potential Therapeutic Implications of Gelsolin in Alzheimer's Disease</span></div><div class="casAuthors">Ji, Lina; Zhao, Xi; Hua, Zichun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-25</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The presence of amyloid plaques and vascular amyloid deposits is one of the pathol. features of Alzheimer's disease (AD).  Amyloid plaques and vascular deposits mainly consist of amyloid-β (Aβ), which is a metabolic product of amyloid-β protein precursor cleaved by β- and γ-secretase.  Sol. Aβ monomers readily aggregate into oligomers preceding the formation of insol. fibrils, and Aβ oligomers are more toxic than fibrils.  Intensive therapeutic efforts have been attempted in the treatment of AD targeting Aβ, including preventing Aβ generation, inhibiting Aβ aggregation, and promoting Aβ clearance.  The results show that amyloid plaque burden is reduced together with improved cognition performance in AD.  Gelsolin, a multifunctional actin-binding protein, exists intracellularly as a cytoplasmic form and extracellularly as a secreted form in blood/cerebrospinal fluid.  Gelsolin is suggested to be implicated in AD, based on the findings that some changes of gelsolin are correlated with disease progression rate in AD patients.  Gelsolin binds Aβ, inhibits its aggregation into fibrils, and protects cells from apoptosis induced by Aβ.  More importantly, administration or overexpression of gelsolin results in significant redn. of amyloid load and decrease of Aβ level in AD transgenic mice.  In this article, we review the most recent progress of gelsolin as a potential therapeutic strategy for treatment of AD, and discuss the possible mechanism involved in the clearance of amyloid plaques in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhoVmvIcBY0rVg90H21EOLACvtfcHk0ljFTCIXGEBHuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1GksQ%253D%253D&md5=30fa81c8004f05d3db262dfb4c631b19</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3233%2FJAD-141548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-141548%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DZ.%26atitle%3DPotential%2520therapeutic%2520implications%2520of%2520gelsolin%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2015%26volume%3D44%26spage%3D13%26epage%3D25%26doi%3D10.3233%2FJAD-141548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagare, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">Role of clusterin in the brain vascular clearance of amyloid-β</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">8681</span>– <span class="NLM_lpage">8682</span>, <span class="refDoi"> DOI: 10.1073/pnas.1711357114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1073%2Fpnas.1711357114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28765369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlelsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=8681-8682&author=A.+R.+Nelsonauthor=A.+P.+Sagareauthor=B.+V.+Zlokovic&title=Role+of+clusterin+in+the+brain+vascular+clearance+of+amyloid-%CE%B2&doi=10.1073%2Fpnas.1711357114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Role of clusterin in the brain vascular clearance of amyloid-β</span></div><div class="casAuthors">Nelson, Amy R.; Sagare, Abhay P.; Zlokovic, Berislav V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">8681-8682</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A polemic in response to A. M. Wojtas et al. (ibid., E6962-71) is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroVVXFgm8wvbVg90H21EOLACvtfcHk0ljFTCIXGEBHuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlelsrnO&md5=01ace9869d9b7682aae06849586427e1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1711357114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1711357114%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DA.%2BR.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DRole%2520of%2520clusterin%2520in%2520the%2520brain%2520vascular%2520clearance%2520of%2520amyloid-%25CE%25B2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D8681%26epage%3D8682%26doi%3D10.1073%2Fpnas.1711357114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beeg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stravalaci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrá, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diomede, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span> <span> </span><span class="NLM_article-title">Clusterin binds to Aβ1-42 oligomers with high affinity and interferes with peptide aggregation by inhibiting primary and secondary nucleation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">6958</span>– <span class="NLM_lpage">6966</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.689539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1074%2Fjbc.M115.689539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=26884339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVynsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=6958-6966&author=M.+Beegauthor=M.+Stravalaciauthor=M.+Romeoauthor=A.+D.+Carr%C3%A1author=A.+Cagnottoauthor=A.+Rossiauthor=L.+Diomedeauthor=M.+Salmonaauthor=M.+Gobbi&title=Clusterin+binds+to+A%CE%B21-42+oligomers+with+high+affinity+and+interferes+with+peptide+aggregation+by+inhibiting+primary+and+secondary+nucleation&doi=10.1074%2Fjbc.M115.689539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Clusterin Binds to Aβ1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation</span></div><div class="casAuthors">Beeg, Marten; Stravalaci, Matteo; Romeo, Margherita; Carra, Arianna Dorotea; Cagnotto, Alfredo; Rossi, Alessandro; Diomede, Luisa; Salmona, Mario; Gobbi, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6958-6966</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The aggregation of amyloid β protein (Aβ) is a fundamental pathogenic mechanism leading to the neuronal damage present in Alzheimer disease, and sol. Aβ oligomers are thought to be a major toxic culprit.  Thus, better knowledge and specific targeting of the pathways that lead to these noxious species may result in valuable therapeutic strategies.  We characterized some effects of the mol. chaperone clusterin, providing new and more detailed evidence of its potential neuroprotective effects.  Using a classical thioflavin T assay, we obsd. a dose-dependent inhibition of the aggregation process.  The global anal. of time courses under different conditions demonstrated that clusterin has no effect on the elongation rate but mainly interferes with the nucleation processes (both primary and secondary), reducing the no. of nuclei available for further fibril growth.  Then, using a recently developed immunoassay based on surface plasmon resonance, we obtained direct evidence of a high-affinity (KD = 1 nm) interaction of clusterin with biol. relevant Aβ1-42 oligomers, selectively captured on the sensor chip.  Moreover, with the same technol., we obsd. that substoichiometric concns. of clusterin prevent oligomer interaction with the antibody 4G8, suggesting that the chaperone shields hydrophobic residues exposed on the oligomeric assemblies.  Finally, we found that preincubation with clusterin antagonizes the toxic effects of Aβ1-42 oligomers, as evaluated in a recently developed in vivo model in Caenorhabditis elegans.  These data substantiate the interaction of clusterin with biol. active regions exposed on nuclei/oligomers of Aβ1-42, providing a mol. basis for the neuroprotective effects of the chaperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX7V8aBxdCj7Vg90H21EOLACvtfcHk0lgnVfU7w3qUEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVynsLs%253D&md5=6235942d9ef2008aaf73efa5d22106f1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.689539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.689539%26sid%3Dliteratum%253Aachs%26aulast%3DBeeg%26aufirst%3DM.%26aulast%3DStravalaci%26aufirst%3DM.%26aulast%3DRomeo%26aufirst%3DM.%26aulast%3DCarr%25C3%25A1%26aufirst%3DA.%2BD.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DDiomede%26aufirst%3DL.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DM.%26atitle%3DClusterin%2520binds%2520to%2520A%25CE%25B21-42%2520oligomers%2520with%2520high%2520affinity%2520and%2520interferes%2520with%2520peptide%2520aggregation%2520by%2520inhibiting%2520primary%2520and%2520secondary%2520nucleation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D6958%26epage%3D6966%26doi%3D10.1074%2Fjbc.M115.689539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allington, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martá-Ariza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholtzova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verghese, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, T.</span></span> <span> </span><span class="NLM_article-title">Targeting Apolipoprotein E/amyloid β binding by peptoid CPO_Aβ17-21 P ameliorates Alzheimer’s disease related pathology and cognitive decline</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">8009</span> <span class="refDoi"> DOI: 10.1038/s41598-017-08604-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1038%2Fs41598-017-08604-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28808293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BC1cfnsF2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=S.+Liuauthor=S.+Parkauthor=G.+Allingtonauthor=F.+Prelliauthor=Y.+Sunauthor=M.+Mart%C3%A1-Arizaauthor=H.+Scholtzovaauthor=G.+Biswasauthor=B.+Brownauthor=P.+B.+Vergheseauthor=P.+D.+Mehtaauthor=Y.+U.+Kwonauthor=T.+Wisniewski&title=Targeting+Apolipoprotein+E%2Famyloid+%CE%B2+binding+by+peptoid+CPO_A%CE%B217-21+P+ameliorates+Alzheimer%E2%80%99s+disease+related+pathology+and+cognitive+decline&doi=10.1038%2Fs41598-017-08604-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer's Disease Related Pathology and Cognitive Decline</span></div><div class="casAuthors">Liu Shan; Prelli Frances; Sun Yanjie; Marta-Ariza Mitchell; Scholtzova Henrieta; Brown Bernard; Park Shinae; Biswas Goutam; Kwon Yong-Uk; Allington Grant; Verghese Philip B; Mehta Pankaj D; Wisniewski Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8009</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inheritance of the apolipoprotein E4 (apoE4) genotype has been identified as the major genetic risk factor for late onset Alzheimer's disease (AD).  Studies have shown that apoE, apoE4 in particular, binds to amyloid-β (Aβ) peptides at residues 12-28 of Aβ and this binding modulates Aβ accumulation and disease progression.  We have previously shown in several AD transgenic mice lines that blocking the apoE/Aβ interaction with Aβ12-28 P reduced Aβ and tau-related pathology, leading to cognitive improvements in treated AD mice.  Recently, we have designed a small peptoid library derived from the Aβ12-28 P sequence to screen for new apoE/Aβ binding inhibitors with higher efficacy and safety.  Peptoids are better drug candidates than peptides due to their inherently more favorable pharmacokinetic properties.  One of the lead peptoid compounds, CPO_Aβ17-21 P, diminished the apoE/Aβ interaction and attenuated the apoE4 pro-fibrillogenic effects on Aβ aggregation in vitro as well as apoE4 potentiation of Aβ cytotoxicity.  CPO_Aβ17-21 P reduced Aβ-related pathology coupled with cognitive improvements in an AD APP/PS1 transgenic mouse model.  Our study suggests the non-toxic, non-fibrillogenic peptoid CPO_Aβ17-21 P has significant promise as a new AD therapeutic agent which targets the Aβ related apoE pathway, with improved efficacy and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjd31aDSCp-g5nADWVYHg1fW6udTcc2eZ_ugUHYPGDc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfnsF2gtw%253D%253D&md5=e304422373adcdc18b5cffdf49da9e74</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-08604-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-08604-8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DAllington%26aufirst%3DG.%26aulast%3DPrelli%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMart%25C3%25A1-Ariza%26aufirst%3DM.%26aulast%3DScholtzova%26aufirst%3DH.%26aulast%3DBiswas%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DVerghese%26aufirst%3DP.%2BB.%26aulast%3DMehta%26aufirst%3DP.%2BD.%26aulast%3DKwon%26aufirst%3DY.%2BU.%26aulast%3DWisniewski%26aufirst%3DT.%26atitle%3DTargeting%2520Apolipoprotein%2520E%252Famyloid%2520%25CE%25B2%2520binding%2520by%2520peptoid%2520CPO_A%25CE%25B217-21%2520P%2520ameliorates%2520Alzheimer%25E2%2580%2599s%2520disease%2520related%2520pathology%2520and%2520cognitive%2520decline%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26doi%3D10.1038%2Fs41598-017-08604-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nasica-Labouze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterpone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthoumieu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchete, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coté, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doig, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchionna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mousseau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paravastu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strodel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viles, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derreumaux, P.</span></span> <span> </span><span class="NLM_article-title">Amyloid β Protein and Alzheimer’s Disease: When Computer Simulations Complement Experimental Studies</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">3518</span>– <span class="NLM_lpage">3563</span>, <span class="refDoi"> DOI: 10.1021/cr500638n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500638n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksl2hurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=3518-3563&author=J.+Nasica-Labouzeauthor=P.+H.+Nguyenauthor=F.+Sterponeauthor=O.+Berthoumieuauthor=N.+V.+Bucheteauthor=S.+Cot%C3%A9author=A.+De+Simoneauthor=A.+J.+Doigauthor=P.+Fallerauthor=A.+Garciaauthor=A.+Laioauthor=M.+S.+Liauthor=S.+Melchionnaauthor=N.+Mousseauauthor=Y.+Muauthor=A.+Paravastuauthor=S.+Pasqualiauthor=D.+J.+Rosenmanauthor=B.+Strodelauthor=B.+Tarusauthor=J.+H.+Vilesauthor=T.+Zhangauthor=C.+Wangauthor=P.+Derreumaux&title=Amyloid+%CE%B2+Protein+and+Alzheimer%E2%80%99s+Disease%3A+When+Computer+Simulations+Complement+Experimental+Studies&doi=10.1021%2Fcr500638n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies</span></div><div class="casAuthors">Nasica-Labouze, Jessica; Nguyen, Phuong H.; Sterpone, Fabio; Berthoumieu, Olivia; Buchete, Nicolae-Viorel; Cote, Sebastien; De Simone, Alfonso; Doig, Andrew J.; Faller, Peter; Garcia, Angel; Laio, Alessandro; Mai, Suan Li; Melchionna, Simone; Mousseau, Normand; Mu, Yuguang; Paravastu, Anant; Pasquali, Samuela; Rosenman, David J.; Strodel, Birgit; Tarus, Bogdan; Viles, John H.; Zhang, Tong; Wang, Chunyu; Derreumaux, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3518-3563</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, discussing the contribution of biophys. and biochem. studies and computer simulations to characterize the mol. structures of Aβ1-40/1-42 monomers, oligomers, protofibrils, and amyloid fibrils in aq. soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5CTJQj138t7Vg90H21EOLACvtfcHk0liy349p52a87A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksl2hurs%253D&md5=fdd061847c9171aec5d4a4b9d871768d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcr500638n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500638n%26sid%3Dliteratum%253Aachs%26aulast%3DNasica-Labouze%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DP.%2BH.%26aulast%3DSterpone%26aufirst%3DF.%26aulast%3DBerthoumieu%26aufirst%3DO.%26aulast%3DBuchete%26aufirst%3DN.%2BV.%26aulast%3DCot%25C3%25A9%26aufirst%3DS.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DDoig%26aufirst%3DA.%2BJ.%26aulast%3DFaller%26aufirst%3DP.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DLaio%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DM.%2BS.%26aulast%3DMelchionna%26aufirst%3DS.%26aulast%3DMousseau%26aufirst%3DN.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DParavastu%26aufirst%3DA.%26aulast%3DPasquali%26aufirst%3DS.%26aulast%3DRosenman%26aufirst%3DD.%2BJ.%26aulast%3DStrodel%26aufirst%3DB.%26aulast%3DTarus%26aufirst%3DB.%26aulast%3DViles%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DDerreumaux%26aufirst%3DP.%26atitle%3DAmyloid%2520%25CE%25B2%2520Protein%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520When%2520Computer%2520Simulations%2520Complement%2520Experimental%2520Studies%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D3518%26epage%3D3563%26doi%3D10.1021%2Fcr500638n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Algamal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahsan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melacini, G.</span></span> <span> </span><span class="NLM_article-title">Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid β (Aβ) peptides in the monomer and protofibril states</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">17158</span>– <span class="NLM_lpage">17168</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.792853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1074%2Fjbc.M117.792853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28798235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs12lsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=17158-17168&author=M.+Algamalauthor=R.+Ahmedauthor=N.+Jafariauthor=B.+Ahsanauthor=J.+Ortegaauthor=G.+Melacini&title=Atomic-resolution+map+of+the+interactions+between+an+amyloid+inhibitor+protein+and+amyloid+%CE%B2+%28A%CE%B2%29+peptides+in+the+monomer+and+protofibril+states&doi=10.1074%2Fjbc.M117.792853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid β (Aβ) peptides in the monomer and protofibril states</span></div><div class="casAuthors">Algamal, Moustafa; Ahmed, Rashik; Jafari, Naeimeh; Ahsan, Bilal; Ortega, Joaquin; Melacini, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">17158-17168</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Self-assocn. of amyloid β (Aβ) peptides is a hallmark of Alzheimer's disease and serves as a general prototype for amyloid formation.  A key endogenous inhibitor of Aβ self-assocn. is human serum albumin (HSA), which binds ∼90% of plasma Aβ.  However, the exact mol. mechanism by which HSA binds Aβ monomers and protofibrils is not fully understood.  Here, using dark-state exchange satn. transfer NMR and relaxation expts. complemented by morphol. characterization, we mapped the HSA-Aβ interactions at at. resoln. by examg. the effects of HSA on Aβ monomers and sol. high-mol. wt. oligomeric protofibrils.  We found that HSA binds both monomeric and protofibrillar Aβ, but the affinity of HSA for Aβ monomers is lower than for Aβ protofibrils (Kd values are submillimolar rather than micromolar) yet physiol. relevant because of the ∼0.6-0.7 mm plasma HSA concn.  In both Aβ protofibrils and monomers, HSA targets key Aβ self-recognition sites spanning the β strands found in cross-β protofibril structures, leading to a net switch from direct to tethered contacts between the monomeric Aβ and the protofibril surface.  These HSA-Aβ interactions are isoform-specific, because the HSA affinity of Aβ monomers is lower for Aβ(1-42) than for Aβ(1-40).  In addn., the HSA-induced perturbations of the monomer/protofibrils pseudo-equil. extend to the C-terminal residues in the Aβ(1-42) isoform but not in Aβ(1-40).  These results provide an unprecedented view of how albumin interacts with Aβ and illustrate the potential of dark-state exchange satn. transfer NMR in mapping the interactions between amyloid-inhibitory proteins and amyloidogenic peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7KTuRtShbhbVg90H21EOLACvtfcHk0liy349p52a87A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs12lsrrL&md5=a3a292d4cb8875a3fd6d1e937e7aa5a2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.792853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.792853%26sid%3Dliteratum%253Aachs%26aulast%3DAlgamal%26aufirst%3DM.%26aulast%3DAhmed%26aufirst%3DR.%26aulast%3DJafari%26aufirst%3DN.%26aulast%3DAhsan%26aufirst%3DB.%26aulast%3DOrtega%26aufirst%3DJ.%26aulast%3DMelacini%26aufirst%3DG.%26atitle%3DAtomic-resolution%2520map%2520of%2520the%2520interactions%2520between%2520an%2520amyloid%2520inhibitor%2520protein%2520and%2520amyloid%2520%25CE%25B2%2520%2528A%25CE%25B2%2529%2520peptides%2520in%2520the%2520monomer%2520and%2520protofibril%2520states%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D17158%26epage%3D17168%26doi%3D10.1074%2Fjbc.M117.792853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczepiorkowski, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grifols, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Páez, A.</span></span> <span> </span><span class="NLM_article-title">Plasma exchange for Alzheimer’s disease Management by Albumin Replacement (AMBAR) trial: study design and progress</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2019.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.trci.2019.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BB3cbivFWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=61-69&author=M.+Boadaauthor=O.+L%C3%B3pezauthor=L.+N%C3%BA%C3%B1ezauthor=Z.+M.+Szczepiorkowskiauthor=M.+Torresauthor=C.+Grifolsauthor=A.+P%C3%A1ez&title=Plasma+exchange+for+Alzheimer%E2%80%99s+disease+Management+by+Albumin+Replacement+%28AMBAR%29+trial%3A+study+design+and+progress&doi=10.1016%2Fj.trci.2019.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress</span></div><div class="casAuthors">Boada Merce; Boada Merce; Lopez Oscar; Nunez Laura; Torres Mireia; Grifols Carlota; Paez Antonio; Szczepiorkowski Zbigniew M</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61-69</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction:  Preliminary studies have shown that treatment with plasma exchange (PE) plus therapeutic albumin replacement in patients with Alzheimer's disease (AD) induced mobilization of plasma and cerebrospinal fluid amyloid β protein, associated with an improvement in memory and language functions, as well as the stabilization of brain perfusion, which persisted after treatment discontinuation.  Methods:  Alzheimer's Management By Albumin Replacement (AMBAR) is a multicenter, randomized, blinded and placebo-controlled, parallel-group, phase IIb/III trial enrolling patients with mild to moderate AD.  The study evaluates PE with different replacement volumes of therapeutic albumin (5% and 20% Albutein(®), Grifols), with or without intravenous immunoglobulin (Flebogamma(®) 5% DIF, Grifols).  Patients are randomized to one of three active treatment groups or one control (sham PE) group (1:1:1:1).  The intervention regime includes a first 6-week stage of intensive treatment, followed by a second 12-month stage of maintenance treatment.  The change from the baseline to the end of treatment periods in the ADAS-Cog and ADCS-ADL scores are the coprimary efficacy variables.  Secondary efficacy variables include change from the baseline in scores on cognitive, functional, behavioral, and overall progression tests; changes in plasma and cerebrospinal fluid levels of amyloid β and tau protein; and assessment of structural and functional changes in brain areas of interest.  Safety and tolerability are assessed.  Results:  The study has enrolled 496 patients from 41 centers (19 in Spain and 22 in the USA); 347 of these patients were randomized and underwent close to 5000 PEs, of which approximately 25% were sham PEs.  Discussion:  We present an innovative approach for treating AD.  The study has been designed to demonstrate clinical efficacy, defined as slow decline of the patient's cognition and brain function.  The sample size has adequate power to detect differences between any of the active treatment groups and the control group, as well as between the three active treatment groups combined and the control group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCXP-Ku5LR4CCEBeYuoi7AfW6udTcc2eY2zd2gQPAFubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbivFWqtQ%253D%253D&md5=bae6d62543f0f3a49014694ba49a5cc3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2019.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2019.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DBoada%26aufirst%3DM.%26aulast%3DL%25C3%25B3pez%26aufirst%3DO.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DL.%26aulast%3DSzczepiorkowski%26aufirst%3DZ.%2BM.%26aulast%3DTorres%26aufirst%3DM.%26aulast%3DGrifols%26aufirst%3DC.%26aulast%3DP%25C3%25A1ez%26aufirst%3DA.%26atitle%3DPlasma%2520exchange%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520Management%2520by%2520Albumin%2520Replacement%2520%2528AMBAR%2529%2520trial%253A%2520study%2520design%2520and%2520progress%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2019%26volume%3D5%26spage%3D61%26epage%3D69%26doi%3D10.1016%2Fj.trci.2019.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stravalaci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiordaliso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diomede, L.</span></span> <span> </span><span class="NLM_article-title">Humanin specifically interacts with amyloid-β oligomers and counteracts their in vivo toxicity</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.3233/JAD-160951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3233%2FJAD-160951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28282805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvFyjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=857-871&author=M.+Romeoauthor=M.+Stravalaciauthor=M.+Beegauthor=A.+Rossiauthor=F.+Fiordalisoauthor=A.+Corbelliauthor=M.+Salmonaauthor=M.+Gobbiauthor=A.+Cagnottoauthor=L.+Diomede&title=Humanin+specifically+interacts+with+amyloid-%CE%B2+oligomers+and+counteracts+their+in+vivo+toxicity&doi=10.3233%2FJAD-160951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity</span></div><div class="casAuthors">Romeo, Margherita; Stravalaci, Matteo; Beeg, Marten; Rossi, Alessandro; Fiordaliso, Fabio; Corbelli, Alessandro; Salmona, Mario; Gobbi, Marco; Cagnotto, Alfredo; Diomede, Luisa; Galzitskaya, Oxana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">857-871</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The 24-residue peptide humanin (HN) has been proposed as a peptide-based inhibitor able to interact directly with amyloid-β (Aβ) oligomers and interfere with the formation and/or biol. properties of toxic Aβ species.  When administered exogenously, HN, or its synthetic S14G-deriv. (HNG), exerted multiple cytoprotective effects, counteracting the Aβ-induced toxicity.  Whether these peptides interact directly with Aβ, particularly with the sol. oligomeric assemblies, remains largely unknown.  We here investigated the ability of HN and HNG to interact directly with highly aggregating Aβ42, and interfere with the formation and toxicity of its oligomers.  Expts. were run in cell-free conditions and in vivo in a transgenic C. elegans strain in which the Aβ toxicity was specifically due to oligomeric species.  Thioflavin-T assay indicated that both HN and HNG delay the formation and reduce the final amt. of Aβ42 fibrils.  In vitro surface plasmon resonance studies indicated that they interact with Aβ42 oligomers favoring the formation of amorphous larger assemblies, obsd. with turbidity and electron microscopy.  In vivo studies indicated that both HN and HNG decrease the relative abundance of A11-pos. prefibrillar oligomers as well as OC-pos. fibrillar oligomers and had similar protective effects.  However, while HN possibly decreased the oligomers by promoting their assembly into larger aggregates, the redn. of oligomers caused by HNG can be ascribed to a marked decrease of the total Aβ levels, likely the consequence of the HNG-induced overexpression of the Aβ-degrading enzyme neprilysin.  These findings provide information on the mechanisms underlying the anti-oligomeric effects of HN and HNG and illustrate the role of S14G substitution in regulating the in vivo mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDuGmS6GKK17Vg90H21EOLACvtfcHk0liv5jSm_s47jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvFyjs78%253D&md5=a70ec1027f04b1f429bde2552254eca8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3233%2FJAD-160951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-160951%26sid%3Dliteratum%253Aachs%26aulast%3DRomeo%26aufirst%3DM.%26aulast%3DStravalaci%26aufirst%3DM.%26aulast%3DBeeg%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DFiordaliso%26aufirst%3DF.%26aulast%3DCorbelli%26aufirst%3DA.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DDiomede%26aufirst%3DL.%26atitle%3DHumanin%2520specifically%2520interacts%2520with%2520amyloid-%25CE%25B2%2520oligomers%2520and%2520counteracts%2520their%2520in%2520vivo%2520toxicity%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2017%26volume%3D57%26spage%3D857%26epage%3D871%26doi%3D10.3233%2FJAD-160951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wallin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiruma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wärmländer, S. K. T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huvent, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahams, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gräslund, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippens, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span> <span> </span><span class="NLM_article-title">The neuronal Tau protein blocks in vitro fibrillation of the amyloid-β (Aβ) peptide at the oligomeric stage</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">8138</span>– <span class="NLM_lpage">8146</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b13623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b13623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Gmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=8138-8146&author=C.+Wallinauthor=Y.+Hirumaauthor=S.+K.+T.+S.+W%C3%A4rml%C3%A4nderauthor=I.+Huventauthor=J.+Jarvetauthor=J.+P.+Abrahamsauthor=A.+Gr%C3%A4slundauthor=G.+Lippensauthor=J.+Luo&title=The+neuronal+Tau+protein+blocks+in+vitro+fibrillation+of+the+amyloid-%CE%B2+%28A%CE%B2%29+peptide+at+the+oligomeric+stage&doi=10.1021%2Fjacs.7b13623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Neuronal Tau Protein Blocks in Vitro Fibrillation of the Amyloid-β (Aβ) Peptide at the Oligomeric Stage</span></div><div class="casAuthors">Wallin, Cecilia; Hiruma, Yoshitaka; Waermlaender, Sebastian K. T. S.; Huvent, Isabelle; Jarvet, Juri; Abrahams, Jan Pieter; Graeslund, Astrid; Lippens, Guy; Luo, Jinghui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">8138-8146</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In Alzheimer's disease, amyloid-β (Aβ) plaques and tau neurofibrillary tangles are the 2 pathol. hallmarks.  The co-occurrence and combined reciprocal pathol. effects of Aβ and tau protein aggregation have been obsd. in animal models of the disease.  However, the mol. mechanism of their interaction remain unknown.  Here, using a variety of biophys. measurements, we show that the native full-length tau protein solubilizes the Aβ40 peptide and prevents its fibrillation.  The tau protein delayed the amyloid fibrillation of the Aβ40 peptide at substoichiometric ratios, showing different binding affinities toward the different stages of the aggregated Aβ40 peptides.  The Aβ monomer structure remained random coil in the presence of tau, as obsd. by NMR and CD spectroscopy and photoinduced crosslinking methods.  We propose a potential interaction mechanism for the influence of tau on Aβ fibrillation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDMOOQ1oInOLVg90H21EOLACvtfcHk0liv5jSm_s47jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Gmtb4%253D&md5=76c3262edb560cc457d2414be674308e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b13623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b13623%26sid%3Dliteratum%253Aachs%26aulast%3DWallin%26aufirst%3DC.%26aulast%3DHiruma%26aufirst%3DY.%26aulast%3DW%25C3%25A4rml%25C3%25A4nder%26aufirst%3DS.%2BK.%2BT.%2BS.%26aulast%3DHuvent%26aufirst%3DI.%26aulast%3DJarvet%26aufirst%3DJ.%26aulast%3DAbrahams%26aufirst%3DJ.%2BP.%26aulast%3DGr%25C3%25A4slund%26aufirst%3DA.%26aulast%3DLippens%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DJ.%26atitle%3DThe%2520neuronal%2520Tau%2520protein%2520blocks%2520in%2520vitro%2520fibrillation%2520of%2520the%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520peptide%2520at%2520the%2520oligomeric%2520stage%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D8138%26epage%3D8146%26doi%3D10.1021%2Fjacs.7b13623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwarzman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitek, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyubski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strittmatter, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enghilde, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhasin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisgraber, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagorki, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talafous, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roses, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldgaber, D.</span></span> <span> </span><span class="NLM_article-title">Transthyretin sequesters amyloid beta protein and prevents amyloid formation</span>. <i>Proc. Nat. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">8368</span>– <span class="NLM_lpage">8372</span>, <span class="refDoi"> DOI: 10.1073/pnas.91.18.8368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1073%2Fpnas.91.18.8368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=8078889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8368-8372&author=A.+L.+Schwarzmanauthor=L.+Gregoriauthor=M.+P.+Vitekauthor=S.+Lyubskiauthor=W.+J.+Strittmatterauthor=J.+J.+Enghildeauthor=R.+Bhasinauthor=J.+Silvermanauthor=K.+H.+Weisgraberauthor=P.+K.+Coyleauthor=M.+G.+Zagorkiauthor=J.+Talafousauthor=M.+Eisenbergauthor=A.+M.+Saundersauthor=A.+D.+Rosesauthor=D.+Goldgaber&title=Transthyretin+sequesters+amyloid+beta+protein+and+prevents+amyloid+formation&doi=10.1073%2Fpnas.91.18.8368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin sequesters amyloid β protein and prevents amyloid formation</span></div><div class="casAuthors">Schwarzman, Alexander L.; Gregori, Luisa; Vitek, Michael P.; Lyubski, Sergey; Strittmatter, Warren J.; Enghilde, Jan J.; Bhasin, Ramaninder; Silverman, Josh; Weisgraber, Karl H.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8368-72</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The cardinal pathol. features of Alzheimer disease are depositions of aggregated amyloid β protein (Aβ) in the brain and cerebrovasculature.  However, the Aβ is found in a sol. form in cerebrospinal fluid in healthy individuals and patients with Alzheimer disease.  The authors postulate that sequestration of Aβ precludes amyloid formation.  Failure to sequester Aβ in Alzheimer disease may result in amyloidosis.  When the authors added Aβ to cerebrospinal fluid of patients and controls it was rapidly sequestered into stable complexes with transthyretin.  Complexes with apolipoprotein E, which has been shown to bind Aβ in vitro, were not obsd. in cerebrospinal fluid.  Addnl. in vitro studies showed that both purified transthyretin and apolipoprotein E prevent amyloid formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9A7K_dww2NLVg90H21EOLACvtfcHk0lj3DF94HMsxbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKktLk%253D&md5=bf6aeaf5679794ea29c69933064a9b6c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8368%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarzman%26aufirst%3DA.%2BL.%26aulast%3DGregori%26aufirst%3DL.%26aulast%3DVitek%26aufirst%3DM.%2BP.%26aulast%3DLyubski%26aufirst%3DS.%26aulast%3DStrittmatter%26aufirst%3DW.%2BJ.%26aulast%3DEnghilde%26aufirst%3DJ.%2BJ.%26aulast%3DBhasin%26aufirst%3DR.%26aulast%3DSilverman%26aufirst%3DJ.%26aulast%3DWeisgraber%26aufirst%3DK.%2BH.%26aulast%3DCoyle%26aufirst%3DP.%2BK.%26aulast%3DZagorki%26aufirst%3DM.%2BG.%26aulast%3DTalafous%26aufirst%3DJ.%26aulast%3DEisenberg%26aufirst%3DM.%26aulast%3DSaunders%26aufirst%3DA.%2BM.%26aulast%3DRoses%26aufirst%3DA.%2BD.%26aulast%3DGoldgaber%26aufirst%3DD.%26atitle%3DTransthyretin%2520sequesters%2520amyloid%2520beta%2520protein%2520and%2520prevents%2520amyloid%2520formation%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D8368%26epage%3D8372%26doi%3D10.1073%2Fpnas.91.18.8368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pate, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shusta, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. M.</span></span> <span> </span><span class="NLM_article-title">Transthyretin mimetics as anti-β-amyloid agents: a comparison of peptide and protein approaches</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">968</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fcmdc.201800031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=29512286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVKksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=968-979&author=K.+M.+Pateauthor=B.+J.+Kimauthor=E.+V.+Shustaauthor=R.+M.+Murphy&title=Transthyretin+mimetics+as+anti-%CE%B2-amyloid+agents%3A+a+comparison+of+peptide+and+protein+approaches&doi=10.1002%2Fcmdc.201800031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin mimetics as anti-β-amyloid agents: A comparison of peptide and protein approaches</span></div><div class="casAuthors">Pate, Kayla M.; Kim, Brandon J.; Shusta, Eric V.; Murphy, Regina M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">968-979</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">β-Amyloid (Aβ) aggregation is causally linked to neuronal pathol. in Alzheimer's disease; therefore, several small mols., antibodies, and peptides have been tested as anti-Aβ agents.  We developed 2 compds. based on the Aβ-binding domain of transthyretin (TTR): cyclic peptide cG8 and engineered protein mTTR (F87M/L110M mutant), and compared them for therapeutically relevant properties.  Both mTTR and cG8 inhibited fibrillogenesis of Aβ, with mTTR inhibiting at a lower concn. than cG8.  Both inhibited the aggregation of amylin but not of α-synuclein.  They both bound more Aβ aggregates than monomers, and neither disaggregates preformed fibrils; cG8 retained more of its activity in the presence of biol. materials and was more resistant to proteolysis than mTTR.  We examd. the effect of mTTR or cG8 on Aβ binding to human neurons.  When mTTR was co-incubated with Aβ under oligomer-forming conditions, Aβ morphol. was drastically changed and Aβ-cell deposition significantly decreased.  In contrast, cG8 did not affect the morphol. but decreased the amt. of Aβ deposited.  These results provide guidance for further evolution of TTR-mimetic anti-amyloid agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEdFGuWGkpU7Vg90H21EOLACvtfcHk0lj3DF94HMsxbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVKksbw%253D&md5=72b028ec9c92fa9007652131f9a74d94</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800031%26sid%3Dliteratum%253Aachs%26aulast%3DPate%26aufirst%3DK.%2BM.%26aulast%3DKim%26aufirst%3DB.%2BJ.%26aulast%3DShusta%26aufirst%3DE.%2BV.%26aulast%3DMurphy%26aufirst%3DR.%2BM.%26atitle%3DTransthyretin%2520mimetics%2520as%2520anti-%25CE%25B2-amyloid%2520agents%253A%2520a%2520comparison%2520of%2520peptide%2520and%2520protein%2520approaches%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D968%26epage%3D979%26doi%3D10.1002%2Fcmdc.201800031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posey, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buxbaum, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappu, R. V.</span></span> <span> </span><span class="NLM_article-title">Inhibition of amyloid beta fibril formation by monomeric human transthyretin</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1252</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1002/pro.3396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fpro.3396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=29498118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlyksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=1252-1261&author=K.+Garaiauthor=A.+E.+Poseyauthor=X.+Liauthor=J.+N.+Buxbaumauthor=R.+V.+Pappu&title=Inhibition+of+amyloid+beta+fibril+formation+by+monomeric+human+transthyretin&doi=10.1002%2Fpro.3396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of amyloid beta fibril formation by monomeric human transthyretin</span></div><div class="casAuthors">Garai, Kanchan; Posey, Ammon E.; Li, Xinyi; Buxbaum, Joel N.; Pappu, Rohit V.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1252-1261</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Transthyretin (TTR) is a homotetrameric protein that is found in the plasma and cerebrospinal fluid.  Dissocn. of TTR tetramers sets off a downhill cascade of amyloid formation through polymn. of monomeric TTR.  Interestingly, TTR has an addnl., biol. relevant activity, which pertains to its ability to slow the progression of amyloid beta (Aβ) assocd. pathol. in transgenic mice.  In vitro, both TTR and a kinetically stable variant of monomeric TTR (M-TTR) inhibit the fibril formation of Aβ1-40/42 mols.  Published evidence suggests that tetrameric TTR binds preferentially to Aβ monomers, thus destabilizing fibril formation by depleting the pool of Aβ monomers from aggregating mixts.  Here, we investigate the effects of M-TTR on the in vitro aggregation of Aβ1-42.  Our data confirm previous observations that fibril formation of Aβ is suppressed in the presence of sub-stoichiometric amts. of M-TTR.  Despite this, we find that sub-stoichiometric levels of M-TTR are not bona fide inhibitors of aggregation.  Instead, they co-aggregate with Aβ to promote the formation of large, micron-scale insol., non-fibrillar amorphous deposits.  Based on fluorescence correlation spectroscopy measurements, we find that M-TTR does not interact with monomeric Aβ.  Two-color coincidence anal. of the fluorescence bursts of Aβ and M-TTR labeled with different fluorophores shows that M-TTR co-assembles with sol. Aβ aggregates and this appears to drive the co-aggregation into amorphous ppts.  Our results suggest that mimicking the co-aggregation activity with protein-based therapeutics might be a worthwhile strategy for rerouting amyloid beta peptides into inert, insol., and amorphous deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMdzV8KWyTGbVg90H21EOLACvtfcHk0lgdWyAVMrReoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlyksbY%253D&md5=4b02a5bb17d2912438782d65f1629b58</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fpro.3396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3396%26sid%3Dliteratum%253Aachs%26aulast%3DGarai%26aufirst%3DK.%26aulast%3DPosey%26aufirst%3DA.%2BE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BN.%26aulast%3DPappu%26aufirst%3DR.%2BV.%26atitle%3DInhibition%2520of%2520amyloid%2520beta%2520fibril%2520formation%2520by%2520monomeric%2520human%2520transthyretin%26jtitle%3DProtein%2520Sci.%26date%3D2018%26volume%3D27%26spage%3D1252%26epage%3D1261%26doi%3D10.1002%2Fpro.3396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span> <span> </span><span class="NLM_article-title">Transthyretin: a multifaceted protein</span>. <i>Biomol. Concepts</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1515/bmc-2013-0038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1515%2Fbmc-2013-0038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=25372741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKmurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=45-54&author=M.+Vieiraauthor=M.+J.+Saraiva&title=Transthyretin%3A+a+multifaceted+protein&doi=10.1515%2Fbmc-2013-0038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin: a multifaceted protein</span></div><div class="casAuthors">Vieira, Marta; Saraiva, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular Concepts</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">BCIOB8</span>;
        ISSN:<span class="NLM_cas:issn">1868-5021</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Transthyretin is a highly conserved homotetrameric protein, mainly synthesized by the liver and the choroid plexus of brain.  The carrier role of TTR is well-known; however, many other functions have emerged, namely in the nervous system.  Behavior, cognition, neuropeptide amidation, neurogenesis, nerve regeneration, axonal growth and 14-3-3ζ metab. are some of the processes where TTR has an important role.  TTR aggregates are responsible for many amyloidosis such as familial amyloidotic polyneuropathy and cardiomyopathy.  Normal TTR can also aggregate and deposit in the heart of old people and in preeclampsia placental tissue.  Differences in TTR levels have been found in several neuropathologies, but its neuroprotective role, until now, was described in ischemia and Alzheimer's disease.  The aim of this review is to stress the relevance of TTR, besides its well-known role on transport of thyroxine and retinol-binding protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyXcOGE6oRy7Vg90H21EOLACvtfcHk0lgdWyAVMrReoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKmurbE&md5=5dfaf06a6cb8a0394d17d1586aa6a1e8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1515%2Fbmc-2013-0038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbmc-2013-0038%26sid%3Dliteratum%253Aachs%26aulast%3DVieira%26aufirst%3DM.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26atitle%3DTransthyretin%253A%2520a%2520multifaceted%2520protein%26jtitle%3DBiomol.%2520Concepts%26date%3D2014%26volume%3D5%26spage%3D45%26epage%3D54%26doi%3D10.1515%2Fbmc-2013-0038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serot, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couturier, M.</span></span> <span> </span><span class="NLM_article-title">Cerebrospinal fluid transthyretin: aging and late onset Alzheimer’s disease</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1136/jnnp.63.4.506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1136%2Fjnnp.63.4.506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=9343132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADyaK1c%252FgtFaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1997&pages=506-550&author=J.+M.+Serotauthor=D.+Christmannauthor=T.+Dubostauthor=M.+Couturier&title=Cerebrospinal+fluid+transthyretin%3A+aging+and+late+onset+Alzheimer%E2%80%99s+disease&doi=10.1136%2Fjnnp.63.4.506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease</span></div><div class="casAuthors">Serot J M; Christmann D; Dubost T; Couturier M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">506-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">The deposition of insoluble beta-amyloid protein fibrils is probably the central event in the pathogenesis of Alzheimer's disease.  Cerebrospinal fluid inhibits this fibril formation, likely by the intervention of one or several proteins binding to soluble beta-amyloid protein.  In vitro, transthyretin (TTR), a CSF protein, impedes amyloid fibrillogenesis.  Lowered concentrations of CSFTTR could therefore be associated with Alzheimer's disease.  Concentrations of TTR in CSF samples from 149 consecutive patients were assayed, using a kinetic nephelemetric method.  These concentrations were correlated positively with age, but were significantly lower in patients with Alzheimer's disease.  These data raise the possibility that amyloid fibril formation could be promoted in patients with late onset Alzheimer's disease by the lack of sufficient concentrations of TTR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOYErehQplYwMthz5_Rx5rfW6udTcc2ebf8UKvLMubrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c%252FgtFaqtQ%253D%253D&md5=7760afe63a5908e9bbbf5e85c6c840dd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.63.4.506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.63.4.506%26sid%3Dliteratum%253Aachs%26aulast%3DSerot%26aufirst%3DJ.%2BM.%26aulast%3DChristmann%26aufirst%3DD.%26aulast%3DDubost%26aufirst%3DT.%26aulast%3DCouturier%26aufirst%3DM.%26atitle%3DCerebrospinal%2520fluid%2520transthyretin%253A%2520aging%2520and%2520late%2520onset%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D1997%26volume%3D63%26spage%3D506%26epage%3D550%26doi%3D10.1136%2Fjnnp.63.4.506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldeiras, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span> <span> </span><span class="NLM_article-title">Transthyretin decrease in plasma of MCI and AD patients: investigation of mechanisms for disease modulation</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">889</span>, <span class="refDoi"> DOI: 10.2174/156720512803251057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.2174%2F156720512803251057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=22698061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1yhurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=881-889&author=C.+A.+Ribeiroauthor=I.+Santanaauthor=C.+Oliveiraauthor=I.+Baldeirasauthor=J.+Moreiraauthor=M.+J.+Saraivaauthor=I.+Cardoso&title=Transthyretin+decrease+in+plasma+of+MCI+and+AD+patients%3A+investigation+of+mechanisms+for+disease+modulation&doi=10.2174%2F156720512803251057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin decrease in plasma of MCI and AD patients: investigation of mechanisms for disease modulation</span></div><div class="casAuthors">Ribeiro, Carlos A.; Santana, Isabel; Oliveira, Catarina; Baldeiras, Ines; Moreira, Jorge; Saraiva, Maria Joao; Cardoso, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">881-889</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Different authors described that transthyretin (TTR) is decreased in the cerebrospinal fluid (CSF) of Alzheimer's disease (AD) patients and thus TTR is a potential CSF biomarker in AD.  However, descriptions of what happens to TTR in plasma of these patients are lacking in the literature.  The authors investigated TTR levels in plasma samples from 55 patients with mild-cognitive impairment (MCI), 56 patients with AD and 41 non-demented controls, and found that TTR is decreased in both MCI and AD groups, suggesting that TTR might be used for staging early AD.  In MCI and AD groups, women showed significantly lower plasma TTR levels when compared to MCI and AD men, resp., and to women control group.  In the AD women group, TTR levels correlated with disease stage, reflecting disease severity.  Although MCI and AD men groups presented TTR levels lower than men in the control group, the difference was not statistically significant.  Genetic anal. for ApoE revealed no relationship between TTR levels and the presence of the ε4 allele, for both men and women, in both patient groups.  Importantly, the authors assessed thyroxine binding to TTR in plasma and found, in both MCI and AD groups, that TTR had reduced capacity to carry the hormone.  Finally, the authors measured plasma estradiol levels in women and showed a redn. in both groups.  Thus, this study prompts TTR as an early plasma biomarker in AD indicating that disease modulation by TTR is gender dependent; this study provides hypotheses into the mechanisms involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTvYA3nXqQDLVg90H21EOLACvtfcHk0lj3vDKCpLYXjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1yhurzL&md5=3bab515c300be0fab1a31ef6b59eae0b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F156720512803251057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720512803251057%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DC.%2BA.%26aulast%3DSantana%26aufirst%3DI.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DBaldeiras%26aufirst%3DI.%26aulast%3DMoreira%26aufirst%3DJ.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DCardoso%26aufirst%3DI.%26atitle%3DTransthyretin%2520decrease%2520in%2520plasma%2520of%2520MCI%2520and%2520AD%2520patients%253A%2520investigation%2520of%2520mechanisms%2520for%2520disease%2520modulation%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2012%26volume%3D9%26spage%3D881%26epage%3D889%26doi%3D10.2174%2F156720512803251057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span> <span> </span><span class="NLM_article-title">Human serum transthyretin levels correlate inversely with Alzheimer’s disease</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.3233/JAD-2011-102145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3233%2FJAD-2011-102145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=21335655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=77-84&author=S.+H.+Hanauthor=E.+S.+Jungauthor=J.+H.+Sohnauthor=H.+J.+Hongauthor=H.+S.+Hongauthor=J.+W.+Kimauthor=D.+L.+Naauthor=M.+Kimauthor=H.+Kimauthor=H.+J.+Haauthor=Y.+H.+Kimauthor=N.+Huhauthor=M.+W.+Jungauthor=I.+Mook-Jung&title=Human+serum+transthyretin+levels+correlate+inversely+with+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2011-102145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Human Serum Transthyretin Levels Correlate Inversely with Alzheimer's Disease</span></div><div class="casAuthors">Han, Sun-Ho; Jung, Eun Sun; Sohn, Ji-Hoon; Hong, Hyun Joo; Hong, Hyun Seok; Kim, Jong Won; Na, Duk Lyul; Kim, Manho; Kim, Hee; Ha, Hee Jin; Kim, Young Ho; Huh, Namjung; Jung, Min Whan; Mook-Jung, Inhee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the fastest growing neurodegenerative disease in the elderly population, and the search for therapeutic targets and diagnostic AD biomarkers is an exigent issue.  Because amyloid-β (Aβ) aggregation constitutes the epicenter of AD pathol., Aβ-binding proteins that regulate Aβ aggregation, such as transthyretin (TTR), have attracted much attention.  TTR binds to Aβ, prevents its aggregation, and consequently inhibits Aβ-induced cellular toxicity.  Decreased TTR levels in cerebrospinal fluid (CSF) from AD patients suggest that TTR is a biomarker of AD.  But, studies on TTR as a biomarker have focused on CSF; no study has evaluated peripheral levels of TTR in AD.  Here, we examd. the relationship between serum TTR levels and AD.  We measured TTR levels in serum samples from 90 nondemented controls and 111 AD patients and obsd. significantly lower serum TTR levels in AD (p < 0.001).  Notably, females in the control group had lower serum TTR levels compared with male in the control (p = 0.006), while no difference in gender was noted in the AD group.  There were no age-related changes in serum TTR levels.  Thus, this study demonstrates a clear neg. correlation between serum TTR levels and AD, suggesting that TTR is not only involved in AD pathol. process but also suggested as possible peripheral biomarker for AD diagnosis in serum level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2bGIIN2VFbVg90H21EOLACvtfcHk0lj3vDKCpLYXjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSit74%253D&md5=8aa840966876bcc39fc97424f3343c47</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-102145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-102145%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DJung%26aufirst%3DE.%2BS.%26aulast%3DSohn%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DH.%2BJ.%26aulast%3DHong%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DNa%26aufirst%3DD.%2BL.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DHuh%26aufirst%3DN.%26aulast%3DJung%26aufirst%3DM.%2BW.%26aulast%3DMook-Jung%26aufirst%3DI.%26atitle%3DHuman%2520serum%2520transthyretin%2520levels%2520correlate%2520inversely%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D25%26spage%3D77%26epage%3D84%26doi%3D10.3233%2FJAD-2011-102145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velayudhan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Güntert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lourdusamy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovestone, S.</span></span> <span> </span><span class="NLM_article-title">Plasma transthyretin as a candidate marker for Alzheimer’s disease</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.3233/JAD-2011-110611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3233%2FJAD-2011-110611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=22002789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVertLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=369-375&author=L.+Velayudhanauthor=R.+Killickauthor=A.+Hyeauthor=A.+Kinseyauthor=A.+G%C3%BCntertauthor=S.+Lynhamauthor=M.+Wardauthor=R.+Leungauthor=A.+Lourdusamyauthor=A.+W.+Toauthor=J.+Powellauthor=S.+Lovestone&title=Plasma+transthyretin+as+a+candidate+marker+for+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2011-110611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma Transthyretin as a Candidate Marker for Alzheimer's Disease</span></div><div class="casAuthors">Velayudhan, Latha; Killick, Richard; Hye, Abdul; Kinsey, Anna; Guntert, Andreas; Lynham, Steven; Ward, Malcolm; Leung, Rufina; Lourdusamy, Anbarasu; To, Alvina W. M.; Powell, John; Lovestone, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">369-375</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Diagnosis of the progressive neurodegenerative disorder Alzheimer's disease (AD) can only definitively be made postmortem.  The most promising AD biomarkers identified to date are found in cerebrospinal fluid (CSF).  Among these, one of the most interesting candidates is transthyretin (TTR), the carrier of thyroxine and retinol, which also binds with amyloid-β (Aβ), and it has been suggested that it protects against Aβ deposition.  A biomarker detectable in plasma would have great diagnostic value and could be of use for detg. disease progression and the monitoring of therapeutic efficacy due to its greater accessibility over CSF-based markers.  We aimed to validate TTR as a prognostic marker in AD and to det. its relation with cognitive measures.  We examd. the plasma protein levels of TTR in 90 people with late-onset AD and 50 age-matched non-demented controls (NDC) by immunoblotting and found lower plasma TTR levels in AD compared to NDC (p = 0.004).  We then quantified plasma TTR by enzyme-linked immunosorbent assays in a larger independent cohort (n = 270) including subjects with mild to severe AD.  Plasma TTR levels were significantly lower in AD cases with rapid cognitive decline and with severe cognitive impairment.  Regression analyses showed plasma TTR levels also predicted cognitive decline over the ensuing 6 mo.  These data indicate that plasma TTR is a strong candidate AD biomarker that should be included in the development of blood based biomarker panels for disease diagnosis and also suggests that plasma TTR is a marker of disease severity and progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyk4X7q1SOk7Vg90H21EOLACvtfcHk0lis3IRPV853cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVertLc%253D&md5=c649917f74adaf8c0cc4c376be62e4b1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-110611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-110611%26sid%3Dliteratum%253Aachs%26aulast%3DVelayudhan%26aufirst%3DL.%26aulast%3DKillick%26aufirst%3DR.%26aulast%3DHye%26aufirst%3DA.%26aulast%3DKinsey%26aufirst%3DA.%26aulast%3DG%25C3%25BCntert%26aufirst%3DA.%26aulast%3DLynham%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DR.%26aulast%3DLourdusamy%26aufirst%3DA.%26aulast%3DTo%26aufirst%3DA.%2BW.%26aulast%3DPowell%26aufirst%3DJ.%26aulast%3DLovestone%26aufirst%3DS.%26atitle%3DPlasma%2520transthyretin%2520as%2520a%2520candidate%2520marker%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D28%26spage%3D369%26epage%3D375%26doi%3D10.3233%2FJAD-2011-110611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pate, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. M.</span></span> <span> </span><span class="NLM_article-title">Cerebrospinal fluid proteins as regulators of beta-amyloid aggregation and toxicity</span>. <i>Isr. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1002/ijch.201600078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fijch.201600078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=29129937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ohs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=602-612&author=K.+M.+Pateauthor=R.+M.+Murphy&title=Cerebrospinal+fluid+proteins+as+regulators+of+beta-amyloid+aggregation+and+toxicity&doi=10.1002%2Fijch.201600078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity</span></div><div class="casAuthors">Pate, Kayla M.; Murphy, Regina M.</div><div class="citationInfo"><span class="NLM_cas:title">Israel Journal of Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">602-612</span>CODEN:
                <span class="NLM_cas:coden">ISJCAT</span>;
        ISSN:<span class="NLM_cas:issn">0021-2148</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Amyloid disorders, such as Alzheimer's, are almost invariably late-onset diseases.  One defining diagnostic feature of Alzheimer's disease is the deposition of beta-amyloid as extracellular plaques, primarily in the hippocampus.  This raises the question: are there natural protective agents that prevent beta-amyloid from depositing, and is it loss of this protection that leads to onset of disease.  Proteins in cerebrospinal fluid (CSF) have been suggested to act as just such natural protective agents.  Here, we describe some of the early evidence that led to this suggestion, and we discuss, in greater detail, two CSF proteins that have garnered the bulk of the attention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRUaVQOrwMrbVg90H21EOLACvtfcHk0lis3IRPV853cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ohs7c%253D&md5=1dac62ca9864485de6291117454dba4a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fijch.201600078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijch.201600078%26sid%3Dliteratum%253Aachs%26aulast%3DPate%26aufirst%3DK.%2BM.%26aulast%3DMurphy%26aufirst%3DR.%2BM.%26atitle%3DCerebrospinal%2520fluid%2520proteins%2520as%2520regulators%2520of%2520beta-amyloid%2520aggregation%2520and%2520toxicity%26jtitle%3DIsr.%2520J.%2520Chem.%26date%3D2017%26volume%3D57%26spage%3D602%26epage%3D612%26doi%3D10.1002%2Fijch.201600078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davidsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westman-Brinkmalm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindbjer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreasen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjögren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span> <span> </span><span class="NLM_article-title">Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients</span>. <i>Neuroreport</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">615</span>, <span class="refDoi"> DOI: 10.1097/00001756-200204160-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1097%2F00001756-200204160-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=11973456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFKktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=611-615&author=P.+Davidssonauthor=A.+Westman-Brinkmalmauthor=C.+L.+Nilssonauthor=M.+Lindbjerauthor=L.+Paulsonauthor=N.+Andreasenauthor=M.+Sj%C3%B6grenauthor=K.+Blennow&title=Proteome+analysis+of+cerebrospinal+fluid+proteins+in+Alzheimer+patients&doi=10.1097%2F00001756-200204160-00015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients</span></div><div class="casAuthors">Davidsson, Pia; Westman-Brinkmalm, Ann; Nilsson, Carol L.; Lindbjer, Maria; Paulson, Linda; Andreasen, Niels; Sjoegren, Magnus; Blennow, Kaj</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">611-615</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">By comparing the CSF proteome between Alzheimer disease (AD) patients and controls it may be possible to identify proteins that play a role in the disease process and thus to study the pathogenesis of AD.  We used mini-gel technol. in a two-dimensional electrophoresis procedure, sensitive SYPRO Ruby staining and mass spectrometry for clin. screening of disease-influenced CSF proteins in 15 AD patients and 12 controls.  The levels of six proteins and their isoforms, including proapolipoprotein, apolipoprotein E, β-2 microglobulin, retinol-binding protein, transthyretin, and ubiquitin, were significantly altered in CSF of AD patients.  The most prominently altered proteins were the apolipoproteins, esp. proapolipoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbJ1YZVvyqZrVg90H21EOLACvtfcHk0lgPyiuO6dqUVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFKktLs%253D&md5=54c1cd338404291f20628e092a82be7d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1097%2F00001756-200204160-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200204160-00015%26sid%3Dliteratum%253Aachs%26aulast%3DDavidsson%26aufirst%3DP.%26aulast%3DWestman-Brinkmalm%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DC.%2BL.%26aulast%3DLindbjer%26aufirst%3DM.%26aulast%3DPaulson%26aufirst%3DL.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DSj%25C3%25B6gren%26aufirst%3DM.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DProteome%2520analysis%2520of%2520cerebrospinal%2520fluid%2520proteins%2520in%2520Alzheimer%2520patients%26jtitle%3DNeuroreport%26date%3D2002%26volume%3D13%26spage%3D611%26epage%3D615%26doi%3D10.1097%2F00001756-200204160-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span> <span> </span><span class="NLM_article-title">Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">7380</span>– <span class="NLM_lpage">7388</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.22-17-07380.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1523%2FJNEUROSCI.22-17-07380.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=12196559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFCmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=7380-7388&author=T.+D.+Steinauthor=J.+A.+Johnson&title=Lack+of+neurodegeneration+in+transgenic+mice+overexpressing+mutant+amyloid+precursor+protein+is+associated+with+increased+levels+of+transthyretin+and+the+activation+of+cell+survival+pathways&doi=10.1523%2FJNEUROSCI.22-17-07380.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways</span></div><div class="casAuthors">Stein, Thor D.; Johnson, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7380-7388</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Tg2576 mice overexpress a mutant form of human amyloid precursor protein with the Swedish mutation (APPSw), resulting in high β-amyloid (Aβ) levels in the brain.  Despite this, amyloid plaques do not develop until 12 mo of age, and there is no neuronal loss in mice as old as 16 mo.  Gene expression profiles in the hippocampus and cerebellum of 6-mo-old APPSw mice were compared with age-matched controls.  The expression of transthyretin, a protein shown to sequester Aβ and prevent amyloid fibril formation in vitro, and several genes in the insulin-signaling pathway, e.g., insulin-like growth factor-2, were increased selectively in the hippocampus of APPSw mice.  Concomitant activation of the insulin-like growth factor-1 receptor, Akt, and extracellular signal-regulated protein kinase 1 and 2 as well as increased phosphorylation of Bad also were unique to the hippocampus of APPSw mice.  In addn., the increased expression of transthyretin and insulin-like growth factor-2 and the increased phosphorylation of Bad in hippocampal neurons were maintained in 12-mo-old APPSw mice when compared with age-matched controls.  These results suggest that the slow progression and lack of full-fledged Alzheimer's disease pathol. in the hippocampal neurons of APPSw mice result from the genetic reprogramming of neural cells to cope with increased levels of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf0bjlyYSWG7Vg90H21EOLACvtfcHk0lgPyiuO6dqUVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFCmsLs%253D&md5=6b294e87ff29438db1364f3b99a44079</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-17-07380.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-17-07380.2002%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DT.%2BD.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26atitle%3DLack%2520of%2520neurodegeneration%2520in%2520transgenic%2520mice%2520overexpressing%2520mutant%2520amyloid%2520precursor%2520protein%2520is%2520associated%2520with%2520increased%2520levels%2520of%2520transthyretin%2520and%2520the%2520activation%2520of%2520cell%2520survival%2520pathways%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D7380%26epage%3D7388%26doi%3D10.1523%2FJNEUROSCI.22-17-07380.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buxbaum, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reixach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friske, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masliah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartfai, T.</span></span> <span> </span><span class="NLM_article-title">Transthyretin protects Alzheimer’s mice from the behavioral and biochemical effects of Aβ toxicity</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">2681</span>– <span class="NLM_lpage">2686</span>, <span class="refDoi"> DOI: 10.1073/pnas.0712197105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1073%2Fpnas.0712197105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=18272491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1yjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2681-2686&author=J.+N.+Buxbaumauthor=Z.+Yeauthor=N.+Reixachauthor=L.+Friskeauthor=C.+Levyauthor=P.+Dasauthor=T.+Goldeauthor=E.+Masliahauthor=A.+R.+Robertsauthor=T.+Bartfai&title=Transthyretin+protects+Alzheimer%E2%80%99s+mice+from+the+behavioral+and+biochemical+effects+of+A%CE%B2+toxicity&doi=10.1073%2Fpnas.0712197105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity</span></div><div class="casAuthors">Buxbaum, Joel N.; Ye, Zhengyi; Reixach, Natalia; Friske, Linsey; Levy, Coree; Das, Pritam; Golde, Todd; Masliah, Eliezer; Roberts, Amanda R.; Bartfai, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2681-2686</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cells that have evolved to produce large quantities of secreted proteins to serve the integrated functions of complex multicellular organisms are equipped to compensate for protein misfolding.  Hepatocytes and plasma cells have well developed chaperone and proteasome systems to ensure that secreted proteins transit the cell efficiently.  The no. of neurodegenerative disorders assocd. with protein misfolding suggests that neurons are particularly sensitive to the pathogenic effects of aggregates of misfolded mols. because those systems are less well developed in this lineage.  Aggregates of the amyloidogenic (Aβ1-42) peptide play a major role in the pathogenesis of Alzheimer's disease (AD), although the precise mechanism is unclear.  In genetic studies examg. protein-protein interactions that could constitute native mechanisms of neuroprotection in vivo, overexpression of a WT human transthyretin (TTR) transgene was ameliorative in the APP23 transgenic murine model of human AD.  Targeted silencing of the endogenous TTR gene accelerated the development of the neuropathol. phenotype.  Intraneuronal TTR was seen in the brains of normal humans and mice and in AD patients and APP23 mice.  The APP23 brains showed colocalization of extracellular TTR with AP in plaques.  Using surface plasmon resonance we obtained in vitro evidence of direct protein-protein interaction between TTR and Aβ aggregates.  These findings suggest that TTR is protective because of its capacity to bind toxic or pretoxic Aβ aggregates in both the intracellular and extracellular environment in a chaper-one-like manner.  The interaction may represent a unique normal host defense mechanism, enhancement of which could be therapeutically useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZznQdfQDwg7Vg90H21EOLACvtfcHk0lgPyiuO6dqUVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1yjur8%253D&md5=07b152af53f06d57d8855a538d970e2f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0712197105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0712197105%26sid%3Dliteratum%253Aachs%26aulast%3DBuxbaum%26aufirst%3DJ.%2BN.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DReixach%26aufirst%3DN.%26aulast%3DFriske%26aufirst%3DL.%26aulast%3DLevy%26aufirst%3DC.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DGolde%26aufirst%3DT.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DA.%2BR.%26aulast%3DBartfai%26aufirst%3DT.%26atitle%3DTransthyretin%2520protects%2520Alzheimer%25E2%2580%2599s%2520mice%2520from%2520the%2520behavioral%2520and%2520biochemical%2520effects%2520of%2520A%25CE%25B2%2520toxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2681%26epage%3D2686%26doi%3D10.1073%2Fpnas.0712197105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anders, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Carli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span> <span> </span><span class="NLM_article-title">Neutralization of transthyretin reverses the neuroprotective effects of secreted Amyloid Precursor Protein (APP) in APPSw mice resulting in Tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">7707</span>– <span class="NLM_lpage">7717</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2211-04.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1523%2FJNEUROSCI.2211-04.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=15342738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1Oqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=7707-7717&author=T.+D.+Steinauthor=N.+J.+Andersauthor=C.+De+Carliauthor=S.+L.+Chanauthor=M.+P.+Mattsonauthor=J.+A.+Johnson&title=Neutralization+of+transthyretin+reverses+the+neuroprotective+effects+of+secreted+Amyloid+Precursor+Protein+%28APP%29+in+APPSw+mice+resulting+in+Tau+phosphorylation+and+loss+of+hippocampal+neurons%3A+support+for+the+amyloid+hypothesis&doi=10.1523%2FJNEUROSCI.2211-04.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons: Support for the amyloid hypothesis</span></div><div class="casAuthors">Stein, Thor D.; Anders, Nicholas J.; DeCarli, Charles; Chan, Sic L.; Mattson, Mark P.; Johnson, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">7707-7717</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) may be caused by the abnormal processing of the amyloid precursor protein (APP) and the accumulation of β-amyloid (Aβ).  The amyloid precursor protein can be proteolytically cleaved into multiple fragments, many of which have distinct biol. actions.  Although a high level of Aβ can be toxic, the α-secretase cleaved APP (sAPPα) is neuroprotective.  However, the mechanism of sAPPα protection is unknown.  The sAPPα increases the expression levels of several neuroprotective genes and protects organotypic hippocampal cultures from Aβ-induced tau phosphorylation and neuronal death.  Antibody interference and small interfering RNA knock-down demonstrate that the sAPPα-driven expression of transthyretin and insulin-like growth factor 2 is necessary for protection against Aβ-induced neuronal death.  Mice overexpressing mutant APP possess high levels of sAPPα and transthyretin and do not develop the tau phosphorylation or neuronal loss characteristic of human AD.  Chronic infusion of an antibody against transthyretin into the hippocampus of mice overexpressing APP with the Swedish mutation (APPSw) leads to increased Aβ, tau phosphorylation, and neuronal loss and apoptosis within the CA1 neuronal field.  Therefore, the elevated expression of transthyretin is mediated by sAPPα and protects APPSw mice from developing many of the neuropathologies obsd. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_CIiDkIw1CbVg90H21EOLACvtfcHk0lh-gz_aMdz4qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1Oqtr4%253D&md5=6e08733e5461c9becedb355f6880c3fa</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2211-04.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2211-04.2004%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DT.%2BD.%26aulast%3DAnders%26aufirst%3DN.%2BJ.%26aulast%3DDe%2BCarli%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DS.%2BL.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26atitle%3DNeutralization%2520of%2520transthyretin%2520reverses%2520the%2520neuroprotective%2520effects%2520of%2520secreted%2520Amyloid%2520Precursor%2520Protein%2520%2528APP%2529%2520in%2520APPSw%2520mice%2520resulting%2520in%2520Tau%2520phosphorylation%2520and%2520loss%2520of%2520hippocampal%2520neurons%253A%2520support%2520for%2520the%2520amyloid%2520hypothesis%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D7707%26epage%3D7717%26doi%3D10.1523%2FJNEUROSCI.2211-04.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span> <span> </span><span class="NLM_article-title">Transthyretin binding to A-beta peptide--impact on A-beta fibrillogenesis and toxicity</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>582</i></span>,  <span class="NLM_fpage">936</span>– <span class="NLM_lpage">942</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2008.02.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.febslet.2008.02.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=18295603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFyitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2008&pages=936-942&author=R.+Costaauthor=A.+Gon%C3%A7alvesauthor=M.+J.+Saraivaauthor=I.+Cardoso&title=Transthyretin+binding+to+A-beta+peptide%2D%2Dimpact+on+A-beta+fibrillogenesis+and+toxicity&doi=10.1016%2Fj.febslet.2008.02.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin binding to A-Beta peptide -Impact on A-Beta fibrillogenesis and toxicity</span></div><div class="casAuthors">Costa, R.; Goncalves, A.; Saraiva, M. J.; Cardoso, I.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">582</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">936-942</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">It has been suggested that transthyretin (TTR) is involved in preventing A-Beta fibrillization in Alzheimer's disease (AD).  Here, we characterized the TTR/A-Beta interaction by competition binding assays.  TTR binds to different A-Beta peptide species: sol. (Kd, 28 nM), oligomers and fibrils; diverse TTR variants bind differentially to A-Beta.  TEM anal. demonstrated that TTR is capable of interfering with A-Beta fibrillization by both inhibiting and disrupting fibril formation.  Co-incubation of the two mols. resulted in the abolishment of A-Beta toxicity.  Our results confirmed TTR as an A-Beta ligand and indicated the inhibition/disruption of A-Beta fibrils as a possible mechanism underlying the protective role of TTR in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFLjMqE4Vzj7Vg90H21EOLACvtfcHk0lh-gz_aMdz4qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFyitLw%253D&md5=6f61a15215bc5fea32e14f8cf68b696d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2008.02.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2008.02.034%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DR.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DA.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DCardoso%26aufirst%3DI.%26atitle%3DTransthyretin%2520binding%2520to%2520A-beta%2520peptide--impact%2520on%2520A-beta%2520fibrillogenesis%2520and%2520toxicity%26jtitle%3DFEBS%2520Lett.%26date%3D2008%26volume%3D582%26spage%3D936%26epage%3D942%26doi%3D10.1016%2Fj.febslet.2008.02.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span> <span> </span><span class="NLM_article-title">stability of the transthyretin molecule as a key factor in the interaction with A-beta peptide - relevance in Alzheimer’s disease</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e45368</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0045368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1371%2Fjournal.pone.0045368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=23028965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWjsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=C.+A.+Ribeiroauthor=M.+J.+Saraivaauthor=I.+Cardoso&title=stability+of+the+transthyretin+molecule+as+a+key+factor+in+the+interaction+with+A-beta+peptide+-+relevance+in+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0045368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Stability of the transthyretin molecule as a key factor in the interaction with A-Beta peptide - relevance in Alzheimer's disease</span></div><div class="casAuthors">Ribeiro, Carlos A.; Saraiva, Maria Joao; Cardoso, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e45368</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Transthyretin (TTR) protects against A-Beta toxicity by binding the peptide thus inhibiting its aggregation.  Previous work showed different TTR mutations interact differently with A-Beta, with increasing affinities correlating with decreasing amyloidogenicity of the TTR mutant; this did not impact on the levels of inhibition of A-Beta aggregation, as assessed by transmission electron microscopy.  Our work aimed at probing differences in binding to A-Beta by WT, T119M and L55P TTR using quant. assays, and at identifying factors affecting this interaction.  We addressed the impact of such factors in TTR ability to degrade A-Beta.  Using a dot blot approach with the anti-oligomeric antibody A11, we showed that A-Beta formed oligomers transiently, indicating aggregation and fibril formation, whereas in the presence of WT and T119M TTR the oligomers persisted longer, indicative that these variants avoided further aggregation into fibrils.  In contrast, L55PTTR was not able to inhibit oligomerization or to prevent evolution to aggregates and fibrils.  Furthermore, apoptosis assessment showed WT and T119M TTR were able to protect against A-Beta toxicity.  Because the amyloidogenic potential of TTR is inversely correlated with its stability, the use of drugs able to stabilize TTR tetrameric fold could result in increased TTR/A-Beta binding.  Here we showed that iododiflunisal, 3-dinitrophenol, resveratrol, [2-(3,5-dichlorophenyl)amino] (DCPA) and [4-(3,5-difluorophenyl)] (DFPB) were able to increase TTR binding to A-Beta; however only DCPA and DFPB improved TTR proteolytic activity.  Thyroxine, a TTR ligand, did not influence TTR/A-Beta interaction and A-Beta degrdn. by TTR, whereas RBP, another TTR ligand, not only obstructed the interaction but also inhibited TTR proteolytic activity.  Our results showed differences between WT and T119M TTR, and L55PTTR mutant regarding their interaction with A-Beta and prompt the stability of TTR as a key factor in this interaction, which may be relevant in AD pathogenesis and for the design of therapeutic TTR-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz7GYGzRGrDLVg90H21EOLACvtfcHk0ljLlx1lEtXOmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWjsLzI&md5=2d431c7778452e72163669dabce3ac44</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0045368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0045368%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DC.%2BA.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DCardoso%26aufirst%3DI.%26atitle%3Dstability%2520of%2520the%2520transthyretin%2520molecule%2520as%2520a%2520key%2520factor%2520in%2520the%2520interaction%2520with%2520A-beta%2520peptide%2520-%2520relevance%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0045368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pamrén, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brännström, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golchin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iakovleva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandblad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharibyan, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, A.</span></span> <span> </span><span class="NLM_article-title">Transthyretin Interferes with Aβ Amyloid Formation by Redirecting Oligomeric Nuclei into Non-Amyloid Aggregates</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">2722</span>– <span class="NLM_lpage">2733</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2018.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.jmb.2018.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=29890120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCmsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2018&pages=2722-2733&author=L.+Nilssonauthor=A.+Pamr%C3%A9nauthor=T.+Islamauthor=K.+Br%C3%A4nnstr%C3%B6mauthor=S.+A.+Golchinauthor=N.+Petterssonauthor=I.+Iakovlevaauthor=L.+Sandbladauthor=A.+L.+Gharibyanauthor=A.+Olofsson&title=Transthyretin+Interferes+with+A%CE%B2+Amyloid+Formation+by+Redirecting+Oligomeric+Nuclei+into+Non-Amyloid+Aggregates&doi=10.1016%2Fj.jmb.2018.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin Interferes with Aβ Amyloid Formation by Redirecting Oligomeric Nuclei into Non-Amyloid Aggregates</span></div><div class="casAuthors">Nilsson, Lina; Pamren, Annelie; Islam, Tohidul; Braennstroem, Kristoffer; Golchin, Solmaz A.; Pettersson, Nina; Iakovleva, Irina; Sandblad, Linda; Gharibyan, Anna L.; Olofsson, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2722-2733</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The pathol. Aβ aggregates assocd. with Alzheimer's disease follow a nucleation-dependent path of formation.  A nucleus represents an oligomeric assembly of Aβ peptides that acts as a template for subsequent incorporation of monomers to form a fibrillar structure.  Nuclei can form de novo or via surface-catalyzed secondary nucleation, and the combined rates of elongation and nucleation control the overall rate of fibril formation.  Transthyretin (TTR) obstructs Aβ fibril formation in favor of alternative non-fibrillar assemblies, but the mechanism behind this activity is not fully understood.  This study shows that TTR does not significantly disturb fibril elongation; rather, it effectively interferes with the formation of oligomeric nuclei.  We demonstrate that this interference can be modulated by altering the relative contribution of elongation and nucleation, and we show how TTR's effects can range from being essentially ineffective to almost complete inhibition of fibril formation without changing the concn. of TTR or monomeric Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzrSVXFPuNvbVg90H21EOLACvtfcHk0ljLlx1lEtXOmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCmsbbJ&md5=85815a1f5a2aa5b78283b048d25523c5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2018.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2018.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DL.%26aulast%3DPamr%25C3%25A9n%26aufirst%3DA.%26aulast%3DIslam%26aufirst%3DT.%26aulast%3DBr%25C3%25A4nnstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DGolchin%26aufirst%3DS.%2BA.%26aulast%3DPettersson%26aufirst%3DN.%26aulast%3DIakovleva%26aufirst%3DI.%26aulast%3DSandblad%26aufirst%3DL.%26aulast%3DGharibyan%26aufirst%3DA.%2BL.%26aulast%3DOlofsson%26aufirst%3DA.%26atitle%3DTransthyretin%2520Interferes%2520with%2520A%25CE%25B2%2520Amyloid%2520Formation%2520by%2520Redirecting%2520Oligomeric%2520Nuclei%2520into%2520Non-Amyloid%2520Aggregates%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D430%26spage%3D2722%26epage%3D2733%26doi%3D10.1016%2Fj.jmb.2018.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span> <span> </span><span class="NLM_article-title">Transthyretin stability is critical in assisting beta amyloid clearance-Relevance of transthyretin stabilization in Alzheimer’s disease</span>. <i>CNS Neurosci. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1111/cns.12707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1111%2Fcns.12707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28570028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKitrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=605-619&author=M.+Alemiauthor=S.+C.+Silvaauthor=I.+Santanaauthor=I.+Cardoso&title=Transthyretin+stability+is+critical+in+assisting+beta+amyloid+clearance-Relevance+of+transthyretin+stabilization+in+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fcns.12707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease</span></div><div class="casAuthors">Alemi, Mobina; Silva, Sara C.; Santana, Isabel; Cardoso, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : The absence of transthyretin (TTR) in AD mice decreases brain Aβ clearance and reduces the low-d. lipoprotein receptor-related protein 1 (LRP1).  It is possible that neuroprotection by TTR is dependent on its tetramer structural stability, as studies using TTR mutants showed that unstable L55P TTR has low affinity for Aβ, and TTR tetrameric stabilizers such as iododiflunisal ameliorate AD features in vivo.  Methods : We firstly investigated TTR folding status in human plasma measuring the resistance to urea denaturation.  The importance of TTR stability on Aβ internalization was studied in human cerebral microvascular endothelial (hCMEC/D3) and hepatoma cells (HepG2), by flow cytometry.  To investigate the fate of Aβ at the blood-brain barrier, Aβ efflux from hCMEC/D3 cells seeded on transwells was measured using ELISA.  Further, to assess Aβ colocalization with lysosomes, Lysotracker was used.  Moreover, levels of LRP1 were assessed in the liver and plasma of mice with different TTR backgrounds or treated with iododiflunisal.  Results : We showed that TTR stability is decreased in AD and that WT TTR and drug-stabilized L55P TTR are able to increase uptake of Aβ.  Furthermore, measurement of Aβ efflux showed that stable or stabilized TTR increased Aβ efflux from the basolateral to the apical side.  Moreover, HepG2 cells incubated with Aβ in the presence of WT TTR, but not L55P TTR, showed an increased no. of lysosomes.  Further, in the presence of WT TTR, Aβ peptide colocalized with lysosomes, indicating that only stable TTR assists Aβ internalization, leading to its degrdn.  Finally, we demonstrated that only stable TTR can increase LRP1 levels.  Conclusion : TTR stabilization exerts a pos. effect on Aβ clearance and LRP1 levels, suggesting that TTR protective role in AD is dependent on its stability.  These results provide relevant information for the design of TTR-based therapeutic strategies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrKmDdsa4lU7Vg90H21EOLACvtfcHk0ljLlx1lEtXOmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKitrvE&md5=df944637335b6c7e67728794b4bbbdb9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fcns.12707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcns.12707%26sid%3Dliteratum%253Aachs%26aulast%3DAlemi%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DS.%2BC.%26aulast%3DSantana%26aufirst%3DI.%26aulast%3DCardoso%26aufirst%3DI.%26atitle%3DTransthyretin%2520stability%2520is%2520critical%2520in%2520assisting%2520beta%2520amyloid%2520clearance-Relevance%2520of%2520transthyretin%2520stabilization%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2017%26volume%3D23%26spage%3D605%26epage%3D619%26doi%3D10.1111%2Fcns.12707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerschen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planté-Bordeneuve, V.</span></span> <span> </span><span class="NLM_article-title">Current and future treatment approaches in transthyretin Familial Amyloid Polyneuropathy</span>. <i>Curr. Treat. Options Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">53</span>, <span class="refDoi"> DOI: 10.1007/s11940-016-0436-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1007%2Fs11940-016-0436-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=27873215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BC2snptVSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=53&author=P.+Kerschenauthor=V.+Plant%C3%A9-Bordeneuve&title=Current+and+future+treatment+approaches+in+transthyretin+Familial+Amyloid+Polyneuropathy&doi=10.1007%2Fs11940-016-0436-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy</span></div><div class="casAuthors">Kerschen Philippe; Plante-Bordeneuve Violaine; Plante-Bordeneuve Violaine</div><div class="citationInfo"><span class="NLM_cas:title">Current treatment options in neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">53</span>
        ISSN:<span class="NLM_cas:issn">1092-8480</span>.
    </div><div class="casAbstract">OPINION STATEMENT:  Treatment of transthyretin familial amyloid polyneuropathy (TTR FAP) must be tailored to disease stage.  Patients with early stage disease (i.e., without major impairment in walking ability), especially younger patients, should be referred as soon as possible for liver transplantation (LT) in the absence of major comorbid conditions.  LT remains the most effective treatment option to date and should be offered to these patients as early as possible.  Bridging therapy with an oral TTR stabilizer (tafamidis or diflunisal, according to local access to these treatments) should be started as soon as the diagnosis of TTR FAP is established.  Early stage patients who do not wish to or have contraindications to LT should be treated with an oral TTR stabilizer or get access to the newly developed therapeutic options (IONIS TTR-Rx, patisiran, doxycycline/TUDCA).  Late stage patients (presenting with significant walking impairment) are usually older and notoriously difficult to treat.  They should be offered an oral TTR stabilizer but are not candidates for LT due to a significant rate of perioperative complications and increased risk of progressive neurological and especially cardiac disease despite LT.  Access to the different therapies in development should also be considered depending on respective inclusion and exclusion criteria.  The abovementioned treatment options were mostly validated in Val30Met mutation patients, but should also be offered to non-Val30Met patients, although mortality rates after LT are higher in these patients.  Treatment decisions should be made on an individual basis.  Screening for heart, eye, and renal involvement is mandatory for every patient at disease diagnosis and regularly thereafter, even in transplanted patients.  Symptomatic treatment should be offered as needed, as well as genetic counseling to at-risk family members.  Asymptomatic mutation carriers should benefit from regular screening for early symptoms of disease.  Current therapeutic management of TTR FAP will hopefully be changed in the near future with data from the ongoing phase 2/3 studies testing the TTR gene silencing agents.  In the longer term, it is likely that combined therapeutic approaches will be necessary to reverse the disease process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJfr6oNEsYE5ggzHGM8X5CfW6udTcc2eb-Nc8dClVnlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snptVSqtg%253D%253D&md5=1b59079c6a8ab55941bb2aaf7c252d47</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs11940-016-0436-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11940-016-0436-z%26sid%3Dliteratum%253Aachs%26aulast%3DKerschen%26aufirst%3DP.%26aulast%3DPlant%25C3%25A9-Bordeneuve%26aufirst%3DV.%26atitle%3DCurrent%2520and%2520future%2520treatment%2520approaches%2520in%2520transthyretin%2520Familial%2520Amyloid%2520Polyneuropathy%26jtitle%3DCurr.%2520Treat.%2520Options%2520Neurol.%26date%3D2016%26volume%3D18%26spage%3D53%26doi%3D10.1007%2Fs11940-016-0436-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gales, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damas, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span> <span> </span><span class="NLM_article-title">Small Transthyretin (TTR) Ligands as Possible Therapeutic Agents in TTR Amyloidoses</span>. <i>Curr. Drug Targets CNS Neurol. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.2174/156800705774322076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.2174%2F156800705774322076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=16266291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2gsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=587-596&author=M.+R.+Almeidaauthor=L.+Galesauthor=A.+M.+Damasauthor=I.+Cardosoauthor=M.+J.+Saraiva&title=Small+Transthyretin+%28TTR%29+Ligands+as+Possible+Therapeutic+Agents+in+TTR+Amyloidoses&doi=10.2174%2F156800705774322076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidosis</span></div><div class="casAuthors">Almeida, M. R.; Gales, L.; Damas, A. M.; Cardoso, I.; Saraiva, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">587-596</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  In transthyretin (TTR) amyloidosis TTR variants deposit as amyloid fibrils giving origin, in most cases, to peripheral polyneuropathy, cardiomyopathy, carpal tunnel syndrome and/or amyloid deposition in the eye.  More than eighty TTR variants are known, most of them being pathogenic.  The mechanism of TTR fibril formation is still not completely elucidated.  However it is widely accepted that the amino acid substitutions in the TTR variants contribute to a destabilizing effect on the TTR tetramer mol., which in particular conditions dissoc. into non native monomeric intermediates that aggregate and polymerize in amyloid fibrils that further elongate.  Since this is a multi-step process there is the possibility to impair TTR amyloid fibril formation at different stages of the process namely by tetramer stabilization, inhibition of fibril formation or fibril disruption.  Till now the only efficient therapy available is liver transplant when performed in an early phase of the onset of the disease symptoms.  Since this is a very invasive therapy alternatives are desirable.  In that sense, several compds. have been proposed to impair amyloid formation or disruption.  Based on the proposed mechanism for TTR amyloid fibril formation we discuss the action of some of the proposed TTR stabilizers such as derivs. of some NSAIDs (diflunisal, diclofenac, flufenamic acid, and derivs.) and the action of amyloid disrupters such as 4'-iodo-4'-deoxydoxorubicin (I-DOX) and tetracyclines.  Among all these compds., TTR stabilizers seems to be the most interesting since they would impair very early the process of amyloid formation and could also have a prophylactic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdNXW22cs8UbVg90H21EOLACvtfcHk0li2tFl4SudMzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2gsLrL&md5=5587e7a5c156e29c1772f5b7bb4f4107</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F156800705774322076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800705774322076%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DM.%2BR.%26aulast%3DGales%26aufirst%3DL.%26aulast%3DDamas%26aufirst%3DA.%2BM.%26aulast%3DCardoso%26aufirst%3DI.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26atitle%3DSmall%2520Transthyretin%2520%2528TTR%2529%2520Ligands%2520as%2520Possible%2520Therapeutic%2520Agents%2520in%2520TTR%2520Amyloidoses%26jtitle%3DCurr.%2520Drug%2520Targets%2520CNS%2520Neurol.%2520Disord.%26date%3D2005%26volume%3D4%26spage%3D587%26epage%3D596%26doi%3D10.2174%2F156800705774322076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span> <span> </span><span class="NLM_article-title">Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1042/BJ20040011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1042%2FBJ20040011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=15080795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslGntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2004&pages=351-356&author=M.+R.+Almeidaauthor=B.+Macedoauthor=I.+Cardosoauthor=I.+Alvesauthor=G.+Valenciaauthor=G.+Arsequellauthor=A.+Planasauthor=M.+J.+Saraiva&title=Selective+binding+to+transthyretin+and+tetramer+stabilization+in+serum+from+patients+with+familial+amyloidotic+polyneuropathy+by+an+iodinated+diflunisal+derivative&doi=10.1042%2FBJ20040011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative</span></div><div class="casAuthors">Almeida, Maria Rosario; Macedo, Barbara; Cardoso, Isabel; Alves, Isabel; Valencia, Gregorio; Arsequell, Gemma; Planas, Antoni; Saraiva, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-356</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">In familial amyloidotic polyneuropathy, TTR (transthyretin) variants are deposited as amyloid fibrils.  It is thought that this process involves TTR tetramer dissocn., which leads to partially unfolded monomers that aggregate and polymerize into amyloid fibrils.  This process can be counteracted by stabilization of the tetramer.  Several small compds., such as diclofenac, diflunisal and flufenamic acid, have been reported to bind to TTR in vitro, in the T4 (thyroxine) binding channel that runs through the TTR tetramer, and consequently are considered to stabilize TTR.  However, if these agents bind plasma proteins other than TTR, decreased drug availability will occur, compromising their use as therapeutic agents for TTR amyloidosis.  In the present work, the authors compared the action of these compds. and of new derivs. designed to increase both selectivity of binding to TTR and inhibitory potency in relation to TTR amyloid fibril formation.  The authors found two diflunisal derivs. that, in contrast with diclofenac, flufenamic acid and diflunisal, displaced T4 from TTR in plasma preferentially over binding to albumin and thyroxine binding globulin.  The same diflunisal derivs. also had a stabilizing effect on TTR tetramers in plasma, as studied by isoelec. focusing of whole plasma under semi-denaturing conditions.  In addn., by TEM, the authors demonstrated that, in contrast with other proposed TTR stabilizers (namely diclofenac, flufenamic acid and diflunisal), one of the diflunisal derivs. tested efficiently inhibited TTR aggregation.  Taken together, our ex vivo and in vitro studies present evidence for the selectivity and efficiency of novel diflunisal derivs. as TTR stabilizers and as inhibitors of fibril formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7yUhh-llFj7Vg90H21EOLACvtfcHk0lhy8yQZyKyMjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslGntr8%253D&md5=02ccfa2b447c263613ea8b7bf95eb49a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1042%2FBJ20040011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20040011%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DM.%2BR.%26aulast%3DMacedo%26aufirst%3DB.%26aulast%3DCardoso%26aufirst%3DI.%26aulast%3DAlves%26aufirst%3DI.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DPlanas%26aufirst%3DA.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26atitle%3DSelective%2520binding%2520to%2520transthyretin%2520and%2520tetramer%2520stabilization%2520in%2520serum%2520from%2520patients%2520with%2520familial%2520amyloidotic%2520polyneuropathy%2520by%2520an%2520iodinated%2520diflunisal%2520derivative%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D381%26spage%3D351%26epage%3D356%26doi%3D10.1042%2FBJ20040011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekijima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamski-Werner, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span> <span> </span><span class="NLM_article-title">Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidosis</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">911</span>– <span class="NLM_lpage">921</span>, <span class="refDoi"> DOI: 10.1021/ar020073i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar020073i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWnurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2005&pages=911-921&author=S.+M.+Johnsonauthor=R.+L.+Wisemanauthor=Y.+Sekijimaauthor=N.+S.+Greenauthor=S.+L.+Adamski-Wernerauthor=J.+W.+Kelly&title=Native+state+kinetic+stabilization+as+a+strategy+to+ameliorate+protein+misfolding+diseases%3A+a+focus+on+the+transthyretin+amyloidosis&doi=10.1021%2Far020073i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Native State Kinetic Stabilization as a Strategy To Ameliorate Protein Misfolding Diseases: A Focus on the Transthyretin Amyloidoses</span></div><div class="casAuthors">Johnson, Steven M.; Wiseman, R. Luke; Sekijima, Yoshiki; Green, Nora S.; Adamski-Werner, Sara L.; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">911-921</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Small mol.-mediated protein stabilization inside or outside of the cell is a promising strategy to treat protein misfolding/misassembly diseases.  Herein we focus on the transthyretin (TTR) amyloidoses and demonstrate that preferential ligand binding to and stabilization of the native state over the dissociative transition state raises the kinetic barrier of dissocn. (rate-limiting for amyloidogenesis), slowing and in many cases preventing TTR amyloid fibril formation.  Since T119M-TTR subunit incorporation into tetramers otherwise composed of disease-assocd. subunits also imparts kinetic stability on the tetramer and ameliorates amyloidosis in humans, it is likely that small mol.-mediated native state kinetic stabilization will also alleviate TTR amyloidoses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO_-e1jnwgLbVg90H21EOLACvtfcHk0lhy8yQZyKyMjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWnurvO&md5=864588505ec798d1fd87ce3423320af4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Far020073i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far020073i%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DWiseman%26aufirst%3DR.%2BL.%26aulast%3DSekijima%26aufirst%3DY.%26aulast%3DGreen%26aufirst%3DN.%2BS.%26aulast%3DAdamski-Werner%26aufirst%3DS.%2BL.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DNative%2520state%2520kinetic%2520stabilization%2520as%2520a%2520strategy%2520to%2520ameliorate%2520protein%2520misfolding%2520diseases%253A%2520a%2520focus%2520on%2520the%2520transthyretin%2520amyloidosis%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2005%26volume%3D38%26spage%3D911%26epage%3D921%26doi%3D10.1021%2Far020073i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nencetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span> <span> </span><span class="NLM_article-title">TTR fibril formation inhibitors: is there a SAR?</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2356</span>– <span class="NLM_lpage">2379</span>, <span class="refDoi"> DOI: 10.2174/092986712800269326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.2174%2F092986712800269326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=22471984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1egsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=2356-2379&author=S.+Nencettiauthor=E.+Orlandini&title=TTR+fibril+formation+inhibitors%3A+is+there+a+SAR%3F&doi=10.2174%2F092986712800269326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">TTR fibril formation inhibitors: is there a SAR?</span></div><div class="casAuthors">Nencetti, S.; Orlandini, E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2356-2379</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Transthyretin is a homotetrameric protein that carries thyroxine and retinol binding protein in plasma and is assocd. with a variety of amyloid diseases.  One approach to the potential treatment of TTR amyloidosis is the stabilization of the native tetramer, over the dissociative transition state, through the binding of small mols.; this increases the kinetic barrier for tetramer dissocn. and prevents protein misfolding.  Several mols. discovered through focused screening, or created utilizing the structure-based design, were studied to identify the structural features that could make up for a good candidate drug.  In this review, we examine several different chem. classes of TTR fibril formation inhibitors, highlighting the structural modifications that have led to an improvement or to a decrease of their potency and/or selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFCEaKYu7bnbVg90H21EOLACvtfcHk0lgMVL3zPiZ7GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1egsro%253D&md5=1cdf556f5cedc4f1c83168d018ce1e07</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F092986712800269326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712800269326%26sid%3Dliteratum%253Aachs%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DOrlandini%26aufirst%3DE.%26atitle%3DTTR%2520fibril%2520formation%2520inhibitors%253A%2520is%2520there%2520a%2520SAR%253F%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D2356%26epage%3D2379%26doi%3D10.2174%2F092986712800269326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berk, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhr, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekijima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heneghan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldenrust, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorevic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisbee, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyck, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obici, L.</span></span> <span> </span><span class="NLM_article-title">Familial amyloidosis consortium. the diflunisal trial: study accrual and drug tolerance</span>. <i>Amyloid</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.3109/13506129.2012.678509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3109%2F13506129.2012.678509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=22551208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsF2rsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=37-38&author=J.+L.+Berkauthor=O.+B.+Suhrauthor=Y.+Sekijimaauthor=T.+Yamashitaauthor=M.+Heneghanauthor=S.+R.+Zeldenrustauthor=Y.+Andoauthor=S.+Ikedaauthor=P.+Gorevicauthor=G.+Merliniauthor=J.+W.+Kellyauthor=M.+Skinnerauthor=A.+B.+Bisbeeauthor=P.+J.+Dyckauthor=L.+Obici&title=Familial+amyloidosis+consortium.+the+diflunisal+trial%3A+study+accrual+and+drug+tolerance&doi=10.3109%2F13506129.2012.678509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The Diflunisal Trial: Study accrual and drug tolerance</span></div><div class="casAuthors">Berk, John L.; Suhr, Ole B.; Sekijima, Yoshiki; Yamashita, Taro; Heneghan, Michael; Zeldenrust, Steven R.; Ando, Yukio; Ikeda, Shu-ichi; Gorevic, Peter; Merlini, Giampaolo; Kelly, Jeffrey W.; Skinner, Martha; Bisbee, Alice B.; Dyck, Peter J.; Obici, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Amyloid</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">37-38</span>CODEN:
                <span class="NLM_cas:coden">AIJIET</span>;
        ISSN:<span class="NLM_cas:issn">1350-6129</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Familial amyloidotic polyneuropathy (FAP) is a protein folding disorder that induces neuropathy and cardiomyopathy, leading to death within 7-15 years after onset of clin. disease.  In vitro, small ligands binding the thyroid hormone docking site stabilize tetrameric transthyretin, inhibiting amyloid fibril formation.  We undertook a randomized, placebo-controlled clin. trial to det. whether diflunisal, a well-known non-steroidal anti-inflammatory drug (NSAID) alters neurol. disease progression in FAP.  We enrolled 130 subjects with wide age and FAP mutation representation.  To date, few recognized complications of NSAIDs have occurred in the study cohort.  Data collection will be completed by Nov. 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAhVf5wQzYqrVg90H21EOLACvtfcHk0lgMVL3zPiZ7GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsF2rsbk%253D&md5=b0cef903001d53bbc743b99ffc575a1d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3109%2F13506129.2012.678509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F13506129.2012.678509%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DJ.%2BL.%26aulast%3DSuhr%26aufirst%3DO.%2BB.%26aulast%3DSekijima%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DHeneghan%26aufirst%3DM.%26aulast%3DZeldenrust%26aufirst%3DS.%2BR.%26aulast%3DAndo%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DGorevic%26aufirst%3DP.%26aulast%3DMerlini%26aufirst%3DG.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DSkinner%26aufirst%3DM.%26aulast%3DBisbee%26aufirst%3DA.%2BB.%26aulast%3DDyck%26aufirst%3DP.%2BJ.%26aulast%3DObici%26aufirst%3DL.%26atitle%3DFamilial%2520amyloidosis%2520consortium.%2520the%2520diflunisal%2520trial%253A%2520study%2520accrual%2520and%2520drug%2520tolerance%26jtitle%3DAmyloid%26date%3D2012%26volume%3D19%26spage%3D37%26epage%3D38%26doi%3D10.3109%2F13506129.2012.678509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulawa, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planté-Bordeneuve, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaudinière, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mundayat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huertas, P.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action and clinical application of Tafamidis in hereditary transthyretin amyloidosis</span>. <i>Neurol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1007/s40120-016-0040-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1007%2Fs40120-016-0040-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=26894299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BC28jit12rtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=1-25&author=T.+Coelhoauthor=G.+Merliniauthor=C.+E.+Bulawaauthor=J.+A.+Flemingauthor=D.+P.+Judgeauthor=J.+W.+Kellyauthor=M.+S.+Maurerauthor=V.+Plant%C3%A9-Bordeneuveauthor=R.+Labaudini%C3%A8reauthor=R.+Mundayatauthor=S.+Rileyauthor=I.+Lombardoauthor=P.+Huertas&title=Mechanism+of+action+and+clinical+application+of+Tafamidis+in+hereditary+transthyretin+amyloidosis&doi=10.1007%2Fs40120-016-0040-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis</span></div><div class="casAuthors">Coelho Teresa; Merlini Giampaolo; Bulawa Christine E; Fleming James A; Judge Daniel P; Kelly Jeffery W; Maurer Mathew S; Plante-Bordeneuve Violaine; Labaudiniere Richard; Mundayat Rajiv; Riley Steve; Lombardo Ilise; Huertas Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Neurology and therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-25</span>
        ISSN:<span class="NLM_cas:issn">2193-8253</span>.
    </div><div class="casAbstract">Transthyretin (TTR) transports the retinol-binding protein-vitamin A complex and is a minor transporter of thyroxine in blood.  Its tetrameric structure undergoes rate-limiting dissociation and monomer misfolding, enabling TTR to aggregate or to become amyloidogenic.  Mutations in the TTR gene generally destabilize the tetramer and/or accelerate tetramer dissociation, promoting amyloidogenesis.  TTR-related amyloidoses are rare, fatal, protein-misfolding disorders, characterized by formation of soluble aggregates of variable structure and tissue deposition of amyloid.  The TTR amyloidoses present with a spectrum of manifestations, encompassing progressive neuropathy and/or cardiomyopathy.  Until recently, the only accepted treatment to halt progression of hereditary TTR amyloidosis was liver transplantation, which replaces the hepatic source of mutant TTR with the less amyloidogenic wild-type TTR.  Tafamidis meglumine is a rationally designed, non-NSAID benzoxazole derivative that binds with high affinity and selectivity to TTR and kinetically stabilizes the tetramer, slowing monomer formation, misfolding, and amyloidogenesis.  Tafamidis is the first pharmacotherapy approved to slow the progression of peripheral neurologic impairment in TTR familial amyloid polyneuropathy.  Here we describe the mechanism of action of tafamidis and review the clinical data, demonstrating that tafamidis treatment slows neurologic deterioration and preserves nutritional status, as well as quality of life in patients with early-stage Val30Met amyloidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcjwtDHHoc2pQHPYJuLg8TfW6udTcc2ebJ8NG3x4_r9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jit12rtA%253D%253D&md5=cbf6666ed975691337c8b2f351036d7f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs40120-016-0040-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40120-016-0040-x%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DT.%26aulast%3DMerlini%26aufirst%3DG.%26aulast%3DBulawa%26aufirst%3DC.%2BE.%26aulast%3DFleming%26aufirst%3DJ.%2BA.%26aulast%3DJudge%26aufirst%3DD.%2BP.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DMaurer%26aufirst%3DM.%2BS.%26aulast%3DPlant%25C3%25A9-Bordeneuve%26aufirst%3DV.%26aulast%3DLabaudini%25C3%25A8re%26aufirst%3DR.%26aulast%3DMundayat%26aufirst%3DR.%26aulast%3DRiley%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DI.%26aulast%3DHuertas%26aufirst%3DP.%26atitle%3DMechanism%2520of%2520action%2520and%2520clinical%2520application%2520of%2520Tafamidis%2520in%2520hereditary%2520transthyretin%2520amyloidosis%26jtitle%3DNeurol.%2520Ther.%26date%3D2016%26volume%3D5%26spage%3D1%26epage%3D25%26doi%3D10.1007%2Fs40120-016-0040-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nencetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span> <span> </span><span class="NLM_article-title">Tafamidis (Vyndaqel): A light for FAP patients</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1617</span>– <span class="NLM_lpage">1619</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fcmdc.201300245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=24000164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGlur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1617-1619&author=S.+Nencettiauthor=A.+Rosselloauthor=E.+Orlandini&title=Tafamidis+%28Vyndaqel%29%3A+A+light+for+FAP+patients&doi=10.1002%2Fcmdc.201300245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tafamidis (Vyndaqel): A Light for FAP Patients</span></div><div class="casAuthors">Nencetti, Susanna; Rossello, Armando; Orlandini, Elisabetta</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1617-1619</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Transthyretin familial amyloid polyneuropathies (TTR- FAP) are a rare form of autosomal-dominant amyloidosis characterized by extracellular deposition of TTRamyloid fibrils resulting from TTR misfolding.  This pathol. induces nerve lesions and polyneuropathy, particularly in the peripheral nervous system.  Native-state kinetic stabilization of the TTR tetramer by small mols. acting in a similar manner to the natural hormone T4 is recognized as a potential therapeutic strategy in preventνing TTR amyloid fibril formation, offering a potential alternative to liver transplantation for the treatment of patients with FAP.  In Dec. 2012, a well- known USFDA-approved nonsteroidal anti-inflammatory drug, diflunisal, completed clin. trials in FAP patients.  However, its primary activity eventually becomes a side effect in the theraνpy of FAP patients.  In conjunction with Pfizer, Kelly's group recently received approval by the European Medicines Agency for tafamidis meglumine (Fx-1006A, trade name Vyndaqel) in the treatment of FAP.  This compd. lacks the anti-inflammatory activity (present in NSAIDs) contraindicated for patients with cardiomyopathy.  This important advance originated from the observation that the benzoxazole scaffold, appropriately substituted with a carboxylic acid at C4-C7, and with a halogenated Ph ring at C2, is a good fit for the TTR binding site.  On the basis of promising results obtained from preclin. studies, tafamidis was selected for clin. development, on the hypothesis that it could halt or slow the progression of neurodegeneration in FAP patients.  A randomized placebo-controlled double-blind trial in patients with TTR-FAP was carried out to evaluate the ability of tafamidis to stabilize the TTR tetramer and the clin. progression of the disease over 18 mo.  Tafamidis was administered orally at 20 mg per day as a single dose to patients.  The results indicated that relative to placebo control, tafamidis can delay peripheral neurol. deterioration, preserve nerve fiber function, and maintain nutritional status over the clin. trial period, supporting the hypothesis that preventing TTR tetramer dissocn. with tafamidis can slow the neurodegenerative process.  The limited duraνtion of the clin. trial did not afford ests. of long-term effects, such as side effects that result from stabilization of the TTR tetramer, survival of TTR-FAP patients, and non-neurol. manifestation of disease such as cardiomyopathy.  In concluνsion, further studies will evaluate whether tafamidis could become a viable therapeutic treatment that slows disease progression, providing a light for FAP patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWVq_IkPtnx7Vg90H21EOLACvtfcHk0lgWanp_SlkHWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGlur7I&md5=9185e02f28100272d3f30508d7883e98</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300245%26sid%3Dliteratum%253Aachs%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DRossello%26aufirst%3DA.%26aulast%3DOrlandini%26aufirst%3DE.%26atitle%3DTafamidis%2520%2528Vyndaqel%2529%253A%2520A%2520light%2520for%2520FAP%2520patients%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1617%26epage%3D1619%26doi%3D10.1002%2Fcmdc.201300245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, E. D.</span></span> <span> </span><span class="NLM_article-title">Tafamidis: A review in transthyretin amyloidosis with polyneuropathy</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1007/s40265-019-01129-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1007%2Fs40265-019-01129-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=31098895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWmtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=863-874&author=Y.+N.+Lambauthor=E.+D.+Deeks&title=Tafamidis%3A+A+review+in+transthyretin+amyloidosis+with+polyneuropathy&doi=10.1007%2Fs40265-019-01129-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy</span></div><div class="casAuthors">Lamb, Yvette N.; Deeks, Emma D.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">863-874</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Transthyretin amyloidosis with polyneuropathy (ATTR-PN), a rare and progressive hereditary disorder, results from mutations in the gene coding for the transthyretin (TTR) protein that destabilize the protein's tetrameric structure.  In over 40 countries worldwide, tafamidis (Vyndaqel) is approved for the treatment of TTR amyloidosis in adults with stage 1 symptomatic polyneuropathy, to delay peripheral neurol. impairment.  Tafamidis is administered orally once daily, as a soft capsule.  Evidence from clin. studies, including an 18-mo placebo-controlled trial and subsequent long-term, open-label extension studies (providing data from ≤ 6 years of treatment), indicate that tafamidis slowed deterioration of neurol. function and maintained health-related quality of life in patients with early-stage ATTR-PN and the Val30Met mutation.  TTR tetramers were stabilized in nearly all patients, and nutritional status was generally maintained or improved.  Similar benefit was seen with tafamidis over 12 mo in a noncomparative trial in patients with non-Val30Met ATTR-PN, although disease progression in this population (which was older and had had ATTR-PN for longer than Val30Met patients) became more notable with continued therapy in an extension study.  Data for up to 10 years from large registry and referral center studies support the long-term effectiveness and safety of tafamidis in delaying disease progression and conferring survival benefits in patients with stage 1 ATTR-PN.  Tafamidis was generally well tolerated, with no new safety signals detected during the long-term trial or real-world experience.  Thus, based on up to 10 years' experience, tafamidis continues to be a valuable option in the treatment of early-stage ATTR-PN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMa9d1adtjwLVg90H21EOLACvtfcHk0lgWanp_SlkHWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWmtL3F&md5=4b24681e65dfc76805b1afe0257a58ae</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs40265-019-01129-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-019-01129-6%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DY.%2BN.%26aulast%3DDeeks%26aufirst%3DE.%2BD.%26atitle%3DTafamidis%253A%2520A%2520review%2520in%2520transthyretin%2520amyloidosis%2520with%2520polyneuropathy%26jtitle%3DDrugs%26date%3D2019%26volume%3D79%26spage%3D863%26epage%3D874%26doi%3D10.1007%2Fs40265-019-01129-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulawa, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foss, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaudinière, R.</span></span> <span> </span><span class="NLM_article-title">Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">9629</span>– <span class="NLM_lpage">9634</span>, <span class="refDoi"> DOI: 10.1073/pnas.1121005109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1073%2Fpnas.1121005109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=22645360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=9629-9634&author=C.+E.+Bulawaauthor=S.+Connellyauthor=M.+Devitauthor=L.+Wangauthor=C.+Weigelauthor=J.+A.+Flemingauthor=J.+Packmanauthor=E.+T.+Powersauthor=R.+L.+Wisemanauthor=T.+R.+Fossauthor=I.+A.+Wilsonauthor=J.+W.+Kellyauthor=R.+Labaudini%C3%A8re&title=Tafamidis%2C+a+potent+and+selective+transthyretin+kinetic+stabilizer+that+inhibits+the+amyloid+cascade&doi=10.1073%2Fpnas.1121005109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade</span></div><div class="casAuthors">Bulawa, Christine E.; Connelly, Stephen; DeVit, Michael; Wang, Lan; Weigel, Charlotte; Fleming, James A.; Packman, Jeff; Powers, Evan T.; Wiseman, R. Luke; Foss, Theodore R.; Wilson, Ian A.; Kelly, Jeffery W.; Labaudiniere, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9629-9634, S9629/1-S9629/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The transthyretin amyloidoses (ATTR) are invariably fatal diseases characterized by progressive neuropathy and/or cardiomyopathy.  ATTR are caused by aggregation of transthyretin (TTR), a natively tetrameric protein involved in the transport of thyroxine and the vitamin A-retinol-binding protein complex.  Mutations within TTR that cause autosomal dominant forms of disease facilitate tetramer dissocn., monomer misfolding, and aggregation, although wild-type TTR can also form amyloid fibrils in elderly patients.  Because tetramer dissocn. is the rate-limiting step in TTR amyloidogenesis, targeted therapies have focused on small mols. that kinetically stabilize the tetramer, inhibiting TTR amyloid fibril formation.  One such compd., tafamidis meglumine (Fx-1006A), has recently completed Phase II/111 trials for the treatment of Transthyretin type familial amyloid polyneuropathy (TTR-FAP) and demonstrated a slowing of disease progression in patients heterozygous for the V30M TTR mutation.  Herein we describe the mol. and structural basis of TTR tetramer stabilization by tafamidis.  Tafamidis binds selectively and with neg. cooperativity (KdS ∼2 nM and ∼200 nM) to the two normally unoccupied thyroxine-binding sites of the tetramer, and kinetically stabilizes TTR.  Patient-derived amyloidogenic variants of TTR, including kinetically and thermodynamically less stable mutants, are also stabilized by tafamidis binding.  The crystal structure of tafamidis-bound TTR suggests that binding stabilizes the weaker dimer-dimer interface against dissocn., the rate-limiting step of amyloidogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfzfMIrqJGHLVg90H21EOLACvtfcHk0ljj6zkTLuqx5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWjtb4%253D&md5=05bf9cd644ab6a3dda78bb1620986910</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1121005109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1121005109%26sid%3Dliteratum%253Aachs%26aulast%3DBulawa%26aufirst%3DC.%2BE.%26aulast%3DConnelly%26aufirst%3DS.%26aulast%3DDevit%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWeigel%26aufirst%3DC.%26aulast%3DFleming%26aufirst%3DJ.%2BA.%26aulast%3DPackman%26aufirst%3DJ.%26aulast%3DPowers%26aufirst%3DE.%2BT.%26aulast%3DWiseman%26aufirst%3DR.%2BL.%26aulast%3DFoss%26aufirst%3DT.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DLabaudini%25C3%25A8re%26aufirst%3DR.%26atitle%3DTafamidis%252C%2520a%2520potent%2520and%2520selective%2520transthyretin%2520kinetic%2520stabilizer%2520that%2520inhibits%2520the%2520amyloid%2520cascade%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D9629%26epage%3D9634%26doi%3D10.1073%2Fpnas.1121005109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sant’Anna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallego, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira-Henriques, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esperante, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huertas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reixach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez-Campoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reverter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reig, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventura, S.</span></span> <span> </span><span class="NLM_article-title">Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">10787</span> <span class="refDoi"> DOI: 10.1038/ncomms10787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1038%2Fncomms10787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=26902880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1ehtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=R.+Sant%E2%80%99Annaauthor=P.+Gallegoauthor=L.+Z.+Robinsonauthor=A.+Pereira-Henriquesauthor=N.+Ferreiraauthor=F.+Pinheiroauthor=S.+Esperanteauthor=I.+Pallaresauthor=O.+Huertasauthor=M.+R.+Almeidaauthor=N.+Reixachauthor=R.+Insaauthor=A.+Velazquez-Campoyauthor=D.+Reverterauthor=N.+Reigauthor=S.+Ventura&title=Repositioning+tolcapone+as+a+potent+inhibitor+of+transthyretin+amyloidogenesis+and+associated+cellular+toxicity&doi=10.1038%2Fncomms10787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity</span></div><div class="casAuthors">Sant'Anna, Ricardo; Gallego, Pablo; Robinson, Lei Z.; Pereira-Henriques, Alda; Ferreira, Nelson; Pinheiro, Francisca; Esperante, Sebastian; Pallares, Irantzu; Huertas, Oscar; Rosario Almeida, Maria; Reixach, Natalia; Insa, Raul; Velazquez-Campoy, Adrian; Reverter, David; Reig, Nuria; Ventura, Salvador</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10787</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Transthyretin (TTR) is a plasma homotetrameric protein implicated in fatal systemic amyloidoses.  TTR tetramer dissocn. precedes pathol. TTR aggregation.  Native state stabilizers are promising drugs to treat TTR amyloidoses.  Here we repurpose tolcapone, an FDA-approved mol. for Parkinson's disease, as a potent TTR aggregation inhibitor.  Tolcapone binds specifically to TTR in human plasma, stabilizes the native tetramer in vivo in mice and humans and inhibits TTR cytotoxicity.  Crystal structures of tolcapone bound to wild-type TTR and to the V122I cardiomyopathy-assocd. variant show that it docks better into the TTR T4 pocket than tafamidis, so far the only drug on the market to treat TTR amyloidoses.  These data indicate that tolcapone, already in clin. trials for familial amyloid polyneuropathy, is a strong candidate for therapeutic intervention in these diseases, including those affecting the central nervous system, for which no small-mol. therapy exists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptjm7CULfu47Vg90H21EOLACvtfcHk0ljj6zkTLuqx5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1ehtr0%253D&md5=a0a29250b2f01100f5226f092ee8b562</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fncomms10787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10787%26sid%3Dliteratum%253Aachs%26aulast%3DSant%25E2%2580%2599Anna%26aufirst%3DR.%26aulast%3DGallego%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DL.%2BZ.%26aulast%3DPereira-Henriques%26aufirst%3DA.%26aulast%3DFerreira%26aufirst%3DN.%26aulast%3DPinheiro%26aufirst%3DF.%26aulast%3DEsperante%26aufirst%3DS.%26aulast%3DPallares%26aufirst%3DI.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DAlmeida%26aufirst%3DM.%2BR.%26aulast%3DReixach%26aufirst%3DN.%26aulast%3DInsa%26aufirst%3DR.%26aulast%3DVelazquez-Campoy%26aufirst%3DA.%26aulast%3DReverter%26aufirst%3DD.%26aulast%3DReig%26aufirst%3DN.%26aulast%3DVentura%26aufirst%3DS.%26atitle%3DRepositioning%2520tolcapone%2520as%2520a%2520potent%2520inhibitor%2520of%2520transthyretin%2520amyloidogenesis%2520and%2520associated%2520cellular%2520toxicity%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26doi%3D10.1038%2Fncomms10787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gamez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadó, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reig, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suñé, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casasnovas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas-Garcia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insa, R.</span></span> <span> </span><span class="NLM_article-title">Transthyretin stabilization activity of the catechol-<i>O</i>-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study</span>. <i>Amyloid</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1080/13506129.2019.1597702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1080%2F13506129.2019.1597702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=31119947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVajtr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=74-84&author=J.+Gamezauthor=M.+Salvad%C3%B3author=N.+Reigauthor=P.+Su%C3%B1%C3%A9author=C.+Casasnovasauthor=R.+Rojas-Garciaauthor=R.+Insa&title=Transthyretin+stabilization+activity+of+the+catechol-O-methyltransferase+inhibitor+tolcapone+%28SOM0226%29+in+hereditary+ATTR+amyloidosis+patients+and+asymptomatic+carriers%3A+proof-of-concept+study&doi=10.1080%2F13506129.2019.1597702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study#</span></div><div class="casAuthors">Gamez, Josep; Salvado, Maria; Reig, Nuria; Sune, Pilar; Casasnovas, Carles; Rojas-Garcia, Ricard; Insa, Raul</div><div class="citationInfo"><span class="NLM_cas:title">Amyloid</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">74-84</span>CODEN:
                <span class="NLM_cas:coden">AIJIET</span>;
        ISSN:<span class="NLM_cas:issn">1350-6129</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">To assess the transthyretin (TTR) stabilization activity of tolcapone (SOM0226) in patients with hereditary ATTR amyloidosis, asymptomatic carriers and healthy volunteers.  A phase IIa proof-of-concept trial included two phases sepd. by a 6-wk washout period.  Phase A: single 200 mg dose of tolcapone; phase B: three 100 mg doses taken at 4 h intervals.  The primary efficacy variable was TTR stabilization.  Seventeen subjects were included (wild type, n = 6; mutation TTR Val30Met, n = 11).  TTR stabilization was obsd. in all participants.  Two hours after dosing, 82% of participants in phase A and 93% of those in phase B reached a TTR stabilization value of at least 20%.  In phase A, there was an increase of 52% in TTR stabilization vs baseline values 2 h after dosing, which decreased to 22.9% at 8 h.  In phase B, there was a significant increase of 38.8% in TTR stabilization 2 h after the first 100 mg dose.  This difference was maintained after 10 h and decreased after 24 h.  No serious adverse events were obsd.  The ability of tolcapone for stabilizing TTR supports further development and repositioning of the drug for the treatment of ATTR amyloidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3MIzn1HTglrVg90H21EOLACvtfcHk0ljTPcGgDF4LYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVajtr7O&md5=663e7e6944fdf8335c57983a6539a735</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1080%2F13506129.2019.1597702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13506129.2019.1597702%26sid%3Dliteratum%253Aachs%26aulast%3DGamez%26aufirst%3DJ.%26aulast%3DSalvad%25C3%25B3%26aufirst%3DM.%26aulast%3DReig%26aufirst%3DN.%26aulast%3DSu%25C3%25B1%25C3%25A9%26aufirst%3DP.%26aulast%3DCasasnovas%26aufirst%3DC.%26aulast%3DRojas-Garcia%26aufirst%3DR.%26aulast%3DInsa%26aufirst%3DR.%26atitle%3DTransthyretin%2520stabilization%2520activity%2520of%2520the%2520catechol-O-methyltransferase%2520inhibitor%2520tolcapone%2520%2528SOM0226%2529%2520in%2520hereditary%2520ATTR%2520amyloidosis%2520patients%2520and%2520asymptomatic%2520carriers%253A%2520proof-of-concept%2520study%26jtitle%3DAmyloid%26date%3D2019%26volume%3D26%26spage%3D74%26epage%3D84%26doi%3D10.1080%2F13506129.2019.1597702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span> <span> </span><span class="NLM_article-title">Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1042/BJ20040011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1042%2FBJ20040011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=15080795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslGntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2004&pages=351-356&author=M.+R.+Almeidaauthor=B.+Macedoauthor=I.+Cardosoauthor=I.+Alvesauthor=G.+Valenciaauthor=G.+Arsequellauthor=A.+Planasauthor=M.+J.+Saraiva&title=Selective+binding+to+transthyretin+and+tetramer+stabilization+in+serum+from+patients+with+familial+amyloidotic+polyneuropathy+by+an+iodinated+diflunisal+derivative&doi=10.1042%2FBJ20040011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative</span></div><div class="casAuthors">Almeida, Maria Rosario; Macedo, Barbara; Cardoso, Isabel; Alves, Isabel; Valencia, Gregorio; Arsequell, Gemma; Planas, Antoni; Saraiva, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-356</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">In familial amyloidotic polyneuropathy, TTR (transthyretin) variants are deposited as amyloid fibrils.  It is thought that this process involves TTR tetramer dissocn., which leads to partially unfolded monomers that aggregate and polymerize into amyloid fibrils.  This process can be counteracted by stabilization of the tetramer.  Several small compds., such as diclofenac, diflunisal and flufenamic acid, have been reported to bind to TTR in vitro, in the T4 (thyroxine) binding channel that runs through the TTR tetramer, and consequently are considered to stabilize TTR.  However, if these agents bind plasma proteins other than TTR, decreased drug availability will occur, compromising their use as therapeutic agents for TTR amyloidosis.  In the present work, the authors compared the action of these compds. and of new derivs. designed to increase both selectivity of binding to TTR and inhibitory potency in relation to TTR amyloid fibril formation.  The authors found two diflunisal derivs. that, in contrast with diclofenac, flufenamic acid and diflunisal, displaced T4 from TTR in plasma preferentially over binding to albumin and thyroxine binding globulin.  The same diflunisal derivs. also had a stabilizing effect on TTR tetramers in plasma, as studied by isoelec. focusing of whole plasma under semi-denaturing conditions.  In addn., by TEM, the authors demonstrated that, in contrast with other proposed TTR stabilizers (namely diclofenac, flufenamic acid and diflunisal), one of the diflunisal derivs. tested efficiently inhibited TTR aggregation.  Taken together, our ex vivo and in vitro studies present evidence for the selectivity and efficiency of novel diflunisal derivs. as TTR stabilizers and as inhibitors of fibril formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7yUhh-llFj7Vg90H21EOLACvtfcHk0ljTPcGgDF4LYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslGntr8%253D&md5=02ccfa2b447c263613ea8b7bf95eb49a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1042%2FBJ20040011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20040011%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DM.%2BR.%26aulast%3DMacedo%26aufirst%3DB.%26aulast%3DCardoso%26aufirst%3DI.%26aulast%3DAlves%26aufirst%3DI.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DPlanas%26aufirst%3DA.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26atitle%3DSelective%2520binding%2520to%2520transthyretin%2520and%2520tetramer%2520stabilization%2520in%2520serum%2520from%2520patients%2520with%2520familial%2520amyloidotic%2520polyneuropathy%2520by%2520an%2520iodinated%2520diflunisal%2520derivative%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D381%26spage%3D351%26epage%3D356%26doi%3D10.1042%2FBJ20040011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mairal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gales, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballesteros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barluenga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centeno, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damas, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span> <span> </span><span class="NLM_article-title">Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e4124</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0004124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1371%2Fjournal.pone.0004124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=19125186" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=T.+Mairalauthor=J.+Nietoauthor=M.+Pintoauthor=M.+R.+Almeidaauthor=L.+Galesauthor=A.+Ballesterosauthor=J.+Barluengaauthor=J.+J.+P%C3%A9rezauthor=J.+T.+V%C3%A1zquezauthor=N.+B.+Centenoauthor=M.+J.+Saraivaauthor=A.+M.+Damasauthor=A.+Planasauthor=G.+Arsequellauthor=G.+Valencia&title=Iodine+atoms%3A+a+new+molecular+feature+for+the+design+of+potent+transthyretin+fibrillogenesis+inhibitors&doi=10.1371%2Fjournal.pone.0004124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004124%26sid%3Dliteratum%253Aachs%26aulast%3DMairal%26aufirst%3DT.%26aulast%3DNieto%26aufirst%3DJ.%26aulast%3DPinto%26aufirst%3DM.%26aulast%3DAlmeida%26aufirst%3DM.%2BR.%26aulast%3DGales%26aufirst%3DL.%26aulast%3DBallesteros%26aufirst%3DA.%26aulast%3DBarluenga%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez%26aufirst%3DJ.%2BJ.%26aulast%3DV%25C3%25A1zquez%26aufirst%3DJ.%2BT.%26aulast%3DCenteno%26aufirst%3DN.%2BB.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DDamas%26aufirst%3DA.%2BM.%26aulast%3DPlanas%26aufirst%3DA.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DValencia%26aufirst%3DG.%26atitle%3DIodine%2520atoms%253A%2520a%2520new%2520molecular%2520feature%2520for%2520the%2520design%2520of%2520potent%2520transthyretin%2520fibrillogenesis%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0004124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gales, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo-Ribeiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damas, A. M.</span></span> <span> </span><span class="NLM_article-title">Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1042/BJ20042035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1042%2FBJ20042035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=15689188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Glt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2005&pages=615-662&author=L.+Galesauthor=S.+Macedo-Ribeiroauthor=G.+Arsequellauthor=G.+Valenciaauthor=M.+J.+Saraivaauthor=A.+M.+Damas&title=Human+transthyretin+in+complex+with+iododiflunisal%3A+structural+features+associated+with+a+potent+amyloid+inhibitor&doi=10.1042%2FBJ20042035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor</span></div><div class="casAuthors">Gales, Luis; Macedo-Ribeiro, Sandra; Arsequell, Gemma; Valencia, Gregorio; Saraiva, Maria Joao; Damas, Ana Margarida</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">615-621</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Ex vivo and in vitro studies have revealed the remarkable amyloid inhibitory potency and specificity of iododiflunisal in relation to transthyretin, a protein implicated in familial amyloidotic polyneuropathy.  In the present paper, the crystal structure of transthyretin complexed with this diflunisal deriv. is reported, which enables a detailed anal. of the protein-ligand interactions.  Iododiflunisal binds very deep in the hormone-binding channel.  The iodine substituent is tightly anchored into a pocket of the binding site and the fluorine atoms provide extra hydrophobic contacts with the protein.  The carboxylate substituent is involved in an electrostatic interaction with the Nζ of a lysine residue.  Moreover, ligand-induced conformational alterations in the side chain of some residues result in the formation of new intersubunit hydrogen bonds.  All these new interactions, induced by iododiflunisal, increase the stability of the tetramer impairing the formation of amyloid fibrils.  The crystal structure of this complex opens perspectives for the design of more specific and effective drugs for familial amyloidotic polyneuropathy patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkgoLC5Fn1AbVg90H21EOLACvtfcHk0lgkCwnAUNy-Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Glt78%253D&md5=9b1f6421c1c11ec1cc80dbc0498a4438</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1042%2FBJ20042035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20042035%26sid%3Dliteratum%253Aachs%26aulast%3DGales%26aufirst%3DL.%26aulast%3DMacedo-Ribeiro%26aufirst%3DS.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DDamas%26aufirst%3DA.%2BM.%26atitle%3DHuman%2520transthyretin%2520in%2520complex%2520with%2520iododiflunisal%253A%2520structural%2520features%2520associated%2520with%2520a%2520potent%2520amyloid%2520inhibitor%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D388%26spage%3D615%26epage%3D662%26doi%3D10.1042%2FBJ20042035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guido, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span> <span> </span><span class="NLM_article-title">Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer’s disease mouse model</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.3233/JAD-131355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.3233%2FJAD-131355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=24169237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=357-370&author=C.+A.+Ribeiroauthor=S.+M.+Oliveiraauthor=L.+F.+Guidoauthor=A.+Magalhaesauthor=G.+Valenciaauthor=G.+Arsequellauthor=M.+J.+Saraivaauthor=I.+Cardoso&title=Transthyretin+stabilization+by+iododiflunisal+promotes+amyloid-%CE%B2+peptide+clearance%2C+decreases+its+deposition%2C+and+ameliorates+cognitive+deficits+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.3233%2FJAD-131355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Transthyretin Stabilization by Iododiflunisal Promotes Amyloid-β Peptide Clearance, Decreases its Deposition, and Ameliorates Cognitive Deficits in an Alzheimer's Disease Mouse Model</span></div><div class="casAuthors">Ribeiro, Carlos A.; Oliveira, Sandra Marisa; Guido, Luis F.; Magalhaes, Ana; Valencia, Gregorio; Arsequell, Gemma; Saraiva, Maria Joao; Cardoso, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-370</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common form of dementia and now represents 50-70% of total dementia cases.  Over the last two decades, transthyretin (TTR) has been assocd. with AD and, very recently, a novel concept of TTR stability has been established in vitro as a key factor in TTR/amyloid-β (Aβ) interaction.  Small compds., TTR stabilizers (usually non-steroid anti-inflammatory drugs), bind to the thyroxine (T4) central binding channel, increasing TTR tetrameric stability and TTR/Aβ interaction.  In this work, we evaluated in vivo the effects of one of the TTR stabilizers identified as improving TTR/Aβ interaction, iododiflunisal (IDIF), in Aβ deposition and other AD features, using AβPPswe/PS1A246E transgenic mice, either carrying two or just one copy of the TTR gene (AD/TTR+/+ or AD/TTR+/-, resp.), available and characterized in our lab.  The results showed that IDIF administered orally bound TTR in plasma and stabilized the protein, as assessed by T4 displacement assays, and was able to enter the brain as revealed by mass spectrometry anal. of cerebrospinal fluid.  TTR levels, both in plasma and cerebrospinal fluid, were not altered.  In AD/TTR+/- mice, IDIF administration resulted not only in decreased brain Aβ levels and deposition but also in improved cognitive function assocd. with the AD-like neuropathol. in this mouse model, although no improvements were detectable in the AD/TTR+/+ animals.  Further, in AD/TTR+/- mice, Aβ levels were reduced in plasma suggesting TTR promoted Aβ clearance from the brain and from the periphery.  Taken together, these results strengthen the importance of TTR stability in the design of therapeutic drugs, highlighting the capacity of IDIF to be used in AD treatment to prevent and to slow the progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj-Xs6bazqTbVg90H21EOLACvtfcHk0lilfHRO42uifA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKls70%253D&md5=d5874bd24bbc016cf2836e7e1060d95e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3233%2FJAD-131355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-131355%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DC.%2BA.%26aulast%3DOliveira%26aufirst%3DS.%2BM.%26aulast%3DGuido%26aufirst%3DL.%2BF.%26aulast%3DMagalhaes%26aufirst%3DA.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26aulast%3DCardoso%26aufirst%3DI.%26atitle%3DTransthyretin%2520stabilization%2520by%2520iododiflunisal%2520promotes%2520amyloid-%25CE%25B2%2520peptide%2520clearance%252C%2520decreases%2520its%2520deposition%252C%2520and%2520ameliorates%2520cognitive%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D39%26spage%3D357%26epage%3D370%26doi%3D10.3233%2FJAD-131355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, M. L.</span></span> <span> </span><span class="NLM_article-title">Characterization of binding interactions by isothermal titration calorimetry</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/S0958-1669(97)80154-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2FS0958-1669%2897%2980154-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=9013658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFCnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=31-35&author=M.+L.+Doyle&title=Characterization+of+binding+interactions+by+isothermal+titration+calorimetry&doi=10.1016%2FS0958-1669%2897%2980154-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of binding interactions by isothermal titration calorimetry</span></div><div class="casAuthors">Doyle, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-35</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">Isothermal titrn. calorimetry is a high-accuracy method for measuring binding affinities.  Titrn. calorimetry is a universal method that has broad impact throughout biotechnol.  In recent years, microcalorimeters that are capable of characterizing binding interactions of biol. macromols. have become com. available.  Results from these studies are providing new insight into the mol. nature of macromol. interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk3s4qStjFsbVg90H21EOLACvtfcHk0lilfHRO42uifA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFCnurk%253D&md5=7276363da1012547157036cd25ab75ed</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0958-1669%2897%2980154-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0958-1669%252897%252980154-1%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DM.%2BL.%26atitle%3DCharacterization%2520of%2520binding%2520interactions%2520by%2520isothermal%2520titration%2520calorimetry%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D1997%26volume%3D8%26spage%3D31%26epage%3D35%26doi%3D10.1016%2FS0958-1669%2897%2980154-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raman, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nall, B. T.</span></span> <span> </span><span class="NLM_article-title">Isothermal titration calorimetry of protein-protein interactions</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1006/meth.1999.0852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1006%2Fmeth.1999.0852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10527727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK1MXms1ynsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=213-221&author=M.+M.+Pierceauthor=C.+S.+Ramanauthor=B.+T.+Nall&title=Isothermal+titration+calorimetry+of+protein-protein+interactions&doi=10.1006%2Fmeth.1999.0852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Isothermal Titration Calorimetry of Protein-Protein Interactions</span></div><div class="casAuthors">Pierce, Michael M.; Raman, C. S.; Nall, Barry T.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Orlando, Florida)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The interaction of biological macromols., whether protein-DNA, antibody-antigen, hormone-receptor, etc., illustrates the complexity and diversity of mol. recognition.  The importance of such interactions in the immune response, signal transduction cascades, and gene expression cannot be overstated.  It is of great interest to det. the nature of the forces that stabilize the interaction.  The thermodn. of assocn. are characterized by the stoichiometry of the interaction (n), the assocn. const. (Ka), the free energy (ΔGb), enthalpy (ΔHb), entropy (ΔSb), and heat capacity of binding (ΔCp).  In combination with structural information, the energetics of binding can provide a complete dissection of the interaction and aid in identifying the most important regions of the interface and the energetic contributions.  Various indirect methods (ELISA, RIA, surface plasmon resonance, etc.) are routinely used to characterize biol. important interactions.  Here we describe the use of isothermal titrn. calorimetry (ITC) in the study of protein-protein interactions.  ITC is the most quant. means available for measuring the thermodn. properties of a protein-protein interaction.  ITC measures the binding equil. directly by detg. the heat evolved on assocn. of a ligand with its binding partner.  In a single expt., the values of the binding const. (Ka), the stoichiometry (n), and the enthalpy of binding (ΔHb) are detd.  The free energy and entropy of binding are detd. from the assocn. const.  The temp. dependence of the ΔHb parameter, measured by performing the titrn. at varying temps., describes the ΔCp term.  As a practical application of the method, we describe the use of ITC to study the interaction between cytochrome c and two monoclonal antibodies.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwZfOrMhYWUbVg90H21EOLACvtfcHk0liwNjUgG9mT_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXms1ynsrs%253D&md5=fe8d90e5475a5a4d95464c3889697b79</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1006%2Fmeth.1999.0852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmeth.1999.0852%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DM.%2BM.%26aulast%3DRaman%26aufirst%3DC.%2BS.%26aulast%3DNall%26aufirst%3DB.%2BT.%26atitle%3DIsothermal%2520titration%2520calorimetry%2520of%2520protein-protein%2520interactions%26jtitle%3DMethods%26date%3D1999%26volume%3D19%26spage%3D213%26epage%3D221%26doi%3D10.1006%2Fmeth.1999.0852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jelesarov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosshard, H. R.</span></span> <span> </span><span class="NLM_article-title">Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition</span>. <i>J. Mol. Recognit.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2F%28SICI%291099-1352%28199901%2F02%2912%3A1%3C3%3A%3AAID-JMR441%3E3.0.CO%3B2-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10398392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK1MXit1CjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1999&pages=3-10&author=I.+Jelesarovauthor=H.+R.+Bosshard&title=Isothermal+titration+calorimetry+and+differential+scanning+calorimetry+as+complementary+tools+to+investigate+the+energetics+of+biomolecular+recognition&doi=10.1002%2F%28SICI%291099-1352%28199901%2F02%2912%3A1%3C3%3A%3AAID-JMR441%3E3.0.CO%3B2-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition</span></div><div class="casAuthors">Jelesarov, Ilian; Bosshard, Hans Rudolf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-18</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  The principles of isothermal titrn. calorimetry (ITC) and differential scanning calorimetry (DSC) are reviewed together with the basic thermodn. formalism on which the two techniques are based.  Although ITC is particularly suitable to follow the energetics of an assocn. reaction between biomols., the combination of ITC and DSC provides a more comprehensive description of the thermodn. of an assocg. system.  The reason is that the parameters ΔG, ΔH, ΔS, and ΔCp obtained from ITC are global properties of the system under study.  They may be composed to varying degrees of contributions from the binding reaction proper, from conformational changes of the component mols. during assocn., and from changes in mol./solvent interactions and in the state of protonation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQTbTlhTQlwLVg90H21EOLACvtfcHk0liwNjUgG9mT_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1CjsrY%253D&md5=eb36c32891890f3289a9356f56e47327</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1352%28199901%2F02%2912%3A1%3C3%3A%3AAID-JMR441%3E3.0.CO%3B2-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1352%2528199901%252F02%252912%253A1%253C3%253A%253AAID-JMR441%253E3.0.CO%253B2-6%26sid%3Dliteratum%253Aachs%26aulast%3DJelesarov%26aufirst%3DI.%26aulast%3DBosshard%26aufirst%3DH.%2BR.%26atitle%3DIsothermal%2520titration%2520calorimetry%2520and%2520differential%2520scanning%2520calorimetry%2520as%2520complementary%2520tools%2520to%2520investigate%2520the%2520energetics%2520of%2520biomolecular%2520recognition%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D1999%26volume%3D12%26spage%3D3%26epage%3D10%26doi%3D10.1002%2F%28SICI%291099-1352%28199901%2F02%2912%3A1%3C3%3A%3AAID-JMR441%3E3.0.CO%3B2-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brautigam, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuck, P.</span></span> <span> </span><span class="NLM_article-title">Integration and global analysis of isothermal titration calorimetry data for studying macromolecular interactions</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">882</span>– <span class="NLM_lpage">894</span>, <span class="refDoi"> DOI: 10.1038/nprot.2016.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1038%2Fnprot.2016.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=27055097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlWjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=882-894&author=C.+A.+Brautigamauthor=H.+Zhaoauthor=C.+Vargasauthor=S.+Kellerauthor=P.+Schuck&title=Integration+and+global+analysis+of+isothermal+titration+calorimetry+data+for+studying+macromolecular+interactions&doi=10.1038%2Fnprot.2016.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Integration and global analysis of isothermal titration calorimetry data for studying macromolecular interactions</span></div><div class="casAuthors">Brautigam, Chad A.; Zhao, Huaying; Vargas, Carolyn; Keller, Sandro; Schuck, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">882-894</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Isothermal titrn. calorimetry (ITC) is a powerful and widely used method to measure the energetics of macromol. interactions by recording a thermogram of differential heating power during a titrn.  However, traditional ITC anal. is limited by stochastic thermogram noise and by the limited information content of a single titrn. expt.  Here we present a protocol for bias-free thermogram integration based on automated shape anal. of the injection peaks, followed by combination of isotherms from different calorimetric titrn. expts. into a global anal., statistical anal. of binding parameters and graphical presentation of the results.  This is performed using the integrated public-domain software packages NITPIC, SEDPHAT and GUSSI.  The recently developed low-noise thermogram integration approach and global anal. allow for more precise parameter ests. and more reliable quantification of multisite and multicomponent cooperative and competitive interactions.  Titrn. expts. typically take 1-2.5 h each, and global anal. usually takes 10-20 min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2Yx-XI9KHMrVg90H21EOLACvtfcHk0liwNjUgG9mT_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlWjt70%253D&md5=3684775a4b363c89378d291ec7e538b1</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2016.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2016.044%26sid%3Dliteratum%253Aachs%26aulast%3DBrautigam%26aufirst%3DC.%2BA.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DVargas%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DS.%26aulast%3DSchuck%26aufirst%3DP.%26atitle%3DIntegration%2520and%2520global%2520analysis%2520of%2520isothermal%2520titration%2520calorimetry%2520data%2520for%2520studying%2520macromolecular%2520interactions%26jtitle%3DNat.%2520Protoc.%26date%3D2016%26volume%3D11%26spage%3D882%26epage%3D894%26doi%3D10.1038%2Fnprot.2016.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez-Campoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leavitt, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">Characterization of protein-protein interactions by isothermal titration calorimetry</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>261</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=15064448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslyjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=2004&pages=35-54&author=A.+Velazquez-Campoyauthor=S.+A.+Leavittauthor=E.+Freire&title=Characterization+of+protein-protein+interactions+by+isothermal+titration+calorimetry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of protein-protein interactions by isothermal titration calorimetry</span></div><div class="casAuthors">Velazquez-Campoy, Adrian; Leavitt, Stephanie A.; Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">Protein-Protein Interactions</span>),
    <span class="NLM_cas:pages">35-54</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Isothermal titrn. calorimetry (ITC) is a powerful technique to study both protein-ligand and protein-protein interactions.  This methods chapter is devoted to describing protein-protein interactions, in particular, the assocn. between two different proteins and the self-assocn. of a protein into homodimers.  ITC is the only technique that dets. directly the thermodn. parameters of a given reaction: ΔG, ΔH, ΔS, and ΔCP.  Isothermal titrn. calorimeters have evolved over the years and one of the latest models is the VP-ITC produced by Microcal, Inc.  In this chapter we will be describing the general procedure for performing an ITC expt. as well as for the specific cases of porcine pancreatic trypsin binding to soybean trypsin inhibitor and the dissocn. of bovine pancreatic α-chymotrypsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1uW12dYTq8LVg90H21EOLACvtfcHk0liD9jzKni8Gtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslyjtL8%253D&md5=dd7530e6677a825692de77ff7b5dc914</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelazquez-Campoy%26aufirst%3DA.%26aulast%3DLeavitt%26aufirst%3DS.%2BA.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DCharacterization%2520of%2520protein-protein%2520interactions%2520by%2520isothermal%2520titration%2520calorimetry%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2004%26volume%3D261%26spage%3D35%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clavería-Gimeno, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vega, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abian, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez-Campoy, A.</span></span> <span> </span><span class="NLM_article-title">A look at ligand binding thermodynamics in drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1080/17460441.2017.1297418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1080%2F17460441.2017.1297418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=28276703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1WmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=363-377&author=R.+Claver%C3%ADa-Gimenoauthor=S.+Vegaauthor=O.+Abianauthor=A.+Velazquez-Campoy&title=A+look+at+ligand+binding+thermodynamics+in+drug+discovery&doi=10.1080%2F17460441.2017.1297418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A look at ligand binding thermodynamics in drug discovery</span></div><div class="casAuthors">Claveria-Gimeno, Rafael; Vega, Sonia; Abian, Olga; Velazquez-Campoy, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">363-377</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug discovery is a challenging endeavor requiring the interplay of many different research areas.  Gathering information on ligand binding thermodn. may help considerably in reducing the risk within a high uncertainty scenario, allowing early rejection of flawed compds. and pushing forward optimal candidates.  In particular, the free energy, the enthalpy, and the entropy of binding provide fundamental information on the intermol. forces driving such interaction.  The authors review the current status and recent developments in the application of ligand binding thermodn. in drug discovery.  The thermodn. binding profile (Gibbs energy, enthalpy, and entropy of binding) can be used for lead selection and optimization (binding enthalpy, selectivity, and adaptability).  Binding thermodn. provides fundamental information on the forces driving the formation of the drug-target complex.  It has been widely accepted that binding thermodn. may be used as a decision criterion along the ligand optimization process in drug discovery and development.  In particular, the binding enthalpy may be used as a guide when selecting and optimizing compds. over a set of potential candidates.  However, this has been recently called into question by arguing certain difficulties and in the light of certain exptl. examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooaiRxAajaz7Vg90H21EOLACvtfcHk0liD9jzKni8Gtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1WmsLY%253D&md5=db8bc2ee1e5da6b60ea95c83fb8d3d06</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1080%2F17460441.2017.1297418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2017.1297418%26sid%3Dliteratum%253Aachs%26aulast%3DClaver%25C3%25ADa-Gimeno%26aufirst%3DR.%26aulast%3DVega%26aufirst%3DS.%26aulast%3DAbian%26aufirst%3DO.%26aulast%3DVelazquez-Campoy%26aufirst%3DA.%26atitle%3DA%2520look%2520at%2520ligand%2520binding%2520thermodynamics%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26spage%3D363%26epage%3D377%26doi%3D10.1080%2F17460441.2017.1297418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez-Campoy, A.</span>; <span class="NLM_string-name">Leavitt, S. A.</span>; <span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">Characterization of Protein-Protein Interactions by Isothermal Titration Calorimetry in Protein–Protein Interactions: Methods and Applications</span>. In  <i>Methods in Molecular Biology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerkord, C.L.</span>; <span class="NLM_string-name">Fu, H.</span></span>, Eds.; <span class="NLM_publisher-name">Springer Science + Business Media</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">1278</span>, pp  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">204</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=183-204&author=A.+Velazquez-Campoy&author=S.+A.+Leavitt&author=E.+Freireauthor=C.L.+Meyerkord&author=H.+Fu&title=Methods+in+Molecular+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVelazquez-Campoy%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520Protein-Protein%2520Interactions%2520by%2520Isothermal%2520Titration%2520Calorimetry%2520in%2520Protein%25E2%2580%2593Protein%2520Interactions%253A%2520Methods%2520and%2520Applications%26btitle%3DMethods%2520in%2520Molecular%2520Biology%26aulast%3DMeyerkord%26aufirst%3DC.L.%26pub%3DSpringer%2520Science%2520%252B%2520Business%2520Media%26date%3D2015%26volume%3D1278%26spage%3D183%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradrick, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beechem, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howell, E. E.</span></span> <span> </span><span class="NLM_article-title">Unusual binding stoichiometries and cooperativity are observed during binary and ternary complex formation in the single active pore of R67 dihydrofolate reductase, a D2 symmetric protein</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">11414</span>– <span class="NLM_lpage">11424</span>, <span class="refDoi"> DOI: 10.1021/bi960205d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi960205d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK28XkvVGqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=11414-11424&author=T.+D.+Bradrickauthor=J.+M.+Beechemauthor=E.+E.+Howell&title=Unusual+binding+stoichiometries+and+cooperativity+are+observed+during+binary+and+ternary+complex+formation+in+the+single+active+pore+of+R67+dihydrofolate+reductase%2C+a+D2+symmetric+protein&doi=10.1021%2Fbi960205d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Unusual Binding Stoichiometries and Cooperativity Are Observed during Binary and Ternary Complex Formation in the Single Active Pore of R67 Dihydrofolate Reductase, a D2 Symmetric Protein</span></div><div class="casAuthors">Bradrick, Thomas D.; Beechem, Joseph M.; Howell, Elizabeth E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">11414-11424</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">R67 dihydrofolate reductase (DHFR) is an R-plasmid-encoded enzyme that confers resistance to the antibacterial drug, trimethoprim.  This DHFR variant is not homologous in either sequence or structure to chromosomal DHFRs.  A recent crystal structure of the active tetrameric species describes a single active site pore that traverses the length of the protein (Narayana et al., 1995).  Related sites (due to a 222 symmetry element at the center of the active site pore) are used for binding of ligands, i.e., each half-pore can accommodate either the substrate, dihydrofolate, or the cofactor, NADPH, although dihydrofolate and NADPH are bound differently.  Ligand binding in R67 DHFR was evaluated using time-resolved fluorescence anisotropy and isothermal titrn. calorimetry techniques.  Under binary complex conditions, two mols. of either NADPH, folate, dihydrofolate, or N10 propargyl-5,8-dideazafolate (CB3717) can be bound.  Binding of NADPH displays neg. cooperativity, binding of either folate or dihydrofolate shows pos. cooperativity, and binding of CB3717 shows two identical sites.  Any asymmetry introduced by binding of one ligand is proposed to induce the cooperativity assocd. with binding of the second ligand.  Evaluation of ternary complex formation demonstrates that one mol. of folate binds to a 1:1 mixt. of R67 DHFR + NADPH.  These binding results indicate a max. of two ligands bind in the pore.  A mechanism describing catalysis is proposed that is consistent with the binding results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPTl2c8AvGKLVg90H21EOLACvtfcHk0li-RulgAOMRHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvVGqsbc%253D&md5=f85af8ec7de91eb41c60c55aae8604a9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fbi960205d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi960205d%26sid%3Dliteratum%253Aachs%26aulast%3DBradrick%26aufirst%3DT.%2BD.%26aulast%3DBeechem%26aufirst%3DJ.%2BM.%26aulast%3DHowell%26aufirst%3DE.%2BE.%26atitle%3DUnusual%2520binding%2520stoichiometries%2520and%2520cooperativity%2520are%2520observed%2520during%2520binary%2520and%2520ternary%2520complex%2520formation%2520in%2520the%2520single%2520active%2520pore%2520of%2520R67%2520dihydrofolate%2520reductase%252C%2520a%2520D2%2520symmetric%2520protein%26jtitle%3DBiochemistry%26date%3D1996%26volume%3D35%26spage%3D11414%26epage%3D11424%26doi%3D10.1021%2Fbi960205d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez-Campoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goñi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peregrina, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, M.</span></span> <span> </span><span class="NLM_article-title">Exact analysis of heterotropic interactions in proteins: Characterization of cooperative ligand binding by isothermal titration calorimetry</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1887</span>– <span class="NLM_lpage">1904</span>, <span class="refDoi"> DOI: 10.1529/biophysj.106.086561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1529%2Fbiophysj.106.086561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=16766617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD28XovFynsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2006&pages=1887-1904&author=A.+Velazquez-Campoyauthor=G.+Go%C3%B1iauthor=J.+R.+Peregrinaauthor=M.+Medina&title=Exact+analysis+of+heterotropic+interactions+in+proteins%3A+Characterization+of+cooperative+ligand+binding+by+isothermal+titration+calorimetry&doi=10.1529%2Fbiophysj.106.086561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Exact analysis of heterotropic interactions in proteins: Characterization of cooperative ligand binding by isothermal titration calorimetry</span></div><div class="casAuthors">Velazquez-Campoy, Adrian; Goni, Guillermina; Peregrina, Jose Ramon; Medina, Milagros</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1887-1904</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">Intramol. interaction networks in proteins are responsible for heterotropic ligand binding cooperativity, a biol. important, widespread phenomenon in nature (e.g., signaling transduction cascades, enzymic cofactors, enzymic allosteric activators or inhibitors, gene transcription, or repression).  The cooperative binding of two (or more) different ligands to a macromol. is the underlying principle.  To date, heterotropic effects have been studied mainly kinetically in enzymic systems.  Until now, approx. approaches have been employed for studying equil. heterotropic ligand binding effects, except in two special cases in which an exact anal. was developed: independent binding (no cooperativity) and competitive binding (maximal neg. cooperativity).  The exact anal. and methodol. for characterizing ligand binding cooperativity interactions in the general case (any degree of cooperativity) using isothermal titrn. calorimetry are presented in this work.  Intramol. interaction pathways within the allosteric macromol. can be identified and characterized using this methodol.  As an example, the thermodn. characterization of the binding interaction between ferredoxin-NADP+ reductase and its three substrates, NADP+, ferredoxin, and flavodoxin, as well as the characterization of their binding cooperativity interaction, is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7klTmXU5cD7Vg90H21EOLACvtfcHk0li-RulgAOMRHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovFynsr8%253D&md5=820520c40a1f7f0cc5b00cbba380c3fe</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1529%2Fbiophysj.106.086561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1529%252Fbiophysj.106.086561%26sid%3Dliteratum%253Aachs%26aulast%3DVelazquez-Campoy%26aufirst%3DA.%26aulast%3DGo%25C3%25B1i%26aufirst%3DG.%26aulast%3DPeregrina%26aufirst%3DJ.%2BR.%26aulast%3DMedina%26aufirst%3DM.%26atitle%3DExact%2520analysis%2520of%2520heterotropic%2520interactions%2520in%2520proteins%253A%2520Characterization%2520of%2520cooperative%2520ligand%2520binding%2520by%2520isothermal%2520titration%2520calorimetry%26jtitle%3DBiophys.%2520J.%26date%3D2006%26volume%3D91%26spage%3D1887%26epage%3D1904%26doi%3D10.1529%2Fbiophysj.106.086561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verstraete, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Schie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyncke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavernier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauwels, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peelman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, S. N.</span></span> <span> </span><span class="NLM_article-title">Structural basis of the proinflammatory signaling complex mediated by TSLP</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1038/nsmb.2794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1038%2Fnsmb.2794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=24632570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlCrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=375-382&author=K.+Verstraeteauthor=L.+van+Schieauthor=L.+Vynckeauthor=Y.+Blochauthor=J.+Tavernierauthor=E.+Pauwelsauthor=F.+Peelmanauthor=S.+N.+Savvides&title=Structural+basis+of+the+proinflammatory+signaling+complex+mediated+by+TSLP&doi=10.1038%2Fnsmb.2794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of the proinflammatory signaling complex mediated by TSLP</span></div><div class="casAuthors">Verstraete, Kenneth; van Schie, Loes; Vyncke, Laurens; Bloch, Yehudi; Tavernier, Jan; Pauwels, Ewald; Peelman, Frank; Savvides, Savvas N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-382</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thymic stromal lymphopoietin (TSLP), a cytokine produced by epithelial cells at barrier surfaces, is pivotal for the development of widespread chronic inflammatory disorders such as asthma and atopic dermatitis.  The structure of the mouse TSLP-mediated signaling complex reveals how TSLP establishes extensive interfaces with its cognate receptor (TSLPR) and the shared interleukin 7 receptor α-chain (IL-7Rα) to evoke membrane-proximal receptor-receptor contacts poised for intracellular signaling.  Binding of TSLP to TSLPR is a mechanistic prerequisite for recruitment of IL-7Rα to the high-affinity ternary complex, which we propose is coupled to a structural switch in TSLP at the crossroads of the cytokine-receptor interfaces.  Functional interrogation of TSLP-receptor interfaces points to putative interaction hotspots that could be exploited for antagonist design.  Finally, we derive the structural rationale for the functional duality of IL-7Rα and establish a consensus for the geometry of ternary complexes mediated by interleukin 2 (IL-2)-family cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn5mK6rmKOlLVg90H21EOLACvtfcHk0lhGnfWBOz4StA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlCrsb0%253D&md5=e0a570c26ca4ddef14199500872b1563</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2794%26sid%3Dliteratum%253Aachs%26aulast%3DVerstraete%26aufirst%3DK.%26aulast%3Dvan%2BSchie%26aufirst%3DL.%26aulast%3DVyncke%26aufirst%3DL.%26aulast%3DBloch%26aufirst%3DY.%26aulast%3DTavernier%26aufirst%3DJ.%26aulast%3DPauwels%26aufirst%3DE.%26aulast%3DPeelman%26aufirst%3DF.%26aulast%3DSavvides%26aufirst%3DS.%2BN.%26atitle%3DStructural%2520basis%2520of%2520the%2520proinflammatory%2520signaling%2520complex%2520mediated%2520by%2520TSLP%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D375%26epage%3D382%26doi%3D10.1038%2Fnsmb.2794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders</span>. <i>Essays Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1042/EBC20170041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1042%2FEBC20170041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=29118097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A280%3ADC%252BC1M7pt1Gmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=505-516&author=S.+J.+Hughesauthor=A.+Ciulli&title=Molecular+recognition+of+ternary+complexes%3A+a+new+dimension+in+the+structure-guided+design+of+chemical+degraders&doi=10.1042%2FEBC20170041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders</span></div><div class="casAuthors">Hughes Scott J; Ciulli Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Essays in biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">505-516</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Molecular glues and bivalent inducers of protein degradation (also known as PROTACs) represent a fascinating new modality in pharmacotherapeutics: the potential to knockdown previously thought 'undruggable' targets at sub-stoichiometric concentrations in ways not possible using conventional inhibitors.  Mounting evidence suggests these chemical agents, in concert with their target proteins, can be modelled as three-body binding equilibria that can exhibit significant cooperativity as a result of specific ligand-induced molecular recognition.  Despite this, many existing drug design and optimization regimens still fixate on binary target engagement, in part due to limited structural data on ternary complexes.  Recent crystal structures of protein complexes mediated by degrader molecules, including the first PROTAC ternary complex, underscore the importance of protein-protein interactions and intramolecular contacts to the mode of action of this class of compounds.  These discoveries have opened the door to a new paradigm for structure-guided drug design: borrowing surface area and molecular recognition from nature to elicit cellular signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqZGQ3bfUY0b5XHngOXiV_fW6udTcc2eYOzCx_dyBbkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7pt1Gmuw%253D%253D&md5=7470e559372f05d34c5924524a6d04bc</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1042%2FEBC20170041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FEBC20170041%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DS.%2BJ.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DMolecular%2520recognition%2520of%2520ternary%2520complexes%253A%2520a%2520new%2520dimension%2520in%2520the%2520structure-guided%2520design%2520of%2520chemical%2520degraders%26jtitle%3DEssays%2520Biochem.%26date%3D2017%26volume%3D61%26spage%3D505%26epage%3D516%26doi%3D10.1042%2FEBC20170041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houtman, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samelson, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuck, P.</span></span> <span> </span><span class="NLM_article-title">Studying multisite binary and ternary protein interactions by global analysis of isothermal titration calorimetry data in SEDPHAT: application to adaptor protein complexes in cell signaling</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1110/ps.062558507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1110%2Fps.062558507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=17192587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsF2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=30-42&author=J.+C.+Houtmanauthor=P.+H.+Brownauthor=B.+Bowdenauthor=H.+Yamaguchiauthor=E.+Appellaauthor=L.+E.+Samelsonauthor=P.+Schuck&title=Studying+multisite+binary+and+ternary+protein+interactions+by+global+analysis+of+isothermal+titration+calorimetry+data+in+SEDPHAT%3A+application+to+adaptor+protein+complexes+in+cell+signaling&doi=10.1110%2Fps.062558507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Studying multisite binary and ternary protein interactions by global analysis of isothermal titration calorimetry data in SEDPHAT: application to adaptor protein complexes in cell signaling</span></div><div class="casAuthors">Houtman, Jon C. D.; Brown, Patrick H.; Bowden, Brent; Yamaguchi, Hiroshi; Appella, Ettore; Samelson, Lawrence E.; Schuck, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-42</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Multisite interactions and the formation of ternary or higher-order protein complexes are ubiquitous features of protein interactions.  Cooperativity between different ligands is a hallmark for information transfer, and is frequently crit. for the biol. function.  We describe a new computational platform for the global anal. of isothermal titrn. calorimetry (ITC) data for the study of binary and ternary multisite interactions, implemented as part of the public domain multimethod anal. software SEDPHAT.  The global anal. of titrns. performed in different orientations was explored, and the potential for unraveling cooperativity parameters in multisite interactions was assessed in theory and expt.  To demonstrate the practical potential and limitations of global analyses of ITC titrns. for the study of cooperative multiprotein interactions, we have examd. the interactions of three proteins that are crit. for signal transduction after T-cell activation, LAT, Grb2, and Sos1.  We have shown previously that multivalent interactions between these three mols. promote the assembly of large multiprotein complexes important for T-cell receptor activation.  By global anal. of the heats of binding obsd. in sets of ITC injections in different orientations, which allowed us to follow the formation of binary and ternary complexes, we obsd. neg. and pos. cooperativity that may be important to control the pathway of assembly and disassembly of adaptor protein particles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZxOktxBGCHbVg90H21EOLACvtfcHk0lg5rIKXBEWFrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsF2huw%253D%253D&md5=ee98cdbbdaf5249b60c6d31f689b4402</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1110%2Fps.062558507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.062558507%26sid%3Dliteratum%253Aachs%26aulast%3DHoutman%26aufirst%3DJ.%2BC.%26aulast%3DBrown%26aufirst%3DP.%2BH.%26aulast%3DBowden%26aufirst%3DB.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DAppella%26aufirst%3DE.%26aulast%3DSamelson%26aufirst%3DL.%2BE.%26aulast%3DSchuck%26aufirst%3DP.%26atitle%3DStudying%2520multisite%2520binary%2520and%2520ternary%2520protein%2520interactions%2520by%2520global%2520analysis%2520of%2520isothermal%2520titration%2520calorimetry%2520data%2520in%2520SEDPHAT%253A%2520application%2520to%2520adaptor%2520protein%2520complexes%2520in%2520cell%2520signaling%26jtitle%3DProtein%2520Sci.%26date%3D2007%26volume%3D16%26spage%3D30%26epage%3D42%26doi%3D10.1110%2Fps.062558507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gimeno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotrina, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Barbero, J.</span></span> <span> </span><span class="NLM_article-title">Insights on the interaction between transthyretin and Aβ in solution. A Saturation Transfer Difference (STD) NMR analysis of the role of iododiflunisal</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5749</span>– <span class="NLM_lpage">5758</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00428</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00428" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1Kntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5749-5758&author=A.+Gimenoauthor=L.+M.+Santosauthor=M.+Alemiauthor=J.+Rivasauthor=D.+Blasiauthor=Y.+Cotrinaauthor=J.+Llopauthor=G.+Valenciaauthor=I.+Cardosoauthor=J.+Quintanaauthor=G.+Arsequellauthor=J.+Jim%C3%A9nez-Barbero&title=Insights+on+the+interaction+between+transthyretin+and+A%CE%B2+in+solution.+A+Saturation+Transfer+Difference+%28STD%29+NMR+analysis+of+the+role+of+iododiflunisal&doi=10.1021%2Facs.jmedchem.7b00428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Insights on the Interaction between Transthyretin and Aβ in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of Iododiflunisal</span></div><div class="casAuthors">Gimeno, Ana; Santos, Luis M.; Alemi, Mobina; Rivas, Josep; Blasi, Daniel; Cotrina, Ellen Y.; Llop, Jordi; Valencia, Gregorio; Cardoso, Isabel; Quintana, Jordi; Arsequell, Gemma; Jimenez-Barbero, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5749-5758</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several strategies against Alzheimer disease (AD) are directed toward targeting Aβ-peptides.  The ability of transthyretin (TTR) to bind Aβ-peptides and the pos. effect exerted by some TTR stabilizers for modulating the TTR-Aβ interaction have been previously studied.  Here, key structural features of the interaction between TTR and Aβ(12-28) peptide, the essential recognition element of Aβ, have been unraveled by STD-NMR spectroscopy methods in soln.  Mol. aspects related with the role of the TTR stabilizer, iododiflunisal (IDIF), on the TTR-Aβ complex were also examd.  The NMR results, assisted by mol. modeling protocols, provided a structural model for the TTR-Aβ interaction, as well as for the ternary complex formed in the presence of IDIF.  This basic structural information could be relevant for providing light on the mechanisms involved in the ameliorating effects of AD symptoms obsd. in AD/TTR± animal models after IDIF treatment and eventually for designing new mols. toward AD therapeutic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYFHzRMCro1rVg90H21EOLACvtfcHk0lg5rIKXBEWFrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1Kntrw%253D&md5=8e4c5275309c8d1129655c6d30a9c82d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00428%26sid%3Dliteratum%253Aachs%26aulast%3DGimeno%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DL.%2BM.%26aulast%3DAlemi%26aufirst%3DM.%26aulast%3DRivas%26aufirst%3DJ.%26aulast%3DBlasi%26aufirst%3DD.%26aulast%3DCotrina%26aufirst%3DY.%26aulast%3DLlop%26aufirst%3DJ.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DCardoso%26aufirst%3DI.%26aulast%3DQuintana%26aufirst%3DJ.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DJim%25C3%25A9nez-Barbero%26aufirst%3DJ.%26atitle%3DInsights%2520on%2520the%2520interaction%2520between%2520transthyretin%2520and%2520A%25CE%25B2%2520in%2520solution.%2520A%2520Saturation%2520Transfer%2520Difference%2520%2528STD%2529%2520NMR%2520analysis%2520of%2520the%2520role%2520of%2520iododiflunisal%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5749%26epage%3D5758%26doi%3D10.1021%2Facs.jmedchem.7b00428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sohma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span> <span> </span><span class="NLM_article-title">Design synthesis of a novel water-soluble Aβ1-42 isopeptide: an efficient strategy for the preparation of Alzheimer’s disease-related peptide Aβ1–42 via O–N intramolecular acyl migration reaction</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5965</span>– <span class="NLM_lpage">5968</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2004.06.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.tetlet.2004.06.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Wnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=5965-5968&author=Y.+Sohmaauthor=M.+Sasakiauthor=Y.+Hayashiauthor=T.+Kimuraauthor=Y.+Kiso&title=Design+synthesis+of+a+novel+water-soluble+A%CE%B21-42+isopeptide%3A+an+efficient+strategy+for+the+preparation+of+Alzheimer%E2%80%99s+disease-related+peptide+A%CE%B21%E2%80%9342+via+O%E2%80%93N+intramolecular+acyl+migration+reaction&doi=10.1016%2Fj.tetlet.2004.06.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of a novel water-soluble Aβ1-42 isopeptide: an efficient strategy for the preparation of Alzheimer's disease-related peptide, Aβ1-42, via O-N intramolecular acyl migration reaction</span></div><div class="casAuthors">Sohma, Youhei; Sasaki, Masato; Hayashi, Yoshio; Kimura, Tooru; Kiso, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">5965-5968</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A novel water-sol. isopeptide of Alzheimer's disease-related peptide Aβ1-42, 26-O-acyl isoAβ1-42, which could efficiently convert to intact Aβ1-42 under physiol. conditions via O-N intramol. acyl migration, was synthesized providing a new system useful for investigation of biol. function of Aβ1-42.  26-O-acyl isoAβ1-42 was prepd. by std. solid phase synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHckVStHmzK7Vg90H21EOLACvtfcHk0lhgWlnNRi2mTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Wnu7Y%253D&md5=7f919ee073cfce215f0e83ca5ca9d6ab</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2004.06.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2004.06.059%26sid%3Dliteratum%253Aachs%26aulast%3DSohma%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DKiso%26aufirst%3DY.%26atitle%3DDesign%2520synthesis%2520of%2520a%2520novel%2520water-soluble%2520A%25CE%25B21-42%2520isopeptide%253A%2520an%2520efficient%2520strategy%2520for%2520the%2520preparation%2520of%2520Alzheimer%25E2%2580%2599s%2520disease-related%2520peptide%2520A%25CE%25B21%25E2%2580%259342%2520via%2520O%25E2%2580%2593N%2520intramolecular%2520acyl%2520migration%2520reaction%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D5965%26epage%3D5968%26doi%3D10.1016%2Fj.tetlet.2004.06.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beeg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stravalaci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span> <span> </span><span class="NLM_article-title">A modified protocol to prepare seed-free starting solutions of amyloid-β (Aβ) 1-40 and Aβ 1-42 from the corresponding depsipeptides</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>411</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2010.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2Fj.ab.2010.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=21185802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFOrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2011&pages=297-299&author=M.+Beegauthor=M.+Stravalaciauthor=A.+Bastoneauthor=M.+Salmonaauthor=M.+Gobbi&title=A+modified+protocol+to+prepare+seed-free+starting+solutions+of+amyloid-%CE%B2+%28A%CE%B2%29+1-40+and+A%CE%B2+1-42+from+the+corresponding+depsipeptides&doi=10.1016%2Fj.ab.2010.12.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Modified protocol to prepare seed-free starting solutions of amyloid-β (Aβ)1-40 and Aβ1-42 from corresponding depsipeptides</span></div><div class="casAuthors">Beeg, Marten; Stravalaci, Matteo; Bastone, Antonio; Salmona, Mario; Gobbi, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">297-299</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prepg. reliable, seed-free stock solns. of the highly amyloidogenic peptides amyloid-β (Aβ) is difficult.  Besides the formation of aggregates during synthesis and storage, dissoln. of the peptide is a crit. step because vortexing can induce aggregation.  To overcome this, synthesis of the more water-sol. depsi-Aβ1-42 peptide, from which the native sequence is easily obtained, has been suggested.  We further refined this technique, including a cutoff filtration step and switching the depsipeptide in basic conditions, to stabilize the formed native peptide.  The obtained solns. of native Aβ1-40 and Aβ1-42 peptides were homogeneous and aggregate free, as indicated by thioflavin T and CD anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq737R6Q-u0S7Vg90H21EOLACvtfcHk0lhgWlnNRi2mTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFOrur8%253D&md5=1085960627ab139a374d424a4e519471</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2010.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2010.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DBeeg%26aufirst%3DM.%26aulast%3DStravalaci%26aufirst%3DM.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DM.%26atitle%3DA%2520modified%2520protocol%2520to%2520prepare%2520seed-free%2520starting%2520solutions%2520of%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%25201-40%2520and%2520A%25CE%25B2%25201-42%2520from%2520the%2520corresponding%2520depsipeptides%26jtitle%3DAnal.%2520Biochem.%26date%3D2011%26volume%3D411%26spage%3D297%26epage%3D299%26doi%3D10.1016%2Fj.ab.2010.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladiwala, A. R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tessier, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buxbaum, J. N.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">19423</span>– <span class="NLM_lpage">19433</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2561-13.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1523%2FJNEUROSCI.2561-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=24336709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOrtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=19423-19433&author=X.+Liauthor=X.+Zhangauthor=A.+R.+A.+Ladiwalaauthor=D.+Duauthor=J.+K.+Yadavauthor=P.+M.+Tessierauthor=P.+E.+Wrightauthor=J.+W.+Kellyauthor=J.+N.+Buxbaum&title=Mechanisms+of+transthyretin+inhibition+of+%CE%B2-amyloid+aggregation+in+vitro&doi=10.1523%2FJNEUROSCI.2561-13.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro</span></div><div class="casAuthors">Li, Xinyi; Zhang, Xin; Ladiwala, Ali Reza A.; Du, Deguo; Yadav, Jay K.; Tessier, Peter M.; Wright, Peter E.; Kelly, Jeffery W.; Buxbaum, Joel N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">19423-19433</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Tissue-specific overexpression of the human systemic amyloid precursor transthyretin (TTR) ameliorates Alzheimer's disease (AD) phenotypes in APP23 mice.  TTR-β-amyloid (Aβ) complexes have been isolated from APP23 and some human AD brains.  We now show that substoichiometric concns. of TTR tetramers suppress Aβ aggregation in vitro via an interaction between the thyroxine binding pocket of the TTR tetramer and Aβ residues 18-21 (NMR and epitope mapping).  The KD is micromolar, and the stoichiometry is <1 for the interaction (isothermal titrn. calorimetry).  Similar expts. show that engineered monomeric TTR, the best inhibitor of Aβ fibril formation in vitro, did not bind Aβ monomers in liq. phase, suggesting that inhibition of fibrillogenesis is mediated by TTR tetramer binding to Aβ monomer and both tetramer and monomer binding of Aβ oligomers.  The thousand-fold greater concn. of tetramer relative to monomer in vivo makes it the likely suppressor of Aβ aggregation and disease in the APP23 mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq52OKtnJ05hbVg90H21EOLACvtfcHk0lhUgCTFaSkXJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOrtLzK&md5=48fabf89f9aed01aa8226a0569f6706e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2561-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2561-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLadiwala%26aufirst%3DA.%2BR.%2BA.%26aulast%3DDu%26aufirst%3DD.%26aulast%3DYadav%26aufirst%3DJ.%2BK.%26aulast%3DTessier%26aufirst%3DP.%2BM.%26aulast%3DWright%26aufirst%3DP.%2BE.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BN.%26atitle%3DMechanisms%2520of%2520transthyretin%2520inhibition%2520of%2520%25CE%25B2-amyloid%2520aggregation%2520in%2520vitro%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D19423%26epage%3D19433%26doi%3D10.1523%2FJNEUROSCI.2561-13.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meisl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellstrand, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frohm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkegaard, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowles, T. P.</span></span> <span> </span><span class="NLM_article-title">Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">9384</span>– <span class="NLM_lpage">9389</span>, <span class="refDoi"> DOI: 10.1073/pnas.1401564111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1073%2Fpnas.1401564111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=24938782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVSltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=9384-9389&author=G.+Meislauthor=X.+Yangauthor=E.+Hellstrandauthor=B.+Frohmauthor=J.+B.+Kirkegaardauthor=S.+I.+Cohenauthor=C.+M.+Dobsonauthor=S.+Linseauthor=T.+P.+Knowles&title=Differences+in+nucleation+behavior+underlie+the+contrasting+aggregation+kinetics+of+the+A%CE%B240+and+A%CE%B242+peptides&doi=10.1073%2Fpnas.1401564111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides</span></div><div class="casAuthors">Meisl, Georg; Yang, Xiaoting; Hellstrand, Erik; Frohm, Birgitta; Kirkegaard, Julius B.; Cohen, Samuel I. A.; Dobson, Christopher M.; Linse, Sara; Knowles, Tuomas P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9384-9389</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The two major forms of the amyloid-beta (Aβ) peptide found in plaques in patients suffering from Alzheimer's disease, Aβ40 and Aβ42, only differ by two amino acids in the C-terminal region, yet they display markedly different aggregation behavior.  The origins of these differences have remained challenging to connect to specific mol.-level processes underlying the aggregation reaction.  In this paper we use a general strategy to apply the conventional workflow of chem. kinetics to the aggregation of the Aβ40 peptide to identify the differences between Aβ40 and Aβ42 in terms of the microscopic determinants of the aggregation reaction.  Our results reveal that the major source of aggregates in the case of Aβ40 is a fibril-catalyzed nucleation process, the multistep nature of which is evident through its satn. behavior.  Moreover, our results show that the significant differences in the obsd. behavior of the two proteins originate not simply from a uniform increase in all microscopic rates for Aβ42 compared with Aβ40, but rather are due to a shift of more than one order of magnitude in the relative importance of primary nucleation vs. fibril-catalyzed secondary nucleation processes.  This anal. sheds light on the microscopic determinants of the aggregation behavior of the principal forms of Aβ and outlines a general approach toward achieving an understanding at the mol. level of the aberrant deposition of insol. peptides in neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVUCSJmBA-wbVg90H21EOLACvtfcHk0lhUgCTFaSkXJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVSltrg%253D&md5=227d47c161dae92810a90e94c4467c4c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1401564111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1401564111%26sid%3Dliteratum%253Aachs%26aulast%3DMeisl%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DHellstrand%26aufirst%3DE.%26aulast%3DFrohm%26aufirst%3DB.%26aulast%3DKirkegaard%26aufirst%3DJ.%2BB.%26aulast%3DCohen%26aufirst%3DS.%2BI.%26aulast%3DDobson%26aufirst%3DC.%2BM.%26aulast%3DLinse%26aufirst%3DS.%26aulast%3DKnowles%26aufirst%3DT.%2BP.%26atitle%3DDifferences%2520in%2520nucleation%2520behavior%2520underlie%2520the%2520contrasting%2520aggregation%2520kinetics%2520of%2520the%2520A%25CE%25B240%2520and%2520A%25CE%25B242%2520peptides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2014%26volume%3D111%26spage%3D9384%26epage%3D9389%26doi%3D10.1073%2Fpnas.1401564111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LeVine, H.,  3rd</span></span> <span> </span><span class="NLM_article-title">Thioflavine T interaction with synthetic Alzheimer’s disease beta-amyloid peptides: detection of amyloid aggregation in solution</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1002/pro.5560020312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fpro.5560020312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=8453378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK3sXksVCntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1993&pages=404-410&author=H.+LeVine&title=Thioflavine+T+interaction+with+synthetic+Alzheimer%E2%80%99s+disease+beta-amyloid+peptides%3A+detection+of+amyloid+aggregation+in+solution&doi=10.1002%2Fpro.5560020312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Thioflavin T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution</span></div><div class="casAuthors">LeVine, Harry, III</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">404-10</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    </div><div class="casAbstract">Thioflavine T (ThT) assocs. rapidly with aggregated fibrils of the synthetic β/A4-derived peptides β(1-28) and β(1-40), giving rise to a new excitation (ex) (absorption) max. at 450 nm and enhanced emission (em) at 482 nm, as opposed to the 385 nm (ex) and 445 nm (em) of the free dye.  This change is dependent on the aggregated state as monomeric or dimeric peptides do not react, and guanidine dissocn. of aggregates destroys the signal.  There was no effect of high salt concns.  Binding to the β(1-40) is of lower affinity, Kd 2 μM, while it sats. with a Kd of 0.54 μM for β(1-28).  Insulin fibrils converted to a β-sheet conformation fluoresce intensely with ThT.  A variety of polyhydroxy, polyanionic, or polycationic materials fail to interact or impede interaction with the amyloid peptides.  This fluorometric technique should allow the kinetic elucidation of the amyloid fibril assembly process as well as the testing of agents that might modulate their assembly or disassembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGqSauseHbKrVg90H21EOLACvtfcHk0li9r4GKKg7TkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVCntLo%253D&md5=d4bfff1cedf68a3c9379a87d88c3f97a</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560020312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560020312%26sid%3Dliteratum%253Aachs%26aulast%3DLeVine%26aufirst%3DH.%26atitle%3DThioflavine%2520T%2520interaction%2520with%2520synthetic%2520Alzheimer%25E2%2580%2599s%2520disease%2520beta-amyloid%2520peptides%253A%2520detection%2520of%2520amyloid%2520aggregation%2520in%2520solution%26jtitle%3DProtein%2520Sci.%26date%3D1993%26volume%3D2%26spage%3D404%26epage%3D410%26doi%3D10.1002%2Fpro.5560020312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLachlan, D. R.</span></span> <span> </span><span class="NLM_article-title">Alzheimer Aβ amyloid forms an inhibitory neuronal substrate</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1227</span>– <span class="NLM_lpage">1230</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1994.62031227.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1046%2Fj.1471-4159.1994.62031227.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=8113806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK2cXitFCgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1994&pages=1227-1230&author=P.+E.+Fraserauthor=L.+Levesqueauthor=D.+R.+McLachlan&title=Alzheimer+A%CE%B2+amyloid+forms+an+inhibitory+neuronal+substrate&doi=10.1046%2Fj.1471-4159.1994.62031227.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer Aβ amyloid forms an inhibitory neuronal substrate</span></div><div class="casAuthors">Fraser, P. E.; Levesque, L.; McLachlan, D. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1227-30</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is identified by the accumulation of amyloid plaques, neurofibrillary degeneration, and the accompanying neuronal loss.  AD amyloid assembles into compact fibrous deposits from the amyloid (A) protein, which is a proteolytic fragment of the membrane-assocd. amyloid precursor protein.  To examine the effects of amyloid on neuron growth, a hybrid mouse motoneuron cell line (NSC34) exhibiting spontaneous process formation was exposed to artificial "plaques" created from aggregated synthetic Aβ peptides.  These correspond to full-length Aβ- residues 1-40 (Aβ1-40), an internal β-sheet region comprising residues 11-28 (Aβ-11-28), and a proposed toxic fragment comprising residues 25-35 (Aβ-25-35).  Fibers were immobilized onto culture dishes, and addn. of cells to these in vitro plaques revealed that Aβ was not a permissive substrate for cell adhesion.  Neurites in close contact with these deposits displayed abnormal swelling and a tendency to avoid contact with the Aβ fibers.  In contrast, Aβ did not affect the adhesion or growth of rat astrocytes, implicating a specific Aβ-neuron relationship.  The inhibitory effects were also unique to Aβ-neuron relationship.  The inhibitory effects were also unique to Aβ as no response was obsd. to deposits of pancreatic islet amyloid polypeptide fibers.  Considering the importance of cell adhesion in neurite elongation and axonal guidance, the antiadhesive properties of Aβ amyloid plaques found in vivo may contribute to the neuronal loss responsible for the clin. manifestations of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXSzQBAZskJ7Vg90H21EOLACvtfcHk0li9r4GKKg7TkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitFCgur4%253D&md5=8dbe9629dc5329bb9ba871515dd113a1</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1994.62031227.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1994.62031227.x%26sid%3Dliteratum%253Aachs%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DLevesque%26aufirst%3DL.%26aulast%3DMcLachlan%26aufirst%3DD.%2BR.%26atitle%3DAlzheimer%2520A%25CE%25B2%2520amyloid%2520forms%2520an%2520inhibitory%2520neuronal%2520substrate%26jtitle%3DJ.%2520Neurochem.%26date%3D1994%26volume%3D62%26spage%3D1227%26epage%3D1230%26doi%3D10.1046%2Fj.1471-4159.1994.62031227.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flood, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span> <span> </span><span class="NLM_article-title">An amyloid β protein fragment, Aβ (12-28), equipotently impairs post-training memory processing when injected into different limbic system structures</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>663</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(94)91273-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1016%2F0006-8993%2894%2991273-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=7874511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFygtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=663&publication_year=1994&pages=271-276&author=J.+F.+Floodauthor=J.+E.+Morleyauthor=E.+Roberts&title=An+amyloid+%CE%B2+protein+fragment%2C+A%CE%B2+%2812-28%29%2C+equipotently+impairs+post-training+memory+processing+when+injected+into+different+limbic+system+structures&doi=10.1016%2F0006-8993%2894%2991273-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">An amyloid β-protein fragment, Aβ[12-28], equipotently impairs post-training memory processing when injected into different limbic system structures</span></div><div class="casAuthors">Flood, James F.; Morley, John E.; Roberts, Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">663</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-6</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Previously, amyloid β-protein (Aβ) fragments 1-28, 12-28 and 12-20 were found to impair retention in mice when injected intracerebroventricularly after footshock active avoidance training.  The authors now have measured the dose-dependence of amnestic effects of peptide 12-28 stereotactically injected into amygdala, caudate, hippocampus, mammillary bodies and septum, which limbic structures are known to be involved in memory processing and into the medial thalamus, which largely is involved in sensory processing during training.  Peptide 12-28 impaired retention with remarkably similar efficacy when injected into limbic structures but was not at all amnestic upon thalamic injection.  Present results together with those in the literature lead the authors to suggest that Aβ may exert dysregulatory cognitive effects by incoordination of K+-channel function in neurons, glia and endothelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruiVip1QctKrVg90H21EOLACvtfcHk0lhRzx7VVhPnuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFygtbo%253D&md5=6d4b0ea361d04efd2d701220719f0c61</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2894%2991273-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252894%252991273-4%26sid%3Dliteratum%253Aachs%26aulast%3DFlood%26aufirst%3DJ.%2BF.%26aulast%3DMorley%26aufirst%3DJ.%2BE.%26aulast%3DRoberts%26aufirst%3DE.%26atitle%3DAn%2520amyloid%2520%25CE%25B2%2520protein%2520fragment%252C%2520A%25CE%25B2%2520%252812-28%2529%252C%2520equipotently%2520impairs%2520post-training%2520memory%2520processing%2520when%2520injected%2520into%2520different%2520limbic%2520system%2520structures%26jtitle%3DBrain%2520Res.%26date%3D1994%26volume%3D663%26spage%3D271%26epage%3D276%26doi%3D10.1016%2F0006-8993%2894%2991273-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarvet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, L. E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graslund, A.</span></span> <span> </span><span class="NLM_article-title">Reversible random coil to β-sheet transition and the early stage of aggregation of the Aβ(12–28) fragment from the Alzheimer peptide</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">4261</span>– <span class="NLM_lpage">4268</span>, <span class="refDoi"> DOI: 10.1021/ja991167z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja991167z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFChu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=4261-4268&author=J.+Jarvetauthor=P.+Dambergauthor=K.+Bodellauthor=L.+E.+G.+Erikssonauthor=A.+Graslund&title=Reversible+random+coil+to+%CE%B2-sheet+transition+and+the+early+stage+of+aggregation+of+the+A%CE%B2%2812%E2%80%9328%29+fragment+from+the+Alzheimer+peptide&doi=10.1021%2Fja991167z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible Random Coil to β-Sheet Transition and the Early Stage of Aggregation of the Aβ(12-28) Fragment from the Alzheimer Peptide</span></div><div class="casAuthors">Jarvet, Jueri; Damberg, Peter; Bodell, Karl; Eriksson, L. E. Goeran; Graeslund, Astrid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4261-4268</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Alzheimer peptide fragment Aβ(12-28) was studied at millimolar concn. by parallel expts. with high-resoln. NMR and CD in soln. at a pH close to the isoelec. point of the peptide.  A prepn. procedure using low temp. and low ionic strength buffer gave a sample with stable and reproducible properties.  Reversible changes in secondary structure and state of aggregation were studied by variation of temp.  High-temp. promotes aggregation and β-sheet induction, whereas low-temp. shifts the equil. toward low mol. wt. fractions and less β-sheet like structure.  NMR diffusion expts. show that the dominating, most low mol. wt. fraction is monomeric.  With increasing temp., residues F20A21E22, overlapping with the so-called central hydrophobic segment of the Aβ peptide, exhibit the most pronounced α-proton NMR secondary chem. shift changes from random coil toward more β-sheet like structure.  High ionic strength also promotes aggregation and β-sheet induction.  The combined spectroscopic results, including also mol. wt. estns. by cutoff filters, are summarized in a scheme in which monomeric mostly random coil and heterogeneous aggregated partly β-sheet forms of the peptide are in a temp.-dependent equil., a situation which corresponds to an early stage of the fibrillogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmx4BiYmoYXrVg90H21EOLACvtfcHk0lhRzx7VVhPnuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFChu7g%253D&md5=3f411cd6e20865be3bdf32bb41a5d26d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fja991167z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja991167z%26sid%3Dliteratum%253Aachs%26aulast%3DJarvet%26aufirst%3DJ.%26aulast%3DDamberg%26aufirst%3DP.%26aulast%3DBodell%26aufirst%3DK.%26aulast%3DEriksson%26aufirst%3DL.%2BE.%2BG.%26aulast%3DGraslund%26aufirst%3DA.%26atitle%3DReversible%2520random%2520coil%2520to%2520%25CE%25B2-sheet%2520transition%2520and%2520the%2520early%2520stage%2520of%2520aggregation%2520of%2520the%2520A%25CE%25B2%252812%25E2%2580%259328%2529%2520fragment%2520from%2520the%2520Alzheimer%2520peptide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D4261%26epage%3D4268%26doi%3D10.1021%2Fja991167z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Razavi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palaninathan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamedmohaideen, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deechongkit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dendle, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span> <span> </span><span class="NLM_article-title">Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">2758</span>– <span class="NLM_lpage">2761</span>, <span class="refDoi"> DOI: 10.1002/anie.200351179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=10.1002%2Fanie.200351179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlCjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2758-2761&author=H.+Razaviauthor=S.+K.+Palaninathanauthor=E.+T.+Powersauthor=R.+L.+Wisemanauthor=H.+E.+Purkeyauthor=N.+N.+Mohamedmohaideenauthor=S.+Deechongkitauthor=K.+P.+Chiangauthor=M.+T.+Dendleauthor=J.+C.+Sacchettiniauthor=J.+W.+Kelly&title=Benzoxazoles+as+transthyretin+amyloid+fibril+inhibitors%3A+synthesis%2C+evaluation%2C+and+mechanism+of+action&doi=10.1002%2Fanie.200351179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazoles as transthyretin amyloid fibril inhibitors: Synthesis, evaluation, and mechanism of action</span></div><div class="casAuthors">Razavi, Hossein; Palaninathan, Satheesh K.; Powers, Evan T.; Wiseman, R. Luke; Purkey, Hans E.; Mohamedmohaideen, Nilofar N.; Deechongkit, Songpon; Chiang, Kyle P.; Dendle, Maria T. A.; Sacchettini, James C.; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2758-2761</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Benzoxazoles prevent misfolding: Benzoxazole-based inhibitors of transthyretin (TTR) amyloid fibril formation are among the most effective found to date.  They stabilize TTR against both acid-mediated misfolding and urea denaturation by raising the activation barrier to tetramer dissocn., the rate-limiting step for amyloid formation.  The figure depicts the co-crystal structure of one of the better benzoxazole inhibitors bound to TTR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN6V6zDEc-irVg90H21EOLACvtfcHk0lh7czTTleN5hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlCjtb0%253D&md5=0d83f0e2ee80978801d7f51c250ee88a</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351179%26sid%3Dliteratum%253Aachs%26aulast%3DRazavi%26aufirst%3DH.%26aulast%3DPalaninathan%26aufirst%3DS.%2BK.%26aulast%3DPowers%26aufirst%3DE.%2BT.%26aulast%3DWiseman%26aufirst%3DR.%2BL.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DMohamedmohaideen%26aufirst%3DN.%2BN.%26aulast%3DDeechongkit%26aufirst%3DS.%26aulast%3DChiang%26aufirst%3DK.%2BP.%26aulast%3DDendle%26aufirst%3DM.%2BT.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DBenzoxazoles%2520as%2520transthyretin%2520amyloid%2520fibril%2520inhibitors%253A%2520synthesis%252C%2520evaluation%252C%2520and%2520mechanism%2520of%2520action%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D2758%26epage%3D2761%26doi%3D10.1002%2Fanie.200351179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolado, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsequell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A.</span></span> <span> </span><span class="NLM_article-title">Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1021/cc049849s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc049849s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Olsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=246-252&author=I.+Doladoauthor=J.+Nietoauthor=M.+J.+M.+Saraivaauthor=G.+Arsequellauthor=G.+Valenciaauthor=A.+Planas&title=Kinetic+assay+for+high-throughput+screening+of+in+vitro+transthyretin+amyloid+fibrillogenesis+inhibitors&doi=10.1021%2Fcc049849s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic Assay for High-Throughput Screening of In Vitro Transthyretin Amyloid Fibrillogenesis Inhibitors</span></div><div class="casAuthors">Dolado, Ignacio; Nieto, Joan; Saraiva, Maria Joao M.; Arsequell, Gemma; Valencia, Gregori; Planas, Antoni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-252</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stabilization of tetrameric transthyretin (TTR) by binding of small ligands is a current strategy aimed at inhibiting amyloid fibrillogenesis in transthyretin-assocd. pathologies, such as senile systemic amyloidosis (SSA) and familial amyloidotic polyneuropathy (FAP).  A kinetic assay is developed for rapid evaluation of compds. as potential in vitro inhibitors in a high-throughput screening format.  It is based on monitoring the time-dependent increase of absorbance due to turbidity occurring by acid-induced protein aggregation.  The method uses the highly amyloidogenic Y78F mutant of human transthyretin (heterologously expressed in Escherichia coli cells).  Initial rates of protein aggregation at different inhibitor concns. follow a monoexponential dose-response curve from which inhibition parameters are calcd.  For the assay development, thyroid hormones and nonsteroidal anti-inflammatory drugs were chosen among other ref. compds.  Some of them are already known to be in vitro inhibitors of TTR amyloidogenesis.  Anal. time is optimized to last 1.5 h, and the method is implemented in microtiter plates for screening of libraries of potential fibrillogenesis inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplJThxssB3ErVg90H21EOLACvtfcHk0lh7czTTleN5hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Olsrs%253D&md5=dbb3a5b90bb9e98548354cf82b9f89e9</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fcc049849s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc049849s%26sid%3Dliteratum%253Aachs%26aulast%3DDolado%26aufirst%3DI.%26aulast%3DNieto%26aufirst%3DJ.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%2BM.%26aulast%3DArsequell%26aufirst%3DG.%26aulast%3DValencia%26aufirst%3DG.%26aulast%3DPlanas%26aufirst%3DA.%26atitle%3DKinetic%2520assay%2520for%2520high-throughput%2520screening%2520of%2520in%2520vitro%2520transthyretin%2520amyloid%2520fibrillogenesis%2520inhibitors%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2005%26volume%3D7%26spage%3D246%26epage%3D252%26doi%3D10.1021%2Fcc049849s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i24"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01970">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_17085"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01970?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01970</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Recombinant wild-type human (wt rhTTR) production and purification and MALDI-TOF MS; turbidity assays of the binary and ternary assay complex formation using Aβ(1–42); synthesis of Aβ(12–28) (<b>7</b>) and three Ala mutants (<b>8</b>, <b>9</b>, and <b>10</b>); additional isothermal titration calorimetry (ITC) studies (binary and ternary interactions and control experiments) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of key compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_001.pdf">jm9b01970_si_001.pdf (2.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01970/suppl_file/jm9b01970_si_002.csv">jm9b01970_si_002.csv (5.59 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01970&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01970%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-6" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01970" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799562e7f0b3d18","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
